data_2fhm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fhm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.416 0.151 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mp -134.19 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.596 1.159 . . . . 0.0 111.051 -160.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.32 154.08 42.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.46 1.904 . . . . 0.0 107.401 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.7 164.62 15.09 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.453 0.701 . . . . 0.0 110.51 165.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -125.67 140.83 52.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 147.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.52 142.98 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 137.49 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.87 149.79 23.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.202 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -138.96 155.71 47.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.572 1.549 . . . . 0.0 107.807 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.71 -156.35 25.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -79.75 65.98 5.08 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 163.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 27.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.133 0.973 . . . . 0.0 111.076 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.366 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.66 -45.48 75.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.941 0.791 . . . . 0.0 109.931 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.32 -50.29 65.28 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.2 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.4 -38.92 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.463 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -71.67 -22.58 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 113.078 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.1 mtm -64.32 -46.75 82.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.637 1.108 . . . . 0.0 108.826 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.79 -31.33 72.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.54 -54.79 41.16 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.988 0.915 . . . . 0.0 109.675 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.15 -40.49 96.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.957 0.503 . . . . 0.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -55.21 -28.7 54.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.122 . . . . 0.0 111.887 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -118.59 20.71 12.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.697 0.799 . . . . 0.0 111.617 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 41.59 42.14 1.91 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.771 2.428 . . . . 0.0 113.67 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.47 163.67 27.64 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.08 130.76 17.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.74 -162.52 34.17 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.029 -168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -130.86 161.7 31.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.047 . . . . 0.0 112.168 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.43 148.12 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.948 1.299 . . . . 0.0 109.22 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.99 156.75 43.0 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.243 1.817 . . . . 0.0 108.143 -170.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -115.54 121.48 42.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.18 151.26 36.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.487 1.115 . . . . 0.0 109.177 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.14 -28.7 69.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.976 0.51 . . . . 0.0 111.382 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -7.63 48.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.153 0.981 . . . . 0.0 113.259 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.81 -19.57 32.92 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.03 1.3 . . . . 0.0 113.265 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.33 163.66 22.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.918 1.359 . . . . 0.0 110.435 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.89 149.77 5.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 158.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -135.23 144.91 47.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -141.33 144.78 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.85 130.1 13.69 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.07 154.51 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.102 0.864 . . . . 0.0 111.07 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.24 157.16 16.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.927 1.291 . . . . 0.0 109.838 168.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 178.49 40.31 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.715 0.674 . . . . 0.0 112.577 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.49 155.69 40.72 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.311 2.008 . . . . 0.0 110.174 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.27 -47.54 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 111.432 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.06 -39.62 93.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.941 0.337 . . . . 0.0 111.248 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.95 -46.66 77.33 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.02 0.373 . . . . 0.0 110.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.12 -43.19 99.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.687 0.795 . . . . 0.0 110.509 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -71.83 -38.7 70.12 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.757 -0.589 . . . . 0.0 111.918 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.4 m -62.57 -39.56 94.06 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.664 -0.648 . . . . 0.0 110.075 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -60.75 -46.95 88.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.695 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.76 -44.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 119.861 1.21 . . . . 0.0 109.486 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -62.16 -42.04 98.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.972 0.805 . . . . 0.0 111.408 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.39 87.87 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.025 0.93 . . . . 0.0 111.901 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.76 -54.74 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.26 -38.67 80.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.403 1.081 . . . . 0.0 112.062 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.31 -26.23 68.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.135 0.574 . . . . 0.0 111.69 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.34 47.28 91.63 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -53.08 -39.63 72.39 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.901 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -66.23 -174.81 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.806 3.004 . . . . 0.0 114.841 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -63.42 -37.03 85.71 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.319 1.048 . . . . 0.0 111.045 164.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.1 m -70.06 137.98 51.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.377 1.071 . . . . 0.0 108.244 165.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 150.7 35.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.415 0.552 . . . . 0.0 111.049 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.08 151.38 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.152 1.381 . . . . 0.0 107.998 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -128.45 -11.55 5.07 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.099 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -151.56 140.57 21.11 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.652 1.181 . . . . 0.0 108.957 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.1 tt -140.98 149.08 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.793 1.237 . . . . 0.0 108.746 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 m -139.13 144.88 38.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.04 143.0 34.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.6 m -130.04 150.84 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 153.44 50.88 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.529 0.731 . . . . 0.0 110.415 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.6 m -151.53 173.77 14.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.498 1.519 . . . . 0.0 109.208 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 1.33 24.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.901 1.28 . . . . 0.0 110.988 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -72.69 75.73 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.74 2.016 . . . . 0.0 111.839 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.67 153.76 9.99 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.58 -0.7 . . . . 0.0 110.41 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.99 -26.29 7.36 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.781 1.232 . . . . 0.0 110.671 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.11 24.22 59.92 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -163.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 139.78 49.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.685 1.243 . . . . 0.0 108.332 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -134.41 14.58 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.082 . . . . 0.0 111.705 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.2 171.94 15.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.444 1.497 . . . . 0.0 109.111 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -98.33 153.59 18.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -140.38 154.15 46.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 110.075 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.74 111.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.237 0.421 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.46 178.53 7.53 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.979 -1.076 . . . . 0.0 110.062 -167.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -152.91 158.48 42.19 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.988 1.715 . . . . 0.0 108.549 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.37 165.99 16.09 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.991 0.916 . . . . 0.0 110.465 168.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -131.03 135.82 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 151.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.27 145.43 33.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.92 138.8 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 170.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.53 146.27 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.136 0.975 . . . . 0.0 109.938 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.87 157.17 46.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 108.805 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.05 25.11 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -81.4 92.61 6.46 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 160.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.77 10.42 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.487 1.515 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 . . . . . 0 N--CA 1.465 0.287 0 O-C-N 120.917 -1.114 . . . . 0.0 110.663 -178.66 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.54 -35.43 80.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.414 1.007 . . . . 0.0 110.608 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -50.22 66.22 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.732 1.151 . . . . 0.0 110.728 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.8 -33.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.218 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -74.11 -25.31 59.71 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.854 1.207 . . . . 0.0 112.278 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -62.83 -47.56 82.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.902 0.773 . . . . 0.0 109.139 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -66.67 -29.66 69.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.613 0.365 . . . . 0.0 110.835 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.866 1.266 . . . . 0.0 109.975 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.27 -39.75 91.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.947 0.499 . . . . 0.0 111.197 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.29 -18.77 51.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.634 1.173 . . . . 0.0 112.545 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -114.59 15.17 17.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.012 1.278 . . . . 0.0 111.389 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.87 33.17 2.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.29 1.836 . . . . 0.0 112.724 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.97 161.96 29.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.18 134.82 42.56 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.2 -172.93 42.98 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 118.182 0.446 . . . . 0.0 112.107 -164.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -135.09 162.39 32.61 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.521 0.729 . . . . 0.0 112.124 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.83 149.76 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.562 1.145 . . . . 0.0 108.84 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.42 156.02 42.49 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.51 1.924 . . . . 0.0 107.585 -170.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.32 122.57 45.3 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -76.88 159.73 29.79 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.135 0.974 . . . . 0.0 110.337 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -61.19 -30.17 70.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.246 0.618 . . . . 0.0 111.458 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -10.19 57.96 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.98 -23.84 24.6 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.527 1.536 . . . . 0.0 112.204 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -87.81 166.09 14.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.229 1.514 . . . . 0.0 110.469 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.9 150.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -133.51 143.41 48.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.89 1.276 . . . . 0.0 107.667 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.05 142.71 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.64 123.55 10.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.26 162.98 40.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.413 0.552 . . . . 0.0 110.818 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.61 151.75 32.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 109.871 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.54 177.92 40.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.23 1.395 . . . . 0.0 110.351 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 154.45 67.79 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.353 2.035 . . . . 0.0 110.086 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.0 -42.42 76.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.558 0.743 . . . . 0.0 111.577 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.02 -41.19 99.49 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.148 -0.345 . . . . 0.0 111.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.48 84.19 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.988 0.515 . . . . 0.0 109.987 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.92 -43.34 99.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.565 0.746 . . . . 0.0 110.699 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -70.48 -40.9 73.34 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.636 -0.665 . . . . 0.0 111.697 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.5 m -59.8 -39.9 86.54 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.059 -0.401 . . . . 0.0 110.019 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -61.87 -47.43 85.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.952 173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -53.99 -46.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.078 1.308 . . . . 0.0 109.593 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -61.78 -39.99 93.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.001 0.364 . . . . 0.0 111.039 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.75 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.282 0.633 . . . . 0.0 111.899 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.73 -49.44 80.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -57.86 -41.64 82.86 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.036 0.534 . . . . 0.0 110.826 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -72.12 -20.78 61.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.125 0.97 . . . . 0.0 112.451 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 40.81 92.67 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.365 0.984 . . . . 0.0 111.832 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 m -46.47 -54.33 19.15 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -160.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.36 -52.28 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 121.797 1.678 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -167.82 158.43 10.82 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.253 2.221 . . . . 0.0 107.412 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 p 129.48 176.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 131.713 4.005 . . . . 0.0 108.717 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.77 157.74 43.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 145.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.21 137.65 56.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -126.39 -5.69 6.53 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.233 1.413 . . . . 0.0 110.788 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.17 134.12 13.97 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.363 1.865 . . . . 0.0 106.405 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.42 138.42 21.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.0 m -140.58 147.82 40.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.92 143.63 28.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.1 m -130.19 152.44 49.62 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -129.2 145.07 51.4 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.4 m -143.61 167.65 21.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.902 1.281 . . . . 0.0 109.582 -160.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.73 1.89 10.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 110.971 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.6 m -65.91 -26.17 67.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.145 0.978 . . . . 0.0 112.709 -173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.5 mt 60.82 175.76 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.381 1.872 . . . . 0.0 111.414 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.8 -16.52 0.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.023 0.929 . . . . 0.0 113.046 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.8 90.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.221 -1.322 . . . . 0.0 116.198 155.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -81.83 178.41 8.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.039 1.919 . . . . 0.0 109.929 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -130.16 17.24 5.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.554 1.541 . . . . 0.0 110.718 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -149.38 167.54 25.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.551 1.541 . . . . 0.0 109.292 -172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -86.04 151.63 23.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 163.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -142.95 162.34 35.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.838 0.855 . . . . 0.0 110.53 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.59 114.82 18.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.095 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.205 -0.426 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.13 177.42 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.882 1.219 . . . . 0.0 111.248 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -146.79 155.22 42.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.675 2.39 . . . . 0.0 108.081 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.44 165.18 14.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.99 0.916 . . . . 0.0 110.426 169.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -131.06 133.78 46.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 154.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.45 141.63 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.68 128.73 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.16 137.59 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.67 1.188 . . . . 0.0 109.83 -164.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -131.44 150.83 52.0 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.655 1.182 . . . . 0.0 108.393 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -152.65 24.74 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.55 78.88 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 164.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.71 4.17 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.651 0.78 . . . . 0.0 111.892 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.235 0.322 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.281 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -72.33 -45.42 60.01 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.897 1.226 . . . . 0.0 108.97 163.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -48.68 64.12 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.964 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 m -62.12 -37.1 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 119.802 1.183 . . . . 0.0 110.791 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -73.53 -23.18 59.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.5 1.5 . . . . 0.0 112.273 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.4 mtm -62.94 -47.07 84.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.262 0.937 . . . . 0.0 109.34 165.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -66.65 -32.6 74.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.494 . . . . 0.0 110.804 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.51 72.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.585 1.154 . . . . 0.0 109.583 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.34 -42.07 99.09 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 111.235 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.01 -21.49 45.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.635 1.174 . . . . 0.0 112.255 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 16.22 12.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.995 -1.066 . . . . 0.0 111.947 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? 45.69 38.57 4.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.869 2.067 . . . . 0.0 112.31 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.5 mt -75.66 164.23 26.51 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.73 130.98 22.07 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.71 -162.07 33.63 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.39 163.63 30.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.626 0.713 . . . . 0.0 111.994 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.42 142.53 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.058 0.943 . . . . 0.0 109.732 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -149.21 151.86 35.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 125.3 1.44 . . . . 0.0 108.248 -162.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 120.07 29.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 166.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -74.21 153.24 39.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.96 -25.52 67.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.884 0.874 . . . . 0.0 112.341 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.54 -27.64 67.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.382 1.073 . . . . 0.0 112.104 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.21 -31.78 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.318 1.437 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -68.32 163.67 22.49 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.732 0.766 . . . . 0.0 110.54 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.35 156.53 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -134.05 141.53 47.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.658 1.583 . . . . 0.0 107.881 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -134.03 141.01 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -149.91 119.41 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.2 160.23 42.78 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.488 0.715 . . . . 0.0 111.205 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.83 154.93 20.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.179 1.392 . . . . 0.0 110.313 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 175.61 37.63 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.057 1.313 . . . . 0.0 111.001 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.89 153.43 68.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.146 1.897 . . . . 0.0 110.261 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -55.33 -43.32 74.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.653 0.781 . . . . 0.0 111.533 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -62.69 -40.43 97.1 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.245 -0.284 . . . . 0.0 111.459 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.64 74.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.14 -44.87 92.08 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.45 0.7 . . . . 0.0 110.023 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -68.87 -40.51 79.25 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.88 -0.512 . . . . 0.0 111.955 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -60.67 -42.68 97.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.567 0.621 . . . . 0.0 110.063 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -59.53 -48.97 79.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.432 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.72 -42.92 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.953 1.251 . . . . 0.0 110.0 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.17 -41.89 99.3 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.871 0.76 . . . . 0.0 110.743 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.82 96.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.657 0.783 . . . . 0.0 111.366 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.1 -52.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -56.75 -41.63 77.89 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.81 0.844 . . . . 0.0 111.046 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -72.75 -20.96 61.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.018 -0.515 . . . . 0.0 112.365 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.73 40.42 48.72 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.436 1.017 . . . . 0.0 111.906 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -45.63 -53.94 17.58 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -157.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -49.65 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 CA-C-N 121.481 1.565 . . . . 0.0 112.216 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 67' ' ' SER . 17.5 p90 -167.48 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.012 0.925 . . . . 0.0 112.718 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.403 ' HA ' ' CD1' ' A' ' 66' ' ' PHE 0.269 1.4 m -62.63 -57.32 11.49 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -120.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 161.63 40.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 130.277 3.431 . . . . 0.0 108.511 -5.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.54 157.18 7.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.318 0.647 . . . . 0.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.2 p -127.21 -11.88 5.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.22 1.408 . . . . 0.0 110.378 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.22 144.83 25.87 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.926 1.291 . . . . 0.0 108.471 172.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.28 144.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.0 108.217 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 m -139.46 145.29 38.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.337 1.455 . . . . 0.0 107.219 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.07 142.69 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.375 1.07 . . . . 0.0 108.281 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -132.45 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.396 1.878 . . . . 0.0 106.048 168.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -137.99 149.04 45.75 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 m -148.76 162.83 38.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.375 1.47 . . . . 0.0 109.114 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.11 -13.24 57.55 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.602 -0.686 . . . . 0.0 111.362 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 88.83 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 111.899 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.84 147.58 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.531 0.732 . . . . 0.0 110.26 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -81.95 -28.2 32.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.892 0.877 . . . . 0.0 112.026 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.98 68.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.038 0.828 . . . . 0.0 111.219 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.67 150.17 34.58 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.808 1.304 . . . . 0.0 109.378 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -134.76 9.37 3.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.958 0.903 . . . . 0.0 112.547 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -149.26 177.55 9.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.149 1.38 . . . . 0.0 109.158 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -101.79 145.02 29.74 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 163.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 161.81 37.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.628 0.728 . . . . 0.0 111.431 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.1 mt -133.88 126.86 51.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 109.656 -163.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp -129.29 176.03 8.26 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.686 -1.259 . . . . 0.0 111.18 -165.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.55 152.8 38.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.844 1.658 . . . . 0.0 109.183 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.68 165.22 18.98 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.387 1.075 . . . . 0.0 111.054 169.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -134.28 133.41 40.73 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 158.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.41 142.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.54 133.26 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.65 141.92 29.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.71 151.77 49.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.888 1.275 . . . . 0.0 108.054 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.61 -153.75 25.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -76.72 82.45 3.34 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 158.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -107.59 -1.63 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.496 HE22 ' HB3' ' A' ' 18' ' ' ARG . 9.9 mm-40 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.7 ptt-85 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -69.08 -23.56 64.04 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 117.608 -1.186 . . . . 0.0 111.125 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.04 -52.14 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.283 1.402 . . . . 0.0 111.736 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.51 -31.83 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.716 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -66.51 -31.14 71.69 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.872 1.214 . . . . 0.0 112.288 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.7 mtm -65.76 -49.94 66.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.456 1.026 . . . . 0.0 108.637 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -67.8 -33.12 74.19 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.205 0.457 . . . . 0.0 110.875 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -53.21 57.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.482 1.113 . . . . 0.0 110.336 173.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.13 -40.05 93.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.561 0.745 . . . . 0.0 111.288 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -53.52 -28.14 29.61 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.165 1.386 . . . . 0.0 111.817 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -118.58 22.8 11.86 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.567 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 tttt 50.21 36.18 11.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.506 1.922 . . . . 0.0 113.089 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.69 163.6 27.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.23 126.18 21.02 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.1 -161.86 29.72 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.926 0.785 . . . . 0.0 113.148 -168.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -135.06 166.09 23.87 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.79 144.0 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.754 1.221 . . . . 0.0 108.818 162.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.0 161.74 40.19 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.818 0.847 . . . . 0.0 110.34 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.76 148.06 38.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 158.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -126.08 140.29 52.71 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.929 1.291 . . . . 0.0 107.785 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.11 -24.78 63.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.402 1.481 . . . . 0.0 114.318 -163.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.0 -23.03 65.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.188 0.595 . . . . 0.0 112.301 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 37.16 1.39 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.753 1.168 . . . . 0.0 111.123 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -145.81 163.88 33.65 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.358 1.063 . . . . 0.0 109.144 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.26 150.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.26 143.17 51.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.405 1.882 . . . . 0.0 107.259 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -137.6 139.32 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -150.04 126.58 10.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.11 161.96 39.42 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 119.049 0.84 . . . . 0.0 111.374 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.99 154.3 23.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.177 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.39 177.29 39.9 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.312 0.958 . . . . 0.0 111.53 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.28 157.59 53.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.771 2.314 . . . . 0.0 110.757 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -55.37 -53.29 58.09 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.526 0.731 . . . . 0.0 111.511 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -59.98 -37.49 79.81 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.967 -0.458 . . . . 0.0 111.527 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.36 76.25 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.28 -47.13 85.69 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.467 0.707 . . . . 0.0 110.534 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -68.53 -42.09 78.96 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.888 -0.508 . . . . 0.0 111.339 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 m -63.37 -37.74 88.46 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.765 -0.584 . . . . 0.0 110.204 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.6 -45.54 93.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.448 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t -55.23 -45.61 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 120.013 1.279 . . . . 0.0 109.535 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.4 -41.01 88.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.043 0.383 . . . . 0.0 111.031 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.79 95.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.14 0.976 . . . . 0.0 111.631 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.55 -50.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.179 0.9 . . . . 0.0 108.668 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -58.77 -41.63 87.07 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.703 0.401 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -71.41 -22.14 61.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.073 0.549 . . . . 0.0 112.393 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.1 39.12 40.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.944 1.259 . . . . 0.0 112.756 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -41.11 -50.05 8.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -159.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.81 -31.49 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.649 1.625 . . . . 0.0 114.704 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -164.26 -31.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.083 1.31 . . . . 0.0 113.264 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.03 170.87 13.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.799 1.64 . . . . 0.0 111.723 -170.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.13 145.03 19.15 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -83.92 153.23 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.6 p -118.25 -14.17 9.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.065 1.346 . . . . 0.0 109.376 165.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.64 137.89 21.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.328 1.451 . . . . 0.0 107.68 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tt -144.61 136.49 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 m -133.77 142.69 48.03 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.84 141.48 40.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.27 146.2 51.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 171.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.55 154.72 46.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.809 0.731 . . . . 0.0 110.102 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -147.89 176.72 9.92 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.878 1.671 . . . . 0.0 108.245 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -119.46 -7.16 10.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.719 0.808 . . . . 0.0 110.191 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m -70.22 100.54 1.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.623 1.169 . . . . 0.0 108.851 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.3 155.26 9.2 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.97 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.6 -27.74 51.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.668 0.787 . . . . 0.0 110.967 170.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.38 30.62 58.27 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -161.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.11 155.09 35.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.116 0.958 . . . . 0.0 110.202 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.39 14.57 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.345 1.058 . . . . 0.0 111.291 -173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -149.34 172.49 14.83 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.846 1.658 . . . . 0.0 108.644 -170.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -133.42 119.97 20.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 160.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -136.93 156.78 48.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -153.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.45 124.84 64.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 C--O 1.237 0.42 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.234 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.87 177.85 8.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.613 1.097 . . . . 0.0 110.513 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.84 153.49 32.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.411 1.884 . . . . 0.0 108.968 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -114.18 163.42 15.25 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.81 0.844 . . . . 0.0 109.785 166.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -131.41 138.23 49.0 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 151.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.02 145.64 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -169.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.44 139.28 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 167.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.47 151.1 29.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.47 152.82 49.95 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.63 1.572 . . . . 0.0 107.147 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.76 -155.46 26.55 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -78.51 60.28 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 162.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -85.73 18.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.287 -0.883 . . . . 0.0 111.713 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 167.032 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -76.32 -32.51 58.76 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.454 1.479 . . . . 0.0 111.493 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.97 -45.93 75.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.073 1.306 . . . . 0.0 109.967 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.74 -47.96 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.099 0.959 . . . . 0.0 109.285 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -70.05 -25.7 63.68 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.306 1.412 . . . . 0.0 113.45 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.1 mtm -65.5 -48.05 73.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.2 1.364 . . . . 0.0 109.097 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -66.67 -35.06 79.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.307 0.643 . . . . 0.0 110.048 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.31 47.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.555 1.142 . . . . 0.0 109.791 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.08 -39.6 92.98 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.284 0.634 . . . . 0.0 111.406 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -16.09 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 0.0 112.576 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.53 17.57 16.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.304 1.442 . . . . 0.0 110.915 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 49.39 30.36 3.26 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.12 1.768 . . . . 0.0 112.911 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 mt -77.31 160.09 29.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.24 134.86 18.63 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.959 0.504 . . . . 0.0 110.584 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.57 -161.06 31.09 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.086 1.326 . . . . 0.0 110.545 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -106.09 162.29 13.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.226 1.513 . . . . 0.0 113.298 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.14 146.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.697 1.199 . . . . 0.0 108.001 163.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -154.13 155.37 35.24 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 108.958 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -99.72 123.74 44.28 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 161.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -80.3 147.3 31.2 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.04 -27.8 65.83 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.491 0.716 . . . . 0.0 112.25 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.61 -27.44 68.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.338 1.055 . . . . 0.0 112.81 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.06 -21.74 5.48 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.9 1.238 . . . . 0.0 112.322 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.38 157.0 11.77 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.056 0.928 . . . . 0.0 110.753 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -96.6 146.68 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 149.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.54 144.57 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.907 1.683 . . . . 0.0 106.812 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.54 142.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -148.32 123.02 9.88 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.84 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.293 0.951 . . . . 0.0 111.255 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.87 155.43 16.78 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.228 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 177.18 41.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.412 1.482 . . . . 0.0 111.077 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.88 159.78 49.56 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.725 2.283 . . . . 0.0 110.321 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 -48.14 78.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.232 0.613 . . . . 0.0 111.602 -168.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.79 -37.45 86.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.666 0.386 . . . . 0.0 111.852 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -46.3 87.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.53 -45.11 92.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.108 0.563 . . . . 0.0 109.556 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.49 -44.83 85.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.769 0.713 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.7 m -60.98 -42.31 98.12 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.849 0.46 . . . . 0.0 109.99 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.54 -48.08 83.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.062 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.0 t -56.96 -41.27 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.913 1.233 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.75 -41.93 99.44 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.692 0.678 . . . . 0.0 110.851 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.0 86.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.676 0.79 . . . . 0.0 111.756 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.01 -55.48 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.25 -38.47 83.56 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.709 0.804 . . . . 0.0 111.263 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.55 -24.75 67.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.47 0.708 . . . . 0.0 112.154 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.2 97.83 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 m -49.72 -45.87 79.52 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.83 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.728 1.653 . . . . 0.0 112.299 -166.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.2 t80 179.51 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.31 2.244 . . . . 0.0 106.094 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -58.85 141.23 53.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 157.1 40.03 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.971 0.909 . . . . 0.0 110.325 -171.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.96 157.08 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -119.77 -13.91 9.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.004 1.321 . . . . 0.0 109.708 158.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 141.22 25.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.87 1.268 . . . . 0.0 108.547 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.63 135.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.4 m -132.36 140.77 48.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.249 1.419 . . . . 0.0 107.206 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.7 t -140.19 145.53 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -168.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.0 m -127.79 140.72 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 161.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.92 134.34 23.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m -139.1 155.71 47.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.054 0.941 . . . . 0.0 109.983 -162.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -4.85 57.22 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.55 0.74 . . . . 0.0 110.877 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 m -58.57 165.6 2.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.617 1.167 . . . . 0.0 110.361 161.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.3 162.92 40.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.239 1.816 . . . . 0.0 108.173 167.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -79.42 -29.67 42.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.317 0.647 . . . . 0.0 111.823 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.92 54.06 6.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -162.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -51.11 153.63 1.85 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.595 1.158 . . . . 0.0 113.319 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -135.95 -3.88 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.866 1.266 . . . . 0.0 111.715 166.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -156.96 172.06 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.52 1.528 . . . . 0.0 109.158 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.92 140.65 38.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 162.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -148.68 153.92 38.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.813 0.816 . . . . 0.0 112.834 -150.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.46 115.63 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.237 0.398 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 164.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.3 177.03 11.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.499 -0.751 . . . . 0.0 112.773 -161.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -148.48 154.36 39.73 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.609 2.364 . . . . 0.0 108.216 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.07 165.86 17.43 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.551 0.74 . . . . 0.0 110.437 161.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -133.61 141.59 47.72 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 157.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mt -137.45 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.42 140.26 48.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 143.66 21.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.488 0.715 . . . . 0.0 109.702 -166.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -144.11 153.47 42.19 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.972 1.309 . . . . 0.0 108.347 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.74 -157.65 27.43 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 107.524 -2.231 . . . . 0.0 107.524 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -78.22 75.86 4.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 158.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.06 25.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 164.762 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -64.47 -45.31 87.91 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -55.69 -50.03 71.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.623 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.24 -36.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.592 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -74.97 -19.4 60.12 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.642 -1.286 . . . . 0.0 113.069 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -65.22 -48.93 71.65 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.965 1.257 . . . . 0.0 108.708 164.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -65.7 -22.85 66.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 111.383 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.16 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.028 0.931 . . . . 0.0 109.261 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.64 -37.76 71.2 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.502 1.121 . . . . 0.0 111.468 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -49.53 -38.41 30.63 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.882 1.673 . . . . 0.0 112.406 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -112.71 16.78 19.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.24 1.416 . . . . 0.0 111.468 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.77 5.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.636 1.574 . . . . 0.0 112.079 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.5 155.71 40.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.4 133.97 30.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.89 -171.33 42.85 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.937 -166.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -117.06 161.46 19.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.977 0.889 . . . . 0.0 111.541 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.72 142.71 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 158.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -144.37 157.7 44.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.486 1.515 . . . . 0.0 108.357 -164.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -118.06 121.23 40.05 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -75.58 154.28 36.84 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.12 -28.14 67.62 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 0.0 110.759 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.8 -16.1 37.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.787 2.035 . . . . 0.0 113.38 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -37.63 3.72 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.116 1.341 . . . . 0.0 111.525 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.61 150.85 11.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.149 0.979 . . . . 0.0 110.321 171.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.36 157.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 162.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.99 147.48 40.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -138.4 139.69 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -150.29 124.04 9.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.82 162.2 40.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 119.248 0.931 . . . . 0.0 110.896 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.94 156.87 24.23 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.611 1.564 . . . . 0.0 109.714 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.36 40.51 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.828 0.728 . . . . 0.0 111.596 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.22 151.82 49.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.024 1.816 . . . . 0.0 110.477 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.53 -48.57 78.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.387 1.075 . . . . 0.0 111.29 -170.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -64.53 -40.31 95.38 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.262 -0.273 . . . . 0.0 111.339 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 -48.56 75.76 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.78 -43.78 98.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.173 0.589 . . . . 0.0 110.458 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.86 -35.45 76.92 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.482 -0.761 . . . . 0.0 111.299 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 m -62.85 -41.18 99.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.644 -0.66 . . . . 0.0 110.703 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -58.8 -46.91 86.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.243 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.28 -41.92 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.866 1.212 . . . . 0.0 109.521 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.37 -41.18 98.42 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.19 88.86 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.688 0.795 . . . . 0.0 111.748 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.12 -53.24 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.6 -37.93 76.88 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.355 1.062 . . . . 0.0 111.808 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.27 -24.12 67.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.18 0.592 . . . . 0.0 112.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.58 40.13 98.31 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 m -52.82 -44.73 96.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.7 -164.44 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.472 2.115 . . . . 0.0 112.302 -166.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -1.47 0.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.504 2.722 . . . . 0.0 115.616 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.9 m -141.85 148.09 38.24 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.889 2.076 . . . . 0.0 106.304 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.4 154.49 35.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.983 0.811 . . . . 0.0 111.434 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.62 155.62 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.259 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -121.4 -11.75 8.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.187 1.395 . . . . 0.0 109.595 162.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.13 143.04 25.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.283 1.433 . . . . 0.0 108.383 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -148.71 140.42 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -138.33 134.89 34.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.11 144.87 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.702 0.801 . . . . 0.0 109.824 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.1 m -134.43 149.94 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.422 1.889 . . . . 0.0 106.093 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.15 154.45 51.2 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.9 m -155.93 146.5 21.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -71.4 -29.21 64.66 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.538 -0.727 . . . . 0.0 110.95 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.77 121.45 12.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.731 1.212 . . . . 0.0 111.653 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.09 164.17 13.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.47 0.708 . . . . 0.0 109.342 163.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.14 -13.78 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.6 -11.66 7.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.551 158.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.54 145.96 31.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.243 2.021 . . . . 0.0 111.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -132.37 7.65 4.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.891 1.276 . . . . 0.0 111.118 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.11 164.1 35.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.808 1.643 . . . . 0.0 108.564 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -84.15 144.29 29.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 164.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -143.2 157.78 44.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.674 0.79 . . . . 0.0 110.545 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.7 mt -135.5 135.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.418 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.43 176.84 6.23 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.092 -1.005 . . . . 0.0 111.115 -163.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -140.92 152.92 45.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.52 1.928 . . . . 0.0 108.498 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.58 162.13 16.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 162.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -137.98 125.77 22.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 165.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.27 139.93 45.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 134.84 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -138.59 154.02 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 110.518 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.45 146.17 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.731 1.613 . . . . 0.0 107.51 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.77 -156.22 26.74 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -78.72 98.3 6.19 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 161.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.99 12.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.85 1.26 . . . . 0.0 110.244 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 125.012 1.325 . . . . 0.0 109.206 -177.374 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.74 -33.41 64.31 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.728 1.149 . . . . 0.0 109.711 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -56.74 -39.23 73.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.087 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 m -61.52 -37.14 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.456 1.026 . . . . 0.0 110.447 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -74.63 -28.24 60.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.361 0.982 . . . . 0.0 110.817 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 54.6 mtm -62.17 -49.85 74.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.515 0.598 . . . . 0.0 110.591 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -65.96 -34.22 77.6 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.636 0.775 . . . . 0.0 110.356 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.94 70.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.386 1.475 . . . . 0.0 109.923 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.38 -41.05 96.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.901 0.481 . . . . 0.0 111.178 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -14.97 42.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.138 1.375 . . . . 0.0 112.654 174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -116.57 20.76 13.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.419 1.488 . . . . 0.0 110.874 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.3 pttt 43.59 31.36 0.43 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.143 2.177 . . . . 0.0 114.172 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.91 162.09 29.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.91 0.884 . . . . 0.0 109.017 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.08 138.76 37.38 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.58 -170.94 41.36 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.545 0.611 . . . . 0.0 112.29 -164.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -129.44 160.56 32.76 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.043 0.937 . . . . 0.0 111.525 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.29 140.85 46.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 163.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -145.65 144.22 30.3 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.74 0.816 . . . . 0.0 109.0 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.13 146.45 39.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.97 132.62 55.9 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.94 -25.08 64.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.129 0.972 . . . . 0.0 112.697 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.72 -26.67 67.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.335 1.054 . . . . 0.0 112.284 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.38 -19.57 4.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.823 1.678 . . . . 0.0 112.307 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 172.44 10.8 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.318 1.047 . . . . 0.0 110.532 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.75 147.26 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -115.36 143.84 44.67 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.6 1.96 . . . . 0.0 106.83 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.98 134.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -148.37 124.43 10.73 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.85 162.04 41.79 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.24 0.473 . . . . 0.0 110.568 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.89 151.55 29.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.69 1.596 . . . . 0.0 109.551 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.04 40.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.55 1.071 . . . . 0.0 110.949 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.3 158.32 56.6 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.383 2.055 . . . . 0.0 110.384 171.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.12 -46.48 79.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.435 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -64.2 -37.77 88.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.554 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.86 72.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.305 0.642 . . . . 0.0 109.786 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.83 -46.99 88.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.587 0.755 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.74 -38.2 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.736 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -60.55 -42.62 96.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.734 0.697 . . . . 0.0 110.136 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -59.47 -47.27 86.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.637 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.31 -44.97 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 119.885 1.221 . . . . 0.0 110.071 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.82 -39.9 95.73 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.541 0.609 . . . . 0.0 110.902 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.95 98.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.352 0.661 . . . . 0.0 111.334 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -66.02 -50.35 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -58.29 -38.57 77.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.146 0.578 . . . . 0.0 111.104 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.19 -23.74 63.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.0 112.629 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.8 44.62 94.16 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 118.943 0.792 . . . . 0.0 111.561 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -55.97 -50.93 84.48 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -166.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.39 -49.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.786 1.674 . . . . 0.0 113.491 -163.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.55 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 110.27 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -61.92 151.86 33.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.581 0.752 . . . . 0.0 109.633 169.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.25 146.31 23.64 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 154.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.4 p -122.73 -11.88 8.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.668 1.587 . . . . 0.0 109.485 166.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.63 145.44 25.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.384 1.473 . . . . 0.0 107.848 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.5 tt -149.04 141.87 18.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.713 1.205 . . . . 0.0 107.804 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -135.98 140.77 44.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.409 1.484 . . . . 0.0 107.072 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.7 138.52 47.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.4 m -130.11 155.94 45.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -130.39 152.35 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -147.92 178.48 8.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.334 1.453 . . . . 0.0 107.962 -167.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -130.81 15.5 5.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.474 1.11 . . . . 0.0 109.366 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -69.62 -28.56 66.03 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.386 1.475 . . . . 0.0 112.827 -170.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp 57.75 173.71 0.05 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.988 1.715 . . . . 0.0 111.492 -166.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.95 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.126 0.971 . . . . 0.0 112.948 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 -10.56 60.76 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.461 -1.188 . . . . 0.0 115.689 154.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 173.34 12.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.773 1.787 . . . . 0.0 110.085 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -127.91 19.72 6.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.087 1.355 . . . . 0.0 110.145 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 168.09 24.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.128 1.771 . . . . 0.0 108.732 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -88.03 158.3 18.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.79 0.436 . . . . 0.0 110.102 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -141.62 158.82 43.34 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.231 1.013 . . . . 0.0 110.16 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.14 125.14 43.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -161.082 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.17 178.44 8.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.187 2.195 . . . . 0.0 109.364 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -134.73 147.42 50.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.94 2.096 . . . . 0.0 107.937 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.548 0.739 . . . . 0.0 110.045 165.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -134.45 130.95 37.54 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.84 142.7 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 134.7 59.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 170.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.98 147.98 18.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 124.423 1.089 . . . . 0.0 110.257 -170.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -138.07 155.58 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.68 -158.32 27.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -168.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -78.05 90.11 4.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 158.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.73 10.43 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.792 1.237 . . . . 0.0 110.332 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 . . . . . 0 C--N 1.342 0.258 0 CA-C-N 118.776 0.716 . . . . 0.0 111.468 -166.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -67.95 -25.43 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.052 0.941 . . . . 0.0 111.621 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -48.67 -43.9 37.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.88 -38.1 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.067 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -73.83 -23.46 59.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.869 1.213 . . . . 0.0 111.465 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.68 -53.57 54.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.295 0.952 . . . . 0.0 110.074 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.66 -37.2 80.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.782 0.433 . . . . 0.0 110.341 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.57 55.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.562 1.145 . . . . 0.0 109.952 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.52 -47.24 86.28 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.585 0.754 . . . . 0.0 110.386 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -58.21 -30.66 66.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.19 1.396 . . . . 0.0 111.731 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.97 10.69 39.47 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.959 1.304 . . . . 0.0 111.379 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? 50.47 32.39 6.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.955 1.702 . . . . 0.0 112.101 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.64 165.95 23.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.117 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.4 20.99 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.13 173.94 36.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.549 0.613 . . . . 0.0 112.677 -169.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -101.09 160.99 13.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.36 1.08 . . . . 0.0 111.858 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.57 144.07 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.887 1.275 . . . . 0.0 107.74 158.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -149.23 159.56 44.15 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 107.703 -171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -112.34 120.74 42.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.987 0.812 . . . . 0.0 109.281 170.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -76.09 146.56 39.26 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.81 -28.53 67.53 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.681 0.792 . . . . 0.0 112.357 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.12 -27.61 69.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.479 0.712 . . . . 0.0 112.479 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.18 -37.13 1.88 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.526 1.06 . . . . 0.0 112.315 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 149.64 49.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.006 0.903 . . . . 0.0 111.314 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.61 150.07 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 167.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -124.13 144.84 49.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.012 1.725 . . . . 0.0 106.502 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -135.95 140.76 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.32 118.8 7.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.15 164.1 34.95 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.402 0.681 . . . . 0.0 111.01 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.47 156.72 29.69 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.526 1.531 . . . . 0.0 109.296 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.81 44.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.53 0.586 . . . . 0.0 111.954 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.76 151.44 63.36 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.206 1.938 . . . . 0.0 110.448 171.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.82 -50.06 64.42 Favored 'General case' 0 C--N 1.334 -0.071 0 C-N-CA 124.22 1.008 . . . . 0.0 111.529 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.37 -36.63 82.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.692 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.88 75.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.61 -46.63 81.81 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.127 0.571 . . . . 0.0 110.522 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -66.96 -42.88 84.44 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 121.759 -0.588 . . . . 0.0 111.138 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 m -68.07 -33.43 74.54 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.678 -0.639 . . . . 0.0 110.927 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -58.95 -50.5 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.557 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.64 -43.83 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.556 1.071 . . . . 0.0 109.424 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.14 -40.32 93.37 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.319 0.509 . . . . 0.0 111.215 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.41 97.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.355 0.662 . . . . 0.0 111.217 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -64.39 -51.54 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.35 -41.38 84.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.666 0.786 . . . . 0.0 111.169 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.22 -24.56 64.03 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 112.0 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.15 48.15 82.05 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m -54.79 -47.0 99.32 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 117.364 -1.303 . . . . 0.0 114.145 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.13 -163.55 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.768 2.312 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -59.42 -31.49 69.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 113.132 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -82.61 145.06 29.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.157 0.889 . . . . 0.0 109.662 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.58 148.56 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.102 0.561 . . . . 0.0 110.033 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.16 156.79 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.206 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -125.91 -8.59 6.63 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.041 1.736 . . . . 0.0 109.915 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.64 141.09 23.32 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.595 1.958 . . . . 0.0 107.49 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.6 tt -152.87 142.44 14.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.427 1.091 . . . . 0.0 108.917 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -142.58 144.5 32.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.092 1.757 . . . . 0.0 107.482 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.79 140.65 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 108.314 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -136.49 157.49 46.66 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.402 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -143.76 159.39 42.59 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.112 -0.992 . . . . 0.0 110.311 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.0 m -144.02 151.97 40.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.117 1.367 . . . . 0.0 108.767 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -87.63 35.27 0.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.308 1.043 . . . . 0.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -139.71 106.64 5.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.327 1.051 . . . . 0.0 108.824 -159.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.01 160.83 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 110.086 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.78 -14.48 0.73 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.943 0.897 . . . . 0.0 113.318 -170.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.06 -2.63 14.49 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.236 155.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -61.11 146.27 48.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 121.001 2.401 . . . . 0.0 110.257 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -129.55 9.47 5.52 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.194 1.398 . . . . 0.0 111.028 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.31 166.5 28.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.565 1.946 . . . . 0.0 107.97 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -80.06 148.23 31.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -141.25 156.74 45.85 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 109.771 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 mt -135.93 113.67 14.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tp -142.88 178.63 7.53 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.992 -1.067 . . . . 0.0 110.129 -166.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -152.31 155.05 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.234 1.814 . . . . 0.0 108.097 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.99 163.02 16.86 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.447 0.699 . . . . 0.0 109.813 166.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -134.93 135.45 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 163.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.39 143.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 138.67 52.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 162.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.94 154.99 26.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 124.124 0.97 . . . . 0.0 110.454 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -146.12 154.65 42.04 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.593 1.557 . . . . 0.0 107.885 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 -155.33 26.09 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.806 -2.118 . . . . 0.0 107.806 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -76.16 83.76 2.99 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.04 5.55 4.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 111.129 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.198 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.264 21.7 ptt-85 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -76.51 -44.07 36.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.116 1.326 . . . . 0.0 110.084 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.84 -48.65 63.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.461 0.704 . . . . 0.0 111.156 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.25 -35.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.287 0.949 . . . . 0.0 110.994 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.86 -24.24 58.55 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.623 1.101 . . . . 0.0 111.892 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.8 mtm -63.5 -48.86 75.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.292 0.951 . . . . 0.0 109.868 166.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.76 -23.49 63.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.913 0.885 . . . . 0.0 111.595 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.79 41.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.81 -39.0 90.21 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.223 0.609 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -14.69 61.16 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 112.257 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.16 20.07 14.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.802 1.641 . . . . 0.0 111.082 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 43.29 31.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.113 2.165 . . . . 0.0 114.252 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.83 161.61 30.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.842 0.857 . . . . 0.0 108.74 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.15 28.93 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 108.271 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.02 -154.69 25.77 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.393 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.06 164.32 26.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.404 1.102 . . . . 0.0 112.815 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.03 141.09 47.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 165.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -132.78 140.59 48.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.89 148.19 52.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 158.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -125.9 145.4 50.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.87 0.868 . . . . 0.0 109.23 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.81 125.88 24.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -121.57 31.79 6.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.627 3.171 . . . . 0.0 109.834 5.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.98 -16.31 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 O-C-N 121.267 -0.895 . . . . 0.0 113.866 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -59.05 161.47 5.1 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.279 1.039 . . . . 0.0 109.795 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.22 147.53 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.34 143.02 46.39 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.211 1.405 . . . . 0.0 107.213 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.49 134.47 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.66 132.18 28.67 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.38 157.71 32.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.328 0.967 . . . . 0.0 110.843 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.68 151.32 25.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.688 1.195 . . . . 0.0 109.446 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.18 178.43 40.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.745 1.164 . . . . 0.0 110.793 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 154.9 69.53 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.179 1.92 . . . . 0.0 110.319 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.44 -42.97 79.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.807 0.843 . . . . 0.0 111.695 -172.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.37 -41.1 96.89 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.069 -0.394 . . . . 0.0 111.513 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.41 79.95 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.874 0.47 . . . . 0.0 109.88 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.48 -49.66 76.93 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.921 0.888 . . . . 0.0 110.132 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.81 -35.89 79.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.979 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -61.35 -42.7 99.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.01 0.823 . . . . 0.0 110.175 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -60.94 -46.46 90.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.788 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.72 -41.96 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.632 1.105 . . . . 0.0 109.664 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.75 -41.08 99.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.596 0.634 . . . . 0.0 110.819 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -37.77 80.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.248 0.619 . . . . 0.0 111.703 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.94 -57.4 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -60.87 -35.51 76.8 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.941 0.896 . . . . 0.0 111.738 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -63.53 -26.05 68.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.373 0.669 . . . . 0.0 112.297 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.13 47.82 88.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -173.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.6 -47.9 96.65 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.989 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.01 -172.2 1.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.56 2.173 . . . . 0.0 111.511 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -60.24 -31.36 70.12 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.246 -0.909 . . . . 0.0 111.578 167.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -68.65 142.69 55.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.586 1.154 . . . . 0.0 109.182 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.27 152.17 25.75 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.471 -0.768 . . . . 0.0 110.345 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.88 153.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -121.65 -9.52 8.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.175 1.39 . . . . 0.0 109.697 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -146.98 135.08 21.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.175 1.79 . . . . 0.0 107.123 171.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.21 133.62 7.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -136.55 127.37 27.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.1 145.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.067 1.347 . . . . 0.0 109.493 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 m -136.48 156.92 47.92 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.323 1.849 . . . . 0.0 106.053 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -126.14 150.12 48.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 m -145.63 164.45 31.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.102 0.961 . . . . 0.0 109.582 -163.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -119.36 4.54 11.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.252 1.021 . . . . 0.0 110.467 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -64.52 -30.74 71.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.454 1.102 . . . . 0.0 112.11 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.4 mt 58.68 179.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 111.307 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -153.61 -4.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.995 0.918 . . . . 0.0 113.385 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.26 6.48 53.91 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.746 1.165 . . . . 0.0 114.009 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.78 146.33 52.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.396 1.098 . . . . 0.0 109.469 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -130.27 17.85 5.45 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.633 1.573 . . . . 0.0 109.892 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -149.51 173.4 13.64 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.818 2.047 . . . . 0.0 108.131 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -98.35 150.1 21.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 162.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -139.4 156.14 47.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 110.045 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.1 mt -137.94 134.77 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.164 0.986 . . . . 0.0 108.484 -172.392 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mt -142.88 175.68 9.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 109.726 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -151.88 157.42 41.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.291 1.837 . . . . 0.0 108.379 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.71 162.51 24.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 165.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -135.67 138.59 42.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 156.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.88 143.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -169.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.86 137.79 55.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.79 146.63 20.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.897 0.879 . . . . 0.0 110.356 -168.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.38 152.3 44.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.808 1.643 . . . . 0.0 108.084 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.11 -153.38 25.04 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.39 73.86 3.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 158.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.45 6.19 9.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.359 1.064 . . . . 0.0 110.898 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 120.08 1.309 . . . . 0.0 108.411 174.07 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 119.572 -0.251 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -72.81 -47.68 44.41 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.481 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.27 -43.71 67.65 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.867 0.758 . . . . 0.0 111.419 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -53.16 -48.88 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.652 0.781 . . . . 0.0 109.246 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -78.34 -20.68 50.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 120.817 -1.177 . . . . 0.0 113.443 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -42.96 85.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.382 0.992 . . . . 0.0 109.243 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.29 -35.36 71.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.953 0.797 . . . . 0.0 110.159 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.24 86.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.993 0.517 . . . . 0.0 110.462 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.48 -41.55 98.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.789 0.836 . . . . 0.0 110.938 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.45 -29.98 68.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.495 0.718 . . . . 0.0 111.516 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -98.49 6.62 47.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.286 1.034 . . . . 0.0 112.581 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 42.82 40.88 2.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.697 1.999 . . . . 0.0 113.235 -172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.03 164.39 26.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.325 1.05 . . . . 0.0 109.158 166.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 142.48 32.45 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.093 0.957 . . . . 0.0 108.508 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.03 -154.93 26.01 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.194 -168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.57 162.5 31.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.447 1.123 . . . . 0.0 112.627 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.52 144.43 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.905 1.282 . . . . 0.0 107.971 163.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -149.89 165.91 31.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.005 1.322 . . . . 0.0 109.356 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.9 121.77 45.96 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 167.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -73.73 153.97 39.81 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.138 0.975 . . . . 0.0 108.844 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.52 -31.31 70.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 111.379 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -70.74 -11.53 61.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.87 -27.84 8.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.152 1.358 . . . . 0.0 113.125 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.55 149.77 49.97 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.443 1.622 . . . . 0.0 109.495 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.18 149.69 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 158.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 143.43 50.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -133.65 143.03 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -141.46 135.87 30.71 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.33 34.93 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.629 1.104 . . . . 0.0 111.337 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.03 151.81 30.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.038 1.335 . . . . 0.0 109.418 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.52 42.48 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.162 0.886 . . . . 0.0 111.474 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.61 159.96 51.05 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.54 2.16 . . . . 0.0 110.793 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.65 -53.74 50.85 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.78 0.832 . . . . 0.0 111.064 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.06 -35.73 81.21 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 122.281 -0.262 . . . . 0.0 111.278 -173.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -49.34 71.51 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.78 0.432 . . . . 0.0 110.604 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.61 -49.08 78.03 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.12 0.568 . . . . 0.0 110.237 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.22 -41.03 90.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.608 0.363 . . . . 0.0 111.148 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -62.89 -40.35 97.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.659 0.663 . . . . 0.0 110.566 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.42 -47.52 85.75 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.599 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.54 -41.91 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.684 1.129 . . . . 0.0 109.705 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.86 -40.68 98.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.712 0.687 . . . . 0.0 110.807 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.72 92.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.797 0.839 . . . . 0.0 111.536 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -66.46 -55.68 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.43 -35.32 75.53 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.963 0.905 . . . . 0.0 111.976 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -63.06 -25.2 68.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.415 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.08 44.16 98.52 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -53.58 -44.17 97.25 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.14 -170.54 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.42 2.08 . . . . 0.0 111.245 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -60.29 -42.98 96.62 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.97 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.18 150.85 33.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.235 1.414 . . . . 0.0 110.637 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.25 33.59 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.704 -0.623 . . . . 0.0 109.878 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.06 154.66 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.3 p -120.4 -12.43 8.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.359 1.464 . . . . 0.0 109.56 162.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -147.35 141.12 25.7 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.224 1.41 . . . . 0.0 107.992 168.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.67 136.48 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -134.99 140.78 45.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.42 141.2 40.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -129.76 148.06 51.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -134.4 145.28 48.77 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 m -151.89 168.3 25.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.229 -150.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -125.54 1.37 7.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.428 1.091 . . . . 0.0 111.79 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -64.35 -32.06 73.52 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.795 0.838 . . . . 0.0 111.661 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.31 -177.26 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.115 1.766 . . . . 0.0 110.782 -171.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.45 -13.41 0.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.86 17.24 79.27 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.091 0.853 . . . . 0.0 113.037 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -63.66 152.53 38.76 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.283 1.041 . . . . 0.0 110.444 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.27 4.69 6.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 110.903 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 157.51 43.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.902 1.281 . . . . 0.0 109.237 172.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -71.2 143.22 50.54 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 155.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -139.33 150.98 46.02 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.586 0.754 . . . . 0.0 109.65 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.9 mt -128.57 109.88 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.236 0.367 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.046 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.174 0.035 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.93 -177.1 6.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.376 1.47 . . . . 0.0 110.045 -161.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -146.04 153.7 41.03 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.328 1.851 . . . . 0.0 109.251 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.21 166.74 11.16 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.069 0.947 . . . . 0.0 110.52 164.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -131.92 138.4 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 152.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.0 mt -136.27 146.88 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.89 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 164.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.62 151.8 24.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.53 1.132 . . . . 0.0 109.058 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.71 150.25 39.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.13 -153.87 25.59 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -79.76 63.25 4.26 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.8 m -89.11 8.77 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.806 1.242 . . . . 0.0 111.711 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 7.3 ptt180 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.98 -38.17 78.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 120.003 1.274 . . . . 0.0 108.528 160.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -55.91 -41.05 73.96 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.342 0.519 . . . . 0.0 111.527 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.19 -45.83 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -78.88 -16.28 57.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.627 -0.702 . . . . 0.0 112.894 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.17 -47.77 75.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.636 1.107 . . . . 0.0 108.87 164.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -70.49 -23.12 62.61 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.929 -0.482 . . . . 0.0 111.362 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.66 52.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.288 -0.882 . . . . 0.0 109.662 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.16 -39.66 90.95 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.773 0.829 . . . . 0.0 111.544 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -14.35 60.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.721 -0.612 . . . . 0.0 112.013 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -116.79 11.23 14.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.701 1.601 . . . . 0.0 111.55 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 41.08 40.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.963 2.105 . . . . 0.0 113.034 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.63 163.25 28.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.68 131.72 24.64 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.062 0.945 . . . . 0.0 108.715 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.31 -162.95 34.71 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.223 0.465 . . . . 0.0 112.201 -162.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -135.42 167.7 20.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.777 0.789 . . . . 0.0 112.734 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.0 142.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.045 1.338 . . . . 0.0 109.102 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -145.77 157.36 43.94 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.947 1.699 . . . . 0.0 108.095 -163.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -119.32 123.19 43.61 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -78.6 156.66 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.977 1.311 . . . . 0.0 109.727 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.49 -30.65 70.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.239 0.615 . . . . 0.0 111.677 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -4.85 39.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.864 0.866 . . . . 0.0 113.022 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.98 -23.71 28.5 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.102 1.335 . . . . 0.0 113.247 169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -61.69 145.28 52.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.961 1.38 . . . . 0.0 109.804 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.52 143.54 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 160.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -131.21 145.75 52.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.41 142.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -170.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 tt -150.0 125.61 10.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 153.45 27.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.016 0.826 . . . . 0.0 111.454 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -93.53 154.5 17.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.46 1.104 . . . . 0.0 109.696 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.01 42.28 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 110.762 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.28 154.75 61.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.921 1.747 . . . . 0.0 109.918 165.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.72 -43.4 80.58 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.57 0.748 . . . . 0.0 111.437 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.33 -41.04 98.23 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.151 -0.343 . . . . 0.0 111.472 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.81 82.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.737 0.415 . . . . 0.0 110.064 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.12 -44.09 97.41 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.743 0.817 . . . . 0.0 110.371 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -70.48 -41.12 73.15 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.79 -0.569 . . . . 0.0 111.775 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 m -60.22 -40.05 88.79 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.756 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -61.85 -46.45 89.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.858 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.46 -46.56 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.005 1.275 . . . . 0.0 109.426 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.39 -39.62 91.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.168 0.44 . . . . 0.0 111.191 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.191 0.597 . . . . 0.0 112.133 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.05 -49.8 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.91 -44.04 91.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.185 0.594 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -71.52 -19.95 62.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.674 0.79 . . . . 0.0 112.011 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.71 43.34 94.52 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -172.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 m -51.15 -53.33 49.86 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.09 -39.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.654 1.57 . . . . 0.0 112.496 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -165.83 168.77 15.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.086 1.754 . . . . 0.0 108.188 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m 62.55 175.96 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.963 1.705 . . . . 0.0 113.044 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 160.49 40.28 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.92 0.888 . . . . 0.0 109.406 166.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.51 156.95 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.2 p -119.62 -13.56 9.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.939 1.296 . . . . 0.0 109.648 163.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.8 144.99 26.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.081 1.353 . . . . 0.0 108.749 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.82 142.17 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.289 1.436 . . . . 0.0 107.378 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -140.23 147.8 40.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.21 145.9 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.67 155.7 46.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.147 2.179 . . . . 0.0 105.48 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -138.6 158.63 43.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.0 m -155.51 152.88 29.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.145 1.378 . . . . 0.0 107.901 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -73.33 -30.95 63.7 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.718 -0.614 . . . . 0.0 111.352 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 m -60.07 128.57 37.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.102 0.961 . . . . 0.0 110.903 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.18 169.86 12.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.207 1.003 . . . . 0.0 109.242 163.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -104.76 -18.71 14.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.029 0.932 . . . . 0.0 111.074 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 47.85 7.45 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -171.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -126.83 149.86 49.49 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.608 1.163 . . . . 0.0 108.915 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.86 9.2 3.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.945 0.898 . . . . 0.0 112.092 -172.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 174.28 12.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.514 1.526 . . . . 0.0 109.013 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -116.47 148.97 40.24 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.369 1.067 . . . . 0.0 109.458 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.93 159.96 41.65 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.468 0.652 . . . . 0.0 111.963 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.02 114.51 35.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.153 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 tp -142.21 177.26 8.36 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.905 -1.122 . . . . 0.0 110.422 -166.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -154.57 162.01 41.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.94 1.696 . . . . 0.0 109.47 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.36 166.36 21.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.226 1.01 . . . . 0.0 110.273 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -130.23 138.58 50.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.42 146.86 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 135.71 58.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.61 153.64 16.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.275 1.03 . . . . 0.0 110.699 -172.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.01 153.0 45.35 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.313 1.445 . . . . 0.0 107.943 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.35 -152.28 24.19 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -75.56 77.98 2.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 162.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.66 -1.77 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 111.306 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 125.63 1.572 . . . . 0.0 109.488 -177.892 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -60.62 -32.83 71.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.405 1.002 . . . . 0.0 110.803 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -48.74 71.94 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.921 1.237 . . . . 0.0 111.61 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.86 -30.92 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.16 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -75.14 -24.66 57.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.948 1.249 . . . . 0.0 112.08 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.2 mtm -63.46 -48.9 75.81 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 165.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.81 -30.11 70.69 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 122.195 -0.316 . . . . 0.0 111.058 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.84 -47.49 68.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.292 . . . . 0.0 110.328 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.63 -38.62 88.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.319 0.647 . . . . 0.0 111.124 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.14 -17.59 41.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.769 1.228 . . . . 0.0 112.523 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -116.65 12.9 15.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.225 1.41 . . . . 0.0 111.41 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.44 34.44 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.16 2.184 . . . . 0.0 113.294 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.41 161.59 27.27 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.816 -0.553 . . . . 0.0 109.629 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 128.62 43.74 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.48 -171.21 43.9 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 118.641 0.655 . . . . 0.0 112.272 -164.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.4 p90 -136.61 161.27 36.36 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.066 0.947 . . . . 0.0 112.036 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.15 144.93 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.171 0.988 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -144.71 162.82 35.75 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.143 2.177 . . . . 0.0 107.656 -170.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.43 122.88 40.76 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -75.77 155.46 35.48 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.479 1.112 . . . . 0.0 109.16 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.45 -31.78 70.75 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.918 0.487 . . . . 0.0 111.357 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -71.34 -10.68 60.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.82 10.83 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.228 -1.318 . . . . 0.0 113.476 170.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.35 148.25 52.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.729 1.764 . . . . 0.0 109.391 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.29 146.48 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 161.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -127.77 137.94 52.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.55 142.55 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.57 126.38 12.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.04 41.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.487 0.585 . . . . 0.0 110.926 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.49 155.83 22.63 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.316 1.846 . . . . 0.0 109.443 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.51 178.04 41.64 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.618 1.104 . . . . 0.0 110.364 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.32 154.3 74.44 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.842 1.695 . . . . 0.0 109.781 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.37 -47.7 78.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.183 0.593 . . . . 0.0 110.715 -172.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -60.17 -40.31 89.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.484 0.584 . . . . 0.0 111.788 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.59 83.09 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.855 0.462 . . . . 0.0 110.091 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.66 -45.96 84.48 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 122.809 0.443 . . . . 0.0 110.826 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -64.98 -43.47 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.864 -0.522 . . . . 0.0 110.68 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.4 m -60.93 -40.84 94.77 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.935 0.334 . . . . 0.0 110.54 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.24 -49.09 79.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.575 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.67 -43.25 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.735 1.152 . . . . 0.0 109.67 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.92 -40.91 97.11 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.628 0.649 . . . . 0.0 110.834 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.47 0.708 . . . . 0.0 111.465 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -61.79 -54.04 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.37 -39.44 79.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.809 0.844 . . . . 0.0 111.375 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.4 -27.23 68.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.488 0.715 . . . . 0.0 111.979 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.47 51.26 58.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -173.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -55.53 -49.2 93.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.976 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.49 -173.45 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.261 1.974 . . . . 0.0 111.627 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -40.84 82.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.431 1.092 . . . . 0.0 111.449 173.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.3 m -74.29 138.92 43.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -157.81 164.45 36.99 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 109.533 -162.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.42 149.6 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -127.68 -7.58 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.809 1.643 . . . . 0.0 109.803 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.61 141.22 29.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.224 1.81 . . . . 0.0 106.963 166.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -149.27 140.68 17.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 107.972 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 m -139.29 148.94 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.687 1.595 . . . . 0.0 107.328 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.18 146.18 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.05 149.01 51.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.04 133.17 39.1 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -171.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -145.47 167.93 21.79 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.701 0.4 . . . . 0.0 111.683 -155.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.97 0.11 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.898 1.279 . . . . 0.0 111.253 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.0 m -66.26 -24.88 66.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.121 0.969 . . . . 0.0 113.088 -170.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.48 174.0 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 0.0 111.684 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.18 -16.44 0.58 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 113.179 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 1.41 82.2 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.253 -1.304 . . . . 0.0 116.304 155.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -82.92 -175.48 5.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.102 1.951 . . . . 0.0 109.542 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -129.55 2.85 5.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 112.421 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.57 170.76 17.89 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.052 1.341 . . . . 0.0 109.697 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -72.48 153.27 41.45 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.956 0.503 . . . . 0.0 109.965 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.39 159.22 42.67 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.703 1.201 . . . . 0.0 109.453 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 mt -135.09 110.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -171.102 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.507 0.194 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.13 176.03 9.06 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.946 0.898 . . . . 0.0 111.666 -149.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -147.71 157.81 43.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.446 1.498 . . . . 0.0 109.384 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.14 168.09 11.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 110.629 163.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -134.58 135.42 42.22 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 156.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.34 144.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.78 136.42 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.14 155.48 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.576 1.151 . . . . 0.0 110.293 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -145.98 157.38 43.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 0.0 108.935 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -148.36 19.87 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 106.821 -2.512 . . . . 0.0 106.821 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -77.02 54.48 1.04 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 160.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.73 -13.92 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 111.21 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 168.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.9 -34.47 73.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.171 0.896 . . . . 0.0 111.295 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -37.61 65.23 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.678 0.672 . . . . 0.0 111.288 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.84 -45.22 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -78.97 -18.95 52.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.488 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -63.21 -48.95 76.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.335 0.971 . . . . 0.0 109.309 165.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.58 -29.95 67.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.784 0.434 . . . . 0.0 110.421 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.61 74.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.767 0.827 . . . . 0.0 110.405 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.92 -41.02 90.81 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.341 0.656 . . . . 0.0 110.724 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -59.41 -18.09 36.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.487 1.115 . . . . 0.0 112.854 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -117.33 15.76 14.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.977 1.262 . . . . 0.0 112.372 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.2 mmpt? 47.01 34.0 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.574 1.55 . . . . 0.0 112.768 -176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.3 mt -74.41 163.51 27.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.172 0.589 . . . . 0.0 109.703 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.73 130.11 22.42 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.167 0.987 . . . . 0.0 108.581 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.35 -158.34 28.66 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 123.592 0.615 . . . . 0.0 111.596 -171.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -136.73 163.28 30.97 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.787 0.794 . . . . 0.0 112.047 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.874 1.27 . . . . 0.0 108.66 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -149.22 163.25 38.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.883 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -119.58 131.15 55.44 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -120.77 149.72 42.11 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.925 0.89 . . . . 0.0 110.37 -167.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.08 -19.46 62.96 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.443 1.497 . . . . 0.0 113.524 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.78 -15.29 28.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.757 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.05 45.83 3.77 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.52 153.32 42.47 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.392 1.477 . . . . 0.0 107.238 -168.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.19 148.36 5.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 157.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.96 142.48 48.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -138.62 141.48 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.98 126.37 10.8 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.1 157.02 36.86 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.442 0.697 . . . . 0.0 110.877 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.98 156.9 17.35 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.634 1.573 . . . . 0.0 109.874 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.25 -179.42 41.89 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.039 0.828 . . . . 0.0 111.865 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.4 161.74 37.13 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.554 2.17 . . . . 0.0 110.652 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.35 -47.23 79.23 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.73 0.812 . . . . 0.0 111.137 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.76 -43.06 98.49 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.005 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.96 79.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.1 mt -63.22 -47.08 84.03 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.326 0.65 . . . . 0.0 110.247 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -68.52 -43.51 76.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.031 0.532 . . . . 0.0 111.893 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -62.89 -39.09 93.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.471 0.578 . . . . 0.0 110.139 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.3 -49.24 78.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.423 173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.56 -45.65 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.57 1.077 . . . . 0.0 109.515 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -62.42 -37.81 87.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.096 0.407 . . . . 0.0 111.155 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.85 86.94 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.501 0.72 . . . . 0.0 111.792 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.2 -51.03 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.34 -41.95 76.92 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.442 1.097 . . . . 0.0 111.29 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -68.22 -25.53 65.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.517 0.727 . . . . 0.0 111.933 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.94 48.64 81.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.61 -47.32 98.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.409 -1.281 . . . . 0.0 114.289 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.84 -166.53 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.201 . . . . 0.0 111.479 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -40.74 67.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.828 1.251 . . . . 0.0 111.939 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -79.6 143.72 34.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 162.46 40.51 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.687 0.795 . . . . 0.0 110.548 -172.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.88 158.3 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.371 0.668 . . . . 0.0 110.689 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 p -125.81 -4.8 6.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.715 1.606 . . . . 0.0 110.023 163.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -150.66 138.73 20.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.777 2.031 . . . . 0.0 107.446 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.64 140.98 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.336 1.054 . . . . 0.0 108.613 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -140.86 142.9 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.101 1.76 . . . . 0.0 107.053 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -138.19 143.6 32.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -129.99 151.06 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -137.05 145.36 43.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.0 m -143.2 175.0 10.21 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.037 1.335 . . . . 0.0 109.375 -165.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -128.37 33.53 4.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.537 1.135 . . . . 0.0 109.447 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -134.24 105.09 6.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 108.404 -165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.09 168.63 8.09 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.949 0.9 . . . . 0.0 111.235 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.78 -23.47 9.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.832 1.653 . . . . 0.0 110.496 -175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.69 19.04 76.52 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -166.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.31 139.78 32.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -134.82 25.09 3.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.808 1.243 . . . . 0.0 109.584 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -148.23 167.4 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 127.003 2.121 . . . . 0.0 107.184 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -120.85 132.94 55.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 163.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 m -134.7 160.87 36.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.126 0.57 . . . . 0.0 111.211 -166.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.9 mt -132.24 114.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.237 0.438 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.263 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 119.111 -0.471 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tp -147.46 -177.01 5.47 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.207 1.367 . . . . 0.0 111.344 -159.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.61 152.57 39.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.613 1.965 . . . . 0.0 109.086 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.46 163.7 12.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.319 0.648 . . . . 0.0 109.724 162.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -136.05 131.09 34.45 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 159.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.19 139.65 45.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.29 134.4 66.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -140.35 153.19 21.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.146 0.979 . . . . 0.0 109.557 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.28 151.36 37.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.935 1.294 . . . . 0.0 107.522 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.67 -152.04 24.06 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.67 58.56 1.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 m -85.0 -12.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.019 0.928 . . . . 0.0 110.783 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 164.573 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.301 12.9 ptt85 . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -66.38 -21.96 66.24 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 122.013 2.188 . . . . 0.0 110.468 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.099 1.318 . . . . 0.0 111.349 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.21 -33.66 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.394 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -73.39 -25.98 60.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.051 1.296 . . . . 0.0 112.284 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.4 mtm -65.36 -47.3 76.91 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 166.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -66.09 -27.99 68.48 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.285 -0.26 . . . . 0.0 111.329 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 -48.47 64.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.734 1.614 . . . . 0.0 109.975 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.06 -38.68 87.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.984 0.514 . . . . 0.0 111.209 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -60.0 -16.96 34.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.354 1.062 . . . . 0.0 112.594 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -116.88 11.24 14.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.127 1.371 . . . . 0.0 111.565 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 41.52 39.52 1.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.697 1.999 . . . . 0.0 113.015 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.63 164.85 25.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.732 0.813 . . . . 0.0 108.981 167.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.32 26.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.18 -167.68 38.91 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 118.402 0.546 . . . . 0.0 112.14 -163.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -136.64 159.56 41.44 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.75 0.82 . . . . 0.0 111.991 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.99 141.94 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.735 0.814 . . . . 0.0 110.412 174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -141.85 153.31 44.37 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.833 1.653 . . . . 0.0 108.613 -166.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -106.62 125.22 50.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 170.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -85.33 145.29 27.58 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.961 0.904 . . . . 0.0 108.676 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.55 -29.45 69.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.351 0.66 . . . . 0.0 111.882 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -8.8 56.03 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 45.95 2.23 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 119.109 0.868 . . . . 0.0 112.084 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -136.43 172.99 12.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 107.802 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -116.16 144.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 164.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 140.34 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.79 140.72 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.7 127.69 14.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.44 149.28 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 122.997 0.519 . . . . 0.0 110.24 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.28 153.77 20.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.708 0.803 . . . . 0.0 109.147 166.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.47 173.71 36.56 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.309 0.957 . . . . 0.0 111.604 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.59 153.41 60.06 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.149 1.899 . . . . 0.0 110.073 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.83 -42.3 75.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.679 0.792 . . . . 0.0 111.507 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.4 -41.1 98.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.068 -0.395 . . . . 0.0 111.632 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -45.1 77.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.786 0.434 . . . . 0.0 109.856 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.99 -45.38 95.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.863 0.865 . . . . 0.0 110.129 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -69.71 -39.73 76.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.857 -0.527 . . . . 0.0 112.019 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.1 m -61.05 -41.7 97.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.642 0.656 . . . . 0.0 110.183 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.36 -47.27 86.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.575 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -55.01 -45.84 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.754 1.161 . . . . 0.0 109.602 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.82 -39.1 90.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.585 0.63 . . . . 0.0 111.052 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.55 87.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.425 0.69 . . . . 0.0 111.411 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.61 -48.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.96 -39.76 86.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.41 0.684 . . . . 0.0 111.452 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.49 -24.74 66.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.004 0.522 . . . . 0.0 111.832 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.28 44.0 96.84 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -54.48 -47.68 97.07 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.935 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.78 -169.09 0.67 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.546 2.164 . . . . 0.0 111.722 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -2.87 0.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.911 2.084 . . . . 0.0 115.241 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.4 m -129.53 143.65 50.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.395 1.478 . . . . 0.0 107.737 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.0 164.75 37.66 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.404 0.682 . . . . 0.0 111.21 -162.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.8 m -106.37 158.79 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 123.543 0.737 . . . . 0.0 110.444 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 p -123.01 -11.72 8.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.915 1.686 . . . . 0.0 109.827 162.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.7 146.82 27.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.108 1.363 . . . . 0.0 108.992 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.7 tt -148.19 143.6 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.991 1.316 . . . . 0.0 108.309 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -136.73 144.08 43.65 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.126 1.77 . . . . 0.0 107.213 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.67 140.21 36.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -132.68 157.34 45.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.989 2.115 . . . . 0.0 105.778 168.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.36 142.8 48.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -136.94 153.29 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.785 1.634 . . . . 0.0 107.07 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 mmt-85 -87.76 -24.49 23.78 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.011 -1.056 . . . . 0.0 111.166 -175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 m -62.93 114.67 3.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.81 1.244 . . . . 0.0 111.027 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.61 177.66 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.32 1.048 . . . . 0.0 110.641 164.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -126.92 0.21 6.61 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.893 1.277 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.57 27.94 66.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.878 0.751 . . . . 0.0 111.675 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -94.53 150.35 20.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.894 0.847 . . . . 0.0 109.8 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -137.84 14.98 2.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.64 1.176 . . . . 0.0 111.57 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -148.51 166.72 27.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.16 1.384 . . . . 0.0 108.963 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -88.16 155.88 19.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 163.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.2 m -142.55 156.7 45.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.614 1.166 . . . . 0.0 110.66 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 mt -128.17 112.96 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -174.577 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 tp -140.65 -178.6 5.6 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.789 -1.194 . . . . 0.0 109.527 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -155.12 158.14 38.55 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.868 1.667 . . . . 0.0 108.449 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.05 164.94 15.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.661 0.785 . . . . 0.0 110.536 166.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.27 131.3 29.95 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 157.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.97 147.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -167.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.41 137.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 m -141.53 156.28 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 124.03 0.932 . . . . 0.0 111.301 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.36 155.51 45.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.751 1.62 . . . . 0.0 107.788 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.24 -155.36 26.29 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -77.61 100.21 6.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 152.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.39 6.24 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 124.611 1.194 . . . . 0.0 110.752 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 C--N 1.344 0.352 0 CA-C-N 119.587 1.085 . . . . 0.0 111.12 179.073 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -59.89 -32.34 70.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.289 0.95 . . . . 0.0 110.578 169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -51.72 -37.53 51.33 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.538 0.608 . . . . 0.0 112.07 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.68 -48.06 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -71.29 -25.47 62.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.42 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.71 -39.47 64.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.858 1.208 . . . . 0.0 110.589 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -69.28 -29.82 67.78 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.344 -0.847 . . . . 0.0 111.096 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.54 65.07 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.093 -1.005 . . . . 0.0 109.672 172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.11 -40.42 93.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.053 0.941 . . . . 0.0 111.42 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -15.26 62.72 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.67 -0.644 . . . . 0.0 112.295 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -113.33 15.11 19.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 111.665 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.27 32.97 3.41 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.067 1.747 . . . . 0.0 112.326 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.0 162.22 29.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.09 121.39 19.18 Favored 'General case' 0 CA--C 1.527 0.075 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 -162.17 32.27 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -142.7 163.7 32.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.14 145.98 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.086 1.354 . . . . 0.0 109.507 165.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -149.49 146.14 27.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.641 1.577 . . . . 0.0 108.372 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.98 153.93 40.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.703 0.801 . . . . 0.0 109.487 168.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -134.64 154.6 51.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.297 1.408 . . . . 0.0 110.843 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.01 -30.63 69.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -155.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.05 -27.45 68.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.139 0.576 . . . . 0.0 112.402 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.65 -17.84 10.12 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.366 1.46 . . . . 0.0 110.946 -172.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -59.17 168.32 1.44 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 122.962 1.363 . . . . 0.0 110.422 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.52 150.12 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -131.18 140.12 49.86 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -171.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -136.89 140.81 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -171.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -149.88 126.91 11.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.19 149.52 28.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.527 0.603 . . . . 0.0 110.093 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.92 153.77 19.95 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 174.69 39.72 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.661 0.648 . . . . 0.0 111.807 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.21 152.39 66.98 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.966 1.777 . . . . 0.0 110.152 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.05 -43.87 74.19 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.813 0.845 . . . . 0.0 111.481 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.43 -40.93 98.49 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 122.227 -0.295 . . . . 0.0 111.544 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.33 80.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.988 0.515 . . . . 0.0 110.116 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.04 -45.22 94.54 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.583 0.753 . . . . 0.0 110.211 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.57 -40.12 76.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.885 -0.51 . . . . 0.0 111.75 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 m -61.37 -42.0 98.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.746 0.703 . . . . 0.0 110.215 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.21 -49.81 75.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.591 -0.719 . . . . 0.0 110.243 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.3 t -56.65 -43.59 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 119.496 1.043 . . . . 0.0 109.988 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.69 -41.46 97.6 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.109 0.868 . . . . 0.0 110.72 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.33 97.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 111.438 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.28 -53.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -58.53 -40.93 84.32 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.078 0.951 . . . . 0.0 111.207 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -69.9 -23.65 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.49 . . . . 0.0 111.897 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.33 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -58.41 -42.15 93.08 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-O 117.745 -1.121 . . . . 0.0 112.871 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.13 -172.29 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.742 2.961 . . . . 0.0 114.128 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -59.48 -39.61 84.28 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.48 1.112 . . . . 0.0 111.785 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -72.96 151.71 41.7 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.586 0.755 . . . . 0.0 110.363 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 145.53 23.33 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.76 156.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -124.87 -8.95 7.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.601 . . . . 0.0 109.734 166.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.46 139.7 20.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.419 1.887 . . . . 0.0 107.411 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -152.95 142.75 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.65 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -141.29 145.36 35.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.806 1.643 . . . . 0.0 107.779 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.51 138.85 44.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -169.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -131.73 152.79 50.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.598 1.959 . . . . 0.0 106.063 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -131.31 151.21 51.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 m -146.95 165.29 30.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.539 1.136 . . . . 0.0 109.465 -165.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -118.78 1.34 11.56 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.148 0.979 . . . . 0.0 110.751 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 m -62.2 -37.45 85.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.42 1.088 . . . . 0.0 112.211 -171.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 mp 58.5 170.59 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.26 1.824 . . . . 0.0 111.951 -170.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.19 -20.19 4.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.852 1.261 . . . . 0.0 111.392 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.83 24.69 74.26 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.17 139.52 42.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.126 0.963 . . . . 0.0 108.433 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -131.88 21.0 4.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.498 1.119 . . . . 0.0 110.743 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -149.03 178.28 8.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.022 1.729 . . . . 0.0 108.099 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.46 132.16 35.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.0 m -143.9 163.26 33.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.63 1.205 . . . . 0.0 114.032 -152.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.4 mt -128.39 118.66 48.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.251 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -141.76 179.85 6.61 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.889 -1.132 . . . . 0.0 109.677 -167.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -155.37 156.29 35.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 109.159 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.5 163.21 18.3 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.688 0.795 . . . . 0.0 110.524 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -132.33 137.06 47.28 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 154.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.78 142.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -173.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.21 135.28 59.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 171.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.52 151.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.783 0.833 . . . . 0.0 110.6 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.83 153.31 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 107.681 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.88 -154.36 25.77 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -75.1 88.64 2.44 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -124.52 6.51 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.398 1.079 . . . . 0.0 111.237 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 CA--C 1.534 0.36 0 CA-C-N 119.78 1.173 . . . . 0.0 108.496 168.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.65 -43.32 69.4 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.574 -0.704 . . . . 0.0 110.07 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -53.86 -48.33 70.13 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.029 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.17 -33.99 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 119.39 0.996 . . . . 0.0 110.929 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.61 -32.16 73.59 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.385 1.448 . . . . 0.0 112.164 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -64.0 -46.55 84.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.181 0.901 . . . . 0.0 109.385 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -68.58 -33.3 73.83 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.101 -0.375 . . . . 0.0 110.887 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.48 77.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.299 1.04 . . . . 0.0 109.584 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.68 -35.0 78.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.862 0.465 . . . . 0.0 112.096 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.2 -40.93 59.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.27 1.028 . . . . 0.0 111.715 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -114.87 24.01 12.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.86 1.264 . . . . 0.0 111.279 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp 46.17 39.96 6.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.32 157.43 22.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.12 126.16 44.87 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.33 -171.88 44.67 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 118.643 0.656 . . . . 0.0 112.885 -167.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -142.9 165.85 26.25 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.313 0.645 . . . . 0.0 112.463 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.38 146.56 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.053 1.341 . . . . 0.0 110.075 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.46 159.17 44.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.914 1.286 . . . . 0.0 110.222 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.34 153.94 28.07 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 166.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -112.32 145.25 40.36 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 166.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.64 -28.39 65.63 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.36 -28.05 68.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.922 0.889 . . . . 0.0 112.65 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.08 -17.57 7.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.297 1.427 . . . . 0.0 111.614 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -58.46 164.8 2.39 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.949 0.881 . . . . 0.0 110.691 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 t -119.31 149.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 161.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -129.27 139.53 51.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 141.8 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.79 129.39 14.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.94 145.14 23.89 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.754 0.706 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.69 151.82 23.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 164.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.45 175.68 40.0 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 112.457 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.61 154.95 64.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.142 1.895 . . . . 0.0 110.526 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.46 -45.78 76.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.905 0.882 . . . . 0.0 111.512 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.41 -40.84 98.29 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.294 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.2 80.07 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.48 -46.39 88.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.477 0.711 . . . . 0.0 110.492 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -69.17 -39.58 78.67 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.888 -0.508 . . . . 0.0 111.755 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 m -62.1 -40.49 96.06 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.663 0.665 . . . . 0.0 110.259 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -59.46 -47.54 85.09 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.303 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.88 -42.62 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 119.72 1.145 . . . . 0.0 109.898 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.46 -41.31 98.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.083 0.856 . . . . 0.0 110.984 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.16 89.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.908 0.483 . . . . 0.0 111.619 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.27 -56.02 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.99 -37.18 78.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.955 0.902 . . . . 0.0 111.573 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.01 -24.63 66.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.557 0.743 . . . . 0.0 112.415 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.49 42.62 97.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.785 0.72 . . . . 0.0 111.387 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -51.26 -47.37 88.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.95 -56.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.711 1.647 . . . . 0.0 112.198 -166.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -174.92 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.952 2.101 . . . . 0.0 107.104 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.81 145.34 29.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.553 1.541 . . . . 0.0 109.782 168.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.52 151.52 24.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.561 0.745 . . . . 0.0 109.206 -172.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.85 156.18 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.8 p -121.17 -12.43 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.585 1.554 . . . . 0.0 109.774 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.36 136.02 20.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.266 1.826 . . . . 0.0 106.967 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 tt -148.5 137.73 15.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -139.63 146.14 39.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.311 1.444 . . . . 0.0 107.397 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.49 144.4 32.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.96 147.61 50.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 167.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -138.76 134.53 33.6 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 m -143.62 168.07 20.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.01 0.924 . . . . 0.0 110.634 -155.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.55 0.45 10.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.349 1.059 . . . . 0.0 111.726 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -66.14 -37.2 85.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.29 0.95 . . . . 0.0 112.61 -171.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.52 177.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 0.0 111.236 -165.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -124.06 -26.52 4.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.122 0.969 . . . . 0.0 110.978 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.17 41.24 6.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.351 0.977 . . . . 0.0 110.906 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 165.78 24.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 112.536 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -140.39 33.11 1.88 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.366 1.867 . . . . 0.0 109.279 -172.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -131.14 160.98 33.16 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.467 1.507 . . . . 0.0 108.434 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.35 122.33 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -141.81 163.62 32.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.184 0.992 . . . . 0.0 113.42 -152.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.08 119.89 41.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.505 -160.669 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 119.084 -0.484 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mp -143.42 -177.12 5.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.011 1.278 . . . . 0.0 111.605 -167.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -142.53 155.95 45.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.816 2.846 . . . . 0.0 108.552 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.68 164.68 13.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.794 0.838 . . . . 0.0 109.731 161.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -133.26 137.0 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 153.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -136.19 141.42 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -170.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.55 33.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 163.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.84 155.34 30.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.531 1.132 . . . . 0.0 109.99 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -145.56 155.81 43.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 107.19 172.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.21 -152.48 24.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 107.786 -2.125 . . . . 0.0 107.786 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -78.15 101.66 7.14 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 104.421 -2.436 . . . . 0.0 104.421 154.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.61 18.56 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.403 1.081 . . . . 0.0 110.352 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 125.966 1.706 . . . . 0.0 107.109 169.42 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.28 -44.25 65.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.485 1.039 . . . . 0.0 109.914 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.9 -50.81 63.18 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.765 0.826 . . . . 0.0 110.998 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.13 -35.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.034 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.53 -21.62 60.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.377 1.444 . . . . 0.0 113.054 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.4 mtm -64.06 -46.32 84.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.755 1.161 . . . . 0.0 109.03 165.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -68.32 -23.98 64.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.465 0.706 . . . . 0.0 111.582 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.66 -53.04 38.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.356 -0.84 . . . . 0.0 108.921 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.61 -40.26 91.21 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.205 0.602 . . . . 0.0 111.594 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.27 62.58 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.78 -0.575 . . . . 0.0 112.295 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.1 15.03 17.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.455 1.502 . . . . 0.0 111.393 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 47.94 32.07 2.65 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.183 1.793 . . . . 0.0 112.849 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -73.43 162.26 29.5 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.79 134.87 25.56 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.42 -165.39 38.6 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 118.566 0.621 . . . . 0.0 112.143 -160.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.458 ' CZ3' ' HE2' ' A' ' 35' ' ' LYS . 3.0 p-90 -135.81 169.22 17.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.652 0.781 . . . . 0.0 112.514 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.42 149.85 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.16 1.384 . . . . 0.0 109.73 170.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HE2' ' CZ3' ' A' ' 33' ' ' TRP . 44.3 mtmt -142.23 150.47 40.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.181 1.792 . . . . 0.0 108.56 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -81.27 130.88 35.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 148.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -77.93 137.18 38.2 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 166.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.88 -24.82 62.72 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.196 0.598 . . . . 0.0 111.985 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -28.33 65.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.915 1.686 . . . . 0.0 112.869 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.18 3.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.228 1.394 . . . . 0.0 112.262 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.87 172.15 2.42 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.003 0.921 . . . . 0.0 111.197 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.58 140.58 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -127.07 143.54 51.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.073 0.949 . . . . 0.0 108.805 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.76 143.13 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 tt -149.58 127.74 12.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.55 157.24 35.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.135 0.88 . . . . 0.0 111.284 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.81 150.35 21.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.217 1.407 . . . . 0.0 109.71 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.55 174.08 38.27 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.635 1.588 . . . . 0.0 111.211 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.48 155.34 55.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.659 2.24 . . . . 0.0 110.306 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.55 -42.11 74.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -172.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.71 -41.53 99.19 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.075 -0.391 . . . . 0.0 111.576 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -45.56 79.84 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.945 0.498 . . . . 0.0 110.065 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -59.83 -45.37 92.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.894 0.878 . . . . 0.0 110.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -70.95 -40.87 71.77 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.582 -0.699 . . . . 0.0 112.057 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.6 m -60.18 -40.32 89.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.557 0.617 . . . . 0.0 110.021 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.16 -49.19 78.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.705 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.85 -44.31 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.683 1.129 . . . . 0.0 109.9 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.56 -41.4 98.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 111.215 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.46 96.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.527 0.731 . . . . 0.0 111.316 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 t -64.04 -53.38 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -57.02 -42.16 79.86 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.4 0.68 . . . . 0.0 111.014 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.52 -22.59 62.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.444 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.61 46.03 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 118.931 0.787 . . . . 0.0 111.386 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -50.69 -51.66 63.67 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -161.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.66 -40.42 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.402 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -165.09 172.94 12.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.792 2.037 . . . . 0.0 107.881 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m 62.71 170.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.159 1.383 . . . . 0.0 112.595 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.29 141.73 10.98 Favored 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.85 154.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -119.37 -12.66 9.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.245 1.418 . . . . 0.0 109.38 165.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.26 142.96 25.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.411 1.485 . . . . 0.0 108.155 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.3 tt -146.98 141.08 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -138.09 143.3 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.7 142.88 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -171.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.0 m -130.18 151.43 50.71 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 167.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -136.26 146.1 46.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -137.98 158.1 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.638 1.575 . . . . 0.0 108.384 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.92 -20.05 21.81 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.687 -0.633 . . . . 0.0 111.031 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 m -64.11 126.59 28.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.58 0.752 . . . . 0.0 110.242 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -68.21 173.45 4.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.386 1.075 . . . . 0.0 109.9 159.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -125.15 6.24 7.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.999 1.72 . . . . 0.0 111.025 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.18 22.96 61.37 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.455 1.026 . . . . 0.0 112.386 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -88.17 140.66 29.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.215 1.007 . . . . 0.0 108.713 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -132.69 11.57 4.39 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.55 165.47 32.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.241 1.817 . . . . 0.0 108.025 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -93.34 152.57 19.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.7 m -141.1 150.99 43.59 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.849 0.833 . . . . 0.0 111.185 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.0 110.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 165.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.06 178.78 4.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.21 1.004 . . . . 0.0 110.994 -165.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -153.78 157.5 39.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.217 2.207 . . . . 0.0 108.469 -168.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.9 166.14 23.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.161 0.584 . . . . 0.0 110.673 166.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -133.88 141.1 47.24 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 152.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.1 146.61 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -168.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 134.43 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.2 154.86 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.469 1.108 . . . . 0.0 111.072 -167.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -143.18 157.56 44.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.969 1.708 . . . . 0.0 108.876 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 -154.6 26.0 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 106.649 -2.581 . . . . 0.0 106.649 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -74.93 54.89 0.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.827 -0.807 . . . . 0.0 108.839 163.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.08 -10.72 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 121.256 -0.902 . . . . 0.0 113.206 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.544 HE22 ' HB3' ' A' ' 18' ' ' ARG . 22.0 mm-40 . . . . . 0 C--O 1.232 0.17 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.544 ' HB3' HE22 ' A' ' 13' ' ' GLN . 15.6 ptp180 . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.75 -15.55 63.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 117.432 -1.271 . . . . 0.0 112.457 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.916 1.689 . . . . 0.0 111.886 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.35 -35.32 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.17 0.895 . . . . 0.0 110.245 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.89 -28.36 66.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.566 1.075 . . . . 0.0 110.813 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -42.89 69.78 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.483 -0.76 . . . . 0.0 109.864 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.66 -35.97 81.44 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.621 -0.675 . . . . 0.0 110.197 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.16 89.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.598 1.159 . . . . 0.0 110.178 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.78 -39.4 84.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.115 0.566 . . . . 0.0 111.575 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -57.22 -42.12 80.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.655 0.661 . . . . 0.0 110.58 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -85.62 3.35 41.21 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 111.772 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 46.99 35.77 3.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.44 171.71 8.32 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 163.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.52 139.25 21.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -165.52 38.73 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.023 -163.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.15 160.47 27.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.955 1.302 . . . . 0.0 112.295 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.16 142.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.342 1.057 . . . . 0.0 109.444 164.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -147.88 171.89 15.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 109.563 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -123.76 114.92 20.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -75.57 152.69 37.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.08 -28.56 67.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 112.009 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.0 -27.03 68.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.001 0.921 . . . . 0.0 112.522 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.12 -27.39 4.55 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.086 1.327 . . . . 0.0 112.457 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.37 151.58 31.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.007 0.903 . . . . 0.0 110.258 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.96 149.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 155.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -128.04 144.93 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.068 1.347 . . . . 0.0 107.384 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 146.44 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -141.28 138.52 33.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.78 169.3 21.65 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.712 1.596 . . . . 0.0 110.869 171.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.91 154.87 37.76 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.999 1.32 . . . . 0.0 110.456 167.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.55 179.91 41.11 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.99 1.281 . . . . 0.0 111.49 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.44 156.63 54.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.681 2.254 . . . . 0.0 110.889 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -55.29 -46.88 76.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 111.688 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.6 -38.44 91.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.855 0.298 . . . . 0.0 111.469 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -47.34 75.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.576 0.35 . . . . 0.0 110.147 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.07 -48.53 81.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.385 0.674 . . . . 0.0 109.906 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -65.27 -45.84 82.85 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.197 0.599 . . . . 0.0 111.59 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -40.44 97.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.235 0.47 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.76 -48.68 80.38 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.684 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.02 -40.63 74.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.705 1.139 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.98 -42.13 99.75 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.172 0.897 . . . . 0.0 110.811 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.61 98.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.016 0.526 . . . . 0.0 111.667 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.17 -57.67 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.27 -42.71 91.85 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -171.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.07 -24.86 66.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.627 0.371 . . . . 0.0 111.652 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.97 50.05 66.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -52.09 77.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.831 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.45 -176.22 3.15 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.555 2.17 . . . . 0.0 110.584 170.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -106.23 154.34 20.86 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 153.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 171.3 1.55 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.412 2.685 . . . . 0.0 111.293 -7.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -135.57 161.66 34.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.173 -0.955 . . . . 0.0 110.748 -156.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.72 146.37 34.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -133.26 -5.42 3.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.228 1.011 . . . . 0.0 110.864 171.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.81 141.92 22.23 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.707 1.203 . . . . 0.0 108.858 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.9 146.98 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.506 1.123 . . . . 0.0 108.843 -173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 m -136.0 143.01 44.57 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.76 146.14 26.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -170.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 m -126.93 141.4 51.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 161.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.88 139.92 48.92 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -149.58 175.88 11.14 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.96 1.304 . . . . 0.0 109.43 -159.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.29 17.55 2.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.304 1.042 . . . . 0.0 111.113 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -66.97 -27.64 67.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.114 0.966 . . . . 0.0 111.695 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.95 175.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.154 2.182 . . . . 0.0 111.84 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.52 -13.08 0.39 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.46 1.104 . . . . 0.0 112.487 -170.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.92 15.03 79.96 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.031 0.824 . . . . 0.0 112.387 176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -66.49 126.06 27.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.554 1.177 . . . . 0.0 108.596 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -129.23 23.89 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.543 1.537 . . . . 0.0 108.244 164.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -148.18 161.33 41.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.386 2.274 . . . . 0.0 106.758 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -106.07 145.15 31.79 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -138.38 150.6 46.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.521 1.153 . . . . 0.0 111.675 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.72 133.37 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.237 0.414 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -174.646 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ttp . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.28 176.91 6.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.65 1.114 . . . . 0.0 111.183 -167.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.24 143.94 25.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.474 2.31 . . . . 0.0 107.345 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -103.41 159.64 15.4 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 168.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -119.22 141.38 48.95 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 151.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -140.64 140.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.95 139.18 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.86 153.03 24.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.722 0.809 . . . . 0.0 110.773 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -140.37 147.93 40.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.555 1.542 . . . . 0.0 108.06 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -154.55 25.98 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -76.42 80.71 3.15 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 162.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -107.5 0.76 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.082 0.953 . . . . 0.0 111.391 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.341 0.237 0 O-C-N 121.075 -1.016 . . . . 0.0 109.239 178.048 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -68.65 -36.33 78.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.415 1.007 . . . . 0.0 109.763 171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -52.02 -48.02 64.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.239 0.615 . . . . 0.0 111.907 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.65 -35.21 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.684 0.674 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -75.07 -23.5 58.03 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.803 -1.185 . . . . 0.0 112.037 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.1 mtm -64.33 -50.25 68.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.218 0.917 . . . . 0.0 109.411 167.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.59 -39.27 90.6 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.262 0.625 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.74 54.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.211 1.005 . . . . 0.0 109.843 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.14 -45.71 93.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.152 0.581 . . . . 0.0 110.883 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -59.21 -24.7 63.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.523 1.529 . . . . 0.0 111.888 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -108.38 13.24 25.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.236 1.414 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 50.41 31.15 5.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.974 1.71 . . . . 0.0 112.843 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.8 160.09 28.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.121 0.969 . . . . 0.0 108.503 169.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.03 124.43 12.35 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.488 0.715 . . . . 0.0 109.922 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.51 -175.01 35.67 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.851 0.739 . . . . 0.0 112.091 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -99.78 161.14 13.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -164.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.71 143.61 38.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 156.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.41 152.59 38.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.429 0.692 . . . . 0.0 110.137 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -72.54 123.25 22.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -81.55 132.39 35.31 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.34 -29.44 65.95 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -167.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -17.18 62.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.06 0.944 . . . . 0.0 113.246 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.31 -15.53 6.09 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.472 1.511 . . . . 0.0 112.891 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.12 175.96 3.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.951 1.376 . . . . 0.0 109.721 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.12 145.01 24.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -116.81 143.13 46.04 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.8 133.45 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -150.41 117.18 5.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.54 149.98 28.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.542 0.61 . . . . 0.0 112.355 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.29 157.29 18.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.692 1.197 . . . . 0.0 110.345 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.83 38.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.895 1.236 . . . . 0.0 111.582 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.31 153.99 65.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.259 1.972 . . . . 0.0 110.368 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.3 -48.32 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 111.494 -170.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.14 -38.34 90.69 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.087 0.403 . . . . 0.0 111.786 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.67 89.48 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.045 0.538 . . . . 0.0 109.832 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -47.55 84.81 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.438 0.695 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -67.34 -40.51 85.9 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.802 -0.561 . . . . 0.0 111.553 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -67.15 -35.67 80.21 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.79 -0.568 . . . . 0.0 110.69 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.47 -47.04 87.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.971 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.41 -42.71 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.913 1.233 . . . . 0.0 109.55 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -41.0 96.06 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.257 0.935 . . . . 0.0 111.313 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.74 -40.73 89.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.737 0.815 . . . . 0.0 111.46 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -55.33 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -59.24 -37.89 78.66 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.195 0.598 . . . . 0.0 111.734 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.98 -23.55 65.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.179 0.592 . . . . 0.0 112.261 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.35 43.03 89.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 118.672 0.669 . . . . 0.0 111.508 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -50.28 -49.11 78.41 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -168.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.54 -59.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.735 1.655 . . . . 0.0 112.204 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -171.3 -47.44 0.02 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.213 1.805 . . . . 0.0 108.173 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.61 146.79 24.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.04 0.936 . . . . 0.0 109.546 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -156.2 162.52 40.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.994 0.918 . . . . 0.0 108.97 -167.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -115.02 148.91 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 p -121.42 -9.07 9.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.684 1.594 . . . . 0.0 109.455 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -150.44 143.08 24.55 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.696 1.598 . . . . 0.0 107.57 166.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.5 140.9 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -136.46 143.39 43.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.527 1.531 . . . . 0.0 106.87 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -140.1 147.98 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -127.28 154.32 45.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -133.04 143.6 49.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -158.37 170.8 21.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.037 . . . . 0.0 109.752 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.06 5.47 44.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.829 0.852 . . . . 0.0 110.981 171.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 m -71.53 73.31 0.75 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.755 2.022 . . . . 0.0 111.59 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.16 140.92 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.444 -0.785 . . . . 0.0 109.763 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -78.58 -23.72 45.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.524 0.73 . . . . 0.0 111.394 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.68 48.14 13.53 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -167.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.78 154.87 43.67 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.477 1.111 . . . . 0.0 109.662 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -136.42 8.32 3.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.856 0.862 . . . . 0.0 112.438 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -149.13 166.47 28.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.519 1.528 . . . . 0.0 108.417 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -76.87 163.11 27.06 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.4 m -140.07 152.57 46.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.805 1.242 . . . . 0.0 109.331 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mt -135.11 116.44 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttp . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.01 176.99 7.19 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.878 -1.139 . . . . 0.0 111.891 -159.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -145.4 156.32 43.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.23 1.812 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.2 165.67 15.08 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.53 0.732 . . . . 0.0 110.508 161.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -128.09 143.28 51.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 149.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 98.0 mt -137.62 138.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.36 133.38 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.18 153.33 18.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 111.24 -169.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.42 145.93 35.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.034 1.734 . . . . 0.0 107.447 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.24 -154.12 25.76 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -172.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -78.05 88.31 4.19 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 157.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.96 3.28 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.761 1.224 . . . . 0.0 111.092 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.333 1.053 . . . . 0.0 109.391 -168.784 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -62.99 -35.87 81.64 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.108 1.322 . . . . 0.0 109.025 161.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.55 -50.26 24.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.002 0.819 . . . . 0.0 112.564 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.64 -40.07 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 119.215 0.916 . . . . 0.0 109.898 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -74.25 -23.65 59.18 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.631 -1.293 . . . . 0.0 112.152 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.24 82.46 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 169.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -62.79 -37.38 86.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.083 0.856 . . . . 0.0 109.91 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.53 57.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.13 0.572 . . . . 0.0 109.856 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.82 -46.16 91.62 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.253 0.621 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -58.11 -28.1 64.33 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.892 1.277 . . . . 0.0 111.937 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -107.4 12.43 28.0 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.914 1.286 . . . . 0.0 111.159 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 49.61 31.91 4.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 112.742 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.5 mt -73.88 164.09 27.09 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 168.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.66 135.67 31.9 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.79 -165.79 38.99 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -140.15 161.77 36.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.648 0.779 . . . . 0.0 111.987 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.81 143.08 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.48 1.112 . . . . 0.0 108.625 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -143.95 163.09 34.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.962 1.705 . . . . 0.0 108.435 -164.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -115.21 120.63 40.36 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -75.92 147.23 39.11 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.27 -28.34 66.64 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.377 0.671 . . . . 0.0 112.084 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.01 0.924 . . . . 0.0 112.461 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.36 -29.4 3.17 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.173 1.368 . . . . 0.0 112.225 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.75 152.2 31.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.911 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.34 148.1 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 160.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -128.38 144.6 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.69 141.35 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -146.15 125.76 13.33 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.69 161.07 42.93 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.019 0.528 . . . . 0.0 110.409 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.31 154.47 22.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.409 1.483 . . . . 0.0 108.051 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 179.32 40.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.39 0.519 . . . . 0.0 111.826 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.24 157.44 59.43 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.325 2.016 . . . . 0.0 110.793 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.08 -49.25 74.33 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.148 0.979 . . . . 0.0 111.527 -170.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -66.84 -38.06 85.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 119.406 -0.331 . . . . 0.0 111.395 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.88 74.02 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.238 0.615 . . . . 0.0 109.714 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.98 -44.61 96.38 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.352 0.661 . . . . 0.0 110.803 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.31 -34.7 55.35 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.766 -0.584 . . . . 0.0 111.583 -173.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -68.85 -35.39 76.87 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.305 -0.872 . . . . 0.0 110.743 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.99 -48.72 79.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.316 0.646 . . . . 0.0 109.549 168.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -55.81 -42.97 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.19 0.904 . . . . 0.0 109.67 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.48 -41.91 97.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.401 1.0 . . . . 0.0 111.419 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -40.98 82.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.006 0.923 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.39 -52.49 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.86 0.755 . . . . 0.0 109.5 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.77 -39.17 90.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.132 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -64.33 -21.07 66.49 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.298 1.039 . . . . 0.0 111.904 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.62 172.83 21.55 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -152.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 p -139.65 -179.98 1.15 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 121.839 -0.8 . . . . 0.0 110.031 -164.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.16 -24.62 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.461 2.774 . . . . 0.0 115.742 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.95 2.6 0.44 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 m -126.62 159.1 34.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.56 1.527 . . . . 0.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 145.83 20.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.333 0.969 . . . . 0.0 111.175 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.01 156.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -122.59 -12.46 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.62 1.568 . . . . 0.0 109.506 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -150.07 145.92 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.362 1.465 . . . . 0.0 108.185 165.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.38 144.25 16.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.773 1.229 . . . . 0.0 108.503 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m -139.29 145.64 39.37 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.726 1.611 . . . . 0.0 107.355 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.12 144.27 29.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.8 m -130.91 151.09 51.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.48 145.99 50.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.5 m -147.55 -176.59 5.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.987 1.315 . . . . 0.0 109.263 -167.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -127.73 10.33 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 110.977 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -67.66 -29.46 68.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.788 1.235 . . . . 0.0 114.02 -161.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.9 mt 62.04 171.82 0.13 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.351 1.86 . . . . 0.0 111.924 -170.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -139.03 -30.96 0.72 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.597 1.159 . . . . 0.0 111.412 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.79 30.47 77.29 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -72.86 164.0 27.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.04 1.336 . . . . 0.0 108.922 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.82 11.59 4.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.623 0.769 . . . . 0.0 111.763 -173.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -145.84 167.47 23.14 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.221 1.008 . . . . 0.0 109.253 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -89.04 141.94 28.06 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 139.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -133.14 163.35 29.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.502 0.721 . . . . 0.0 110.758 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 mt -138.06 127.39 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.535 0.397 0 C-N-CA 124.537 1.135 . . . . 0.0 107.95 -175.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.416 0.151 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mp -134.19 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.596 1.159 . . . . 0.0 111.051 -160.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.32 154.08 42.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.46 1.904 . . . . 0.0 107.401 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.7 164.62 15.09 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.453 0.701 . . . . 0.0 110.51 165.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -125.67 140.83 52.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 147.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.52 142.98 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 137.49 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.87 149.79 23.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.202 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -138.96 155.71 47.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.572 1.549 . . . . 0.0 107.807 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.71 -156.35 25.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -79.75 65.98 5.08 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 163.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 27.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.133 0.973 . . . . 0.0 111.076 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -159.44 -174.73 4.81 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.38 -45.27 0.35 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -150.89 -30.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.251 1.02 . . . . 0.0 110.434 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.49 47.44 0.13 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.108 0.867 . . . . 0.0 113.281 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -60.72 -37.43 81.71 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.207 1.504 . . . . 0.0 109.96 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -61.28 -35.48 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.916 -0.49 . . . . 0.0 111.087 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.66 -45.48 75.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.941 0.791 . . . . 0.0 109.931 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.32 -50.29 65.28 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.2 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.4 -38.92 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.463 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -71.67 -22.58 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 113.078 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.1 mtm -64.32 -46.75 82.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.637 1.108 . . . . 0.0 108.826 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.79 -31.33 72.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.54 -54.79 41.16 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.988 0.915 . . . . 0.0 109.675 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.15 -40.49 96.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.957 0.503 . . . . 0.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -55.21 -28.7 54.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.122 . . . . 0.0 111.887 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -118.59 20.71 12.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.697 0.799 . . . . 0.0 111.617 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 41.59 42.14 1.91 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.771 2.428 . . . . 0.0 113.67 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.47 163.67 27.64 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.08 130.76 17.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.74 -162.52 34.17 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.029 -168.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -130.86 161.7 31.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.047 . . . . 0.0 112.168 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.43 148.12 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.948 1.299 . . . . 0.0 109.22 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.99 156.75 43.0 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.243 1.817 . . . . 0.0 108.143 -170.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -115.54 121.48 42.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.18 151.26 36.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.487 1.115 . . . . 0.0 109.177 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.14 -28.7 69.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.976 0.51 . . . . 0.0 111.382 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -7.63 48.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.153 0.981 . . . . 0.0 113.259 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.81 -19.57 32.92 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.03 1.3 . . . . 0.0 113.265 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.33 163.66 22.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.918 1.359 . . . . 0.0 110.435 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.89 149.77 5.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 158.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -135.23 144.91 47.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -141.33 144.78 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.85 130.1 13.69 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.07 154.51 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.102 0.864 . . . . 0.0 111.07 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.24 157.16 16.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.927 1.291 . . . . 0.0 109.838 168.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 178.49 40.31 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.715 0.674 . . . . 0.0 112.577 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.49 155.69 40.72 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.311 2.008 . . . . 0.0 110.174 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.27 -47.54 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 111.432 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.06 -39.62 93.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.941 0.337 . . . . 0.0 111.248 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.95 -46.66 77.33 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.02 0.373 . . . . 0.0 110.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.12 -43.19 99.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.687 0.795 . . . . 0.0 110.509 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -71.83 -38.7 70.12 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.757 -0.589 . . . . 0.0 111.918 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.4 m -62.57 -39.56 94.06 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.664 -0.648 . . . . 0.0 110.075 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -60.75 -46.95 88.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.695 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.76 -44.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 119.861 1.21 . . . . 0.0 109.486 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -62.16 -42.04 98.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.972 0.805 . . . . 0.0 111.408 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.39 87.87 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.025 0.93 . . . . 0.0 111.901 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.76 -54.74 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.26 -38.67 80.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.403 1.081 . . . . 0.0 112.062 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.31 -26.23 68.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.135 0.574 . . . . 0.0 111.69 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.34 47.28 91.63 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -53.08 -39.63 72.39 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.901 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -66.23 -174.81 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.806 3.004 . . . . 0.0 114.841 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -63.42 -37.03 85.71 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.319 1.048 . . . . 0.0 111.045 164.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.1 m -70.06 137.98 51.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.377 1.071 . . . . 0.0 108.244 165.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 150.7 35.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.415 0.552 . . . . 0.0 111.049 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.08 151.38 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.152 1.381 . . . . 0.0 107.998 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -128.45 -11.55 5.07 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.099 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -151.56 140.57 21.11 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.652 1.181 . . . . 0.0 108.957 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.1 tt -140.98 149.08 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.793 1.237 . . . . 0.0 108.746 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 m -139.13 144.88 38.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.04 143.0 34.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.6 m -130.04 150.84 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 153.44 50.88 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.529 0.731 . . . . 0.0 110.415 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.6 m -151.53 173.77 14.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.498 1.519 . . . . 0.0 109.208 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 1.33 24.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.901 1.28 . . . . 0.0 110.988 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -72.69 75.73 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.74 2.016 . . . . 0.0 111.839 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.67 153.76 9.99 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.58 -0.7 . . . . 0.0 110.41 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.99 -26.29 7.36 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.781 1.232 . . . . 0.0 110.671 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.11 24.22 59.92 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -163.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 139.78 49.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.685 1.243 . . . . 0.0 108.332 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -134.41 14.58 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.082 . . . . 0.0 111.705 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.2 171.94 15.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.444 1.497 . . . . 0.0 109.111 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -98.33 153.59 18.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -140.38 154.15 46.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 110.075 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.74 111.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.38 138.78 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -80.49 36.88 0.38 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.474 1.109 . . . . 0.0 111.089 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.445 1.498 . . . . 0.0 110.287 178.051 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.46 178.53 7.53 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.979 -1.076 . . . . 0.0 110.062 -167.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -152.91 158.48 42.19 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.988 1.715 . . . . 0.0 108.549 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.37 165.99 16.09 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.991 0.916 . . . . 0.0 110.465 168.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -131.03 135.82 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 151.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.27 145.43 33.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.92 138.8 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 170.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.53 146.27 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.136 0.975 . . . . 0.0 109.938 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.87 157.17 46.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 108.805 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.05 25.11 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -81.4 92.61 6.46 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 160.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.77 10.42 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.487 1.515 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -140.09 149.43 43.08 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.917 -1.114 . . . . 0.0 110.663 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.82 -170.38 34.19 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.752 2.12 . . . . 0.0 108.04 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.26 -25.41 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.08 1.41 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.067 0.849 . . . . 0.0 113.6 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -69.4 -43.11 74.13 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.399 1.599 . . . . 0.0 110.144 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -69.28 -23.67 63.86 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.764 -1.21 . . . . 0.0 112.105 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.54 -35.43 80.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.414 1.007 . . . . 0.0 110.608 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -50.22 66.22 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.732 1.151 . . . . 0.0 110.728 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.8 -33.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.218 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -74.11 -25.31 59.71 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.854 1.207 . . . . 0.0 112.278 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -62.83 -47.56 82.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.902 0.773 . . . . 0.0 109.139 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -66.67 -29.66 69.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.613 0.365 . . . . 0.0 110.835 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.866 1.266 . . . . 0.0 109.975 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.27 -39.75 91.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.947 0.499 . . . . 0.0 111.197 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.29 -18.77 51.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.634 1.173 . . . . 0.0 112.545 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -114.59 15.17 17.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.012 1.278 . . . . 0.0 111.389 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.87 33.17 2.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.29 1.836 . . . . 0.0 112.724 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.97 161.96 29.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.18 134.82 42.56 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.2 -172.93 42.98 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 118.182 0.446 . . . . 0.0 112.107 -164.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -135.09 162.39 32.61 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.521 0.729 . . . . 0.0 112.124 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.83 149.76 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.562 1.145 . . . . 0.0 108.84 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.42 156.02 42.49 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.51 1.924 . . . . 0.0 107.585 -170.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.32 122.57 45.3 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -76.88 159.73 29.79 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.135 0.974 . . . . 0.0 110.337 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -61.19 -30.17 70.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.246 0.618 . . . . 0.0 111.458 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -10.19 57.96 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.98 -23.84 24.6 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.527 1.536 . . . . 0.0 112.204 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -87.81 166.09 14.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.229 1.514 . . . . 0.0 110.469 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.9 150.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -133.51 143.41 48.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.89 1.276 . . . . 0.0 107.667 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.05 142.71 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.64 123.55 10.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.26 162.98 40.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.413 0.552 . . . . 0.0 110.818 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.61 151.75 32.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 109.871 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.54 177.92 40.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.23 1.395 . . . . 0.0 110.351 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 154.45 67.79 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.353 2.035 . . . . 0.0 110.086 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.0 -42.42 76.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.558 0.743 . . . . 0.0 111.577 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.02 -41.19 99.49 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.148 -0.345 . . . . 0.0 111.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.48 84.19 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.988 0.515 . . . . 0.0 109.987 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.92 -43.34 99.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.565 0.746 . . . . 0.0 110.699 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -70.48 -40.9 73.34 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.636 -0.665 . . . . 0.0 111.697 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.5 m -59.8 -39.9 86.54 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.059 -0.401 . . . . 0.0 110.019 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -61.87 -47.43 85.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.952 173.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -53.99 -46.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.078 1.308 . . . . 0.0 109.593 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -61.78 -39.99 93.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.001 0.364 . . . . 0.0 111.039 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.75 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.282 0.633 . . . . 0.0 111.899 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.73 -49.44 80.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -57.86 -41.64 82.86 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.036 0.534 . . . . 0.0 110.826 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -72.12 -20.78 61.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.125 0.97 . . . . 0.0 112.451 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 40.81 92.67 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.365 0.984 . . . . 0.0 111.832 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 m -46.47 -54.33 19.15 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -160.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.36 -52.28 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 121.797 1.678 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -167.82 158.43 10.82 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.253 2.221 . . . . 0.0 107.412 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 p 129.48 176.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 131.713 4.005 . . . . 0.0 108.717 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.77 157.74 43.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 145.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.21 137.65 56.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -126.39 -5.69 6.53 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.233 1.413 . . . . 0.0 110.788 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.17 134.12 13.97 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.363 1.865 . . . . 0.0 106.405 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.42 138.42 21.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.0 m -140.58 147.82 40.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.92 143.63 28.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.1 m -130.19 152.44 49.62 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -129.2 145.07 51.4 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.4 m -143.61 167.65 21.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.902 1.281 . . . . 0.0 109.582 -160.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.73 1.89 10.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 110.971 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.6 m -65.91 -26.17 67.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.145 0.978 . . . . 0.0 112.709 -173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.5 mt 60.82 175.76 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.381 1.872 . . . . 0.0 111.414 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.8 -16.52 0.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.023 0.929 . . . . 0.0 113.046 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.8 90.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.221 -1.322 . . . . 0.0 116.198 155.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -81.83 178.41 8.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.039 1.919 . . . . 0.0 109.929 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -130.16 17.24 5.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.554 1.541 . . . . 0.0 110.718 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -149.38 167.54 25.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.551 1.541 . . . . 0.0 109.292 -172.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -86.04 151.63 23.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 163.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -142.95 162.34 35.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.838 0.855 . . . . 0.0 110.53 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.59 114.82 18.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.75 141.31 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.7 -46.91 87.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.438 0.295 . . . . 0.0 110.845 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.937 1.695 . . . . 0.0 110.744 179.14 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.205 -0.426 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.13 177.42 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.882 1.219 . . . . 0.0 111.248 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -146.79 155.22 42.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.675 2.39 . . . . 0.0 108.081 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.44 165.18 14.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.99 0.916 . . . . 0.0 110.426 169.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -131.06 133.78 46.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 154.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.45 141.63 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.68 128.73 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.16 137.59 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.67 1.188 . . . . 0.0 109.83 -164.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -131.44 150.83 52.0 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.655 1.182 . . . . 0.0 108.393 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -152.65 24.74 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.55 78.88 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 164.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.71 4.17 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.651 0.78 . . . . 0.0 111.892 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -153.21 153.88 33.6 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.76 80.83 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.507 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.68 9.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.607 1.163 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.0 15.38 80.71 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.909 -0.94 . . . . 0.0 113.099 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -50.39 -48.12 56.06 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.099 1.45 . . . . 0.0 111.121 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -75.67 -15.36 60.32 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.315 -0.954 . . . . 0.0 113.294 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -72.33 -45.42 60.01 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.897 1.226 . . . . 0.0 108.97 163.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -48.68 64.12 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.964 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 m -62.12 -37.1 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 119.802 1.183 . . . . 0.0 110.791 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -73.53 -23.18 59.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.5 1.5 . . . . 0.0 112.273 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.4 mtm -62.94 -47.07 84.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.262 0.937 . . . . 0.0 109.34 165.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -66.65 -32.6 74.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.494 . . . . 0.0 110.804 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.51 72.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.585 1.154 . . . . 0.0 109.583 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.34 -42.07 99.09 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 111.235 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.01 -21.49 45.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.635 1.174 . . . . 0.0 112.255 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 16.22 12.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.995 -1.066 . . . . 0.0 111.947 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? 45.69 38.57 4.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.869 2.067 . . . . 0.0 112.31 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.5 mt -75.66 164.23 26.51 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.73 130.98 22.07 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.71 -162.07 33.63 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.39 163.63 30.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.626 0.713 . . . . 0.0 111.994 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.42 142.53 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.058 0.943 . . . . 0.0 109.732 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -149.21 151.86 35.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 125.3 1.44 . . . . 0.0 108.248 -162.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 120.07 29.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 166.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -74.21 153.24 39.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.96 -25.52 67.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.884 0.874 . . . . 0.0 112.341 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.54 -27.64 67.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.382 1.073 . . . . 0.0 112.104 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.21 -31.78 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.318 1.437 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -68.32 163.67 22.49 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.732 0.766 . . . . 0.0 110.54 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.35 156.53 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -134.05 141.53 47.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.658 1.583 . . . . 0.0 107.881 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -134.03 141.01 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -149.91 119.41 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.2 160.23 42.78 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.488 0.715 . . . . 0.0 111.205 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.83 154.93 20.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.179 1.392 . . . . 0.0 110.313 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 175.61 37.63 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.057 1.313 . . . . 0.0 111.001 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.89 153.43 68.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.146 1.897 . . . . 0.0 110.261 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -55.33 -43.32 74.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.653 0.781 . . . . 0.0 111.533 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -62.69 -40.43 97.1 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.245 -0.284 . . . . 0.0 111.459 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.64 74.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.14 -44.87 92.08 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.45 0.7 . . . . 0.0 110.023 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -68.87 -40.51 79.25 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.88 -0.512 . . . . 0.0 111.955 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -60.67 -42.68 97.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.567 0.621 . . . . 0.0 110.063 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -59.53 -48.97 79.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.432 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.72 -42.92 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.953 1.251 . . . . 0.0 110.0 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.17 -41.89 99.3 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.871 0.76 . . . . 0.0 110.743 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.82 96.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.657 0.783 . . . . 0.0 111.366 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.1 -52.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -56.75 -41.63 77.89 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.81 0.844 . . . . 0.0 111.046 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -72.75 -20.96 61.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.018 -0.515 . . . . 0.0 112.365 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.73 40.42 48.72 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.436 1.017 . . . . 0.0 111.906 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -45.63 -53.94 17.58 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -157.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -49.65 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 CA-C-N 121.481 1.565 . . . . 0.0 112.216 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 67' ' ' SER . 17.5 p90 -167.48 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.012 0.925 . . . . 0.0 112.718 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.403 ' HA ' ' CD1' ' A' ' 66' ' ' PHE 0.269 1.4 m -62.63 -57.32 11.49 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -120.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 161.63 40.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 130.277 3.431 . . . . 0.0 108.511 -5.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.54 157.18 7.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.318 0.647 . . . . 0.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.2 p -127.21 -11.88 5.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.22 1.408 . . . . 0.0 110.378 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.22 144.83 25.87 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.926 1.291 . . . . 0.0 108.471 172.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.28 144.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.0 108.217 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 m -139.46 145.29 38.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.337 1.455 . . . . 0.0 107.219 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.07 142.69 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.375 1.07 . . . . 0.0 108.281 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -132.45 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.396 1.878 . . . . 0.0 106.048 168.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -137.99 149.04 45.75 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 m -148.76 162.83 38.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.375 1.47 . . . . 0.0 109.114 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.11 -13.24 57.55 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.602 -0.686 . . . . 0.0 111.362 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 88.83 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 111.899 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.84 147.58 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.531 0.732 . . . . 0.0 110.26 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -81.95 -28.2 32.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.892 0.877 . . . . 0.0 112.026 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.98 68.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.038 0.828 . . . . 0.0 111.219 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.67 150.17 34.58 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.808 1.304 . . . . 0.0 109.378 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -134.76 9.37 3.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.958 0.903 . . . . 0.0 112.547 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -149.26 177.55 9.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.149 1.38 . . . . 0.0 109.158 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -101.79 145.02 29.74 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 163.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 161.81 37.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.628 0.728 . . . . 0.0 111.431 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.1 mt -133.88 126.86 51.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.72 165.88 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 109.656 -163.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -142.82 50.84 1.43 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.174 0.99 . . . . 0.0 108.661 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.477 1.511 . . . . 0.0 111.416 -177.08 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp -129.29 176.03 8.26 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.686 -1.259 . . . . 0.0 111.18 -165.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.55 152.8 38.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.844 1.658 . . . . 0.0 109.183 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.68 165.22 18.98 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.387 1.075 . . . . 0.0 111.054 169.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -134.28 133.41 40.73 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 158.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.41 142.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.54 133.26 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.65 141.92 29.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.71 151.77 49.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.888 1.275 . . . . 0.0 108.054 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.61 -153.75 25.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -76.72 82.45 3.34 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 158.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -107.59 -1.63 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.496 HE22 ' HB3' ' A' ' 18' ' ' ARG . 9.9 mm-40 -133.82 156.76 47.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.21 -148.7 15.01 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.43 -30.47 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.73 11.3 66.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 118.982 0.81 . . . . 0.0 112.894 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 36.71 -118.44 0.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.541 2.336 . . . . 0.0 110.316 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.7 ptt-85 -114.68 1.45 14.2 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.134 0.974 . . . . 0.0 111.443 170.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -69.08 -23.56 64.04 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 117.608 -1.186 . . . . 0.0 111.125 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.04 -52.14 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.283 1.402 . . . . 0.0 111.736 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.51 -31.83 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.716 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -66.51 -31.14 71.69 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.872 1.214 . . . . 0.0 112.288 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.7 mtm -65.76 -49.94 66.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.456 1.026 . . . . 0.0 108.637 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -67.8 -33.12 74.19 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.205 0.457 . . . . 0.0 110.875 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -53.21 57.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.482 1.113 . . . . 0.0 110.336 173.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.13 -40.05 93.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.561 0.745 . . . . 0.0 111.288 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -53.52 -28.14 29.61 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.165 1.386 . . . . 0.0 111.817 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -118.58 22.8 11.86 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.567 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 tttt 50.21 36.18 11.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.506 1.922 . . . . 0.0 113.089 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.69 163.6 27.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.23 126.18 21.02 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.1 -161.86 29.72 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.926 0.785 . . . . 0.0 113.148 -168.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -135.06 166.09 23.87 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.79 144.0 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.754 1.221 . . . . 0.0 108.818 162.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.0 161.74 40.19 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.818 0.847 . . . . 0.0 110.34 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.76 148.06 38.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 158.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -126.08 140.29 52.71 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.929 1.291 . . . . 0.0 107.785 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.11 -24.78 63.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.402 1.481 . . . . 0.0 114.318 -163.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.0 -23.03 65.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.188 0.595 . . . . 0.0 112.301 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 37.16 1.39 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.753 1.168 . . . . 0.0 111.123 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -145.81 163.88 33.65 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.358 1.063 . . . . 0.0 109.144 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.26 150.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.26 143.17 51.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.405 1.882 . . . . 0.0 107.259 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -137.6 139.32 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -150.04 126.58 10.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.11 161.96 39.42 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 119.049 0.84 . . . . 0.0 111.374 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.99 154.3 23.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.177 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.39 177.29 39.9 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.312 0.958 . . . . 0.0 111.53 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.28 157.59 53.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.771 2.314 . . . . 0.0 110.757 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -55.37 -53.29 58.09 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.526 0.731 . . . . 0.0 111.511 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -59.98 -37.49 79.81 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.967 -0.458 . . . . 0.0 111.527 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.36 76.25 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.28 -47.13 85.69 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.467 0.707 . . . . 0.0 110.534 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -68.53 -42.09 78.96 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.888 -0.508 . . . . 0.0 111.339 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 m -63.37 -37.74 88.46 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.765 -0.584 . . . . 0.0 110.204 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.6 -45.54 93.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.448 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t -55.23 -45.61 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 120.013 1.279 . . . . 0.0 109.535 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.4 -41.01 88.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.043 0.383 . . . . 0.0 111.031 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.79 95.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.14 0.976 . . . . 0.0 111.631 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.55 -50.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.179 0.9 . . . . 0.0 108.668 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -58.77 -41.63 87.07 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.703 0.401 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -71.41 -22.14 61.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.073 0.549 . . . . 0.0 112.393 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.1 39.12 40.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.944 1.259 . . . . 0.0 112.756 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -41.11 -50.05 8.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -159.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.81 -31.49 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.649 1.625 . . . . 0.0 114.704 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -164.26 -31.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.083 1.31 . . . . 0.0 113.264 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.03 170.87 13.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.799 1.64 . . . . 0.0 111.723 -170.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.13 145.03 19.15 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -83.92 153.23 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.6 p -118.25 -14.17 9.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.065 1.346 . . . . 0.0 109.376 165.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.64 137.89 21.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.328 1.451 . . . . 0.0 107.68 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tt -144.61 136.49 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 m -133.77 142.69 48.03 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.84 141.48 40.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.27 146.2 51.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 171.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.55 154.72 46.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.809 0.731 . . . . 0.0 110.102 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -147.89 176.72 9.92 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.878 1.671 . . . . 0.0 108.245 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -119.46 -7.16 10.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.719 0.808 . . . . 0.0 110.191 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m -70.22 100.54 1.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.623 1.169 . . . . 0.0 108.851 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.3 155.26 9.2 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.97 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.6 -27.74 51.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.668 0.787 . . . . 0.0 110.967 170.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.38 30.62 58.27 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -161.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.11 155.09 35.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.116 0.958 . . . . 0.0 110.202 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.39 14.57 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.345 1.058 . . . . 0.0 111.291 -173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -149.34 172.49 14.83 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.846 1.658 . . . . 0.0 108.644 -170.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -133.42 119.97 20.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 160.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -136.93 156.78 48.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -153.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.45 124.84 64.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.5 t -82.87 140.72 15.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -134.88 7.39 3.47 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.255 1.422 . . . . 0.0 111.369 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.094 1.358 . . . . 0.0 110.663 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.87 177.85 8.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.613 1.097 . . . . 0.0 110.513 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.84 153.49 32.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.411 1.884 . . . . 0.0 108.968 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -114.18 163.42 15.25 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.81 0.844 . . . . 0.0 109.785 166.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -131.41 138.23 49.0 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 151.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.02 145.64 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -169.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.44 139.28 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 167.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.47 151.1 29.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.47 152.82 49.95 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.63 1.572 . . . . 0.0 107.147 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.76 -155.46 26.55 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -78.51 60.28 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 162.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -85.73 18.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.287 -0.883 . . . . 0.0 111.713 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -156.25 155.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 167.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.02 -84.21 0.1 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.46 -37.85 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 117.022 0.411 . . . . 0.0 110.803 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.73 50.27 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -57.31 -38.69 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 117.433 0.617 . . . . 0.0 110.944 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -67.43 -37.75 83.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.205 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -76.32 -32.51 58.76 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.454 1.479 . . . . 0.0 111.493 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.97 -45.93 75.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.073 1.306 . . . . 0.0 109.967 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.74 -47.96 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.099 0.959 . . . . 0.0 109.285 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -70.05 -25.7 63.68 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.306 1.412 . . . . 0.0 113.45 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.1 mtm -65.5 -48.05 73.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.2 1.364 . . . . 0.0 109.097 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -66.67 -35.06 79.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.307 0.643 . . . . 0.0 110.048 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.31 47.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.555 1.142 . . . . 0.0 109.791 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.08 -39.6 92.98 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.284 0.634 . . . . 0.0 111.406 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -16.09 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 0.0 112.576 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.53 17.57 16.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.304 1.442 . . . . 0.0 110.915 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 49.39 30.36 3.26 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.12 1.768 . . . . 0.0 112.911 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 mt -77.31 160.09 29.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.24 134.86 18.63 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.959 0.504 . . . . 0.0 110.584 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.57 -161.06 31.09 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.086 1.326 . . . . 0.0 110.545 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -106.09 162.29 13.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.226 1.513 . . . . 0.0 113.298 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.14 146.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.697 1.199 . . . . 0.0 108.001 163.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -154.13 155.37 35.24 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 108.958 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -99.72 123.74 44.28 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 161.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -80.3 147.3 31.2 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.04 -27.8 65.83 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.491 0.716 . . . . 0.0 112.25 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.61 -27.44 68.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.338 1.055 . . . . 0.0 112.81 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.06 -21.74 5.48 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.9 1.238 . . . . 0.0 112.322 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.38 157.0 11.77 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.056 0.928 . . . . 0.0 110.753 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -96.6 146.68 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 149.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.54 144.57 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.907 1.683 . . . . 0.0 106.812 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.54 142.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -148.32 123.02 9.88 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.84 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.293 0.951 . . . . 0.0 111.255 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.87 155.43 16.78 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.228 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 177.18 41.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.412 1.482 . . . . 0.0 111.077 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.88 159.78 49.56 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.725 2.283 . . . . 0.0 110.321 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 -48.14 78.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.232 0.613 . . . . 0.0 111.602 -168.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.79 -37.45 86.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.666 0.386 . . . . 0.0 111.852 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -46.3 87.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.53 -45.11 92.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.108 0.563 . . . . 0.0 109.556 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.49 -44.83 85.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.769 0.713 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.7 m -60.98 -42.31 98.12 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.849 0.46 . . . . 0.0 109.99 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.54 -48.08 83.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.062 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.0 t -56.96 -41.27 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.913 1.233 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.75 -41.93 99.44 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.692 0.678 . . . . 0.0 110.851 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.0 86.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.676 0.79 . . . . 0.0 111.756 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.01 -55.48 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.25 -38.47 83.56 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.709 0.804 . . . . 0.0 111.263 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.55 -24.75 67.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.47 0.708 . . . . 0.0 112.154 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.2 97.83 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 m -49.72 -45.87 79.52 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.83 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.728 1.653 . . . . 0.0 112.299 -166.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.2 t80 179.51 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.31 2.244 . . . . 0.0 106.094 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -58.85 141.23 53.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 157.1 40.03 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.971 0.909 . . . . 0.0 110.325 -171.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.96 157.08 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -119.77 -13.91 9.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.004 1.321 . . . . 0.0 109.708 158.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 141.22 25.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.87 1.268 . . . . 0.0 108.547 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.63 135.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.4 m -132.36 140.77 48.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.249 1.419 . . . . 0.0 107.206 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.7 t -140.19 145.53 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -168.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.0 m -127.79 140.72 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 161.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.92 134.34 23.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m -139.1 155.71 47.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.054 0.941 . . . . 0.0 109.983 -162.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -4.85 57.22 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.55 0.74 . . . . 0.0 110.877 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 m -58.57 165.6 2.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.617 1.167 . . . . 0.0 110.361 161.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.3 162.92 40.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.239 1.816 . . . . 0.0 108.173 167.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -79.42 -29.67 42.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.317 0.647 . . . . 0.0 111.823 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.92 54.06 6.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -162.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -51.11 153.63 1.85 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.595 1.158 . . . . 0.0 113.319 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -135.95 -3.88 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.866 1.266 . . . . 0.0 111.715 166.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -156.96 172.06 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.52 1.528 . . . . 0.0 109.158 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.92 140.65 38.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 162.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -148.68 153.92 38.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.813 0.816 . . . . 0.0 112.834 -150.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.46 115.63 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.41 132.6 32.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 164.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -100.72 31.38 3.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.903 0.881 . . . . 0.0 111.278 -170.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.986 0.914 . . . . 0.0 110.835 175.159 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.3 177.03 11.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.499 -0.751 . . . . 0.0 112.773 -161.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -148.48 154.36 39.73 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.609 2.364 . . . . 0.0 108.216 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.07 165.86 17.43 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.551 0.74 . . . . 0.0 110.437 161.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -133.61 141.59 47.72 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 157.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mt -137.45 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.42 140.26 48.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 143.66 21.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.488 0.715 . . . . 0.0 109.702 -166.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -144.11 153.47 42.19 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.972 1.309 . . . . 0.0 108.347 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.74 -157.65 27.43 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 107.524 -2.231 . . . . 0.0 107.524 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -78.22 75.86 4.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 158.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.06 25.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -131.21 -73.07 0.54 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 164.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 -132.06 39.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.68 -33.26 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.023 0.529 . . . . 0.0 110.801 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.79 46.2 0.03 OUTLIER Glycine 0 C--N 1.342 0.875 0 CA-C-N 119.436 1.016 . . . . 0.0 113.957 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -53.8 -40.64 66.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.982 1.391 . . . . 0.0 111.929 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -58.28 -46.69 85.6 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.739 0.416 . . . . 0.0 110.791 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -64.47 -45.31 87.91 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -55.69 -50.03 71.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.623 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.24 -36.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.592 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -74.97 -19.4 60.12 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.642 -1.286 . . . . 0.0 113.069 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -65.22 -48.93 71.65 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.965 1.257 . . . . 0.0 108.708 164.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -65.7 -22.85 66.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 111.383 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.16 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.028 0.931 . . . . 0.0 109.261 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.64 -37.76 71.2 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.502 1.121 . . . . 0.0 111.468 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -49.53 -38.41 30.63 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.882 1.673 . . . . 0.0 112.406 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -112.71 16.78 19.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.24 1.416 . . . . 0.0 111.468 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.77 5.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.636 1.574 . . . . 0.0 112.079 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.5 155.71 40.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.4 133.97 30.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.89 -171.33 42.85 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.937 -166.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -117.06 161.46 19.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.977 0.889 . . . . 0.0 111.541 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.72 142.71 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 158.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -144.37 157.7 44.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.486 1.515 . . . . 0.0 108.357 -164.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -118.06 121.23 40.05 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -75.58 154.28 36.84 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.12 -28.14 67.62 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 0.0 110.759 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.8 -16.1 37.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.787 2.035 . . . . 0.0 113.38 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -37.63 3.72 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.116 1.341 . . . . 0.0 111.525 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.61 150.85 11.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.149 0.979 . . . . 0.0 110.321 171.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.36 157.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 162.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.99 147.48 40.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -138.4 139.69 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -150.29 124.04 9.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.82 162.2 40.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 119.248 0.931 . . . . 0.0 110.896 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.94 156.87 24.23 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.611 1.564 . . . . 0.0 109.714 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.36 40.51 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.828 0.728 . . . . 0.0 111.596 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.22 151.82 49.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.024 1.816 . . . . 0.0 110.477 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.53 -48.57 78.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.387 1.075 . . . . 0.0 111.29 -170.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -64.53 -40.31 95.38 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.262 -0.273 . . . . 0.0 111.339 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 -48.56 75.76 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.78 -43.78 98.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.173 0.589 . . . . 0.0 110.458 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.86 -35.45 76.92 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.482 -0.761 . . . . 0.0 111.299 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 m -62.85 -41.18 99.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.644 -0.66 . . . . 0.0 110.703 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -58.8 -46.91 86.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.243 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.28 -41.92 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.866 1.212 . . . . 0.0 109.521 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.37 -41.18 98.42 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.19 88.86 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.688 0.795 . . . . 0.0 111.748 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.12 -53.24 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.6 -37.93 76.88 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.355 1.062 . . . . 0.0 111.808 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.27 -24.12 67.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.18 0.592 . . . . 0.0 112.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.58 40.13 98.31 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 m -52.82 -44.73 96.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.7 -164.44 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.472 2.115 . . . . 0.0 112.302 -166.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -1.47 0.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.504 2.722 . . . . 0.0 115.616 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.9 m -141.85 148.09 38.24 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.889 2.076 . . . . 0.0 106.304 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.4 154.49 35.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.983 0.811 . . . . 0.0 111.434 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.62 155.62 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.259 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -121.4 -11.75 8.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.187 1.395 . . . . 0.0 109.595 162.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.13 143.04 25.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.283 1.433 . . . . 0.0 108.383 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -148.71 140.42 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -138.33 134.89 34.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.11 144.87 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.702 0.801 . . . . 0.0 109.824 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.1 m -134.43 149.94 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.422 1.889 . . . . 0.0 106.093 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.15 154.45 51.2 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.9 m -155.93 146.5 21.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -71.4 -29.21 64.66 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.538 -0.727 . . . . 0.0 110.95 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.77 121.45 12.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.731 1.212 . . . . 0.0 111.653 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.09 164.17 13.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.47 0.708 . . . . 0.0 109.342 163.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.14 -13.78 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.6 -11.66 7.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.551 158.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.54 145.96 31.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.243 2.021 . . . . 0.0 111.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -132.37 7.65 4.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.891 1.276 . . . . 0.0 111.118 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.11 164.1 35.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.808 1.643 . . . . 0.0 108.564 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -84.15 144.29 29.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 164.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -143.2 157.78 44.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.674 0.79 . . . . 0.0 110.545 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.7 mt -135.5 135.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 142.29 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -152.51 10.22 0.49 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.914 0.886 . . . . 0.0 111.805 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.249 1.075 0 C-N-CA 125.462 1.505 . . . . 0.0 110.933 -178.29 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.43 176.84 6.23 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.092 -1.005 . . . . 0.0 111.115 -163.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -140.92 152.92 45.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.52 1.928 . . . . 0.0 108.498 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.58 162.13 16.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 162.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -137.98 125.77 22.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 165.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.27 139.93 45.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 134.84 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -138.59 154.02 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 110.518 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.45 146.17 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.731 1.613 . . . . 0.0 107.51 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.77 -156.22 26.74 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -78.72 98.3 6.19 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 161.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.99 12.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.85 1.26 . . . . 0.0 110.244 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -145.85 157.06 43.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.012 1.325 . . . . 0.0 109.206 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.65 -116.76 4.25 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 127.898 2.666 . . . . 0.0 110.022 -0.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.12 141.39 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.218 1.007 . . . . 0.0 108.914 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.94 -56.72 4.57 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -67.18 -17.38 64.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.517 1.127 . . . . 0.0 113.863 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -113.86 1.15 14.68 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.875 1.216 . . . . 0.0 114.214 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.74 -33.41 64.31 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.728 1.149 . . . . 0.0 109.711 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -56.74 -39.23 73.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.087 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 m -61.52 -37.14 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.456 1.026 . . . . 0.0 110.447 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -74.63 -28.24 60.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.361 0.982 . . . . 0.0 110.817 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 54.6 mtm -62.17 -49.85 74.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.515 0.598 . . . . 0.0 110.591 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -65.96 -34.22 77.6 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.636 0.775 . . . . 0.0 110.356 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.94 70.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.386 1.475 . . . . 0.0 109.923 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.38 -41.05 96.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.901 0.481 . . . . 0.0 111.178 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -14.97 42.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.138 1.375 . . . . 0.0 112.654 174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -116.57 20.76 13.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.419 1.488 . . . . 0.0 110.874 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.3 pttt 43.59 31.36 0.43 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.143 2.177 . . . . 0.0 114.172 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.91 162.09 29.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.91 0.884 . . . . 0.0 109.017 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.08 138.76 37.38 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.58 -170.94 41.36 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.545 0.611 . . . . 0.0 112.29 -164.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -129.44 160.56 32.76 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.043 0.937 . . . . 0.0 111.525 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.29 140.85 46.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 163.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -145.65 144.22 30.3 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.74 0.816 . . . . 0.0 109.0 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.13 146.45 39.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.97 132.62 55.9 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.94 -25.08 64.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.129 0.972 . . . . 0.0 112.697 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.72 -26.67 67.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.335 1.054 . . . . 0.0 112.284 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.38 -19.57 4.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.823 1.678 . . . . 0.0 112.307 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 172.44 10.8 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.318 1.047 . . . . 0.0 110.532 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.75 147.26 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -115.36 143.84 44.67 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.6 1.96 . . . . 0.0 106.83 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.98 134.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -148.37 124.43 10.73 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.85 162.04 41.79 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.24 0.473 . . . . 0.0 110.568 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.89 151.55 29.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.69 1.596 . . . . 0.0 109.551 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.04 40.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.55 1.071 . . . . 0.0 110.949 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.3 158.32 56.6 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.383 2.055 . . . . 0.0 110.384 171.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.12 -46.48 79.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.435 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -64.2 -37.77 88.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.554 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.86 72.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.305 0.642 . . . . 0.0 109.786 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.83 -46.99 88.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.587 0.755 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.74 -38.2 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.736 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -60.55 -42.62 96.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.734 0.697 . . . . 0.0 110.136 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -59.47 -47.27 86.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.637 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.31 -44.97 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 119.885 1.221 . . . . 0.0 110.071 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.82 -39.9 95.73 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.541 0.609 . . . . 0.0 110.902 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.95 98.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.352 0.661 . . . . 0.0 111.334 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -66.02 -50.35 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -58.29 -38.57 77.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.146 0.578 . . . . 0.0 111.104 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.19 -23.74 63.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.0 112.629 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.8 44.62 94.16 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 118.943 0.792 . . . . 0.0 111.561 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -55.97 -50.93 84.48 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -166.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.39 -49.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.786 1.674 . . . . 0.0 113.491 -163.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.55 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 110.27 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -61.92 151.86 33.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.581 0.752 . . . . 0.0 109.633 169.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.25 146.31 23.64 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 154.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.4 p -122.73 -11.88 8.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.668 1.587 . . . . 0.0 109.485 166.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.63 145.44 25.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.384 1.473 . . . . 0.0 107.848 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.5 tt -149.04 141.87 18.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.713 1.205 . . . . 0.0 107.804 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -135.98 140.77 44.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.409 1.484 . . . . 0.0 107.072 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.7 138.52 47.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.4 m -130.11 155.94 45.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -130.39 152.35 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -147.92 178.48 8.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.334 1.453 . . . . 0.0 107.962 -167.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -130.81 15.5 5.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.474 1.11 . . . . 0.0 109.366 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -69.62 -28.56 66.03 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.386 1.475 . . . . 0.0 112.827 -170.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp 57.75 173.71 0.05 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.988 1.715 . . . . 0.0 111.492 -166.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.95 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.126 0.971 . . . . 0.0 112.948 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 -10.56 60.76 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.461 -1.188 . . . . 0.0 115.689 154.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 173.34 12.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.773 1.787 . . . . 0.0 110.085 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -127.91 19.72 6.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.087 1.355 . . . . 0.0 110.145 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 168.09 24.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.128 1.771 . . . . 0.0 108.732 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -88.03 158.3 18.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.79 0.436 . . . . 0.0 110.102 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -141.62 158.82 43.34 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.231 1.013 . . . . 0.0 110.16 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.14 125.14 43.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.53 154.99 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -161.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.79 -31.49 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.369 -0.832 . . . . 0.0 112.157 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.313 1.445 . . . . 0.0 111.117 177.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.17 178.44 8.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.187 2.195 . . . . 0.0 109.364 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -134.73 147.42 50.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.94 2.096 . . . . 0.0 107.937 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.548 0.739 . . . . 0.0 110.045 165.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -134.45 130.95 37.54 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.84 142.7 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 134.7 59.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 170.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.98 147.98 18.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 124.423 1.089 . . . . 0.0 110.257 -170.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -138.07 155.58 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.68 -158.32 27.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -168.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -78.05 90.11 4.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 158.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.73 10.43 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.792 1.237 . . . . 0.0 110.332 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -145.74 142.91 29.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.776 0.716 . . . . 0.0 111.468 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.77 170.73 12.75 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.575 2.036 . . . . 0.0 109.007 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.4 127.39 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 -46.12 2.44 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.171 0.891 . . . . 0.0 111.651 -172.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -65.71 -23.26 66.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 116.682 -1.628 . . . . 0.0 114.069 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -91.73 -23.35 19.8 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 121.296 1.862 . . . . 0.0 112.445 161.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -67.95 -25.43 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.052 0.941 . . . . 0.0 111.621 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -48.67 -43.9 37.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.88 -38.1 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.067 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -73.83 -23.46 59.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.869 1.213 . . . . 0.0 111.465 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.68 -53.57 54.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.295 0.952 . . . . 0.0 110.074 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.66 -37.2 80.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.782 0.433 . . . . 0.0 110.341 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.57 55.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.562 1.145 . . . . 0.0 109.952 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.52 -47.24 86.28 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.585 0.754 . . . . 0.0 110.386 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -58.21 -30.66 66.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.19 1.396 . . . . 0.0 111.731 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.97 10.69 39.47 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.959 1.304 . . . . 0.0 111.379 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? 50.47 32.39 6.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.955 1.702 . . . . 0.0 112.101 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.64 165.95 23.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.117 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.4 20.99 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.13 173.94 36.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.549 0.613 . . . . 0.0 112.677 -169.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -101.09 160.99 13.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.36 1.08 . . . . 0.0 111.858 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.57 144.07 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.887 1.275 . . . . 0.0 107.74 158.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -149.23 159.56 44.15 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 107.703 -171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -112.34 120.74 42.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.987 0.812 . . . . 0.0 109.281 170.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -76.09 146.56 39.26 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.81 -28.53 67.53 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.681 0.792 . . . . 0.0 112.357 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.12 -27.61 69.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.479 0.712 . . . . 0.0 112.479 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.18 -37.13 1.88 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.526 1.06 . . . . 0.0 112.315 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 149.64 49.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.006 0.903 . . . . 0.0 111.314 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.61 150.07 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 167.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -124.13 144.84 49.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.012 1.725 . . . . 0.0 106.502 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -135.95 140.76 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.32 118.8 7.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.15 164.1 34.95 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.402 0.681 . . . . 0.0 111.01 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.47 156.72 29.69 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.526 1.531 . . . . 0.0 109.296 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.81 44.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.53 0.586 . . . . 0.0 111.954 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.76 151.44 63.36 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.206 1.938 . . . . 0.0 110.448 171.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.82 -50.06 64.42 Favored 'General case' 0 C--N 1.334 -0.071 0 C-N-CA 124.22 1.008 . . . . 0.0 111.529 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.37 -36.63 82.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.692 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.88 75.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.61 -46.63 81.81 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.127 0.571 . . . . 0.0 110.522 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -66.96 -42.88 84.44 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 121.759 -0.588 . . . . 0.0 111.138 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 m -68.07 -33.43 74.54 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.678 -0.639 . . . . 0.0 110.927 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -58.95 -50.5 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.557 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.64 -43.83 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.556 1.071 . . . . 0.0 109.424 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.14 -40.32 93.37 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.319 0.509 . . . . 0.0 111.215 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.41 97.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.355 0.662 . . . . 0.0 111.217 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -64.39 -51.54 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.35 -41.38 84.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.666 0.786 . . . . 0.0 111.169 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.22 -24.56 64.03 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 112.0 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.15 48.15 82.05 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m -54.79 -47.0 99.32 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 117.364 -1.303 . . . . 0.0 114.145 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.13 -163.55 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.768 2.312 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -59.42 -31.49 69.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 113.132 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -82.61 145.06 29.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.157 0.889 . . . . 0.0 109.662 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.58 148.56 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.102 0.561 . . . . 0.0 110.033 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.16 156.79 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.206 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -125.91 -8.59 6.63 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.041 1.736 . . . . 0.0 109.915 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.64 141.09 23.32 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.595 1.958 . . . . 0.0 107.49 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.6 tt -152.87 142.44 14.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.427 1.091 . . . . 0.0 108.917 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -142.58 144.5 32.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.092 1.757 . . . . 0.0 107.482 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.79 140.65 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 108.314 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -136.49 157.49 46.66 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.402 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -143.76 159.39 42.59 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.112 -0.992 . . . . 0.0 110.311 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.0 m -144.02 151.97 40.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.117 1.367 . . . . 0.0 108.767 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -87.63 35.27 0.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.308 1.043 . . . . 0.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -139.71 106.64 5.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.327 1.051 . . . . 0.0 108.824 -159.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.01 160.83 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 110.086 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.78 -14.48 0.73 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.943 0.897 . . . . 0.0 113.318 -170.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.06 -2.63 14.49 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.236 155.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -61.11 146.27 48.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 121.001 2.401 . . . . 0.0 110.257 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -129.55 9.47 5.52 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.194 1.398 . . . . 0.0 111.028 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.31 166.5 28.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.565 1.946 . . . . 0.0 107.97 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -80.06 148.23 31.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -141.25 156.74 45.85 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 109.771 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 mt -135.93 113.67 14.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -76.05 148.1 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.03 -33.62 76.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.033 0.533 . . . . 0.0 111.794 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.782 1.233 . . . . 0.0 108.377 171.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tp -142.88 178.63 7.53 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.992 -1.067 . . . . 0.0 110.129 -166.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -152.31 155.05 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.234 1.814 . . . . 0.0 108.097 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.99 163.02 16.86 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.447 0.699 . . . . 0.0 109.813 166.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -134.93 135.45 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 163.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.39 143.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 138.67 52.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 162.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.94 154.99 26.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 124.124 0.97 . . . . 0.0 110.454 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -146.12 154.65 42.04 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.593 1.557 . . . . 0.0 107.885 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 -155.33 26.09 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.806 -2.118 . . . . 0.0 107.806 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -76.16 83.76 2.99 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.04 5.55 4.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 111.129 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.96 168.28 21.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.46 70.22 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.84 0.733 . . . . 0.0 113.568 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.56 10.58 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.912 1.285 . . . . 0.0 111.583 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.28 16.11 67.6 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.306 -0.871 . . . . 0.0 113.53 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -52.99 -41.13 64.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.17 1.485 . . . . 0.0 111.681 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.264 21.7 ptt-85 -67.23 -23.34 65.71 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.3 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -76.51 -44.07 36.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.116 1.326 . . . . 0.0 110.084 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.84 -48.65 63.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.461 0.704 . . . . 0.0 111.156 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.25 -35.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.287 0.949 . . . . 0.0 110.994 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.86 -24.24 58.55 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.623 1.101 . . . . 0.0 111.892 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.8 mtm -63.5 -48.86 75.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.292 0.951 . . . . 0.0 109.868 166.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.76 -23.49 63.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.913 0.885 . . . . 0.0 111.595 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.79 41.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.81 -39.0 90.21 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.223 0.609 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -14.69 61.16 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 112.257 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.16 20.07 14.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.802 1.641 . . . . 0.0 111.082 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 43.29 31.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.113 2.165 . . . . 0.0 114.252 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.83 161.61 30.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.842 0.857 . . . . 0.0 108.74 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.15 28.93 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 108.271 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.02 -154.69 25.77 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.393 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.06 164.32 26.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.404 1.102 . . . . 0.0 112.815 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.03 141.09 47.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 165.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -132.78 140.59 48.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.89 148.19 52.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 158.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -125.9 145.4 50.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.87 0.868 . . . . 0.0 109.23 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.81 125.88 24.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -121.57 31.79 6.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.627 3.171 . . . . 0.0 109.834 5.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.98 -16.31 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 O-C-N 121.267 -0.895 . . . . 0.0 113.866 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -59.05 161.47 5.1 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.279 1.039 . . . . 0.0 109.795 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.22 147.53 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.34 143.02 46.39 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.211 1.405 . . . . 0.0 107.213 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.49 134.47 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.66 132.18 28.67 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.38 157.71 32.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.328 0.967 . . . . 0.0 110.843 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.68 151.32 25.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.688 1.195 . . . . 0.0 109.446 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.18 178.43 40.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.745 1.164 . . . . 0.0 110.793 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 154.9 69.53 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.179 1.92 . . . . 0.0 110.319 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.44 -42.97 79.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.807 0.843 . . . . 0.0 111.695 -172.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.37 -41.1 96.89 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.069 -0.394 . . . . 0.0 111.513 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.41 79.95 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.874 0.47 . . . . 0.0 109.88 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.48 -49.66 76.93 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.921 0.888 . . . . 0.0 110.132 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.81 -35.89 79.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.979 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -61.35 -42.7 99.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.01 0.823 . . . . 0.0 110.175 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -60.94 -46.46 90.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.788 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.72 -41.96 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.632 1.105 . . . . 0.0 109.664 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.75 -41.08 99.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.596 0.634 . . . . 0.0 110.819 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -37.77 80.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.248 0.619 . . . . 0.0 111.703 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.94 -57.4 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -60.87 -35.51 76.8 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.941 0.896 . . . . 0.0 111.738 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -63.53 -26.05 68.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.373 0.669 . . . . 0.0 112.297 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.13 47.82 88.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -173.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.6 -47.9 96.65 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.989 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.01 -172.2 1.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.56 2.173 . . . . 0.0 111.511 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -60.24 -31.36 70.12 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.246 -0.909 . . . . 0.0 111.578 167.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -68.65 142.69 55.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.586 1.154 . . . . 0.0 109.182 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.27 152.17 25.75 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.471 -0.768 . . . . 0.0 110.345 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.88 153.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -121.65 -9.52 8.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.175 1.39 . . . . 0.0 109.697 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -146.98 135.08 21.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.175 1.79 . . . . 0.0 107.123 171.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.21 133.62 7.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -136.55 127.37 27.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.1 145.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.067 1.347 . . . . 0.0 109.493 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 m -136.48 156.92 47.92 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.323 1.849 . . . . 0.0 106.053 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -126.14 150.12 48.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 m -145.63 164.45 31.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.102 0.961 . . . . 0.0 109.582 -163.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -119.36 4.54 11.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.252 1.021 . . . . 0.0 110.467 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -64.52 -30.74 71.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.454 1.102 . . . . 0.0 112.11 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.4 mt 58.68 179.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 111.307 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -153.61 -4.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.995 0.918 . . . . 0.0 113.385 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.26 6.48 53.91 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.746 1.165 . . . . 0.0 114.009 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.78 146.33 52.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.396 1.098 . . . . 0.0 109.469 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -130.27 17.85 5.45 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.633 1.573 . . . . 0.0 109.892 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -149.51 173.4 13.64 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.818 2.047 . . . . 0.0 108.131 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -98.35 150.1 21.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 162.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -139.4 156.14 47.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 110.045 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.1 mt -137.94 134.77 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 t -136.71 137.25 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.164 0.986 . . . . 0.0 108.484 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -151.02 12.06 0.66 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.23 1.012 . . . . 0.0 111.687 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.498 1.519 . . . . 0.0 110.911 -179.504 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mt -142.88 175.68 9.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 109.726 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -151.88 157.42 41.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.291 1.837 . . . . 0.0 108.379 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.71 162.51 24.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 165.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -135.67 138.59 42.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 156.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.88 143.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -169.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.86 137.79 55.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.79 146.63 20.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.897 0.879 . . . . 0.0 110.356 -168.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.38 152.3 44.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.808 1.643 . . . . 0.0 108.084 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.11 -153.38 25.04 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.39 73.86 3.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 158.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.45 6.19 9.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.359 1.064 . . . . 0.0 110.898 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -150.11 164.08 36.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.08 1.309 . . . . 0.0 108.411 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 -8.32 76.74 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.084 0.85 . . . . 0.0 113.353 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.99 11.42 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.507 1.123 . . . . 0.0 111.9 -171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.94 8.04 58.27 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.989 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -54.58 -39.78 68.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.398 1.599 . . . . 0.0 111.843 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -60.45 -37.62 81.54 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.203 0.456 . . . . 0.0 110.516 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -72.81 -47.68 44.41 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.481 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.27 -43.71 67.65 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.867 0.758 . . . . 0.0 111.419 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -53.16 -48.88 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.652 0.781 . . . . 0.0 109.246 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -78.34 -20.68 50.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 120.817 -1.177 . . . . 0.0 113.443 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -42.96 85.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.382 0.992 . . . . 0.0 109.243 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.29 -35.36 71.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.953 0.797 . . . . 0.0 110.159 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.24 86.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.993 0.517 . . . . 0.0 110.462 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.48 -41.55 98.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.789 0.836 . . . . 0.0 110.938 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.45 -29.98 68.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.495 0.718 . . . . 0.0 111.516 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -98.49 6.62 47.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.286 1.034 . . . . 0.0 112.581 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 42.82 40.88 2.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.697 1.999 . . . . 0.0 113.235 -172.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.03 164.39 26.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.325 1.05 . . . . 0.0 109.158 166.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 142.48 32.45 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.093 0.957 . . . . 0.0 108.508 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.03 -154.93 26.01 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.194 -168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.57 162.5 31.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.447 1.123 . . . . 0.0 112.627 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.52 144.43 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.905 1.282 . . . . 0.0 107.971 163.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -149.89 165.91 31.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.005 1.322 . . . . 0.0 109.356 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.9 121.77 45.96 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 167.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -73.73 153.97 39.81 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.138 0.975 . . . . 0.0 108.844 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.52 -31.31 70.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 111.379 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -70.74 -11.53 61.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.87 -27.84 8.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.152 1.358 . . . . 0.0 113.125 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.55 149.77 49.97 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.443 1.622 . . . . 0.0 109.495 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.18 149.69 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 158.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 143.43 50.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -133.65 143.03 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -141.46 135.87 30.71 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.33 34.93 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.629 1.104 . . . . 0.0 111.337 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.03 151.81 30.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.038 1.335 . . . . 0.0 109.418 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.52 42.48 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.162 0.886 . . . . 0.0 111.474 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.61 159.96 51.05 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.54 2.16 . . . . 0.0 110.793 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.65 -53.74 50.85 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.78 0.832 . . . . 0.0 111.064 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.06 -35.73 81.21 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 122.281 -0.262 . . . . 0.0 111.278 -173.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -49.34 71.51 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.78 0.432 . . . . 0.0 110.604 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.61 -49.08 78.03 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.12 0.568 . . . . 0.0 110.237 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.22 -41.03 90.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.608 0.363 . . . . 0.0 111.148 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -62.89 -40.35 97.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.659 0.663 . . . . 0.0 110.566 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.42 -47.52 85.75 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.599 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.54 -41.91 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.684 1.129 . . . . 0.0 109.705 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.86 -40.68 98.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.712 0.687 . . . . 0.0 110.807 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.72 92.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.797 0.839 . . . . 0.0 111.536 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -66.46 -55.68 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.43 -35.32 75.53 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.963 0.905 . . . . 0.0 111.976 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -63.06 -25.2 68.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.415 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.08 44.16 98.52 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -53.58 -44.17 97.25 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.14 -170.54 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.42 2.08 . . . . 0.0 111.245 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -60.29 -42.98 96.62 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.97 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.18 150.85 33.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.235 1.414 . . . . 0.0 110.637 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.25 33.59 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.704 -0.623 . . . . 0.0 109.878 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.06 154.66 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.3 p -120.4 -12.43 8.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.359 1.464 . . . . 0.0 109.56 162.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -147.35 141.12 25.7 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.224 1.41 . . . . 0.0 107.992 168.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.67 136.48 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -134.99 140.78 45.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.42 141.2 40.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -129.76 148.06 51.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -134.4 145.28 48.77 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 m -151.89 168.3 25.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.229 -150.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -125.54 1.37 7.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.428 1.091 . . . . 0.0 111.79 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -64.35 -32.06 73.52 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.795 0.838 . . . . 0.0 111.661 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.31 -177.26 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.115 1.766 . . . . 0.0 110.782 -171.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.45 -13.41 0.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.86 17.24 79.27 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.091 0.853 . . . . 0.0 113.037 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -63.66 152.53 38.76 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.283 1.041 . . . . 0.0 110.444 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.27 4.69 6.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 110.903 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 157.51 43.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.902 1.281 . . . . 0.0 109.237 172.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -71.2 143.22 50.54 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 155.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -139.33 150.98 46.02 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.586 0.754 . . . . 0.0 109.65 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.9 mt -128.57 109.88 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.0 142.09 16.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -82.98 36.95 0.52 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.604 1.162 . . . . 0.0 111.445 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.072 1.349 . . . . 0.0 110.425 176.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.174 0.035 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.93 -177.1 6.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.376 1.47 . . . . 0.0 110.045 -161.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -146.04 153.7 41.03 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.328 1.851 . . . . 0.0 109.251 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.21 166.74 11.16 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.069 0.947 . . . . 0.0 110.52 164.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -131.92 138.4 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 152.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.0 mt -136.27 146.88 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.89 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 164.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.62 151.8 24.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.53 1.132 . . . . 0.0 109.058 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.71 150.25 39.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.13 -153.87 25.59 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -79.76 63.25 4.26 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.8 m -89.11 8.77 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.806 1.242 . . . . 0.0 111.711 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.86 161.28 42.16 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.02 -156.78 27.85 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 m -60.51 -25.07 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.986 1.393 . . . . 0.0 113.452 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.16 -4.48 78.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.525 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 t80 17.65 59.64 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 1 C-N-CA 131.713 4.005 . . . . 0.0 115.293 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 7.3 ptt180 47.26 2.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.493 2.317 . . . . 0.0 116.766 -174.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.98 -38.17 78.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 120.003 1.274 . . . . 0.0 108.528 160.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -55.91 -41.05 73.96 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.342 0.519 . . . . 0.0 111.527 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.19 -45.83 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -78.88 -16.28 57.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.627 -0.702 . . . . 0.0 112.894 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.17 -47.77 75.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.636 1.107 . . . . 0.0 108.87 164.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -70.49 -23.12 62.61 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.929 -0.482 . . . . 0.0 111.362 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.66 52.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.288 -0.882 . . . . 0.0 109.662 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.16 -39.66 90.95 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.773 0.829 . . . . 0.0 111.544 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -14.35 60.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.721 -0.612 . . . . 0.0 112.013 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -116.79 11.23 14.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.701 1.601 . . . . 0.0 111.55 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 41.08 40.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.963 2.105 . . . . 0.0 113.034 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.63 163.25 28.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.68 131.72 24.64 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.062 0.945 . . . . 0.0 108.715 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.31 -162.95 34.71 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.223 0.465 . . . . 0.0 112.201 -162.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -135.42 167.7 20.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.777 0.789 . . . . 0.0 112.734 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.0 142.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.045 1.338 . . . . 0.0 109.102 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -145.77 157.36 43.94 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.947 1.699 . . . . 0.0 108.095 -163.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -119.32 123.19 43.61 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -78.6 156.66 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.977 1.311 . . . . 0.0 109.727 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.49 -30.65 70.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.239 0.615 . . . . 0.0 111.677 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -4.85 39.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.864 0.866 . . . . 0.0 113.022 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.98 -23.71 28.5 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.102 1.335 . . . . 0.0 113.247 169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -61.69 145.28 52.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.961 1.38 . . . . 0.0 109.804 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.52 143.54 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 160.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -131.21 145.75 52.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.41 142.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -170.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 tt -150.0 125.61 10.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 153.45 27.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.016 0.826 . . . . 0.0 111.454 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -93.53 154.5 17.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.46 1.104 . . . . 0.0 109.696 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.01 42.28 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 110.762 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.28 154.75 61.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.921 1.747 . . . . 0.0 109.918 165.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.72 -43.4 80.58 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.57 0.748 . . . . 0.0 111.437 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.33 -41.04 98.23 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.151 -0.343 . . . . 0.0 111.472 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.81 82.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.737 0.415 . . . . 0.0 110.064 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.12 -44.09 97.41 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.743 0.817 . . . . 0.0 110.371 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -70.48 -41.12 73.15 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.79 -0.569 . . . . 0.0 111.775 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 m -60.22 -40.05 88.79 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.756 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -61.85 -46.45 89.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.858 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.46 -46.56 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.005 1.275 . . . . 0.0 109.426 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.39 -39.62 91.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.168 0.44 . . . . 0.0 111.191 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.191 0.597 . . . . 0.0 112.133 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.05 -49.8 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.91 -44.04 91.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.185 0.594 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -71.52 -19.95 62.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.674 0.79 . . . . 0.0 112.011 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.71 43.34 94.52 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -172.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 m -51.15 -53.33 49.86 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.09 -39.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.654 1.57 . . . . 0.0 112.496 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -165.83 168.77 15.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.086 1.754 . . . . 0.0 108.188 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m 62.55 175.96 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.963 1.705 . . . . 0.0 113.044 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 160.49 40.28 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.92 0.888 . . . . 0.0 109.406 166.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.51 156.95 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.2 p -119.62 -13.56 9.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.939 1.296 . . . . 0.0 109.648 163.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.8 144.99 26.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.081 1.353 . . . . 0.0 108.749 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.82 142.17 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.289 1.436 . . . . 0.0 107.378 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -140.23 147.8 40.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.21 145.9 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.67 155.7 46.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.147 2.179 . . . . 0.0 105.48 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -138.6 158.63 43.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.0 m -155.51 152.88 29.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.145 1.378 . . . . 0.0 107.901 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -73.33 -30.95 63.7 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.718 -0.614 . . . . 0.0 111.352 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 m -60.07 128.57 37.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.102 0.961 . . . . 0.0 110.903 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.18 169.86 12.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.207 1.003 . . . . 0.0 109.242 163.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -104.76 -18.71 14.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.029 0.932 . . . . 0.0 111.074 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 47.85 7.45 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -171.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -126.83 149.86 49.49 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.608 1.163 . . . . 0.0 108.915 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.86 9.2 3.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.945 0.898 . . . . 0.0 112.092 -172.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 174.28 12.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.514 1.526 . . . . 0.0 109.013 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -116.47 148.97 40.24 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.369 1.067 . . . . 0.0 109.458 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.93 159.96 41.65 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.468 0.652 . . . . 0.0 111.963 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.02 114.51 35.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t -68.51 147.84 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -62.74 -31.3 72.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.222 0.609 . . . . 0.0 112.037 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.25 1.124 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 167.566 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 tp -142.21 177.26 8.36 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.905 -1.122 . . . . 0.0 110.422 -166.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -154.57 162.01 41.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.94 1.696 . . . . 0.0 109.47 -171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.36 166.36 21.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.226 1.01 . . . . 0.0 110.273 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -130.23 138.58 50.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.42 146.86 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 135.71 58.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.61 153.64 16.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.275 1.03 . . . . 0.0 110.699 -172.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.01 153.0 45.35 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.313 1.445 . . . . 0.0 107.943 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.35 -152.28 24.19 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -75.56 77.98 2.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 162.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.66 -1.77 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 111.306 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -140.37 35.41 1.87 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.63 1.572 . . . . 0.0 109.488 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.51 29.67 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 t 55.91 -71.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 129.027 2.931 . . . . 0.0 113.221 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.77 -11.64 46.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.584 1.564 . . . . 0.0 112.151 173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 51.17 -162.87 0.06 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.052 1.741 . . . . 0.0 112.077 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -63.87 -14.89 56.95 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.834 -1.166 . . . . 0.0 112.518 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -60.62 -32.83 71.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.405 1.002 . . . . 0.0 110.803 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -48.74 71.94 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.921 1.237 . . . . 0.0 111.61 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.86 -30.92 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.16 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -75.14 -24.66 57.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.948 1.249 . . . . 0.0 112.08 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.2 mtm -63.46 -48.9 75.81 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 165.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.81 -30.11 70.69 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 122.195 -0.316 . . . . 0.0 111.058 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.84 -47.49 68.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.292 . . . . 0.0 110.328 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.63 -38.62 88.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.319 0.647 . . . . 0.0 111.124 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.14 -17.59 41.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.769 1.228 . . . . 0.0 112.523 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -116.65 12.9 15.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.225 1.41 . . . . 0.0 111.41 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.44 34.44 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.16 2.184 . . . . 0.0 113.294 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.41 161.59 27.27 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.816 -0.553 . . . . 0.0 109.629 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 128.62 43.74 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.48 -171.21 43.9 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 118.641 0.655 . . . . 0.0 112.272 -164.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.4 p90 -136.61 161.27 36.36 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.066 0.947 . . . . 0.0 112.036 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.15 144.93 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.171 0.988 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -144.71 162.82 35.75 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.143 2.177 . . . . 0.0 107.656 -170.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.43 122.88 40.76 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -75.77 155.46 35.48 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.479 1.112 . . . . 0.0 109.16 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.45 -31.78 70.75 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.918 0.487 . . . . 0.0 111.357 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -71.34 -10.68 60.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.82 10.83 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.228 -1.318 . . . . 0.0 113.476 170.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.35 148.25 52.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.729 1.764 . . . . 0.0 109.391 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.29 146.48 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 161.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -127.77 137.94 52.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.55 142.55 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.57 126.38 12.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.04 41.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.487 0.585 . . . . 0.0 110.926 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.49 155.83 22.63 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.316 1.846 . . . . 0.0 109.443 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.51 178.04 41.64 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.618 1.104 . . . . 0.0 110.364 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.32 154.3 74.44 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.842 1.695 . . . . 0.0 109.781 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.37 -47.7 78.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.183 0.593 . . . . 0.0 110.715 -172.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -60.17 -40.31 89.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.484 0.584 . . . . 0.0 111.788 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.59 83.09 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.855 0.462 . . . . 0.0 110.091 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.66 -45.96 84.48 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 122.809 0.443 . . . . 0.0 110.826 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -64.98 -43.47 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.864 -0.522 . . . . 0.0 110.68 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.4 m -60.93 -40.84 94.77 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.935 0.334 . . . . 0.0 110.54 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.24 -49.09 79.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.575 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.67 -43.25 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.735 1.152 . . . . 0.0 109.67 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.92 -40.91 97.11 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.628 0.649 . . . . 0.0 110.834 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.47 0.708 . . . . 0.0 111.465 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -61.79 -54.04 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.37 -39.44 79.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.809 0.844 . . . . 0.0 111.375 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.4 -27.23 68.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.488 0.715 . . . . 0.0 111.979 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.47 51.26 58.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -173.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -55.53 -49.2 93.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.976 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.49 -173.45 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.261 1.974 . . . . 0.0 111.627 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -40.84 82.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.431 1.092 . . . . 0.0 111.449 173.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.3 m -74.29 138.92 43.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -157.81 164.45 36.99 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 109.533 -162.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.42 149.6 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -127.68 -7.58 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.809 1.643 . . . . 0.0 109.803 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.61 141.22 29.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.224 1.81 . . . . 0.0 106.963 166.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -149.27 140.68 17.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 107.972 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 m -139.29 148.94 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.687 1.595 . . . . 0.0 107.328 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.18 146.18 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.05 149.01 51.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.04 133.17 39.1 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -171.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -145.47 167.93 21.79 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.701 0.4 . . . . 0.0 111.683 -155.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.97 0.11 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.898 1.279 . . . . 0.0 111.253 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.0 m -66.26 -24.88 66.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.121 0.969 . . . . 0.0 113.088 -170.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.48 174.0 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 0.0 111.684 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.18 -16.44 0.58 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 113.179 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 1.41 82.2 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.253 -1.304 . . . . 0.0 116.304 155.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -82.92 -175.48 5.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.102 1.951 . . . . 0.0 109.542 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -129.55 2.85 5.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 112.421 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.57 170.76 17.89 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.052 1.341 . . . . 0.0 109.697 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -72.48 153.27 41.45 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.956 0.503 . . . . 0.0 109.965 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.39 159.22 42.67 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.703 1.201 . . . . 0.0 109.453 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 mt -135.09 110.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.67 140.64 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -136.42 4.19 2.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.468 1.107 . . . . 0.0 112.096 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 125.347 1.459 . . . . 0.0 110.883 179.368 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.507 0.194 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.13 176.03 9.06 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.946 0.898 . . . . 0.0 111.666 -149.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -147.71 157.81 43.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.446 1.498 . . . . 0.0 109.384 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.14 168.09 11.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 110.629 163.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -134.58 135.42 42.22 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 156.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.34 144.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.78 136.42 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.14 155.48 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.576 1.151 . . . . 0.0 110.293 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -145.98 157.38 43.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 0.0 108.935 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -148.36 19.87 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 106.821 -2.512 . . . . 0.0 106.821 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -77.02 54.48 1.04 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 160.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.73 -13.92 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 111.21 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.64 155.4 47.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 168.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.29 -153.26 24.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -57.88 -24.43 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 117.766 0.783 . . . . 0.0 112.685 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -0.56 86.02 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.68 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 t80 44.58 -147.27 0.09 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.326 1.45 . . . . 0.0 110.064 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -86.68 -0.82 57.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.128 -0.982 . . . . 0.0 111.117 158.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.9 -34.47 73.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.171 0.896 . . . . 0.0 111.295 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -37.61 65.23 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.678 0.672 . . . . 0.0 111.288 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.84 -45.22 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -78.97 -18.95 52.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.488 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -63.21 -48.95 76.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.335 0.971 . . . . 0.0 109.309 165.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.58 -29.95 67.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.784 0.434 . . . . 0.0 110.421 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.61 74.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.767 0.827 . . . . 0.0 110.405 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.92 -41.02 90.81 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.341 0.656 . . . . 0.0 110.724 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -59.41 -18.09 36.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.487 1.115 . . . . 0.0 112.854 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -117.33 15.76 14.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.977 1.262 . . . . 0.0 112.372 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.2 mmpt? 47.01 34.0 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.574 1.55 . . . . 0.0 112.768 -176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.3 mt -74.41 163.51 27.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.172 0.589 . . . . 0.0 109.703 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.73 130.11 22.42 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.167 0.987 . . . . 0.0 108.581 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.35 -158.34 28.66 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 123.592 0.615 . . . . 0.0 111.596 -171.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -136.73 163.28 30.97 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.787 0.794 . . . . 0.0 112.047 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.874 1.27 . . . . 0.0 108.66 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -149.22 163.25 38.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.883 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -119.58 131.15 55.44 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -120.77 149.72 42.11 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.925 0.89 . . . . 0.0 110.37 -167.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.08 -19.46 62.96 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.443 1.497 . . . . 0.0 113.524 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.78 -15.29 28.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.757 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.05 45.83 3.77 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.52 153.32 42.47 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.392 1.477 . . . . 0.0 107.238 -168.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.19 148.36 5.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 157.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.96 142.48 48.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -138.62 141.48 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.98 126.37 10.8 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.1 157.02 36.86 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.442 0.697 . . . . 0.0 110.877 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.98 156.9 17.35 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.634 1.573 . . . . 0.0 109.874 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.25 -179.42 41.89 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.039 0.828 . . . . 0.0 111.865 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.4 161.74 37.13 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.554 2.17 . . . . 0.0 110.652 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.35 -47.23 79.23 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.73 0.812 . . . . 0.0 111.137 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.76 -43.06 98.49 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.005 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.96 79.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.1 mt -63.22 -47.08 84.03 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.326 0.65 . . . . 0.0 110.247 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -68.52 -43.51 76.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.031 0.532 . . . . 0.0 111.893 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -62.89 -39.09 93.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.471 0.578 . . . . 0.0 110.139 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.3 -49.24 78.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.423 173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.56 -45.65 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.57 1.077 . . . . 0.0 109.515 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -62.42 -37.81 87.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.096 0.407 . . . . 0.0 111.155 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.85 86.94 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.501 0.72 . . . . 0.0 111.792 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.2 -51.03 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.34 -41.95 76.92 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.442 1.097 . . . . 0.0 111.29 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -68.22 -25.53 65.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.517 0.727 . . . . 0.0 111.933 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.94 48.64 81.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.61 -47.32 98.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.409 -1.281 . . . . 0.0 114.289 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.84 -166.53 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.201 . . . . 0.0 111.479 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -40.74 67.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.828 1.251 . . . . 0.0 111.939 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -79.6 143.72 34.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 162.46 40.51 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.687 0.795 . . . . 0.0 110.548 -172.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.88 158.3 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.371 0.668 . . . . 0.0 110.689 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 p -125.81 -4.8 6.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.715 1.606 . . . . 0.0 110.023 163.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -150.66 138.73 20.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.777 2.031 . . . . 0.0 107.446 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.64 140.98 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.336 1.054 . . . . 0.0 108.613 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -140.86 142.9 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.101 1.76 . . . . 0.0 107.053 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -138.19 143.6 32.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -129.99 151.06 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -137.05 145.36 43.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.0 m -143.2 175.0 10.21 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.037 1.335 . . . . 0.0 109.375 -165.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -128.37 33.53 4.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.537 1.135 . . . . 0.0 109.447 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -134.24 105.09 6.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 108.404 -165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.09 168.63 8.09 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.949 0.9 . . . . 0.0 111.235 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.78 -23.47 9.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.832 1.653 . . . . 0.0 110.496 -175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.69 19.04 76.52 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -166.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.31 139.78 32.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -134.82 25.09 3.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.808 1.243 . . . . 0.0 109.584 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -148.23 167.4 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 127.003 2.121 . . . . 0.0 107.184 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -120.85 132.94 55.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 163.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 m -134.7 160.87 36.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.126 0.57 . . . . 0.0 111.211 -166.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.9 mt -132.24 114.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.61 142.28 15.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -139.73 5.14 2.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.819 1.248 . . . . 0.0 112.086 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.36 1.464 . . . . 0.0 110.919 179.349 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 119.111 -0.471 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tp -147.46 -177.01 5.47 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.207 1.367 . . . . 0.0 111.344 -159.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.61 152.57 39.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.613 1.965 . . . . 0.0 109.086 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.46 163.7 12.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.319 0.648 . . . . 0.0 109.724 162.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -136.05 131.09 34.45 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 159.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.19 139.65 45.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.29 134.4 66.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -140.35 153.19 21.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.146 0.979 . . . . 0.0 109.557 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.28 151.36 37.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.935 1.294 . . . . 0.0 107.522 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.67 -152.04 24.06 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.67 58.56 1.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 m -85.0 -12.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.019 0.928 . . . . 0.0 110.783 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -125.33 146.36 49.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 164.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.8 -163.28 30.0 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -161.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 -23.09 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.535 1.168 . . . . 0.0 113.641 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.34 0.93 89.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.62 -1.655 . . . . 0.0 114.347 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 21.09 51.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 130.398 3.479 . . . . 0.0 115.06 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.301 12.9 ptt85 45.06 -1.6 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -169.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -66.38 -21.96 66.24 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 122.013 2.188 . . . . 0.0 110.468 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.099 1.318 . . . . 0.0 111.349 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.21 -33.66 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.394 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -73.39 -25.98 60.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.051 1.296 . . . . 0.0 112.284 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.4 mtm -65.36 -47.3 76.91 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 166.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -66.09 -27.99 68.48 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.285 -0.26 . . . . 0.0 111.329 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 -48.47 64.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.734 1.614 . . . . 0.0 109.975 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.06 -38.68 87.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.984 0.514 . . . . 0.0 111.209 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -60.0 -16.96 34.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.354 1.062 . . . . 0.0 112.594 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -116.88 11.24 14.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.127 1.371 . . . . 0.0 111.565 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 41.52 39.52 1.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.697 1.999 . . . . 0.0 113.015 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.63 164.85 25.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.732 0.813 . . . . 0.0 108.981 167.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.32 26.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.18 -167.68 38.91 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 118.402 0.546 . . . . 0.0 112.14 -163.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -136.64 159.56 41.44 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.75 0.82 . . . . 0.0 111.991 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.99 141.94 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.735 0.814 . . . . 0.0 110.412 174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -141.85 153.31 44.37 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.833 1.653 . . . . 0.0 108.613 -166.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -106.62 125.22 50.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 170.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -85.33 145.29 27.58 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.961 0.904 . . . . 0.0 108.676 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.55 -29.45 69.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.351 0.66 . . . . 0.0 111.882 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -8.8 56.03 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 45.95 2.23 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 119.109 0.868 . . . . 0.0 112.084 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -136.43 172.99 12.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 107.802 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -116.16 144.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 164.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 140.34 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.79 140.72 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.7 127.69 14.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.44 149.28 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 122.997 0.519 . . . . 0.0 110.24 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.28 153.77 20.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.708 0.803 . . . . 0.0 109.147 166.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.47 173.71 36.56 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.309 0.957 . . . . 0.0 111.604 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.59 153.41 60.06 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.149 1.899 . . . . 0.0 110.073 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.83 -42.3 75.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.679 0.792 . . . . 0.0 111.507 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.4 -41.1 98.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.068 -0.395 . . . . 0.0 111.632 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -45.1 77.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.786 0.434 . . . . 0.0 109.856 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.99 -45.38 95.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.863 0.865 . . . . 0.0 110.129 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -69.71 -39.73 76.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.857 -0.527 . . . . 0.0 112.019 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.1 m -61.05 -41.7 97.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.642 0.656 . . . . 0.0 110.183 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.36 -47.27 86.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.575 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -55.01 -45.84 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.754 1.161 . . . . 0.0 109.602 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.82 -39.1 90.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.585 0.63 . . . . 0.0 111.052 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.55 87.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.425 0.69 . . . . 0.0 111.411 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.61 -48.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.96 -39.76 86.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.41 0.684 . . . . 0.0 111.452 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.49 -24.74 66.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.004 0.522 . . . . 0.0 111.832 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.28 44.0 96.84 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -54.48 -47.68 97.07 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.935 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.78 -169.09 0.67 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.546 2.164 . . . . 0.0 111.722 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -2.87 0.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.911 2.084 . . . . 0.0 115.241 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.4 m -129.53 143.65 50.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.395 1.478 . . . . 0.0 107.737 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.0 164.75 37.66 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.404 0.682 . . . . 0.0 111.21 -162.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.8 m -106.37 158.79 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 123.543 0.737 . . . . 0.0 110.444 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 p -123.01 -11.72 8.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.915 1.686 . . . . 0.0 109.827 162.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.7 146.82 27.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.108 1.363 . . . . 0.0 108.992 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.7 tt -148.19 143.6 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.991 1.316 . . . . 0.0 108.309 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -136.73 144.08 43.65 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.126 1.77 . . . . 0.0 107.213 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.67 140.21 36.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -132.68 157.34 45.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.989 2.115 . . . . 0.0 105.778 168.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.36 142.8 48.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -136.94 153.29 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.785 1.634 . . . . 0.0 107.07 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 mmt-85 -87.76 -24.49 23.78 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.011 -1.056 . . . . 0.0 111.166 -175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 m -62.93 114.67 3.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.81 1.244 . . . . 0.0 111.027 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.61 177.66 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.32 1.048 . . . . 0.0 110.641 164.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -126.92 0.21 6.61 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.893 1.277 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.57 27.94 66.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.878 0.751 . . . . 0.0 111.675 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -94.53 150.35 20.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.894 0.847 . . . . 0.0 109.8 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -137.84 14.98 2.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.64 1.176 . . . . 0.0 111.57 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -148.51 166.72 27.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.16 1.384 . . . . 0.0 108.963 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -88.16 155.88 19.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 163.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.2 m -142.55 156.7 45.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.614 1.166 . . . . 0.0 110.66 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 mt -128.17 112.96 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.3 138.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -174.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -138.18 -19.93 1.11 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.594 0.758 . . . . 0.0 112.55 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.53 1.532 . . . . 0.0 107.565 -178.733 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 tp -140.65 -178.6 5.6 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.789 -1.194 . . . . 0.0 109.527 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -155.12 158.14 38.55 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.868 1.667 . . . . 0.0 108.449 -177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.05 164.94 15.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.661 0.785 . . . . 0.0 110.536 166.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.27 131.3 29.95 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 157.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.97 147.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -167.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.41 137.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 m -141.53 156.28 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 124.03 0.932 . . . . 0.0 111.301 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.36 155.51 45.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.751 1.62 . . . . 0.0 107.788 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.24 -155.36 26.29 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -77.61 100.21 6.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 152.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.39 6.24 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 124.611 1.194 . . . . 0.0 110.752 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -141.49 153.38 44.89 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.587 1.085 . . . . 0.0 111.12 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.88 169.14 11.72 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.175 2.321 . . . . 0.0 108.623 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.07 126.2 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.07 -46.34 2.11 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.942 0.782 . . . . 0.0 111.773 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.01 -7.16 10.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.74 -11.85 10.9 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.124 1.784 . . . . 0.0 114.166 155.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -59.89 -32.34 70.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.289 0.95 . . . . 0.0 110.578 169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -51.72 -37.53 51.33 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.538 0.608 . . . . 0.0 112.07 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.68 -48.06 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -71.29 -25.47 62.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.42 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.71 -39.47 64.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.858 1.208 . . . . 0.0 110.589 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -69.28 -29.82 67.78 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.344 -0.847 . . . . 0.0 111.096 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.54 65.07 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.093 -1.005 . . . . 0.0 109.672 172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.11 -40.42 93.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.053 0.941 . . . . 0.0 111.42 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -15.26 62.72 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.67 -0.644 . . . . 0.0 112.295 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -113.33 15.11 19.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 111.665 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.27 32.97 3.41 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.067 1.747 . . . . 0.0 112.326 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.0 162.22 29.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.09 121.39 19.18 Favored 'General case' 0 CA--C 1.527 0.075 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 -162.17 32.27 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -142.7 163.7 32.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.14 145.98 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.086 1.354 . . . . 0.0 109.507 165.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -149.49 146.14 27.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.641 1.577 . . . . 0.0 108.372 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.98 153.93 40.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.703 0.801 . . . . 0.0 109.487 168.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -134.64 154.6 51.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.297 1.408 . . . . 0.0 110.843 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.01 -30.63 69.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -155.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.05 -27.45 68.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.139 0.576 . . . . 0.0 112.402 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.65 -17.84 10.12 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.366 1.46 . . . . 0.0 110.946 -172.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -59.17 168.32 1.44 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 122.962 1.363 . . . . 0.0 110.422 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.52 150.12 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -131.18 140.12 49.86 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -171.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -136.89 140.81 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -171.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -149.88 126.91 11.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.19 149.52 28.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.527 0.603 . . . . 0.0 110.093 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.92 153.77 19.95 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 174.69 39.72 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.661 0.648 . . . . 0.0 111.807 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.21 152.39 66.98 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.966 1.777 . . . . 0.0 110.152 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.05 -43.87 74.19 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.813 0.845 . . . . 0.0 111.481 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.43 -40.93 98.49 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 122.227 -0.295 . . . . 0.0 111.544 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.33 80.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.988 0.515 . . . . 0.0 110.116 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.4 mt -62.04 -45.22 94.54 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.583 0.753 . . . . 0.0 110.211 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.57 -40.12 76.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.885 -0.51 . . . . 0.0 111.75 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 m -61.37 -42.0 98.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.746 0.703 . . . . 0.0 110.215 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.21 -49.81 75.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.591 -0.719 . . . . 0.0 110.243 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.3 t -56.65 -43.59 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 119.496 1.043 . . . . 0.0 109.988 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.69 -41.46 97.6 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.109 0.868 . . . . 0.0 110.72 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.33 97.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 111.438 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.28 -53.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -58.53 -40.93 84.32 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.078 0.951 . . . . 0.0 111.207 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -69.9 -23.65 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.49 . . . . 0.0 111.897 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.33 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -58.41 -42.15 93.08 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-O 117.745 -1.121 . . . . 0.0 112.871 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.13 -172.29 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.742 2.961 . . . . 0.0 114.128 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -59.48 -39.61 84.28 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.48 1.112 . . . . 0.0 111.785 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -72.96 151.71 41.7 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.586 0.755 . . . . 0.0 110.363 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 145.53 23.33 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.76 156.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -124.87 -8.95 7.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.601 . . . . 0.0 109.734 166.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.46 139.7 20.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.419 1.887 . . . . 0.0 107.411 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -152.95 142.75 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.65 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -141.29 145.36 35.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.806 1.643 . . . . 0.0 107.779 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.51 138.85 44.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -169.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -131.73 152.79 50.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.598 1.959 . . . . 0.0 106.063 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -131.31 151.21 51.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 m -146.95 165.29 30.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.539 1.136 . . . . 0.0 109.465 -165.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -118.78 1.34 11.56 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.148 0.979 . . . . 0.0 110.751 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 m -62.2 -37.45 85.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.42 1.088 . . . . 0.0 112.211 -171.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 mp 58.5 170.59 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.26 1.824 . . . . 0.0 111.951 -170.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.19 -20.19 4.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.852 1.261 . . . . 0.0 111.392 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.83 24.69 74.26 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.17 139.52 42.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.126 0.963 . . . . 0.0 108.433 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -131.88 21.0 4.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.498 1.119 . . . . 0.0 110.743 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -149.03 178.28 8.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.022 1.729 . . . . 0.0 108.099 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.46 132.16 35.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.0 m -143.9 163.26 33.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.63 1.205 . . . . 0.0 114.032 -152.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.4 mt -128.39 118.66 48.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.44 155.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -60.49 -44.12 96.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.653 -0.655 . . . . 0.0 110.688 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.511 1.524 . . . . 0.0 109.147 174.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -141.76 179.85 6.61 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.889 -1.132 . . . . 0.0 109.677 -167.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -155.37 156.29 35.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 109.159 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.5 163.21 18.3 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.688 0.795 . . . . 0.0 110.524 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -132.33 137.06 47.28 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 154.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.78 142.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -173.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.21 135.28 59.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 171.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.52 151.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.783 0.833 . . . . 0.0 110.6 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.83 153.31 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 107.681 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.88 -154.36 25.77 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -75.1 88.64 2.44 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -124.52 6.51 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.398 1.079 . . . . 0.0 111.237 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -146.61 165.75 28.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.78 1.173 . . . . 0.0 108.496 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -10.1 73.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.998 0.809 . . . . 0.0 113.255 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.41 15.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.061 1.345 . . . . 0.0 111.289 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.14 70.63 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.969 -0.906 . . . . 0.0 113.575 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -52.87 -43.72 66.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.236 1.518 . . . . 0.0 111.898 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -66.23 -30.91 71.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.685 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.65 -43.32 69.4 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.574 -0.704 . . . . 0.0 110.07 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -53.86 -48.33 70.13 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.029 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.17 -33.99 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 119.39 0.996 . . . . 0.0 110.929 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.61 -32.16 73.59 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.385 1.448 . . . . 0.0 112.164 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -64.0 -46.55 84.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.181 0.901 . . . . 0.0 109.385 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -68.58 -33.3 73.83 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.101 -0.375 . . . . 0.0 110.887 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.48 77.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.299 1.04 . . . . 0.0 109.584 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.68 -35.0 78.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.862 0.465 . . . . 0.0 112.096 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.2 -40.93 59.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.27 1.028 . . . . 0.0 111.715 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -114.87 24.01 12.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.86 1.264 . . . . 0.0 111.279 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp 46.17 39.96 6.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.32 157.43 22.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.12 126.16 44.87 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.33 -171.88 44.67 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 118.643 0.656 . . . . 0.0 112.885 -167.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -142.9 165.85 26.25 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.313 0.645 . . . . 0.0 112.463 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.38 146.56 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.053 1.341 . . . . 0.0 110.075 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.46 159.17 44.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.914 1.286 . . . . 0.0 110.222 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.34 153.94 28.07 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 166.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -112.32 145.25 40.36 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 166.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.64 -28.39 65.63 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.36 -28.05 68.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.922 0.889 . . . . 0.0 112.65 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.08 -17.57 7.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.297 1.427 . . . . 0.0 111.614 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -58.46 164.8 2.39 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.949 0.881 . . . . 0.0 110.691 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 t -119.31 149.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 161.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -129.27 139.53 51.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 141.8 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.79 129.39 14.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.94 145.14 23.89 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.754 0.706 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.69 151.82 23.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 164.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.45 175.68 40.0 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 112.457 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.61 154.95 64.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.142 1.895 . . . . 0.0 110.526 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.46 -45.78 76.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.905 0.882 . . . . 0.0 111.512 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.41 -40.84 98.29 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.294 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.2 80.07 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.48 -46.39 88.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.477 0.711 . . . . 0.0 110.492 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -69.17 -39.58 78.67 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.888 -0.508 . . . . 0.0 111.755 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 m -62.1 -40.49 96.06 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.663 0.665 . . . . 0.0 110.259 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -59.46 -47.54 85.09 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.303 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.88 -42.62 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 119.72 1.145 . . . . 0.0 109.898 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.46 -41.31 98.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.083 0.856 . . . . 0.0 110.984 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.16 89.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.908 0.483 . . . . 0.0 111.619 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.27 -56.02 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.99 -37.18 78.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.955 0.902 . . . . 0.0 111.573 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.01 -24.63 66.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.557 0.743 . . . . 0.0 112.415 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.49 42.62 97.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.785 0.72 . . . . 0.0 111.387 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -51.26 -47.37 88.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.95 -56.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.711 1.647 . . . . 0.0 112.198 -166.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -174.92 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.952 2.101 . . . . 0.0 107.104 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.81 145.34 29.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.553 1.541 . . . . 0.0 109.782 168.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.52 151.52 24.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.561 0.745 . . . . 0.0 109.206 -172.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.85 156.18 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.8 p -121.17 -12.43 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.585 1.554 . . . . 0.0 109.774 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.36 136.02 20.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.266 1.826 . . . . 0.0 106.967 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 tt -148.5 137.73 15.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -139.63 146.14 39.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.311 1.444 . . . . 0.0 107.397 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.49 144.4 32.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.96 147.61 50.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 167.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -138.76 134.53 33.6 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 m -143.62 168.07 20.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.01 0.924 . . . . 0.0 110.634 -155.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.55 0.45 10.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.349 1.059 . . . . 0.0 111.726 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -66.14 -37.2 85.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.29 0.95 . . . . 0.0 112.61 -171.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.52 177.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 0.0 111.236 -165.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -124.06 -26.52 4.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.122 0.969 . . . . 0.0 110.978 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.17 41.24 6.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.351 0.977 . . . . 0.0 110.906 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 165.78 24.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 112.536 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -140.39 33.11 1.88 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.366 1.867 . . . . 0.0 109.279 -172.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -131.14 160.98 33.16 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.467 1.507 . . . . 0.0 108.434 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.35 122.33 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -141.81 163.62 32.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.184 0.992 . . . . 0.0 113.42 -152.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.08 119.89 41.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.96 170.99 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.505 -160.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -131.21 16.31 5.05 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.729 1.612 . . . . 0.0 110.567 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.624 1.57 . . . . 0.0 111.105 -177.883 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 119.084 -0.484 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mp -143.42 -177.12 5.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.011 1.278 . . . . 0.0 111.605 -167.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -142.53 155.95 45.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.816 2.846 . . . . 0.0 108.552 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.68 164.68 13.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.794 0.838 . . . . 0.0 109.731 161.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -133.26 137.0 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 153.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -136.19 141.42 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -170.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.55 33.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 163.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.84 155.34 30.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.531 1.132 . . . . 0.0 109.99 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -145.56 155.81 43.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 107.19 172.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.21 -152.48 24.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 107.786 -2.125 . . . . 0.0 107.786 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -78.15 101.66 7.14 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 104.421 -2.436 . . . . 0.0 104.421 154.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.61 18.56 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.403 1.081 . . . . 0.0 110.352 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -148.48 166.81 27.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.966 1.706 . . . . 0.0 107.109 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 154.63 26.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t 60.39 -56.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.799 2.04 . . . . 0.0 110.981 -161.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.98 39.37 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-O 118.621 -1.1 . . . . 0.0 112.162 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -53.63 -43.34 68.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.489 1.645 . . . . 0.0 112.652 -169.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -69.11 -27.69 65.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.615 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.28 -44.25 65.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.485 1.039 . . . . 0.0 109.914 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.9 -50.81 63.18 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.765 0.826 . . . . 0.0 110.998 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.13 -35.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.034 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.53 -21.62 60.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.377 1.444 . . . . 0.0 113.054 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.4 mtm -64.06 -46.32 84.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.755 1.161 . . . . 0.0 109.03 165.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -68.32 -23.98 64.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.465 0.706 . . . . 0.0 111.582 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.66 -53.04 38.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.356 -0.84 . . . . 0.0 108.921 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.61 -40.26 91.21 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.205 0.602 . . . . 0.0 111.594 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.27 62.58 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.78 -0.575 . . . . 0.0 112.295 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.1 15.03 17.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.455 1.502 . . . . 0.0 111.393 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 47.94 32.07 2.65 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.183 1.793 . . . . 0.0 112.849 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -73.43 162.26 29.5 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.79 134.87 25.56 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.42 -165.39 38.6 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 118.566 0.621 . . . . 0.0 112.143 -160.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.458 ' CZ3' ' HE2' ' A' ' 35' ' ' LYS . 3.0 p-90 -135.81 169.22 17.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.652 0.781 . . . . 0.0 112.514 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.42 149.85 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.16 1.384 . . . . 0.0 109.73 170.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HE2' ' CZ3' ' A' ' 33' ' ' TRP . 44.3 mtmt -142.23 150.47 40.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.181 1.792 . . . . 0.0 108.56 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -81.27 130.88 35.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 148.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -77.93 137.18 38.2 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 166.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.88 -24.82 62.72 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.196 0.598 . . . . 0.0 111.985 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -28.33 65.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.915 1.686 . . . . 0.0 112.869 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.18 3.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.228 1.394 . . . . 0.0 112.262 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.87 172.15 2.42 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.003 0.921 . . . . 0.0 111.197 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.58 140.58 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -127.07 143.54 51.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.073 0.949 . . . . 0.0 108.805 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.76 143.13 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 tt -149.58 127.74 12.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.55 157.24 35.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.135 0.88 . . . . 0.0 111.284 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.81 150.35 21.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.217 1.407 . . . . 0.0 109.71 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.55 174.08 38.27 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.635 1.588 . . . . 0.0 111.211 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.48 155.34 55.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.659 2.24 . . . . 0.0 110.306 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.55 -42.11 74.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -172.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.71 -41.53 99.19 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.075 -0.391 . . . . 0.0 111.576 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -45.56 79.84 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.945 0.498 . . . . 0.0 110.065 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -59.83 -45.37 92.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.894 0.878 . . . . 0.0 110.142 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -70.95 -40.87 71.77 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.582 -0.699 . . . . 0.0 112.057 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.6 m -60.18 -40.32 89.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.557 0.617 . . . . 0.0 110.021 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.16 -49.19 78.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.705 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.85 -44.31 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.683 1.129 . . . . 0.0 109.9 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.56 -41.4 98.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 111.215 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.46 96.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.527 0.731 . . . . 0.0 111.316 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 t -64.04 -53.38 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -57.02 -42.16 79.86 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.4 0.68 . . . . 0.0 111.014 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.52 -22.59 62.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.444 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.61 46.03 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 118.931 0.787 . . . . 0.0 111.386 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -50.69 -51.66 63.67 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -161.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.66 -40.42 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.402 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -165.09 172.94 12.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.792 2.037 . . . . 0.0 107.881 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m 62.71 170.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.159 1.383 . . . . 0.0 112.595 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.29 141.73 10.98 Favored 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.85 154.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -119.37 -12.66 9.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.245 1.418 . . . . 0.0 109.38 165.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.26 142.96 25.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.411 1.485 . . . . 0.0 108.155 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.3 tt -146.98 141.08 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -138.09 143.3 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.7 142.88 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -171.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.0 m -130.18 151.43 50.71 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 167.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -136.26 146.1 46.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -137.98 158.1 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.638 1.575 . . . . 0.0 108.384 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.92 -20.05 21.81 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.687 -0.633 . . . . 0.0 111.031 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 m -64.11 126.59 28.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.58 0.752 . . . . 0.0 110.242 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -68.21 173.45 4.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.386 1.075 . . . . 0.0 109.9 159.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -125.15 6.24 7.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.999 1.72 . . . . 0.0 111.025 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.18 22.96 61.37 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.455 1.026 . . . . 0.0 112.386 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -88.17 140.66 29.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.215 1.007 . . . . 0.0 108.713 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -132.69 11.57 4.39 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.55 165.47 32.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.241 1.817 . . . . 0.0 108.025 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -93.34 152.57 19.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.7 m -141.1 150.99 43.59 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.849 0.833 . . . . 0.0 111.185 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.0 110.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 t -75.37 132.61 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.51 36.21 1.28 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.955 0.902 . . . . 0.0 110.431 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 126.025 1.73 . . . . 0.0 111.046 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.06 178.78 4.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.21 1.004 . . . . 0.0 110.994 -165.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -153.78 157.5 39.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.217 2.207 . . . . 0.0 108.469 -168.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.9 166.14 23.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.161 0.584 . . . . 0.0 110.673 166.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -133.88 141.1 47.24 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 152.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.1 146.61 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -168.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 134.43 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.2 154.86 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.469 1.108 . . . . 0.0 111.072 -167.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -143.18 157.56 44.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.969 1.708 . . . . 0.0 108.876 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 -154.6 26.0 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 106.649 -2.581 . . . . 0.0 106.649 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -74.93 54.89 0.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.827 -0.807 . . . . 0.0 108.839 163.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.08 -10.72 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 121.256 -0.902 . . . . 0.0 113.206 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.544 HE22 ' HB3' ' A' ' 18' ' ' ARG . 22.0 mm-40 -132.05 113.6 13.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -144.66 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.35 -9.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.37 14.22 30.51 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.445 1.021 . . . . 0.0 112.392 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.6 t80 35.62 -127.65 0.12 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.502 2.321 . . . . 0.0 110.185 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.544 ' HB3' HE22 ' A' ' 13' ' ' GLN . 15.6 ptp180 -95.89 -12.41 25.21 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.875 0.87 . . . . 0.0 112.167 166.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.75 -15.55 63.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 117.432 -1.271 . . . . 0.0 112.457 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.916 1.689 . . . . 0.0 111.886 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.35 -35.32 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.17 0.895 . . . . 0.0 110.245 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.89 -28.36 66.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.566 1.075 . . . . 0.0 110.813 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -42.89 69.78 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.483 -0.76 . . . . 0.0 109.864 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.66 -35.97 81.44 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.621 -0.675 . . . . 0.0 110.197 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.16 89.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.598 1.159 . . . . 0.0 110.178 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.78 -39.4 84.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.115 0.566 . . . . 0.0 111.575 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -57.22 -42.12 80.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.655 0.661 . . . . 0.0 110.58 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -85.62 3.35 41.21 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 111.772 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 46.99 35.77 3.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.44 171.71 8.32 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 163.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.52 139.25 21.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -165.52 38.73 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.023 -163.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.15 160.47 27.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.955 1.302 . . . . 0.0 112.295 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.16 142.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.342 1.057 . . . . 0.0 109.444 164.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -147.88 171.89 15.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 109.563 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -123.76 114.92 20.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -75.57 152.69 37.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.08 -28.56 67.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 112.009 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.0 -27.03 68.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.001 0.921 . . . . 0.0 112.522 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.12 -27.39 4.55 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.086 1.327 . . . . 0.0 112.457 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.37 151.58 31.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.007 0.903 . . . . 0.0 110.258 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.96 149.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 155.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -128.04 144.93 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.068 1.347 . . . . 0.0 107.384 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 146.44 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -141.28 138.52 33.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -161.78 169.3 21.65 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.712 1.596 . . . . 0.0 110.869 171.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.91 154.87 37.76 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.999 1.32 . . . . 0.0 110.456 167.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.55 179.91 41.11 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.99 1.281 . . . . 0.0 111.49 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.44 156.63 54.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.681 2.254 . . . . 0.0 110.889 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -55.29 -46.88 76.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 111.688 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.6 -38.44 91.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.855 0.298 . . . . 0.0 111.469 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -47.34 75.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.576 0.35 . . . . 0.0 110.147 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.07 -48.53 81.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.385 0.674 . . . . 0.0 109.906 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -65.27 -45.84 82.85 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.197 0.599 . . . . 0.0 111.59 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -40.44 97.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.235 0.47 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.76 -48.68 80.38 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.684 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.02 -40.63 74.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.705 1.139 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.98 -42.13 99.75 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.172 0.897 . . . . 0.0 110.811 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.61 98.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.016 0.526 . . . . 0.0 111.667 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.17 -57.67 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.27 -42.71 91.85 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -171.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.07 -24.86 66.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.627 0.371 . . . . 0.0 111.652 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.97 50.05 66.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -52.09 77.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.831 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.45 -176.22 3.15 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.555 2.17 . . . . 0.0 110.584 170.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -106.23 154.34 20.86 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 153.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 171.3 1.55 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.412 2.685 . . . . 0.0 111.293 -7.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -135.57 161.66 34.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.173 -0.955 . . . . 0.0 110.748 -156.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.72 146.37 34.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -133.26 -5.42 3.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.228 1.011 . . . . 0.0 110.864 171.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.81 141.92 22.23 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.707 1.203 . . . . 0.0 108.858 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.9 146.98 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.506 1.123 . . . . 0.0 108.843 -173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 m -136.0 143.01 44.57 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.76 146.14 26.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -170.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 m -126.93 141.4 51.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 161.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.88 139.92 48.92 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -149.58 175.88 11.14 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.96 1.304 . . . . 0.0 109.43 -159.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.29 17.55 2.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.304 1.042 . . . . 0.0 111.113 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -66.97 -27.64 67.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.114 0.966 . . . . 0.0 111.695 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.95 175.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.154 2.182 . . . . 0.0 111.84 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.52 -13.08 0.39 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.46 1.104 . . . . 0.0 112.487 -170.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.92 15.03 79.96 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.031 0.824 . . . . 0.0 112.387 176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -66.49 126.06 27.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.554 1.177 . . . . 0.0 108.596 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -129.23 23.89 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.543 1.537 . . . . 0.0 108.244 164.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -148.18 161.33 41.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.386 2.274 . . . . 0.0 106.758 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -106.07 145.15 31.79 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -138.38 150.6 46.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.521 1.153 . . . . 0.0 111.675 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.72 133.37 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.65 157.01 38.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.89 -57.65 6.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 C--O 1.247 0.959 0 C-N-CA 127.03 2.132 . . . . 0.0 107.974 179.076 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ttp . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.28 176.91 6.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.65 1.114 . . . . 0.0 111.183 -167.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.24 143.94 25.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.474 2.31 . . . . 0.0 107.345 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -103.41 159.64 15.4 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 168.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -119.22 141.38 48.95 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 151.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -140.64 140.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.95 139.18 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.86 153.03 24.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.722 0.809 . . . . 0.0 110.773 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -140.37 147.93 40.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.555 1.542 . . . . 0.0 108.06 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -154.55 25.98 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -76.42 80.71 3.15 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 162.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -107.5 0.76 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.082 0.953 . . . . 0.0 111.391 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -139.05 140.82 38.19 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 121.075 -1.016 . . . . 0.0 109.239 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.1 179.5 33.03 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.81 105.07 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.123 0.969 . . . . 0.0 110.098 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 5.73 73.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.322 0.963 . . . . 0.0 113.861 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -70.03 -31.5 69.17 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.979 1.89 . . . . 0.0 111.899 -172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -82.84 -17.7 43.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.229 0.922 . . . . 0.0 112.938 168.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -68.65 -36.33 78.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.415 1.007 . . . . 0.0 109.763 171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -52.02 -48.02 64.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.239 0.615 . . . . 0.0 111.907 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.65 -35.21 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.684 0.674 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -75.07 -23.5 58.03 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.803 -1.185 . . . . 0.0 112.037 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.1 mtm -64.33 -50.25 68.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.218 0.917 . . . . 0.0 109.411 167.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.59 -39.27 90.6 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.262 0.625 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.74 54.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.211 1.005 . . . . 0.0 109.843 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.14 -45.71 93.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.152 0.581 . . . . 0.0 110.883 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -59.21 -24.7 63.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.523 1.529 . . . . 0.0 111.888 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -108.38 13.24 25.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.236 1.414 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 50.41 31.15 5.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.974 1.71 . . . . 0.0 112.843 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.8 160.09 28.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.121 0.969 . . . . 0.0 108.503 169.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.03 124.43 12.35 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.488 0.715 . . . . 0.0 109.922 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.51 -175.01 35.67 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.851 0.739 . . . . 0.0 112.091 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -99.78 161.14 13.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -164.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.71 143.61 38.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 156.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.41 152.59 38.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.429 0.692 . . . . 0.0 110.137 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -72.54 123.25 22.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -81.55 132.39 35.31 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.34 -29.44 65.95 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -167.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -17.18 62.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.06 0.944 . . . . 0.0 113.246 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.31 -15.53 6.09 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.472 1.511 . . . . 0.0 112.891 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.12 175.96 3.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.951 1.376 . . . . 0.0 109.721 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.12 145.01 24.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -116.81 143.13 46.04 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.8 133.45 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -150.41 117.18 5.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.54 149.98 28.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.542 0.61 . . . . 0.0 112.355 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.29 157.29 18.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.692 1.197 . . . . 0.0 110.345 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.83 38.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.895 1.236 . . . . 0.0 111.582 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.31 153.99 65.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.259 1.972 . . . . 0.0 110.368 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.3 -48.32 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 111.494 -170.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.14 -38.34 90.69 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.087 0.403 . . . . 0.0 111.786 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.67 89.48 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.045 0.538 . . . . 0.0 109.832 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -47.55 84.81 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.438 0.695 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -67.34 -40.51 85.9 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.802 -0.561 . . . . 0.0 111.553 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -67.15 -35.67 80.21 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.79 -0.568 . . . . 0.0 110.69 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.47 -47.04 87.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.971 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.41 -42.71 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.913 1.233 . . . . 0.0 109.55 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -41.0 96.06 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.257 0.935 . . . . 0.0 111.313 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.74 -40.73 89.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.737 0.815 . . . . 0.0 111.46 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -55.33 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -59.24 -37.89 78.66 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.195 0.598 . . . . 0.0 111.734 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.98 -23.55 65.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.179 0.592 . . . . 0.0 112.261 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.35 43.03 89.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 118.672 0.669 . . . . 0.0 111.508 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -50.28 -49.11 78.41 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -168.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.54 -59.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.735 1.655 . . . . 0.0 112.204 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -171.3 -47.44 0.02 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.213 1.805 . . . . 0.0 108.173 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.61 146.79 24.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.04 0.936 . . . . 0.0 109.546 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -156.2 162.52 40.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.994 0.918 . . . . 0.0 108.97 -167.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -115.02 148.91 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 p -121.42 -9.07 9.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.684 1.594 . . . . 0.0 109.455 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -150.44 143.08 24.55 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.696 1.598 . . . . 0.0 107.57 166.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.5 140.9 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -136.46 143.39 43.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.527 1.531 . . . . 0.0 106.87 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -140.1 147.98 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -127.28 154.32 45.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -133.04 143.6 49.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -158.37 170.8 21.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.037 . . . . 0.0 109.752 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.06 5.47 44.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.829 0.852 . . . . 0.0 110.981 171.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 m -71.53 73.31 0.75 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.755 2.022 . . . . 0.0 111.59 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.16 140.92 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.444 -0.785 . . . . 0.0 109.763 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -78.58 -23.72 45.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.524 0.73 . . . . 0.0 111.394 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.68 48.14 13.53 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -167.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.78 154.87 43.67 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.477 1.111 . . . . 0.0 109.662 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -136.42 8.32 3.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.856 0.862 . . . . 0.0 112.438 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -149.13 166.47 28.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.519 1.528 . . . . 0.0 108.417 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -76.87 163.11 27.06 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.4 m -140.07 152.57 46.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.805 1.242 . . . . 0.0 109.331 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mt -135.11 116.44 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.65 144.64 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.37 5.09 3.74 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.679 1.192 . . . . 0.0 111.54 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.251 1.162 0 C-N-CA 125.073 1.349 . . . . 0.0 110.72 178.356 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttp . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.01 176.99 7.19 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.878 -1.139 . . . . 0.0 111.891 -159.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -145.4 156.32 43.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.23 1.812 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.2 165.67 15.08 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.53 0.732 . . . . 0.0 110.508 161.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -128.09 143.28 51.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 149.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 98.0 mt -137.62 138.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.36 133.38 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.18 153.33 18.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 111.24 -169.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.42 145.93 35.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.034 1.734 . . . . 0.0 107.447 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.24 -154.12 25.76 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -172.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -78.05 88.31 4.19 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 157.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.96 3.28 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.761 1.224 . . . . 0.0 111.092 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -145.92 142.01 28.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.333 1.053 . . . . 0.0 109.391 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.69 159.51 8.09 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.025 2.25 . . . . 0.0 108.232 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.13 -29.22 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.104 0.562 . . . . 0.0 112.397 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.86 -41.79 3.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.09 -29.6 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 117.581 -1.2 . . . . 0.0 113.458 -169.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -103.7 -4.12 24.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.201 1.364 . . . . 0.0 114.093 167.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -62.99 -35.87 81.64 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.108 1.322 . . . . 0.0 109.025 161.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.55 -50.26 24.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.002 0.819 . . . . 0.0 112.564 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.64 -40.07 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 119.215 0.916 . . . . 0.0 109.898 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -74.25 -23.65 59.18 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.631 -1.293 . . . . 0.0 112.152 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.24 82.46 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 169.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -62.79 -37.38 86.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.083 0.856 . . . . 0.0 109.91 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.53 57.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.13 0.572 . . . . 0.0 109.856 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.82 -46.16 91.62 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.253 0.621 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -58.11 -28.1 64.33 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.892 1.277 . . . . 0.0 111.937 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -107.4 12.43 28.0 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.914 1.286 . . . . 0.0 111.159 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 49.61 31.91 4.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 112.742 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.5 mt -73.88 164.09 27.09 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 168.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.66 135.67 31.9 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.79 -165.79 38.99 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -140.15 161.77 36.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.648 0.779 . . . . 0.0 111.987 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.81 143.08 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.48 1.112 . . . . 0.0 108.625 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -143.95 163.09 34.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.962 1.705 . . . . 0.0 108.435 -164.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -115.21 120.63 40.36 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -75.92 147.23 39.11 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.27 -28.34 66.64 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.377 0.671 . . . . 0.0 112.084 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.01 0.924 . . . . 0.0 112.461 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.36 -29.4 3.17 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.173 1.368 . . . . 0.0 112.225 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.75 152.2 31.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.911 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.34 148.1 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 160.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -128.38 144.6 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.69 141.35 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -146.15 125.76 13.33 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.69 161.07 42.93 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.019 0.528 . . . . 0.0 110.409 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.31 154.47 22.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.409 1.483 . . . . 0.0 108.051 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 179.32 40.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.39 0.519 . . . . 0.0 111.826 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.24 157.44 59.43 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.325 2.016 . . . . 0.0 110.793 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.08 -49.25 74.33 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.148 0.979 . . . . 0.0 111.527 -170.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -66.84 -38.06 85.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 119.406 -0.331 . . . . 0.0 111.395 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.88 74.02 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.238 0.615 . . . . 0.0 109.714 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.98 -44.61 96.38 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.352 0.661 . . . . 0.0 110.803 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.31 -34.7 55.35 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.766 -0.584 . . . . 0.0 111.583 -173.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -68.85 -35.39 76.87 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.305 -0.872 . . . . 0.0 110.743 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.99 -48.72 79.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.316 0.646 . . . . 0.0 109.549 168.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -55.81 -42.97 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.19 0.904 . . . . 0.0 109.67 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.48 -41.91 97.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.401 1.0 . . . . 0.0 111.419 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -40.98 82.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.006 0.923 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.39 -52.49 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.86 0.755 . . . . 0.0 109.5 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.77 -39.17 90.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.132 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -64.33 -21.07 66.49 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.298 1.039 . . . . 0.0 111.904 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.62 172.83 21.55 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -152.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 p -139.65 -179.98 1.15 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 121.839 -0.8 . . . . 0.0 110.031 -164.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.16 -24.62 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.461 2.774 . . . . 0.0 115.742 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.95 2.6 0.44 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 m -126.62 159.1 34.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.56 1.527 . . . . 0.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 145.83 20.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.333 0.969 . . . . 0.0 111.175 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.01 156.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -122.59 -12.46 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.62 1.568 . . . . 0.0 109.506 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -150.07 145.92 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.362 1.465 . . . . 0.0 108.185 165.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.38 144.25 16.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.773 1.229 . . . . 0.0 108.503 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m -139.29 145.64 39.37 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.726 1.611 . . . . 0.0 107.355 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.12 144.27 29.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.8 m -130.91 151.09 51.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.48 145.99 50.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.5 m -147.55 -176.59 5.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.987 1.315 . . . . 0.0 109.263 -167.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -127.73 10.33 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 110.977 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -67.66 -29.46 68.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.788 1.235 . . . . 0.0 114.02 -161.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.9 mt 62.04 171.82 0.13 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.351 1.86 . . . . 0.0 111.924 -170.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -139.03 -30.96 0.72 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.597 1.159 . . . . 0.0 111.412 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.79 30.47 77.29 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -72.86 164.0 27.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.04 1.336 . . . . 0.0 108.922 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.82 11.59 4.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.623 0.769 . . . . 0.0 111.763 -173.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -145.84 167.47 23.14 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.221 1.008 . . . . 0.0 109.253 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -89.04 141.94 28.06 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 139.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -133.14 163.35 29.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.502 0.721 . . . . 0.0 110.758 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 mt -138.06 127.39 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.82 162.58 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.537 1.135 . . . . 0.0 107.95 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -143.9 -28.3 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.619 0.768 . . . . 0.0 112.199 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.388 1.475 . . . . 0.0 111.048 176.448 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.416 0.151 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mp -134.19 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.596 1.159 . . . . 0.0 111.051 -160.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.32 154.08 42.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.46 1.904 . . . . 0.0 107.401 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -118.7 164.62 15.09 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.453 0.701 . . . . 0.0 110.51 165.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -125.67 140.83 52.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 147.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.52 142.98 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 137.49 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.87 149.79 23.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.202 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -138.96 155.71 47.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.572 1.549 . . . . 0.0 107.807 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.71 -156.35 25.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -79.75 65.98 5.08 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 163.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 27.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.133 0.973 . . . . 0.0 111.076 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.573 HE22 ' N ' ' A' ' 18' ' ' ARG . 5.6 tp60 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' N ' HE22 ' A' ' 13' ' ' GLN . 7.4 ptp180 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.66 -45.48 75.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.941 0.791 . . . . 0.0 109.931 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.32 -50.29 65.28 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.2 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.4 -38.92 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.463 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -71.67 -22.58 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 113.078 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.1 mtm -64.32 -46.75 82.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.637 1.108 . . . . 0.0 108.826 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.79 -31.33 72.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.54 -54.79 41.16 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.988 0.915 . . . . 0.0 109.675 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.15 -40.49 96.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.957 0.503 . . . . 0.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -55.21 -28.7 54.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.122 . . . . 0.0 111.887 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -118.59 20.71 12.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.697 0.799 . . . . 0.0 111.617 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 41.59 42.14 1.91 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.771 2.428 . . . . 0.0 113.67 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.47 163.67 27.64 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.08 130.76 17.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.74 -162.52 34.17 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.029 -168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -130.86 161.7 31.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.047 . . . . 0.0 112.168 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.43 148.12 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.948 1.299 . . . . 0.0 109.22 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.99 156.75 43.0 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.243 1.817 . . . . 0.0 108.143 -170.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -115.54 121.48 42.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.18 151.26 36.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.487 1.115 . . . . 0.0 109.177 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.14 -28.7 69.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.976 0.51 . . . . 0.0 111.382 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -7.63 48.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.153 0.981 . . . . 0.0 113.259 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.81 -19.57 32.92 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.03 1.3 . . . . 0.0 113.265 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.33 163.66 22.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.918 1.359 . . . . 0.0 110.435 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.89 149.77 5.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 158.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -135.23 144.91 47.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -141.33 144.78 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.85 130.1 13.69 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.07 154.51 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.102 0.864 . . . . 0.0 111.07 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.24 157.16 16.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.927 1.291 . . . . 0.0 109.838 168.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 178.49 40.31 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.715 0.674 . . . . 0.0 112.577 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.49 155.69 40.72 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.311 2.008 . . . . 0.0 110.174 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.27 -47.54 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 111.432 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.06 -39.62 93.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.941 0.337 . . . . 0.0 111.248 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.95 -46.66 77.33 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.02 0.373 . . . . 0.0 110.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 77.4 mt -62.12 -43.19 99.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.687 0.795 . . . . 0.0 110.509 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -71.83 -38.7 70.12 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.757 -0.589 . . . . 0.0 111.918 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.4 m -62.57 -39.56 94.06 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.664 -0.648 . . . . 0.0 110.075 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -60.75 -46.95 88.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.695 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.76 -44.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 119.861 1.21 . . . . 0.0 109.486 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -62.16 -42.04 98.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.972 0.805 . . . . 0.0 111.408 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.39 87.87 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.025 0.93 . . . . 0.0 111.901 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.76 -54.74 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.26 -38.67 80.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.403 1.081 . . . . 0.0 112.062 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.31 -26.23 68.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.135 0.574 . . . . 0.0 111.69 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.34 47.28 91.63 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -53.08 -39.63 72.39 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.901 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -66.23 -174.81 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.806 3.004 . . . . 0.0 114.841 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -63.42 -37.03 85.71 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.319 1.048 . . . . 0.0 111.045 164.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.1 m -70.06 137.98 51.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.377 1.071 . . . . 0.0 108.244 165.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 150.7 35.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.415 0.552 . . . . 0.0 111.049 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.08 151.38 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.152 1.381 . . . . 0.0 107.998 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -128.45 -11.55 5.07 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.099 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -151.56 140.57 21.11 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.652 1.181 . . . . 0.0 108.957 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.1 tt -140.98 149.08 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.793 1.237 . . . . 0.0 108.746 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 m -139.13 144.88 38.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.04 143.0 34.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.6 m -130.04 150.84 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 153.44 50.88 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.529 0.731 . . . . 0.0 110.415 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.6 m -151.53 173.77 14.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.498 1.519 . . . . 0.0 109.208 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 1.33 24.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.901 1.28 . . . . 0.0 110.988 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -72.69 75.73 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.74 2.016 . . . . 0.0 111.839 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.67 153.76 9.99 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.58 -0.7 . . . . 0.0 110.41 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.99 -26.29 7.36 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.781 1.232 . . . . 0.0 110.671 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.11 24.22 59.92 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -163.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 139.78 49.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.685 1.243 . . . . 0.0 108.332 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -134.41 14.58 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.082 . . . . 0.0 111.705 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.2 171.94 15.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.444 1.497 . . . . 0.0 109.111 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -98.33 153.59 18.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -140.38 154.15 46.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 110.075 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.74 111.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.237 0.421 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.46 178.53 7.53 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.979 -1.076 . . . . 0.0 110.062 -167.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -152.91 158.48 42.19 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.988 1.715 . . . . 0.0 108.549 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -123.37 165.99 16.09 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.991 0.916 . . . . 0.0 110.465 168.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -131.03 135.82 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 151.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.27 145.43 33.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.92 138.8 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 170.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.53 146.27 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.136 0.975 . . . . 0.0 109.938 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.87 157.17 46.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 108.805 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.05 25.11 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -81.4 92.61 6.46 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 160.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.77 10.42 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.487 1.515 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 . . . . . 0 N--CA 1.465 0.287 0 O-C-N 120.917 -1.114 . . . . 0.0 110.663 -178.66 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.54 -35.43 80.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.414 1.007 . . . . 0.0 110.608 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -50.22 66.22 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.732 1.151 . . . . 0.0 110.728 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.8 -33.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.218 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -74.11 -25.31 59.71 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.854 1.207 . . . . 0.0 112.278 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -62.83 -47.56 82.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.902 0.773 . . . . 0.0 109.139 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -66.67 -29.66 69.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.613 0.365 . . . . 0.0 110.835 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.866 1.266 . . . . 0.0 109.975 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.27 -39.75 91.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.947 0.499 . . . . 0.0 111.197 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.29 -18.77 51.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.634 1.173 . . . . 0.0 112.545 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -114.59 15.17 17.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.012 1.278 . . . . 0.0 111.389 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.87 33.17 2.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.29 1.836 . . . . 0.0 112.724 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.97 161.96 29.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.18 134.82 42.56 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.2 -172.93 42.98 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 118.182 0.446 . . . . 0.0 112.107 -164.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -135.09 162.39 32.61 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.521 0.729 . . . . 0.0 112.124 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.83 149.76 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.562 1.145 . . . . 0.0 108.84 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.42 156.02 42.49 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.51 1.924 . . . . 0.0 107.585 -170.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.32 122.57 45.3 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -76.88 159.73 29.79 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.135 0.974 . . . . 0.0 110.337 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -61.19 -30.17 70.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.246 0.618 . . . . 0.0 111.458 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -10.19 57.96 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.98 -23.84 24.6 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.527 1.536 . . . . 0.0 112.204 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -87.81 166.09 14.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.229 1.514 . . . . 0.0 110.469 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.9 150.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -133.51 143.41 48.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.89 1.276 . . . . 0.0 107.667 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.05 142.71 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.64 123.55 10.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -154.26 162.98 40.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.413 0.552 . . . . 0.0 110.818 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.61 151.75 32.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 109.871 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.54 177.92 40.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.23 1.395 . . . . 0.0 110.351 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 154.45 67.79 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.353 2.035 . . . . 0.0 110.086 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.0 -42.42 76.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.558 0.743 . . . . 0.0 111.577 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.02 -41.19 99.49 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.148 -0.345 . . . . 0.0 111.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.48 84.19 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.988 0.515 . . . . 0.0 109.987 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 4' ' ' TYR . 86.4 mt -62.92 -43.34 99.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.565 0.746 . . . . 0.0 110.699 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -70.48 -40.9 73.34 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.636 -0.665 . . . . 0.0 111.697 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.5 m -59.8 -39.9 86.54 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.059 -0.401 . . . . 0.0 110.019 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -61.87 -47.43 85.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.952 173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -53.99 -46.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.078 1.308 . . . . 0.0 109.593 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -61.78 -39.99 93.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.001 0.364 . . . . 0.0 111.039 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.75 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.282 0.633 . . . . 0.0 111.899 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.73 -49.44 80.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -57.86 -41.64 82.86 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.036 0.534 . . . . 0.0 110.826 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -72.12 -20.78 61.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.125 0.97 . . . . 0.0 112.451 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 40.81 92.67 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.365 0.984 . . . . 0.0 111.832 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 m -46.47 -54.33 19.15 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -160.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.36 -52.28 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 121.797 1.678 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -167.82 158.43 10.82 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.253 2.221 . . . . 0.0 107.412 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 p 129.48 176.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 131.713 4.005 . . . . 0.0 108.717 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.77 157.74 43.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 145.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.21 137.65 56.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -126.39 -5.69 6.53 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.233 1.413 . . . . 0.0 110.788 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.17 134.12 13.97 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.363 1.865 . . . . 0.0 106.405 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.42 138.42 21.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.0 m -140.58 147.82 40.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.92 143.63 28.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.1 m -130.19 152.44 49.62 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -129.2 145.07 51.4 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.4 m -143.61 167.65 21.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.902 1.281 . . . . 0.0 109.582 -160.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.73 1.89 10.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 110.971 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.6 m -65.91 -26.17 67.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.145 0.978 . . . . 0.0 112.709 -173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.5 mt 60.82 175.76 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.381 1.872 . . . . 0.0 111.414 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.8 -16.52 0.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.023 0.929 . . . . 0.0 113.046 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.8 90.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.221 -1.322 . . . . 0.0 116.198 155.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -81.83 178.41 8.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.039 1.919 . . . . 0.0 109.929 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -130.16 17.24 5.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.554 1.541 . . . . 0.0 110.718 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -149.38 167.54 25.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.551 1.541 . . . . 0.0 109.292 -172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -86.04 151.63 23.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 163.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -142.95 162.34 35.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.838 0.855 . . . . 0.0 110.53 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.59 114.82 18.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.095 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.205 -0.426 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.13 177.42 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.882 1.219 . . . . 0.0 111.248 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -146.79 155.22 42.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.675 2.39 . . . . 0.0 108.081 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.465 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -119.44 165.18 14.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.99 0.916 . . . . 0.0 110.426 169.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -131.06 133.78 46.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 154.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.45 141.63 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.68 128.73 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.16 137.59 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.67 1.188 . . . . 0.0 109.83 -164.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -131.44 150.83 52.0 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.655 1.182 . . . . 0.0 108.393 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -152.65 24.74 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.55 78.88 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 164.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.71 4.17 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.651 0.78 . . . . 0.0 111.892 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.235 0.322 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.281 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -72.33 -45.42 60.01 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.897 1.226 . . . . 0.0 108.97 163.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -48.68 64.12 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.964 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 m -62.12 -37.1 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 119.802 1.183 . . . . 0.0 110.791 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -73.53 -23.18 59.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.5 1.5 . . . . 0.0 112.273 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.4 mtm -62.94 -47.07 84.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.262 0.937 . . . . 0.0 109.34 165.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -66.65 -32.6 74.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.494 . . . . 0.0 110.804 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.51 72.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.585 1.154 . . . . 0.0 109.583 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.34 -42.07 99.09 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 111.235 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.01 -21.49 45.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.635 1.174 . . . . 0.0 112.255 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 16.22 12.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.995 -1.066 . . . . 0.0 111.947 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? 45.69 38.57 4.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.869 2.067 . . . . 0.0 112.31 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.5 mt -75.66 164.23 26.51 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.73 130.98 22.07 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.71 -162.07 33.63 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.39 163.63 30.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.626 0.713 . . . . 0.0 111.994 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.42 142.53 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.058 0.943 . . . . 0.0 109.732 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -149.21 151.86 35.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 125.3 1.44 . . . . 0.0 108.248 -162.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 120.07 29.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 166.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -74.21 153.24 39.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.96 -25.52 67.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.884 0.874 . . . . 0.0 112.341 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.54 -27.64 67.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.382 1.073 . . . . 0.0 112.104 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.21 -31.78 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.318 1.437 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -68.32 163.67 22.49 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.732 0.766 . . . . 0.0 110.54 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.35 156.53 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -134.05 141.53 47.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.658 1.583 . . . . 0.0 107.881 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -134.03 141.01 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.4 tt -149.91 119.41 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.2 160.23 42.78 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.488 0.715 . . . . 0.0 111.205 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 12.9 pt-20 -106.83 154.93 20.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.179 1.392 . . . . 0.0 110.313 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 175.61 37.63 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.057 1.313 . . . . 0.0 111.001 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.89 153.43 68.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.146 1.897 . . . . 0.0 110.261 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -55.33 -43.32 74.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.653 0.781 . . . . 0.0 111.533 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -62.69 -40.43 97.1 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.245 -0.284 . . . . 0.0 111.459 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.64 74.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 4' ' ' TYR . 91.9 mt -59.14 -44.87 92.08 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.45 0.7 . . . . 0.0 110.023 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -68.87 -40.51 79.25 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.88 -0.512 . . . . 0.0 111.955 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -60.67 -42.68 97.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.567 0.621 . . . . 0.0 110.063 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -59.53 -48.97 79.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.432 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.72 -42.92 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.953 1.251 . . . . 0.0 110.0 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.17 -41.89 99.3 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.871 0.76 . . . . 0.0 110.743 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.82 96.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.657 0.783 . . . . 0.0 111.366 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.1 -52.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -56.75 -41.63 77.89 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.81 0.844 . . . . 0.0 111.046 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -72.75 -20.96 61.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.018 -0.515 . . . . 0.0 112.365 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.73 40.42 48.72 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.436 1.017 . . . . 0.0 111.906 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -45.63 -53.94 17.58 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -157.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -49.65 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 CA-C-N 121.481 1.565 . . . . 0.0 112.216 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 67' ' ' SER . 17.5 p90 -167.48 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.012 0.925 . . . . 0.0 112.718 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 66' ' ' PHE 0.269 1.4 m -62.63 -57.32 11.49 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -120.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 161.63 40.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 130.277 3.431 . . . . 0.0 108.511 -5.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.54 157.18 7.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.318 0.647 . . . . 0.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.2 p -127.21 -11.88 5.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.22 1.408 . . . . 0.0 110.378 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.22 144.83 25.87 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.926 1.291 . . . . 0.0 108.471 172.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.28 144.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.0 108.217 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 m -139.46 145.29 38.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.337 1.455 . . . . 0.0 107.219 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.07 142.69 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.375 1.07 . . . . 0.0 108.281 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -132.45 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.396 1.878 . . . . 0.0 106.048 168.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -137.99 149.04 45.75 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 m -148.76 162.83 38.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.375 1.47 . . . . 0.0 109.114 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.11 -13.24 57.55 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.602 -0.686 . . . . 0.0 111.362 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 88.83 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 111.899 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.84 147.58 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.531 0.732 . . . . 0.0 110.26 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -81.95 -28.2 32.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.892 0.877 . . . . 0.0 112.026 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.98 68.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.038 0.828 . . . . 0.0 111.219 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.67 150.17 34.58 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.808 1.304 . . . . 0.0 109.378 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -134.76 9.37 3.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.958 0.903 . . . . 0.0 112.547 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -149.26 177.55 9.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.149 1.38 . . . . 0.0 109.158 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -101.79 145.02 29.74 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 163.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 161.81 37.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.628 0.728 . . . . 0.0 111.431 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.1 mt -133.88 126.86 51.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 109.656 -163.97 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp -129.29 176.03 8.26 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.686 -1.259 . . . . 0.0 111.18 -165.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.55 152.8 38.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.844 1.658 . . . . 0.0 109.183 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -125.68 165.22 18.98 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.387 1.075 . . . . 0.0 111.054 169.061 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -134.28 133.41 40.73 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 158.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.41 142.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.54 133.26 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.65 141.92 29.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.71 151.77 49.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.888 1.275 . . . . 0.0 108.054 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.61 -153.75 25.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -76.72 82.45 3.34 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 158.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -107.59 -1.63 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.538 HE22 ' HB3' ' A' ' 18' ' ' ARG . 9.9 mm-40 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.7 ptt-85 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -69.08 -23.56 64.04 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 117.608 -1.186 . . . . 0.0 111.125 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.04 -52.14 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.283 1.402 . . . . 0.0 111.736 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.51 -31.83 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.716 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -66.51 -31.14 71.69 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.872 1.214 . . . . 0.0 112.288 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.7 mtm -65.76 -49.94 66.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.456 1.026 . . . . 0.0 108.637 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -67.8 -33.12 74.19 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.205 0.457 . . . . 0.0 110.875 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -53.21 57.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.482 1.113 . . . . 0.0 110.336 173.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.13 -40.05 93.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.561 0.745 . . . . 0.0 111.288 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -53.52 -28.14 29.61 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.165 1.386 . . . . 0.0 111.817 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -118.58 22.8 11.86 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.567 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 tttt 50.21 36.18 11.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.506 1.922 . . . . 0.0 113.089 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.69 163.6 27.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.23 126.18 21.02 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.1 -161.86 29.72 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.926 0.785 . . . . 0.0 113.148 -168.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -135.06 166.09 23.87 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.79 144.0 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.754 1.221 . . . . 0.0 108.818 162.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.0 161.74 40.19 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.818 0.847 . . . . 0.0 110.34 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.76 148.06 38.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 158.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -126.08 140.29 52.71 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.929 1.291 . . . . 0.0 107.785 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.11 -24.78 63.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.402 1.481 . . . . 0.0 114.318 -163.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.0 -23.03 65.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.188 0.595 . . . . 0.0 112.301 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 37.16 1.39 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.753 1.168 . . . . 0.0 111.123 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -145.81 163.88 33.65 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.358 1.063 . . . . 0.0 109.144 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.26 150.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.26 143.17 51.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.405 1.882 . . . . 0.0 107.259 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -137.6 139.32 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -150.04 126.58 10.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.11 161.96 39.42 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 119.049 0.84 . . . . 0.0 111.374 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.99 154.3 23.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.177 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.39 177.29 39.9 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.312 0.958 . . . . 0.0 111.53 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.28 157.59 53.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.771 2.314 . . . . 0.0 110.757 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -55.37 -53.29 58.09 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.526 0.731 . . . . 0.0 111.511 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -59.98 -37.49 79.81 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.967 -0.458 . . . . 0.0 111.527 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.36 76.25 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 4' ' ' TYR . 90.2 mt -62.28 -47.13 85.69 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.467 0.707 . . . . 0.0 110.534 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -68.53 -42.09 78.96 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.888 -0.508 . . . . 0.0 111.339 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 m -63.37 -37.74 88.46 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.765 -0.584 . . . . 0.0 110.204 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.6 -45.54 93.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.448 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t -55.23 -45.61 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 120.013 1.279 . . . . 0.0 109.535 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.4 -41.01 88.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.043 0.383 . . . . 0.0 111.031 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.79 95.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.14 0.976 . . . . 0.0 111.631 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.55 -50.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.179 0.9 . . . . 0.0 108.668 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -58.77 -41.63 87.07 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.703 0.401 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -71.41 -22.14 61.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.073 0.549 . . . . 0.0 112.393 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.1 39.12 40.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.944 1.259 . . . . 0.0 112.756 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -41.11 -50.05 8.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -159.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.81 -31.49 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.649 1.625 . . . . 0.0 114.704 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -164.26 -31.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.083 1.31 . . . . 0.0 113.264 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.03 170.87 13.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.799 1.64 . . . . 0.0 111.723 -170.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.13 145.03 19.15 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -83.92 153.23 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.6 p -118.25 -14.17 9.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.065 1.346 . . . . 0.0 109.376 165.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.64 137.89 21.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.328 1.451 . . . . 0.0 107.68 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tt -144.61 136.49 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 m -133.77 142.69 48.03 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.84 141.48 40.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -172.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.27 146.2 51.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 171.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.55 154.72 46.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.809 0.731 . . . . 0.0 110.102 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -147.89 176.72 9.92 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.878 1.671 . . . . 0.0 108.245 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -119.46 -7.16 10.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.719 0.808 . . . . 0.0 110.191 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m -70.22 100.54 1.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.623 1.169 . . . . 0.0 108.851 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.3 155.26 9.2 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.97 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.6 -27.74 51.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.668 0.787 . . . . 0.0 110.967 170.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.38 30.62 58.27 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -161.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.11 155.09 35.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.116 0.958 . . . . 0.0 110.202 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.39 14.57 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.345 1.058 . . . . 0.0 111.291 -173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -149.34 172.49 14.83 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.846 1.658 . . . . 0.0 108.644 -170.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -133.42 119.97 20.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 160.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -136.93 156.78 48.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -153.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.45 124.84 64.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 C--O 1.237 0.42 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.234 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.87 177.85 8.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.613 1.097 . . . . 0.0 110.513 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.84 153.49 32.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.411 1.884 . . . . 0.0 108.968 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.426 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.2 p90 -114.18 163.42 15.25 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.81 0.844 . . . . 0.0 109.785 166.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -131.41 138.23 49.0 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 151.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.02 145.64 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -169.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.44 139.28 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 167.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.47 151.1 29.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.47 152.82 49.95 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.63 1.572 . . . . 0.0 107.147 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.76 -155.46 26.55 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -78.51 60.28 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 162.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -85.73 18.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.287 -0.883 . . . . 0.0 111.713 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.556 HE22 ' N ' ' A' ' 18' ' ' ARG . 8.3 tp60 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 167.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.556 ' N ' HE22 ' A' ' 13' ' ' GLN . 11.4 ptp180 . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -76.32 -32.51 58.76 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.454 1.479 . . . . 0.0 111.493 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.97 -45.93 75.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.073 1.306 . . . . 0.0 109.967 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.74 -47.96 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.099 0.959 . . . . 0.0 109.285 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -70.05 -25.7 63.68 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.306 1.412 . . . . 0.0 113.45 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.1 mtm -65.5 -48.05 73.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.2 1.364 . . . . 0.0 109.097 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -66.67 -35.06 79.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.307 0.643 . . . . 0.0 110.048 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.31 47.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.555 1.142 . . . . 0.0 109.791 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.08 -39.6 92.98 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.284 0.634 . . . . 0.0 111.406 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -16.09 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 0.0 112.576 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.53 17.57 16.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.304 1.442 . . . . 0.0 110.915 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 49.39 30.36 3.26 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.12 1.768 . . . . 0.0 112.911 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 mt -77.31 160.09 29.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.24 134.86 18.63 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.959 0.504 . . . . 0.0 110.584 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.57 -161.06 31.09 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.086 1.326 . . . . 0.0 110.545 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -106.09 162.29 13.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.226 1.513 . . . . 0.0 113.298 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.14 146.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.697 1.199 . . . . 0.0 108.001 163.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -154.13 155.37 35.24 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 108.958 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -99.72 123.74 44.28 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 161.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -80.3 147.3 31.2 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.04 -27.8 65.83 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.491 0.716 . . . . 0.0 112.25 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.61 -27.44 68.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.338 1.055 . . . . 0.0 112.81 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.06 -21.74 5.48 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.9 1.238 . . . . 0.0 112.322 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.38 157.0 11.77 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.056 0.928 . . . . 0.0 110.753 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -96.6 146.68 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 149.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.54 144.57 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.907 1.683 . . . . 0.0 106.812 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.54 142.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -148.32 123.02 9.88 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.84 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.293 0.951 . . . . 0.0 111.255 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.87 155.43 16.78 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.228 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 177.18 41.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.412 1.482 . . . . 0.0 111.077 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.88 159.78 49.56 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.725 2.283 . . . . 0.0 110.321 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 -48.14 78.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.232 0.613 . . . . 0.0 111.602 -168.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.79 -37.45 86.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.666 0.386 . . . . 0.0 111.852 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -46.3 87.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 4' ' ' TYR . 81.4 mt -59.53 -45.11 92.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.108 0.563 . . . . 0.0 109.556 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.49 -44.83 85.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.769 0.713 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.7 m -60.98 -42.31 98.12 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.849 0.46 . . . . 0.0 109.99 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.54 -48.08 83.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.062 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.0 t -56.96 -41.27 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.913 1.233 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.75 -41.93 99.44 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.692 0.678 . . . . 0.0 110.851 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.0 86.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.676 0.79 . . . . 0.0 111.756 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.01 -55.48 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.25 -38.47 83.56 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.709 0.804 . . . . 0.0 111.263 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.55 -24.75 67.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.47 0.708 . . . . 0.0 112.154 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.2 97.83 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 m -49.72 -45.87 79.52 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.83 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.728 1.653 . . . . 0.0 112.299 -166.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.2 t80 179.51 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.31 2.244 . . . . 0.0 106.094 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -58.85 141.23 53.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 157.1 40.03 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.971 0.909 . . . . 0.0 110.325 -171.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.96 157.08 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -119.77 -13.91 9.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.004 1.321 . . . . 0.0 109.708 158.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 141.22 25.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.87 1.268 . . . . 0.0 108.547 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.63 135.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.4 m -132.36 140.77 48.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.249 1.419 . . . . 0.0 107.206 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.7 t -140.19 145.53 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -168.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.0 m -127.79 140.72 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 161.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.92 134.34 23.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m -139.1 155.71 47.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.054 0.941 . . . . 0.0 109.983 -162.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -4.85 57.22 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.55 0.74 . . . . 0.0 110.877 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 m -58.57 165.6 2.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.617 1.167 . . . . 0.0 110.361 161.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.3 162.92 40.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.239 1.816 . . . . 0.0 108.173 167.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -79.42 -29.67 42.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.317 0.647 . . . . 0.0 111.823 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.92 54.06 6.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -162.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -51.11 153.63 1.85 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.595 1.158 . . . . 0.0 113.319 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -135.95 -3.88 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.866 1.266 . . . . 0.0 111.715 166.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -156.96 172.06 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.52 1.528 . . . . 0.0 109.158 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.92 140.65 38.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 162.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -148.68 153.92 38.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.813 0.816 . . . . 0.0 112.834 -150.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.46 115.63 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.237 0.398 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 164.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.3 177.03 11.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.499 -0.751 . . . . 0.0 112.773 -161.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -148.48 154.36 39.73 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.609 2.364 . . . . 0.0 108.216 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.07 165.86 17.43 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.551 0.74 . . . . 0.0 110.437 161.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -133.61 141.59 47.72 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 157.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mt -137.45 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.42 140.26 48.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 143.66 21.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.488 0.715 . . . . 0.0 109.702 -166.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -144.11 153.47 42.19 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.972 1.309 . . . . 0.0 108.347 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.74 -157.65 27.43 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 107.524 -2.231 . . . . 0.0 107.524 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -78.22 75.86 4.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 158.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.06 25.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 164.762 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -64.47 -45.31 87.91 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -55.69 -50.03 71.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.623 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.24 -36.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.592 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -74.97 -19.4 60.12 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.642 -1.286 . . . . 0.0 113.069 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -65.22 -48.93 71.65 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.965 1.257 . . . . 0.0 108.708 164.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -65.7 -22.85 66.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 111.383 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.16 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.028 0.931 . . . . 0.0 109.261 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.64 -37.76 71.2 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.502 1.121 . . . . 0.0 111.468 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -49.53 -38.41 30.63 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.882 1.673 . . . . 0.0 112.406 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -112.71 16.78 19.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.24 1.416 . . . . 0.0 111.468 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.77 5.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.636 1.574 . . . . 0.0 112.079 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.5 155.71 40.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.4 133.97 30.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.89 -171.33 42.85 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.937 -166.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -117.06 161.46 19.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.977 0.889 . . . . 0.0 111.541 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.72 142.71 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 158.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -144.37 157.7 44.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.486 1.515 . . . . 0.0 108.357 -164.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -118.06 121.23 40.05 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -75.58 154.28 36.84 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.12 -28.14 67.62 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 0.0 110.759 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.8 -16.1 37.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.787 2.035 . . . . 0.0 113.38 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -37.63 3.72 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.116 1.341 . . . . 0.0 111.525 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.61 150.85 11.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.149 0.979 . . . . 0.0 110.321 171.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.36 157.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 162.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.99 147.48 40.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -138.4 139.69 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -150.29 124.04 9.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.82 162.2 40.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 119.248 0.931 . . . . 0.0 110.896 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.94 156.87 24.23 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.611 1.564 . . . . 0.0 109.714 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.36 40.51 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.828 0.728 . . . . 0.0 111.596 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.22 151.82 49.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.024 1.816 . . . . 0.0 110.477 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.53 -48.57 78.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.387 1.075 . . . . 0.0 111.29 -170.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -64.53 -40.31 95.38 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.262 -0.273 . . . . 0.0 111.339 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 -48.56 75.76 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.78 -43.78 98.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.173 0.589 . . . . 0.0 110.458 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.86 -35.45 76.92 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.482 -0.761 . . . . 0.0 111.299 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 m -62.85 -41.18 99.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.644 -0.66 . . . . 0.0 110.703 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -58.8 -46.91 86.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.243 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.28 -41.92 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.866 1.212 . . . . 0.0 109.521 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.37 -41.18 98.42 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.19 88.86 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.688 0.795 . . . . 0.0 111.748 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.12 -53.24 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.6 -37.93 76.88 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.355 1.062 . . . . 0.0 111.808 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.27 -24.12 67.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.18 0.592 . . . . 0.0 112.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.58 40.13 98.31 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 m -52.82 -44.73 96.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.7 -164.44 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.472 2.115 . . . . 0.0 112.302 -166.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -1.47 0.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.504 2.722 . . . . 0.0 115.616 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.9 m -141.85 148.09 38.24 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.889 2.076 . . . . 0.0 106.304 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.4 154.49 35.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.983 0.811 . . . . 0.0 111.434 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.62 155.62 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.259 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -121.4 -11.75 8.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.187 1.395 . . . . 0.0 109.595 162.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.13 143.04 25.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.283 1.433 . . . . 0.0 108.383 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -148.71 140.42 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -138.33 134.89 34.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.11 144.87 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.702 0.801 . . . . 0.0 109.824 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.1 m -134.43 149.94 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.422 1.889 . . . . 0.0 106.093 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.15 154.45 51.2 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.9 m -155.93 146.5 21.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -71.4 -29.21 64.66 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.538 -0.727 . . . . 0.0 110.95 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.77 121.45 12.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.731 1.212 . . . . 0.0 111.653 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.09 164.17 13.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.47 0.708 . . . . 0.0 109.342 163.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.14 -13.78 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.6 -11.66 7.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.551 158.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.54 145.96 31.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.243 2.021 . . . . 0.0 111.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -132.37 7.65 4.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.891 1.276 . . . . 0.0 111.118 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.11 164.1 35.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.808 1.643 . . . . 0.0 108.564 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -84.15 144.29 29.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 164.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -143.2 157.78 44.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.674 0.79 . . . . 0.0 110.545 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.7 mt -135.5 135.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.418 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.43 176.84 6.23 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.092 -1.005 . . . . 0.0 111.115 -163.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -140.92 152.92 45.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.52 1.928 . . . . 0.0 108.498 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.58 162.13 16.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 162.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -137.98 125.77 22.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 165.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.27 139.93 45.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 134.84 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -138.59 154.02 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 110.518 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.45 146.17 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.731 1.613 . . . . 0.0 107.51 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.77 -156.22 26.74 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -78.72 98.3 6.19 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 161.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.99 12.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.85 1.26 . . . . 0.0 110.244 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 125.012 1.325 . . . . 0.0 109.206 -177.374 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.74 -33.41 64.31 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.728 1.149 . . . . 0.0 109.711 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -56.74 -39.23 73.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.087 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 m -61.52 -37.14 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.456 1.026 . . . . 0.0 110.447 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -74.63 -28.24 60.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.361 0.982 . . . . 0.0 110.817 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 54.6 mtm -62.17 -49.85 74.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.515 0.598 . . . . 0.0 110.591 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -65.96 -34.22 77.6 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.636 0.775 . . . . 0.0 110.356 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.94 70.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.386 1.475 . . . . 0.0 109.923 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.38 -41.05 96.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.901 0.481 . . . . 0.0 111.178 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -14.97 42.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.138 1.375 . . . . 0.0 112.654 174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -116.57 20.76 13.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.419 1.488 . . . . 0.0 110.874 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.3 pttt 43.59 31.36 0.43 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.143 2.177 . . . . 0.0 114.172 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.91 162.09 29.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.91 0.884 . . . . 0.0 109.017 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.08 138.76 37.38 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.58 -170.94 41.36 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.545 0.611 . . . . 0.0 112.29 -164.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -129.44 160.56 32.76 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.043 0.937 . . . . 0.0 111.525 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.29 140.85 46.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 163.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -145.65 144.22 30.3 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.74 0.816 . . . . 0.0 109.0 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.13 146.45 39.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.97 132.62 55.9 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.94 -25.08 64.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.129 0.972 . . . . 0.0 112.697 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.72 -26.67 67.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.335 1.054 . . . . 0.0 112.284 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.38 -19.57 4.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.823 1.678 . . . . 0.0 112.307 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 172.44 10.8 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.318 1.047 . . . . 0.0 110.532 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.75 147.26 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -115.36 143.84 44.67 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.6 1.96 . . . . 0.0 106.83 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.98 134.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -148.37 124.43 10.73 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.85 162.04 41.79 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.24 0.473 . . . . 0.0 110.568 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.89 151.55 29.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.69 1.596 . . . . 0.0 109.551 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.04 40.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.55 1.071 . . . . 0.0 110.949 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.3 158.32 56.6 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.383 2.055 . . . . 0.0 110.384 171.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.12 -46.48 79.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.435 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -64.2 -37.77 88.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.554 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.86 72.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.305 0.642 . . . . 0.0 109.786 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.83 -46.99 88.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.587 0.755 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.74 -38.2 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.736 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -60.55 -42.62 96.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.734 0.697 . . . . 0.0 110.136 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -59.47 -47.27 86.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.637 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.31 -44.97 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 119.885 1.221 . . . . 0.0 110.071 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.82 -39.9 95.73 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.541 0.609 . . . . 0.0 110.902 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.95 98.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.352 0.661 . . . . 0.0 111.334 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -66.02 -50.35 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -58.29 -38.57 77.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.146 0.578 . . . . 0.0 111.104 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.19 -23.74 63.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.0 112.629 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.8 44.62 94.16 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 118.943 0.792 . . . . 0.0 111.561 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -55.97 -50.93 84.48 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -166.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.39 -49.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.786 1.674 . . . . 0.0 113.491 -163.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.55 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 110.27 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -61.92 151.86 33.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.581 0.752 . . . . 0.0 109.633 169.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.25 146.31 23.64 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 154.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.4 p -122.73 -11.88 8.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.668 1.587 . . . . 0.0 109.485 166.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.63 145.44 25.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.384 1.473 . . . . 0.0 107.848 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.5 tt -149.04 141.87 18.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.713 1.205 . . . . 0.0 107.804 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -135.98 140.77 44.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.409 1.484 . . . . 0.0 107.072 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.7 138.52 47.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.4 m -130.11 155.94 45.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -130.39 152.35 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -147.92 178.48 8.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.334 1.453 . . . . 0.0 107.962 -167.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -130.81 15.5 5.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.474 1.11 . . . . 0.0 109.366 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -69.62 -28.56 66.03 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.386 1.475 . . . . 0.0 112.827 -170.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp 57.75 173.71 0.05 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.988 1.715 . . . . 0.0 111.492 -166.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.95 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.126 0.971 . . . . 0.0 112.948 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 -10.56 60.76 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.461 -1.188 . . . . 0.0 115.689 154.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 173.34 12.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.773 1.787 . . . . 0.0 110.085 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -127.91 19.72 6.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.087 1.355 . . . . 0.0 110.145 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 168.09 24.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.128 1.771 . . . . 0.0 108.732 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -88.03 158.3 18.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.79 0.436 . . . . 0.0 110.102 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -141.62 158.82 43.34 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.231 1.013 . . . . 0.0 110.16 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.14 125.14 43.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -161.082 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.17 178.44 8.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.187 2.195 . . . . 0.0 109.364 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -134.73 147.42 50.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.94 2.096 . . . . 0.0 107.937 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.548 0.739 . . . . 0.0 110.045 165.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -134.45 130.95 37.54 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.84 142.7 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 134.7 59.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 170.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.98 147.98 18.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 124.423 1.089 . . . . 0.0 110.257 -170.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -138.07 155.58 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.68 -158.32 27.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -168.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -78.05 90.11 4.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 158.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.73 10.43 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.792 1.237 . . . . 0.0 110.332 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 . . . . . 0 C--N 1.342 0.258 0 CA-C-N 118.776 0.716 . . . . 0.0 111.468 -166.864 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -67.95 -25.43 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.052 0.941 . . . . 0.0 111.621 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -48.67 -43.9 37.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.88 -38.1 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.067 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -73.83 -23.46 59.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.869 1.213 . . . . 0.0 111.465 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.68 -53.57 54.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.295 0.952 . . . . 0.0 110.074 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.66 -37.2 80.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.782 0.433 . . . . 0.0 110.341 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.57 55.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.562 1.145 . . . . 0.0 109.952 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.52 -47.24 86.28 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.585 0.754 . . . . 0.0 110.386 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -58.21 -30.66 66.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.19 1.396 . . . . 0.0 111.731 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.97 10.69 39.47 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.959 1.304 . . . . 0.0 111.379 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? 50.47 32.39 6.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.955 1.702 . . . . 0.0 112.101 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.64 165.95 23.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.117 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.4 20.99 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.13 173.94 36.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.549 0.613 . . . . 0.0 112.677 -169.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -101.09 160.99 13.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.36 1.08 . . . . 0.0 111.858 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.57 144.07 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.887 1.275 . . . . 0.0 107.74 158.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -149.23 159.56 44.15 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 107.703 -171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -112.34 120.74 42.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.987 0.812 . . . . 0.0 109.281 170.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -76.09 146.56 39.26 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.81 -28.53 67.53 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.681 0.792 . . . . 0.0 112.357 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.12 -27.61 69.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.479 0.712 . . . . 0.0 112.479 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.18 -37.13 1.88 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.526 1.06 . . . . 0.0 112.315 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 149.64 49.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.006 0.903 . . . . 0.0 111.314 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.61 150.07 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 167.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -124.13 144.84 49.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.012 1.725 . . . . 0.0 106.502 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -135.95 140.76 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.32 118.8 7.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.15 164.1 34.95 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.402 0.681 . . . . 0.0 111.01 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.47 156.72 29.69 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.526 1.531 . . . . 0.0 109.296 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.81 44.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.53 0.586 . . . . 0.0 111.954 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.76 151.44 63.36 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.206 1.938 . . . . 0.0 110.448 171.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.82 -50.06 64.42 Favored 'General case' 0 C--N 1.334 -0.071 0 C-N-CA 124.22 1.008 . . . . 0.0 111.529 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.37 -36.63 82.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.692 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.88 75.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.61 -46.63 81.81 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.127 0.571 . . . . 0.0 110.522 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -66.96 -42.88 84.44 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 121.759 -0.588 . . . . 0.0 111.138 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 m -68.07 -33.43 74.54 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.678 -0.639 . . . . 0.0 110.927 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -58.95 -50.5 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.557 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.64 -43.83 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.556 1.071 . . . . 0.0 109.424 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.14 -40.32 93.37 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.319 0.509 . . . . 0.0 111.215 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.41 97.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.355 0.662 . . . . 0.0 111.217 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -64.39 -51.54 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.35 -41.38 84.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.666 0.786 . . . . 0.0 111.169 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.22 -24.56 64.03 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 112.0 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.15 48.15 82.05 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m -54.79 -47.0 99.32 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 117.364 -1.303 . . . . 0.0 114.145 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.13 -163.55 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.768 2.312 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -59.42 -31.49 69.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 113.132 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -82.61 145.06 29.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.157 0.889 . . . . 0.0 109.662 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.58 148.56 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.102 0.561 . . . . 0.0 110.033 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.16 156.79 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.206 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -125.91 -8.59 6.63 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.041 1.736 . . . . 0.0 109.915 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.64 141.09 23.32 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.595 1.958 . . . . 0.0 107.49 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.6 tt -152.87 142.44 14.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.427 1.091 . . . . 0.0 108.917 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -142.58 144.5 32.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.092 1.757 . . . . 0.0 107.482 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.79 140.65 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 108.314 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -136.49 157.49 46.66 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.402 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -143.76 159.39 42.59 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.112 -0.992 . . . . 0.0 110.311 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.0 m -144.02 151.97 40.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.117 1.367 . . . . 0.0 108.767 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -87.63 35.27 0.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.308 1.043 . . . . 0.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -139.71 106.64 5.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.327 1.051 . . . . 0.0 108.824 -159.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.01 160.83 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 110.086 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.78 -14.48 0.73 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.943 0.897 . . . . 0.0 113.318 -170.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.06 -2.63 14.49 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.236 155.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -61.11 146.27 48.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 121.001 2.401 . . . . 0.0 110.257 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -129.55 9.47 5.52 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.194 1.398 . . . . 0.0 111.028 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.31 166.5 28.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.565 1.946 . . . . 0.0 107.97 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -80.06 148.23 31.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -141.25 156.74 45.85 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 109.771 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 mt -135.93 113.67 14.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tp -142.88 178.63 7.53 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.992 -1.067 . . . . 0.0 110.129 -166.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -152.31 155.05 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.234 1.814 . . . . 0.0 108.097 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.99 163.02 16.86 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.447 0.699 . . . . 0.0 109.813 166.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -134.93 135.45 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 163.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.39 143.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 138.67 52.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 162.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.94 154.99 26.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 124.124 0.97 . . . . 0.0 110.454 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -146.12 154.65 42.04 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.593 1.557 . . . . 0.0 107.885 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 -155.33 26.09 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.806 -2.118 . . . . 0.0 107.806 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -76.16 83.76 2.99 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.04 5.55 4.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 111.129 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.198 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.264 21.7 ptt-85 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -76.51 -44.07 36.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.116 1.326 . . . . 0.0 110.084 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.84 -48.65 63.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.461 0.704 . . . . 0.0 111.156 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.25 -35.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.287 0.949 . . . . 0.0 110.994 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.86 -24.24 58.55 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.623 1.101 . . . . 0.0 111.892 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.8 mtm -63.5 -48.86 75.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.292 0.951 . . . . 0.0 109.868 166.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.76 -23.49 63.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.913 0.885 . . . . 0.0 111.595 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.79 41.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.81 -39.0 90.21 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.223 0.609 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -14.69 61.16 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 112.257 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.16 20.07 14.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.802 1.641 . . . . 0.0 111.082 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 43.29 31.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.113 2.165 . . . . 0.0 114.252 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.83 161.61 30.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.842 0.857 . . . . 0.0 108.74 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.15 28.93 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 108.271 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.02 -154.69 25.77 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.393 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.06 164.32 26.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.404 1.102 . . . . 0.0 112.815 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.03 141.09 47.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 165.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -132.78 140.59 48.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.89 148.19 52.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 158.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -125.9 145.4 50.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.87 0.868 . . . . 0.0 109.23 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 39' ' ' ASP . 21.7 t70 -57.81 125.88 24.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 164.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 26.5 t0 -121.57 31.79 6.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.627 3.171 . . . . 0.0 109.834 5.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.98 -16.31 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 O-C-N 121.267 -0.895 . . . . 0.0 113.866 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -59.05 161.47 5.1 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.279 1.039 . . . . 0.0 109.795 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.22 147.53 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.34 143.02 46.39 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.211 1.405 . . . . 0.0 107.213 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.49 134.47 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.66 132.18 28.67 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.38 157.71 32.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.328 0.967 . . . . 0.0 110.843 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.68 151.32 25.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.688 1.195 . . . . 0.0 109.446 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.18 178.43 40.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.745 1.164 . . . . 0.0 110.793 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 154.9 69.53 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.179 1.92 . . . . 0.0 110.319 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.44 -42.97 79.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.807 0.843 . . . . 0.0 111.695 -172.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.37 -41.1 96.89 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.069 -0.394 . . . . 0.0 111.513 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.41 79.95 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.874 0.47 . . . . 0.0 109.88 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.48 -49.66 76.93 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.921 0.888 . . . . 0.0 110.132 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.81 -35.89 79.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.979 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -61.35 -42.7 99.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.01 0.823 . . . . 0.0 110.175 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -60.94 -46.46 90.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.788 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.72 -41.96 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.632 1.105 . . . . 0.0 109.664 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.75 -41.08 99.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.596 0.634 . . . . 0.0 110.819 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -37.77 80.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.248 0.619 . . . . 0.0 111.703 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.94 -57.4 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -60.87 -35.51 76.8 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.941 0.896 . . . . 0.0 111.738 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -63.53 -26.05 68.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.373 0.669 . . . . 0.0 112.297 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.13 47.82 88.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -173.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.6 -47.9 96.65 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.989 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.01 -172.2 1.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.56 2.173 . . . . 0.0 111.511 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -60.24 -31.36 70.12 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.246 -0.909 . . . . 0.0 111.578 167.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -68.65 142.69 55.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.586 1.154 . . . . 0.0 109.182 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.27 152.17 25.75 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.471 -0.768 . . . . 0.0 110.345 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.88 153.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -121.65 -9.52 8.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.175 1.39 . . . . 0.0 109.697 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -146.98 135.08 21.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.175 1.79 . . . . 0.0 107.123 171.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.21 133.62 7.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -136.55 127.37 27.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.1 145.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.067 1.347 . . . . 0.0 109.493 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 m -136.48 156.92 47.92 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.323 1.849 . . . . 0.0 106.053 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -126.14 150.12 48.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 m -145.63 164.45 31.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.102 0.961 . . . . 0.0 109.582 -163.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -119.36 4.54 11.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.252 1.021 . . . . 0.0 110.467 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -64.52 -30.74 71.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.454 1.102 . . . . 0.0 112.11 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.4 mt 58.68 179.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 111.307 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -153.61 -4.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.995 0.918 . . . . 0.0 113.385 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.26 6.48 53.91 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.746 1.165 . . . . 0.0 114.009 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.78 146.33 52.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.396 1.098 . . . . 0.0 109.469 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -130.27 17.85 5.45 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.633 1.573 . . . . 0.0 109.892 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -149.51 173.4 13.64 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.818 2.047 . . . . 0.0 108.131 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -98.35 150.1 21.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 162.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -139.4 156.14 47.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 110.045 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.1 mt -137.94 134.77 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.164 0.986 . . . . 0.0 108.484 -172.392 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mt -142.88 175.68 9.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 109.726 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -151.88 157.42 41.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.291 1.837 . . . . 0.0 108.379 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.71 162.51 24.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 165.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -135.67 138.59 42.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 156.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.88 143.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -169.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.86 137.79 55.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.79 146.63 20.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.897 0.879 . . . . 0.0 110.356 -168.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.38 152.3 44.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.808 1.643 . . . . 0.0 108.084 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.11 -153.38 25.04 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.39 73.86 3.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 158.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.45 6.19 9.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.359 1.064 . . . . 0.0 110.898 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 120.08 1.309 . . . . 0.0 108.411 174.07 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 119.572 -0.251 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -72.81 -47.68 44.41 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.481 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.27 -43.71 67.65 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.867 0.758 . . . . 0.0 111.419 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -53.16 -48.88 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.652 0.781 . . . . 0.0 109.246 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -78.34 -20.68 50.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 120.817 -1.177 . . . . 0.0 113.443 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -42.96 85.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.382 0.992 . . . . 0.0 109.243 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.29 -35.36 71.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.953 0.797 . . . . 0.0 110.159 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.24 86.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.993 0.517 . . . . 0.0 110.462 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.48 -41.55 98.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.789 0.836 . . . . 0.0 110.938 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.45 -29.98 68.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.495 0.718 . . . . 0.0 111.516 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -98.49 6.62 47.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.286 1.034 . . . . 0.0 112.581 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 42.82 40.88 2.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.697 1.999 . . . . 0.0 113.235 -172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.03 164.39 26.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.325 1.05 . . . . 0.0 109.158 166.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 142.48 32.45 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.093 0.957 . . . . 0.0 108.508 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.03 -154.93 26.01 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.194 -168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.57 162.5 31.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.447 1.123 . . . . 0.0 112.627 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.52 144.43 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.905 1.282 . . . . 0.0 107.971 163.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -149.89 165.91 31.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.005 1.322 . . . . 0.0 109.356 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.9 121.77 45.96 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 167.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -73.73 153.97 39.81 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.138 0.975 . . . . 0.0 108.844 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.52 -31.31 70.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 111.379 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -70.74 -11.53 61.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.87 -27.84 8.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.152 1.358 . . . . 0.0 113.125 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.55 149.77 49.97 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.443 1.622 . . . . 0.0 109.495 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.18 149.69 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 158.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 143.43 50.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -133.65 143.03 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -141.46 135.87 30.71 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.33 34.93 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.629 1.104 . . . . 0.0 111.337 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.03 151.81 30.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.038 1.335 . . . . 0.0 109.418 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.52 42.48 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.162 0.886 . . . . 0.0 111.474 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.61 159.96 51.05 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.54 2.16 . . . . 0.0 110.793 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.65 -53.74 50.85 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.78 0.832 . . . . 0.0 111.064 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.06 -35.73 81.21 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 122.281 -0.262 . . . . 0.0 111.278 -173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -49.34 71.51 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.78 0.432 . . . . 0.0 110.604 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.61 -49.08 78.03 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.12 0.568 . . . . 0.0 110.237 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.22 -41.03 90.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.608 0.363 . . . . 0.0 111.148 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -62.89 -40.35 97.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.659 0.663 . . . . 0.0 110.566 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.42 -47.52 85.75 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.599 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.54 -41.91 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.684 1.129 . . . . 0.0 109.705 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.86 -40.68 98.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.712 0.687 . . . . 0.0 110.807 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.72 92.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.797 0.839 . . . . 0.0 111.536 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -66.46 -55.68 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.43 -35.32 75.53 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.963 0.905 . . . . 0.0 111.976 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -63.06 -25.2 68.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.415 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.08 44.16 98.52 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -53.58 -44.17 97.25 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.14 -170.54 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.42 2.08 . . . . 0.0 111.245 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -60.29 -42.98 96.62 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.97 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.18 150.85 33.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.235 1.414 . . . . 0.0 110.637 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.25 33.59 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.704 -0.623 . . . . 0.0 109.878 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.06 154.66 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.3 p -120.4 -12.43 8.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.359 1.464 . . . . 0.0 109.56 162.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -147.35 141.12 25.7 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.224 1.41 . . . . 0.0 107.992 168.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.67 136.48 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -134.99 140.78 45.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.42 141.2 40.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -129.76 148.06 51.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -134.4 145.28 48.77 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 m -151.89 168.3 25.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.229 -150.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -125.54 1.37 7.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.428 1.091 . . . . 0.0 111.79 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -64.35 -32.06 73.52 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.795 0.838 . . . . 0.0 111.661 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.31 -177.26 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.115 1.766 . . . . 0.0 110.782 -171.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.45 -13.41 0.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.86 17.24 79.27 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.091 0.853 . . . . 0.0 113.037 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -63.66 152.53 38.76 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.283 1.041 . . . . 0.0 110.444 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.27 4.69 6.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 110.903 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 157.51 43.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.902 1.281 . . . . 0.0 109.237 172.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -71.2 143.22 50.54 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 155.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -139.33 150.98 46.02 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.586 0.754 . . . . 0.0 109.65 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.9 mt -128.57 109.88 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.236 0.367 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.046 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.174 0.035 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.93 -177.1 6.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.376 1.47 . . . . 0.0 110.045 -161.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -146.04 153.7 41.03 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.328 1.851 . . . . 0.0 109.251 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.21 166.74 11.16 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.069 0.947 . . . . 0.0 110.52 164.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -131.92 138.4 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 152.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.0 mt -136.27 146.88 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.89 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 164.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.62 151.8 24.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.53 1.132 . . . . 0.0 109.058 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.71 150.25 39.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.13 -153.87 25.59 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -79.76 63.25 4.26 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.8 m -89.11 8.77 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.806 1.242 . . . . 0.0 111.711 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 7.3 ptt180 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.98 -38.17 78.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 120.003 1.274 . . . . 0.0 108.528 160.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -55.91 -41.05 73.96 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.342 0.519 . . . . 0.0 111.527 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.19 -45.83 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -78.88 -16.28 57.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.627 -0.702 . . . . 0.0 112.894 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.17 -47.77 75.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.636 1.107 . . . . 0.0 108.87 164.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -70.49 -23.12 62.61 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.929 -0.482 . . . . 0.0 111.362 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.66 52.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.288 -0.882 . . . . 0.0 109.662 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.16 -39.66 90.95 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.773 0.829 . . . . 0.0 111.544 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -14.35 60.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.721 -0.612 . . . . 0.0 112.013 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -116.79 11.23 14.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.701 1.601 . . . . 0.0 111.55 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 41.08 40.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.963 2.105 . . . . 0.0 113.034 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.63 163.25 28.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.68 131.72 24.64 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.062 0.945 . . . . 0.0 108.715 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.31 -162.95 34.71 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.223 0.465 . . . . 0.0 112.201 -162.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -135.42 167.7 20.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.777 0.789 . . . . 0.0 112.734 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.0 142.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.045 1.338 . . . . 0.0 109.102 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -145.77 157.36 43.94 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.947 1.699 . . . . 0.0 108.095 -163.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -119.32 123.19 43.61 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -78.6 156.66 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.977 1.311 . . . . 0.0 109.727 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.49 -30.65 70.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.239 0.615 . . . . 0.0 111.677 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -4.85 39.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.864 0.866 . . . . 0.0 113.022 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.98 -23.71 28.5 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.102 1.335 . . . . 0.0 113.247 169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -61.69 145.28 52.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.961 1.38 . . . . 0.0 109.804 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.52 143.54 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 160.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -131.21 145.75 52.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.41 142.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -170.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 tt -150.0 125.61 10.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 153.45 27.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.016 0.826 . . . . 0.0 111.454 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -93.53 154.5 17.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.46 1.104 . . . . 0.0 109.696 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.01 42.28 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 110.762 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.28 154.75 61.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.921 1.747 . . . . 0.0 109.918 165.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.72 -43.4 80.58 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.57 0.748 . . . . 0.0 111.437 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.33 -41.04 98.23 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.151 -0.343 . . . . 0.0 111.472 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.81 82.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.737 0.415 . . . . 0.0 110.064 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 72.0 mt -62.12 -44.09 97.41 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.743 0.817 . . . . 0.0 110.371 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -70.48 -41.12 73.15 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.79 -0.569 . . . . 0.0 111.775 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 m -60.22 -40.05 88.79 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.756 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -61.85 -46.45 89.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.858 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.46 -46.56 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.005 1.275 . . . . 0.0 109.426 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.39 -39.62 91.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.168 0.44 . . . . 0.0 111.191 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.191 0.597 . . . . 0.0 112.133 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.05 -49.8 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.91 -44.04 91.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.185 0.594 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -71.52 -19.95 62.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.674 0.79 . . . . 0.0 112.011 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.71 43.34 94.52 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -172.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 m -51.15 -53.33 49.86 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.09 -39.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.654 1.57 . . . . 0.0 112.496 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -165.83 168.77 15.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.086 1.754 . . . . 0.0 108.188 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m 62.55 175.96 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.963 1.705 . . . . 0.0 113.044 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 160.49 40.28 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.92 0.888 . . . . 0.0 109.406 166.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.51 156.95 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.2 p -119.62 -13.56 9.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.939 1.296 . . . . 0.0 109.648 163.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.8 144.99 26.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.081 1.353 . . . . 0.0 108.749 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.82 142.17 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.289 1.436 . . . . 0.0 107.378 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -140.23 147.8 40.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.21 145.9 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.67 155.7 46.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.147 2.179 . . . . 0.0 105.48 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -138.6 158.63 43.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.0 m -155.51 152.88 29.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.145 1.378 . . . . 0.0 107.901 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -73.33 -30.95 63.7 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.718 -0.614 . . . . 0.0 111.352 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 m -60.07 128.57 37.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.102 0.961 . . . . 0.0 110.903 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.18 169.86 12.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.207 1.003 . . . . 0.0 109.242 163.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -104.76 -18.71 14.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.029 0.932 . . . . 0.0 111.074 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 47.85 7.45 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -171.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -126.83 149.86 49.49 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.608 1.163 . . . . 0.0 108.915 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.86 9.2 3.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.945 0.898 . . . . 0.0 112.092 -172.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 174.28 12.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.514 1.526 . . . . 0.0 109.013 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -116.47 148.97 40.24 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.369 1.067 . . . . 0.0 109.458 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.93 159.96 41.65 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.468 0.652 . . . . 0.0 111.963 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.02 114.51 35.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.153 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.5 tp -142.21 177.26 8.36 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.905 -1.122 . . . . 0.0 110.422 -166.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.404 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 63.7 tt0 -154.57 162.01 41.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.94 1.696 . . . . 0.0 109.47 -171.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p90 -131.36 166.36 21.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.226 1.01 . . . . 0.0 110.273 166.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -130.23 138.58 50.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.42 146.86 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 135.71 58.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.61 153.64 16.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.275 1.03 . . . . 0.0 110.699 -172.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.01 153.0 45.35 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.313 1.445 . . . . 0.0 107.943 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.35 -152.28 24.19 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -75.56 77.98 2.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 162.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.66 -1.77 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 111.306 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 125.63 1.572 . . . . 0.0 109.488 -177.892 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -60.62 -32.83 71.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.405 1.002 . . . . 0.0 110.803 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -48.74 71.94 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.921 1.237 . . . . 0.0 111.61 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.86 -30.92 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.16 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -75.14 -24.66 57.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.948 1.249 . . . . 0.0 112.08 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.2 mtm -63.46 -48.9 75.81 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 165.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.81 -30.11 70.69 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 122.195 -0.316 . . . . 0.0 111.058 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.84 -47.49 68.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.292 . . . . 0.0 110.328 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.63 -38.62 88.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.319 0.647 . . . . 0.0 111.124 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.14 -17.59 41.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.769 1.228 . . . . 0.0 112.523 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -116.65 12.9 15.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.225 1.41 . . . . 0.0 111.41 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.44 34.44 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.16 2.184 . . . . 0.0 113.294 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.41 161.59 27.27 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.816 -0.553 . . . . 0.0 109.629 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 128.62 43.74 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.48 -171.21 43.9 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 118.641 0.655 . . . . 0.0 112.272 -164.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.4 p90 -136.61 161.27 36.36 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.066 0.947 . . . . 0.0 112.036 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.15 144.93 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.171 0.988 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -144.71 162.82 35.75 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.143 2.177 . . . . 0.0 107.656 -170.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.43 122.88 40.76 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -75.77 155.46 35.48 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.479 1.112 . . . . 0.0 109.16 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.45 -31.78 70.75 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.918 0.487 . . . . 0.0 111.357 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -71.34 -10.68 60.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.82 10.83 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.228 -1.318 . . . . 0.0 113.476 170.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.35 148.25 52.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.729 1.764 . . . . 0.0 109.391 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.29 146.48 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 161.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -127.77 137.94 52.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.55 142.55 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.57 126.38 12.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -153.95 159.04 41.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.487 0.585 . . . . 0.0 110.926 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.49 155.83 22.63 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.316 1.846 . . . . 0.0 109.443 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.51 178.04 41.64 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.618 1.104 . . . . 0.0 110.364 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.32 154.3 74.44 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.842 1.695 . . . . 0.0 109.781 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.37 -47.7 78.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.183 0.593 . . . . 0.0 110.715 -172.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -60.17 -40.31 89.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.484 0.584 . . . . 0.0 111.788 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.59 83.09 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.855 0.462 . . . . 0.0 110.091 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.66 -45.96 84.48 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 122.809 0.443 . . . . 0.0 110.826 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -64.98 -43.47 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.864 -0.522 . . . . 0.0 110.68 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.4 m -60.93 -40.84 94.77 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.935 0.334 . . . . 0.0 110.54 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.24 -49.09 79.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.575 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.67 -43.25 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.735 1.152 . . . . 0.0 109.67 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.92 -40.91 97.11 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.628 0.649 . . . . 0.0 110.834 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.47 0.708 . . . . 0.0 111.465 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -61.79 -54.04 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.37 -39.44 79.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.809 0.844 . . . . 0.0 111.375 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.4 -27.23 68.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.488 0.715 . . . . 0.0 111.979 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.47 51.26 58.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -173.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -55.53 -49.2 93.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.976 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.49 -173.45 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.261 1.974 . . . . 0.0 111.627 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -40.84 82.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.431 1.092 . . . . 0.0 111.449 173.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.3 m -74.29 138.92 43.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -157.81 164.45 36.99 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 109.533 -162.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.42 149.6 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -127.68 -7.58 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.809 1.643 . . . . 0.0 109.803 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.61 141.22 29.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.224 1.81 . . . . 0.0 106.963 166.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -149.27 140.68 17.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 107.972 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 m -139.29 148.94 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.687 1.595 . . . . 0.0 107.328 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.18 146.18 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.05 149.01 51.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.04 133.17 39.1 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -171.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -145.47 167.93 21.79 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.701 0.4 . . . . 0.0 111.683 -155.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.97 0.11 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.898 1.279 . . . . 0.0 111.253 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.0 m -66.26 -24.88 66.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.121 0.969 . . . . 0.0 113.088 -170.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.48 174.0 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 0.0 111.684 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.18 -16.44 0.58 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 113.179 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 1.41 82.2 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.253 -1.304 . . . . 0.0 116.304 155.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -82.92 -175.48 5.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.102 1.951 . . . . 0.0 109.542 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -129.55 2.85 5.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 112.421 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.57 170.76 17.89 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.052 1.341 . . . . 0.0 109.697 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -72.48 153.27 41.45 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.956 0.503 . . . . 0.0 109.965 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.39 159.22 42.67 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.703 1.201 . . . . 0.0 109.453 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 mt -135.09 110.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -171.102 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.507 0.194 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.13 176.03 9.06 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.946 0.898 . . . . 0.0 111.666 -149.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -147.71 157.81 43.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.446 1.498 . . . . 0.0 109.384 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.14 168.09 11.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 110.629 163.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -134.58 135.42 42.22 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 156.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.34 144.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.78 136.42 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.14 155.48 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.576 1.151 . . . . 0.0 110.293 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -145.98 157.38 43.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 0.0 108.935 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -148.36 19.87 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 106.821 -2.512 . . . . 0.0 106.821 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -77.02 54.48 1.04 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 160.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.73 -13.92 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 111.21 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 168.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.9 -34.47 73.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.171 0.896 . . . . 0.0 111.295 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -37.61 65.23 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.678 0.672 . . . . 0.0 111.288 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.84 -45.22 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -78.97 -18.95 52.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.488 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -63.21 -48.95 76.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.335 0.971 . . . . 0.0 109.309 165.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.58 -29.95 67.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.784 0.434 . . . . 0.0 110.421 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.61 74.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.767 0.827 . . . . 0.0 110.405 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.92 -41.02 90.81 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.341 0.656 . . . . 0.0 110.724 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -59.41 -18.09 36.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.487 1.115 . . . . 0.0 112.854 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -117.33 15.76 14.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.977 1.262 . . . . 0.0 112.372 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.2 mmpt? 47.01 34.0 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.574 1.55 . . . . 0.0 112.768 -176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.3 mt -74.41 163.51 27.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.172 0.589 . . . . 0.0 109.703 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.73 130.11 22.42 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.167 0.987 . . . . 0.0 108.581 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.35 -158.34 28.66 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 123.592 0.615 . . . . 0.0 111.596 -171.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -136.73 163.28 30.97 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.787 0.794 . . . . 0.0 112.047 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.874 1.27 . . . . 0.0 108.66 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -149.22 163.25 38.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.883 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -119.58 131.15 55.44 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -120.77 149.72 42.11 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.925 0.89 . . . . 0.0 110.37 -167.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.08 -19.46 62.96 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.443 1.497 . . . . 0.0 113.524 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.78 -15.29 28.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.757 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.05 45.83 3.77 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.52 153.32 42.47 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.392 1.477 . . . . 0.0 107.238 -168.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.19 148.36 5.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 157.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.96 142.48 48.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -138.62 141.48 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.98 126.37 10.8 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.1 157.02 36.86 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.442 0.697 . . . . 0.0 110.877 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.98 156.9 17.35 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.634 1.573 . . . . 0.0 109.874 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.25 -179.42 41.89 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.039 0.828 . . . . 0.0 111.865 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.4 161.74 37.13 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.554 2.17 . . . . 0.0 110.652 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.35 -47.23 79.23 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.73 0.812 . . . . 0.0 111.137 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.76 -43.06 98.49 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.005 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.96 79.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.1 mt -63.22 -47.08 84.03 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.326 0.65 . . . . 0.0 110.247 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -68.52 -43.51 76.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.031 0.532 . . . . 0.0 111.893 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -62.89 -39.09 93.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.471 0.578 . . . . 0.0 110.139 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.3 -49.24 78.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.423 173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.56 -45.65 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.57 1.077 . . . . 0.0 109.515 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -62.42 -37.81 87.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.096 0.407 . . . . 0.0 111.155 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.85 86.94 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.501 0.72 . . . . 0.0 111.792 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.2 -51.03 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.34 -41.95 76.92 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.442 1.097 . . . . 0.0 111.29 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -68.22 -25.53 65.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.517 0.727 . . . . 0.0 111.933 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.94 48.64 81.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.61 -47.32 98.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.409 -1.281 . . . . 0.0 114.289 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.84 -166.53 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.201 . . . . 0.0 111.479 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -40.74 67.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.828 1.251 . . . . 0.0 111.939 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -79.6 143.72 34.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 162.46 40.51 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.687 0.795 . . . . 0.0 110.548 -172.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.88 158.3 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.371 0.668 . . . . 0.0 110.689 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 p -125.81 -4.8 6.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.715 1.606 . . . . 0.0 110.023 163.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -150.66 138.73 20.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.777 2.031 . . . . 0.0 107.446 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.64 140.98 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.336 1.054 . . . . 0.0 108.613 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -140.86 142.9 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.101 1.76 . . . . 0.0 107.053 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -138.19 143.6 32.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -129.99 151.06 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -137.05 145.36 43.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.0 m -143.2 175.0 10.21 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.037 1.335 . . . . 0.0 109.375 -165.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -128.37 33.53 4.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.537 1.135 . . . . 0.0 109.447 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -134.24 105.09 6.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 108.404 -165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.09 168.63 8.09 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.949 0.9 . . . . 0.0 111.235 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.78 -23.47 9.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.832 1.653 . . . . 0.0 110.496 -175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.69 19.04 76.52 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -166.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.31 139.78 32.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -134.82 25.09 3.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.808 1.243 . . . . 0.0 109.584 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -148.23 167.4 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 127.003 2.121 . . . . 0.0 107.184 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -120.85 132.94 55.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 163.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 m -134.7 160.87 36.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.126 0.57 . . . . 0.0 111.211 -166.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.9 mt -132.24 114.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.237 0.438 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.263 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 119.111 -0.471 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tp -147.46 -177.01 5.47 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.207 1.367 . . . . 0.0 111.344 -159.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.61 152.57 39.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.613 1.965 . . . . 0.0 109.086 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.46 163.7 12.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.319 0.648 . . . . 0.0 109.724 162.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -136.05 131.09 34.45 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 159.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.19 139.65 45.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.29 134.4 66.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -140.35 153.19 21.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.146 0.979 . . . . 0.0 109.557 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.28 151.36 37.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.935 1.294 . . . . 0.0 107.522 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.67 -152.04 24.06 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.67 58.56 1.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 m -85.0 -12.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.019 0.928 . . . . 0.0 110.783 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.411 HE22 ' CG ' ' A' ' 18' ' ' ARG . 7.5 mm-40 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 164.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' CG ' HE22 ' A' ' 13' ' ' GLN 0.301 12.9 ptt85 . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -66.38 -21.96 66.24 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 122.013 2.188 . . . . 0.0 110.468 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.099 1.318 . . . . 0.0 111.349 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.21 -33.66 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.394 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -73.39 -25.98 60.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.051 1.296 . . . . 0.0 112.284 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.4 mtm -65.36 -47.3 76.91 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 166.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -66.09 -27.99 68.48 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.285 -0.26 . . . . 0.0 111.329 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 -48.47 64.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.734 1.614 . . . . 0.0 109.975 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.06 -38.68 87.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.984 0.514 . . . . 0.0 111.209 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -60.0 -16.96 34.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.354 1.062 . . . . 0.0 112.594 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -116.88 11.24 14.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.127 1.371 . . . . 0.0 111.565 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 41.52 39.52 1.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.697 1.999 . . . . 0.0 113.015 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.63 164.85 25.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.732 0.813 . . . . 0.0 108.981 167.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.32 26.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.18 -167.68 38.91 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 118.402 0.546 . . . . 0.0 112.14 -163.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -136.64 159.56 41.44 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.75 0.82 . . . . 0.0 111.991 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.99 141.94 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.735 0.814 . . . . 0.0 110.412 174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -141.85 153.31 44.37 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.833 1.653 . . . . 0.0 108.613 -166.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -106.62 125.22 50.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 170.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -85.33 145.29 27.58 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.961 0.904 . . . . 0.0 108.676 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.55 -29.45 69.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.351 0.66 . . . . 0.0 111.882 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -8.8 56.03 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 45.95 2.23 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 119.109 0.868 . . . . 0.0 112.084 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -136.43 172.99 12.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 107.802 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -116.16 144.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 164.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 140.34 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.79 140.72 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.7 127.69 14.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.44 149.28 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 122.997 0.519 . . . . 0.0 110.24 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.28 153.77 20.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.708 0.803 . . . . 0.0 109.147 166.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.47 173.71 36.56 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.309 0.957 . . . . 0.0 111.604 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.59 153.41 60.06 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.149 1.899 . . . . 0.0 110.073 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.83 -42.3 75.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.679 0.792 . . . . 0.0 111.507 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.4 -41.1 98.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.068 -0.395 . . . . 0.0 111.632 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -45.1 77.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.786 0.434 . . . . 0.0 109.856 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.99 -45.38 95.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.863 0.865 . . . . 0.0 110.129 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -69.71 -39.73 76.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.857 -0.527 . . . . 0.0 112.019 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.1 m -61.05 -41.7 97.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.642 0.656 . . . . 0.0 110.183 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.36 -47.27 86.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.575 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -55.01 -45.84 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.754 1.161 . . . . 0.0 109.602 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.82 -39.1 90.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.585 0.63 . . . . 0.0 111.052 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.55 87.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.425 0.69 . . . . 0.0 111.411 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.61 -48.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.96 -39.76 86.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.41 0.684 . . . . 0.0 111.452 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.49 -24.74 66.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.004 0.522 . . . . 0.0 111.832 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.28 44.0 96.84 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -54.48 -47.68 97.07 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.935 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.78 -169.09 0.67 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.546 2.164 . . . . 0.0 111.722 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -2.87 0.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.911 2.084 . . . . 0.0 115.241 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.4 m -129.53 143.65 50.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.395 1.478 . . . . 0.0 107.737 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.0 164.75 37.66 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.404 0.682 . . . . 0.0 111.21 -162.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.8 m -106.37 158.79 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 123.543 0.737 . . . . 0.0 110.444 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 p -123.01 -11.72 8.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.915 1.686 . . . . 0.0 109.827 162.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.7 146.82 27.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.108 1.363 . . . . 0.0 108.992 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.7 tt -148.19 143.6 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.991 1.316 . . . . 0.0 108.309 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -136.73 144.08 43.65 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.126 1.77 . . . . 0.0 107.213 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.67 140.21 36.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -132.68 157.34 45.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.989 2.115 . . . . 0.0 105.778 168.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.36 142.8 48.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -136.94 153.29 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.785 1.634 . . . . 0.0 107.07 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 mmt-85 -87.76 -24.49 23.78 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.011 -1.056 . . . . 0.0 111.166 -175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 m -62.93 114.67 3.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.81 1.244 . . . . 0.0 111.027 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.61 177.66 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.32 1.048 . . . . 0.0 110.641 164.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -126.92 0.21 6.61 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.893 1.277 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.57 27.94 66.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.878 0.751 . . . . 0.0 111.675 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -94.53 150.35 20.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.894 0.847 . . . . 0.0 109.8 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -137.84 14.98 2.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.64 1.176 . . . . 0.0 111.57 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -148.51 166.72 27.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.16 1.384 . . . . 0.0 108.963 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -88.16 155.88 19.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 163.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.2 m -142.55 156.7 45.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.614 1.166 . . . . 0.0 110.66 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 mt -128.17 112.96 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -174.577 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.3 tp -140.65 -178.6 5.6 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.789 -1.194 . . . . 0.0 109.527 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 33.3 tt0 -155.12 158.14 38.55 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.868 1.667 . . . . 0.0 108.449 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -120.05 164.94 15.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.661 0.785 . . . . 0.0 110.536 166.27 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.27 131.3 29.95 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 157.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.97 147.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -167.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.41 137.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 m -141.53 156.28 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 124.03 0.932 . . . . 0.0 111.301 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.36 155.51 45.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.751 1.62 . . . . 0.0 107.788 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.24 -155.36 26.29 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -77.61 100.21 6.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 152.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.39 6.24 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 124.611 1.194 . . . . 0.0 110.752 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 C--N 1.344 0.352 0 CA-C-N 119.587 1.085 . . . . 0.0 111.12 179.073 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -59.89 -32.34 70.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.289 0.95 . . . . 0.0 110.578 169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -51.72 -37.53 51.33 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.538 0.608 . . . . 0.0 112.07 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.68 -48.06 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -71.29 -25.47 62.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.42 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.71 -39.47 64.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.858 1.208 . . . . 0.0 110.589 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -69.28 -29.82 67.78 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.344 -0.847 . . . . 0.0 111.096 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.54 65.07 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.093 -1.005 . . . . 0.0 109.672 172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.11 -40.42 93.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.053 0.941 . . . . 0.0 111.42 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -15.26 62.72 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.67 -0.644 . . . . 0.0 112.295 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -113.33 15.11 19.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 111.665 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.27 32.97 3.41 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.067 1.747 . . . . 0.0 112.326 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.0 162.22 29.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.09 121.39 19.18 Favored 'General case' 0 CA--C 1.527 0.075 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 -162.17 32.27 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -142.7 163.7 32.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.14 145.98 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.086 1.354 . . . . 0.0 109.507 165.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -149.49 146.14 27.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.641 1.577 . . . . 0.0 108.372 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.98 153.93 40.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.703 0.801 . . . . 0.0 109.487 168.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -134.64 154.6 51.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.297 1.408 . . . . 0.0 110.843 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.01 -30.63 69.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -155.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.05 -27.45 68.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.139 0.576 . . . . 0.0 112.402 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.65 -17.84 10.12 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.366 1.46 . . . . 0.0 110.946 -172.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -59.17 168.32 1.44 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 122.962 1.363 . . . . 0.0 110.422 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.52 150.12 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -131.18 140.12 49.86 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -171.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -136.89 140.81 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -171.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -149.88 126.91 11.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.19 149.52 28.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.527 0.603 . . . . 0.0 110.093 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.92 153.77 19.95 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 174.69 39.72 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.661 0.648 . . . . 0.0 111.807 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.21 152.39 66.98 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.966 1.777 . . . . 0.0 110.152 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.05 -43.87 74.19 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.813 0.845 . . . . 0.0 111.481 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.43 -40.93 98.49 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 122.227 -0.295 . . . . 0.0 111.544 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.33 80.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.988 0.515 . . . . 0.0 110.116 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 4' ' ' TYR . 67.4 mt -62.04 -45.22 94.54 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.583 0.753 . . . . 0.0 110.211 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.57 -40.12 76.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.885 -0.51 . . . . 0.0 111.75 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 m -61.37 -42.0 98.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.746 0.703 . . . . 0.0 110.215 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.21 -49.81 75.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.591 -0.719 . . . . 0.0 110.243 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.3 t -56.65 -43.59 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 119.496 1.043 . . . . 0.0 109.988 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.69 -41.46 97.6 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.109 0.868 . . . . 0.0 110.72 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.33 97.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 111.438 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.28 -53.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -58.53 -40.93 84.32 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.078 0.951 . . . . 0.0 111.207 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -69.9 -23.65 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.49 . . . . 0.0 111.897 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.33 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -58.41 -42.15 93.08 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-O 117.745 -1.121 . . . . 0.0 112.871 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.13 -172.29 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.742 2.961 . . . . 0.0 114.128 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -59.48 -39.61 84.28 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.48 1.112 . . . . 0.0 111.785 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -72.96 151.71 41.7 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.586 0.755 . . . . 0.0 110.363 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 145.53 23.33 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.76 156.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -124.87 -8.95 7.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.601 . . . . 0.0 109.734 166.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.46 139.7 20.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.419 1.887 . . . . 0.0 107.411 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -152.95 142.75 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.65 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -141.29 145.36 35.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.806 1.643 . . . . 0.0 107.779 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.51 138.85 44.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -169.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -131.73 152.79 50.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.598 1.959 . . . . 0.0 106.063 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -131.31 151.21 51.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 m -146.95 165.29 30.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.539 1.136 . . . . 0.0 109.465 -165.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -118.78 1.34 11.56 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.148 0.979 . . . . 0.0 110.751 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 m -62.2 -37.45 85.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.42 1.088 . . . . 0.0 112.211 -171.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 mp 58.5 170.59 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.26 1.824 . . . . 0.0 111.951 -170.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.19 -20.19 4.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.852 1.261 . . . . 0.0 111.392 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.83 24.69 74.26 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.17 139.52 42.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.126 0.963 . . . . 0.0 108.433 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -131.88 21.0 4.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.498 1.119 . . . . 0.0 110.743 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -149.03 178.28 8.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.022 1.729 . . . . 0.0 108.099 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.46 132.16 35.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.0 m -143.9 163.26 33.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.63 1.205 . . . . 0.0 114.032 -152.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.4 mt -128.39 118.66 48.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.251 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -141.76 179.85 6.61 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.889 -1.132 . . . . 0.0 109.677 -167.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -155.37 156.29 35.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 109.159 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.5 163.21 18.3 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.688 0.795 . . . . 0.0 110.524 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -132.33 137.06 47.28 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 154.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.78 142.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -173.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.21 135.28 59.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 171.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.52 151.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.783 0.833 . . . . 0.0 110.6 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.83 153.31 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 107.681 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.88 -154.36 25.77 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -75.1 88.64 2.44 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -124.52 6.51 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.398 1.079 . . . . 0.0 111.237 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 CA--C 1.534 0.36 0 CA-C-N 119.78 1.173 . . . . 0.0 108.496 168.84 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.65 -43.32 69.4 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.574 -0.704 . . . . 0.0 110.07 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -53.86 -48.33 70.13 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.029 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.17 -33.99 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 119.39 0.996 . . . . 0.0 110.929 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.61 -32.16 73.59 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.385 1.448 . . . . 0.0 112.164 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -64.0 -46.55 84.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.181 0.901 . . . . 0.0 109.385 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -68.58 -33.3 73.83 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.101 -0.375 . . . . 0.0 110.887 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.48 77.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.299 1.04 . . . . 0.0 109.584 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.68 -35.0 78.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.862 0.465 . . . . 0.0 112.096 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.2 -40.93 59.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.27 1.028 . . . . 0.0 111.715 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -114.87 24.01 12.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.86 1.264 . . . . 0.0 111.279 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp 46.17 39.96 6.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.32 157.43 22.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.12 126.16 44.87 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.33 -171.88 44.67 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 118.643 0.656 . . . . 0.0 112.885 -167.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -142.9 165.85 26.25 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.313 0.645 . . . . 0.0 112.463 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.38 146.56 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.053 1.341 . . . . 0.0 110.075 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.46 159.17 44.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.914 1.286 . . . . 0.0 110.222 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.34 153.94 28.07 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 166.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -112.32 145.25 40.36 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 166.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.64 -28.39 65.63 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.36 -28.05 68.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.922 0.889 . . . . 0.0 112.65 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.08 -17.57 7.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.297 1.427 . . . . 0.0 111.614 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -58.46 164.8 2.39 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.949 0.881 . . . . 0.0 110.691 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 t -119.31 149.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 161.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -129.27 139.53 51.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 141.8 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.79 129.39 14.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.94 145.14 23.89 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.754 0.706 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.69 151.82 23.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 164.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.45 175.68 40.0 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 112.457 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.61 154.95 64.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.142 1.895 . . . . 0.0 110.526 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.46 -45.78 76.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.905 0.882 . . . . 0.0 111.512 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.41 -40.84 98.29 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.294 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.2 80.07 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.48 -46.39 88.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.477 0.711 . . . . 0.0 110.492 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -69.17 -39.58 78.67 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.888 -0.508 . . . . 0.0 111.755 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 m -62.1 -40.49 96.06 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.663 0.665 . . . . 0.0 110.259 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -59.46 -47.54 85.09 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.303 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.88 -42.62 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 119.72 1.145 . . . . 0.0 109.898 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.46 -41.31 98.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.083 0.856 . . . . 0.0 110.984 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.16 89.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.908 0.483 . . . . 0.0 111.619 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.27 -56.02 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.99 -37.18 78.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.955 0.902 . . . . 0.0 111.573 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.01 -24.63 66.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.557 0.743 . . . . 0.0 112.415 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.49 42.62 97.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.785 0.72 . . . . 0.0 111.387 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -51.26 -47.37 88.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.95 -56.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.711 1.647 . . . . 0.0 112.198 -166.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -174.92 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.952 2.101 . . . . 0.0 107.104 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.81 145.34 29.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.553 1.541 . . . . 0.0 109.782 168.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.52 151.52 24.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.561 0.745 . . . . 0.0 109.206 -172.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.85 156.18 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.8 p -121.17 -12.43 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.585 1.554 . . . . 0.0 109.774 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.36 136.02 20.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.266 1.826 . . . . 0.0 106.967 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 tt -148.5 137.73 15.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -139.63 146.14 39.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.311 1.444 . . . . 0.0 107.397 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.49 144.4 32.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.96 147.61 50.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 167.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -138.76 134.53 33.6 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 m -143.62 168.07 20.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.01 0.924 . . . . 0.0 110.634 -155.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.55 0.45 10.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.349 1.059 . . . . 0.0 111.726 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -66.14 -37.2 85.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.29 0.95 . . . . 0.0 112.61 -171.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.52 177.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 0.0 111.236 -165.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -124.06 -26.52 4.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.122 0.969 . . . . 0.0 110.978 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.17 41.24 6.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.351 0.977 . . . . 0.0 110.906 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 165.78 24.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 112.536 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -140.39 33.11 1.88 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.366 1.867 . . . . 0.0 109.279 -172.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -131.14 160.98 33.16 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.467 1.507 . . . . 0.0 108.434 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.35 122.33 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -141.81 163.62 32.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.184 0.992 . . . . 0.0 113.42 -152.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.08 119.89 41.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.505 -160.669 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.8 ttp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 119.084 -0.484 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mp -143.42 -177.12 5.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.011 1.278 . . . . 0.0 111.605 -167.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -142.53 155.95 45.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.816 2.846 . . . . 0.0 108.552 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.4 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -114.68 164.68 13.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.794 0.838 . . . . 0.0 109.731 161.11 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -133.26 137.0 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 153.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -136.19 141.42 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -170.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.55 33.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 163.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.84 155.34 30.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.531 1.132 . . . . 0.0 109.99 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -145.56 155.81 43.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 107.19 172.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.21 -152.48 24.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 107.786 -2.125 . . . . 0.0 107.786 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -78.15 101.66 7.14 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 104.421 -2.436 . . . . 0.0 104.421 154.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.61 18.56 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.403 1.081 . . . . 0.0 110.352 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 125.966 1.706 . . . . 0.0 107.109 169.42 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.28 -44.25 65.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.485 1.039 . . . . 0.0 109.914 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.9 -50.81 63.18 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.765 0.826 . . . . 0.0 110.998 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.13 -35.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.034 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.53 -21.62 60.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.377 1.444 . . . . 0.0 113.054 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.4 mtm -64.06 -46.32 84.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.755 1.161 . . . . 0.0 109.03 165.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -68.32 -23.98 64.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.465 0.706 . . . . 0.0 111.582 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.66 -53.04 38.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.356 -0.84 . . . . 0.0 108.921 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.61 -40.26 91.21 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.205 0.602 . . . . 0.0 111.594 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.27 62.58 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.78 -0.575 . . . . 0.0 112.295 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.1 15.03 17.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.455 1.502 . . . . 0.0 111.393 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 47.94 32.07 2.65 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.183 1.793 . . . . 0.0 112.849 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -73.43 162.26 29.5 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.79 134.87 25.56 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.42 -165.39 38.6 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 118.566 0.621 . . . . 0.0 112.143 -160.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CZ3' ' HE2' ' A' ' 35' ' ' LYS . 3.0 p-90 -135.81 169.22 17.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.652 0.781 . . . . 0.0 112.514 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.42 149.85 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.16 1.384 . . . . 0.0 109.73 170.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE2' ' CZ3' ' A' ' 33' ' ' TRP . 44.3 mtmt -142.23 150.47 40.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.181 1.792 . . . . 0.0 108.56 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -81.27 130.88 35.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 148.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -77.93 137.18 38.2 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 166.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.88 -24.82 62.72 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.196 0.598 . . . . 0.0 111.985 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -28.33 65.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.915 1.686 . . . . 0.0 112.869 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.18 3.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.228 1.394 . . . . 0.0 112.262 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.87 172.15 2.42 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.003 0.921 . . . . 0.0 111.197 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.58 140.58 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -127.07 143.54 51.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.073 0.949 . . . . 0.0 108.805 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.76 143.13 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 tt -149.58 127.74 12.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.55 157.24 35.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.135 0.88 . . . . 0.0 111.284 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.81 150.35 21.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.217 1.407 . . . . 0.0 109.71 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.55 174.08 38.27 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.635 1.588 . . . . 0.0 111.211 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.48 155.34 55.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.659 2.24 . . . . 0.0 110.306 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.55 -42.11 74.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -172.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.71 -41.53 99.19 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.075 -0.391 . . . . 0.0 111.576 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -45.56 79.84 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.945 0.498 . . . . 0.0 110.065 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 4' ' ' TYR . 93.7 mt -59.83 -45.37 92.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.894 0.878 . . . . 0.0 110.142 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -70.95 -40.87 71.77 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.582 -0.699 . . . . 0.0 112.057 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.6 m -60.18 -40.32 89.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.557 0.617 . . . . 0.0 110.021 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.16 -49.19 78.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.705 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.85 -44.31 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.683 1.129 . . . . 0.0 109.9 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.56 -41.4 98.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 111.215 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.46 96.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.527 0.731 . . . . 0.0 111.316 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 t -64.04 -53.38 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -57.02 -42.16 79.86 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.4 0.68 . . . . 0.0 111.014 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.52 -22.59 62.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.444 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.61 46.03 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 118.931 0.787 . . . . 0.0 111.386 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -50.69 -51.66 63.67 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -161.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.66 -40.42 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.402 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -165.09 172.94 12.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.792 2.037 . . . . 0.0 107.881 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m 62.71 170.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.159 1.383 . . . . 0.0 112.595 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.29 141.73 10.98 Favored 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.85 154.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -119.37 -12.66 9.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.245 1.418 . . . . 0.0 109.38 165.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.26 142.96 25.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.411 1.485 . . . . 0.0 108.155 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.3 tt -146.98 141.08 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -138.09 143.3 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.7 142.88 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -171.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.0 m -130.18 151.43 50.71 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 167.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -136.26 146.1 46.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -137.98 158.1 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.638 1.575 . . . . 0.0 108.384 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.92 -20.05 21.81 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.687 -0.633 . . . . 0.0 111.031 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 m -64.11 126.59 28.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.58 0.752 . . . . 0.0 110.242 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 1' ' ' MET . 10.5 mp -68.21 173.45 4.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.386 1.075 . . . . 0.0 109.9 159.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -125.15 6.24 7.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.999 1.72 . . . . 0.0 111.025 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.18 22.96 61.37 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.455 1.026 . . . . 0.0 112.386 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -88.17 140.66 29.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.215 1.007 . . . . 0.0 108.713 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -132.69 11.57 4.39 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.55 165.47 32.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.241 1.817 . . . . 0.0 108.025 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -93.34 152.57 19.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.7 m -141.1 150.99 43.59 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.849 0.833 . . . . 0.0 111.185 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.0 110.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 165.855 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.06 178.78 4.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.21 1.004 . . . . 0.0 110.994 -165.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -153.78 157.5 39.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.217 2.207 . . . . 0.0 108.469 -168.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.1 p90 -134.9 166.14 23.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.161 0.584 . . . . 0.0 110.673 166.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -133.88 141.1 47.24 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 152.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.1 146.61 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -168.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 134.43 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.2 154.86 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.469 1.108 . . . . 0.0 111.072 -167.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -143.18 157.56 44.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.969 1.708 . . . . 0.0 108.876 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 -154.6 26.0 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 106.649 -2.581 . . . . 0.0 106.649 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -74.93 54.89 0.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.827 -0.807 . . . . 0.0 108.839 163.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.08 -10.72 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 121.256 -0.902 . . . . 0.0 113.206 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.562 HE22 ' HB3' ' A' ' 18' ' ' ARG . 22.0 mm-40 . . . . . 0 C--O 1.232 0.17 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HB3' HE22 ' A' ' 13' ' ' GLN . 15.6 ptp180 . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.75 -15.55 63.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 117.432 -1.271 . . . . 0.0 112.457 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.916 1.689 . . . . 0.0 111.886 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.35 -35.32 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.17 0.895 . . . . 0.0 110.245 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.89 -28.36 66.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.566 1.075 . . . . 0.0 110.813 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -42.89 69.78 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.483 -0.76 . . . . 0.0 109.864 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.66 -35.97 81.44 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.621 -0.675 . . . . 0.0 110.197 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.16 89.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.598 1.159 . . . . 0.0 110.178 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.78 -39.4 84.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.115 0.566 . . . . 0.0 111.575 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -57.22 -42.12 80.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.655 0.661 . . . . 0.0 110.58 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -85.62 3.35 41.21 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 111.772 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 46.99 35.77 3.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.44 171.71 8.32 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 163.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.52 139.25 21.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -165.52 38.73 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.023 -163.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.15 160.47 27.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.955 1.302 . . . . 0.0 112.295 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.16 142.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.342 1.057 . . . . 0.0 109.444 164.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -147.88 171.89 15.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 109.563 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -123.76 114.92 20.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -75.57 152.69 37.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.08 -28.56 67.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 112.009 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.0 -27.03 68.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.001 0.921 . . . . 0.0 112.522 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.12 -27.39 4.55 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.086 1.327 . . . . 0.0 112.457 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.37 151.58 31.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.007 0.903 . . . . 0.0 110.258 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.96 149.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 155.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -128.04 144.93 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.068 1.347 . . . . 0.0 107.384 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 146.44 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -141.28 138.52 33.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -161.78 169.3 21.65 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.712 1.596 . . . . 0.0 110.869 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.91 154.87 37.76 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.999 1.32 . . . . 0.0 110.456 167.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.55 179.91 41.11 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.99 1.281 . . . . 0.0 111.49 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.44 156.63 54.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.681 2.254 . . . . 0.0 110.889 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -55.29 -46.88 76.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 111.688 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.6 -38.44 91.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.855 0.298 . . . . 0.0 111.469 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -47.34 75.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.576 0.35 . . . . 0.0 110.147 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 4' ' ' TYR . 76.5 mt -61.07 -48.53 81.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.385 0.674 . . . . 0.0 109.906 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -65.27 -45.84 82.85 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.197 0.599 . . . . 0.0 111.59 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -40.44 97.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.235 0.47 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.76 -48.68 80.38 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.684 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.02 -40.63 74.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.705 1.139 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.98 -42.13 99.75 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.172 0.897 . . . . 0.0 110.811 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.61 98.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.016 0.526 . . . . 0.0 111.667 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.17 -57.67 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.27 -42.71 91.85 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -171.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.07 -24.86 66.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.627 0.371 . . . . 0.0 111.652 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.97 50.05 66.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -52.09 77.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.831 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.45 -176.22 3.15 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.555 2.17 . . . . 0.0 110.584 170.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -106.23 154.34 20.86 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 153.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 171.3 1.55 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.412 2.685 . . . . 0.0 111.293 -7.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -135.57 161.66 34.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.173 -0.955 . . . . 0.0 110.748 -156.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.72 146.37 34.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -133.26 -5.42 3.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.228 1.011 . . . . 0.0 110.864 171.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.81 141.92 22.23 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.707 1.203 . . . . 0.0 108.858 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.9 146.98 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.506 1.123 . . . . 0.0 108.843 -173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 m -136.0 143.01 44.57 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.76 146.14 26.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -170.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 m -126.93 141.4 51.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 161.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.88 139.92 48.92 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -149.58 175.88 11.14 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.96 1.304 . . . . 0.0 109.43 -159.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.29 17.55 2.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.304 1.042 . . . . 0.0 111.113 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -66.97 -27.64 67.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.114 0.966 . . . . 0.0 111.695 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.95 175.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.154 2.182 . . . . 0.0 111.84 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.52 -13.08 0.39 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.46 1.104 . . . . 0.0 112.487 -170.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.92 15.03 79.96 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.031 0.824 . . . . 0.0 112.387 176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -66.49 126.06 27.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.554 1.177 . . . . 0.0 108.596 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -129.23 23.89 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.543 1.537 . . . . 0.0 108.244 164.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -148.18 161.33 41.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.386 2.274 . . . . 0.0 106.758 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -106.07 145.15 31.79 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -138.38 150.6 46.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.521 1.153 . . . . 0.0 111.675 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.72 133.37 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.237 0.414 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -174.646 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ttp . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.28 176.91 6.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.65 1.114 . . . . 0.0 111.183 -167.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.24 143.94 25.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.474 2.31 . . . . 0.0 107.345 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -103.41 159.64 15.4 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 168.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -119.22 141.38 48.95 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 151.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -140.64 140.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.95 139.18 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.86 153.03 24.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.722 0.809 . . . . 0.0 110.773 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -140.37 147.93 40.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.555 1.542 . . . . 0.0 108.06 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -154.55 25.98 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -76.42 80.71 3.15 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 162.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -107.5 0.76 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.082 0.953 . . . . 0.0 111.391 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.341 0.237 0 O-C-N 121.075 -1.016 . . . . 0.0 109.239 178.048 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -68.65 -36.33 78.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.415 1.007 . . . . 0.0 109.763 171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -52.02 -48.02 64.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.239 0.615 . . . . 0.0 111.907 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.65 -35.21 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.684 0.674 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -75.07 -23.5 58.03 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.803 -1.185 . . . . 0.0 112.037 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.1 mtm -64.33 -50.25 68.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.218 0.917 . . . . 0.0 109.411 167.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.59 -39.27 90.6 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.262 0.625 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.74 54.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.211 1.005 . . . . 0.0 109.843 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.14 -45.71 93.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.152 0.581 . . . . 0.0 110.883 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -59.21 -24.7 63.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.523 1.529 . . . . 0.0 111.888 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -108.38 13.24 25.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.236 1.414 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 50.41 31.15 5.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.974 1.71 . . . . 0.0 112.843 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.8 160.09 28.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.121 0.969 . . . . 0.0 108.503 169.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.03 124.43 12.35 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.488 0.715 . . . . 0.0 109.922 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.51 -175.01 35.67 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.851 0.739 . . . . 0.0 112.091 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -99.78 161.14 13.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -164.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.71 143.61 38.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 156.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.41 152.59 38.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.429 0.692 . . . . 0.0 110.137 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -72.54 123.25 22.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -81.55 132.39 35.31 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.34 -29.44 65.95 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -167.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -17.18 62.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.06 0.944 . . . . 0.0 113.246 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.31 -15.53 6.09 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.472 1.511 . . . . 0.0 112.891 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.12 175.96 3.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.951 1.376 . . . . 0.0 109.721 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.12 145.01 24.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -116.81 143.13 46.04 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.8 133.45 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -150.41 117.18 5.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.54 149.98 28.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.542 0.61 . . . . 0.0 112.355 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.29 157.29 18.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.692 1.197 . . . . 0.0 110.345 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.83 38.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.895 1.236 . . . . 0.0 111.582 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.31 153.99 65.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.259 1.972 . . . . 0.0 110.368 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.3 -48.32 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 111.494 -170.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.14 -38.34 90.69 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.087 0.403 . . . . 0.0 111.786 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.67 89.48 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.045 0.538 . . . . 0.0 109.832 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 4' ' ' TYR . 79.3 mt -61.69 -47.55 84.81 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.438 0.695 . . . . 0.0 110.004 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -67.34 -40.51 85.9 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.802 -0.561 . . . . 0.0 111.553 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -67.15 -35.67 80.21 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.79 -0.568 . . . . 0.0 110.69 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.47 -47.04 87.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.971 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.41 -42.71 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.913 1.233 . . . . 0.0 109.55 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -41.0 96.06 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.257 0.935 . . . . 0.0 111.313 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.74 -40.73 89.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.737 0.815 . . . . 0.0 111.46 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -55.33 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -59.24 -37.89 78.66 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.195 0.598 . . . . 0.0 111.734 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.98 -23.55 65.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.179 0.592 . . . . 0.0 112.261 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.35 43.03 89.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 118.672 0.669 . . . . 0.0 111.508 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -50.28 -49.11 78.41 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -168.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.54 -59.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.735 1.655 . . . . 0.0 112.204 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -171.3 -47.44 0.02 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.213 1.805 . . . . 0.0 108.173 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.61 146.79 24.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.04 0.936 . . . . 0.0 109.546 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -156.2 162.52 40.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.994 0.918 . . . . 0.0 108.97 -167.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -115.02 148.91 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 p -121.42 -9.07 9.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.684 1.594 . . . . 0.0 109.455 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -150.44 143.08 24.55 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.696 1.598 . . . . 0.0 107.57 166.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.5 140.9 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -136.46 143.39 43.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.527 1.531 . . . . 0.0 106.87 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -140.1 147.98 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -127.28 154.32 45.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -133.04 143.6 49.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -158.37 170.8 21.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.037 . . . . 0.0 109.752 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.06 5.47 44.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.829 0.852 . . . . 0.0 110.981 171.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 m -71.53 73.31 0.75 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.755 2.022 . . . . 0.0 111.59 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.16 140.92 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.444 -0.785 . . . . 0.0 109.763 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -78.58 -23.72 45.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.524 0.73 . . . . 0.0 111.394 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.68 48.14 13.53 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -167.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.78 154.87 43.67 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.477 1.111 . . . . 0.0 109.662 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -136.42 8.32 3.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.856 0.862 . . . . 0.0 112.438 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -149.13 166.47 28.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.519 1.528 . . . . 0.0 108.417 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -76.87 163.11 27.06 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.4 m -140.07 152.57 46.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.805 1.242 . . . . 0.0 109.331 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mt -135.11 116.44 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.95 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttp . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.01 176.99 7.19 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.878 -1.139 . . . . 0.0 111.891 -159.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -145.4 156.32 43.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.23 1.812 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.2 165.67 15.08 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.53 0.732 . . . . 0.0 110.508 161.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -128.09 143.28 51.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 149.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 57' ' ' VAL . 98.0 mt -137.62 138.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.36 133.38 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.18 153.33 18.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 111.24 -169.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.42 145.93 35.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.034 1.734 . . . . 0.0 107.447 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.24 -154.12 25.76 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -172.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -78.05 88.31 4.19 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 157.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.96 3.28 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.761 1.224 . . . . 0.0 111.092 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.333 1.053 . . . . 0.0 109.391 -168.784 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -62.99 -35.87 81.64 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.108 1.322 . . . . 0.0 109.025 161.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.55 -50.26 24.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.002 0.819 . . . . 0.0 112.564 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.64 -40.07 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 119.215 0.916 . . . . 0.0 109.898 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -74.25 -23.65 59.18 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.631 -1.293 . . . . 0.0 112.152 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.24 82.46 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 169.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -62.79 -37.38 86.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.083 0.856 . . . . 0.0 109.91 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.53 57.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.13 0.572 . . . . 0.0 109.856 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.82 -46.16 91.62 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.253 0.621 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -58.11 -28.1 64.33 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.892 1.277 . . . . 0.0 111.937 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -107.4 12.43 28.0 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.914 1.286 . . . . 0.0 111.159 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 49.61 31.91 4.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 112.742 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.5 mt -73.88 164.09 27.09 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 168.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.66 135.67 31.9 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.79 -165.79 38.99 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -140.15 161.77 36.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.648 0.779 . . . . 0.0 111.987 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.81 143.08 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.48 1.112 . . . . 0.0 108.625 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -143.95 163.09 34.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.962 1.705 . . . . 0.0 108.435 -164.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -115.21 120.63 40.36 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -75.92 147.23 39.11 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.27 -28.34 66.64 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.377 0.671 . . . . 0.0 112.084 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.01 0.924 . . . . 0.0 112.461 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.36 -29.4 3.17 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.173 1.368 . . . . 0.0 112.225 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.75 152.2 31.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.911 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.34 148.1 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 160.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -128.38 144.6 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.69 141.35 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -146.15 125.76 13.33 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.69 161.07 42.93 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.019 0.528 . . . . 0.0 110.409 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.31 154.47 22.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.409 1.483 . . . . 0.0 108.051 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 179.32 40.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.39 0.519 . . . . 0.0 111.826 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.24 157.44 59.43 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.325 2.016 . . . . 0.0 110.793 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.08 -49.25 74.33 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.148 0.979 . . . . 0.0 111.527 -170.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -66.84 -38.06 85.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 119.406 -0.331 . . . . 0.0 111.395 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.88 74.02 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.238 0.615 . . . . 0.0 109.714 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.98 -44.61 96.38 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.352 0.661 . . . . 0.0 110.803 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.31 -34.7 55.35 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.766 -0.584 . . . . 0.0 111.583 -173.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -68.85 -35.39 76.87 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.305 -0.872 . . . . 0.0 110.743 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.99 -48.72 79.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.316 0.646 . . . . 0.0 109.549 168.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 6' ' ' ILE . 42.1 t -55.81 -42.97 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.19 0.904 . . . . 0.0 109.67 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.48 -41.91 97.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.401 1.0 . . . . 0.0 111.419 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -40.98 82.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.006 0.923 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.39 -52.49 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.86 0.755 . . . . 0.0 109.5 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.77 -39.17 90.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.132 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -64.33 -21.07 66.49 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.298 1.039 . . . . 0.0 111.904 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.62 172.83 21.55 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -152.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 p -139.65 -179.98 1.15 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 121.839 -0.8 . . . . 0.0 110.031 -164.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.16 -24.62 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.461 2.774 . . . . 0.0 115.742 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.95 2.6 0.44 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 m -126.62 159.1 34.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.56 1.527 . . . . 0.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 145.83 20.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.333 0.969 . . . . 0.0 111.175 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.01 156.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -122.59 -12.46 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.62 1.568 . . . . 0.0 109.506 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -150.07 145.92 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.362 1.465 . . . . 0.0 108.185 165.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.38 144.25 16.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.773 1.229 . . . . 0.0 108.503 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m -139.29 145.64 39.37 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.726 1.611 . . . . 0.0 107.355 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.12 144.27 29.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.8 m -130.91 151.09 51.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.48 145.99 50.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.5 m -147.55 -176.59 5.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.987 1.315 . . . . 0.0 109.263 -167.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -127.73 10.33 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 110.977 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -67.66 -29.46 68.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.788 1.235 . . . . 0.0 114.02 -161.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.9 mt 62.04 171.82 0.13 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.351 1.86 . . . . 0.0 111.924 -170.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -139.03 -30.96 0.72 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.597 1.159 . . . . 0.0 111.412 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.79 30.47 77.29 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -72.86 164.0 27.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.04 1.336 . . . . 0.0 108.922 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.82 11.59 4.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.623 0.769 . . . . 0.0 111.763 -173.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -145.84 167.47 23.14 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.221 1.008 . . . . 0.0 109.253 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -89.04 141.94 28.06 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 139.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -133.14 163.35 29.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.502 0.721 . . . . 0.0 110.758 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 mt -138.06 127.39 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.535 0.397 0 C-N-CA 124.537 1.135 . . . . 0.0 107.95 -175.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.416 0.151 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mp -134.19 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.596 1.159 . . . . 0.0 111.051 -160.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.32 154.08 42.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.46 1.904 . . . . 0.0 107.401 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -118.7 164.62 15.09 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.453 0.701 . . . . 0.0 110.51 165.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -125.67 140.83 52.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 147.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.52 142.98 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 137.49 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.87 149.79 23.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.202 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -138.96 155.71 47.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.572 1.549 . . . . 0.0 107.807 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.71 -156.35 25.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -79.75 65.98 5.08 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 163.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 27.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.133 0.973 . . . . 0.0 111.076 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -159.44 -174.73 4.81 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.38 -45.27 0.35 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -150.89 -30.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.251 1.02 . . . . 0.0 110.434 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.49 47.44 0.13 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.108 0.867 . . . . 0.0 113.281 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -60.72 -37.43 81.71 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.207 1.504 . . . . 0.0 109.96 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -61.28 -35.48 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.916 -0.49 . . . . 0.0 111.087 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.66 -45.48 75.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.941 0.791 . . . . 0.0 109.931 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.32 -50.29 65.28 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.2 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.4 -38.92 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.463 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -71.67 -22.58 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 113.078 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.1 mtm -64.32 -46.75 82.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.637 1.108 . . . . 0.0 108.826 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.79 -31.33 72.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.54 -54.79 41.16 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.988 0.915 . . . . 0.0 109.675 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.15 -40.49 96.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.957 0.503 . . . . 0.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -55.21 -28.7 54.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.122 . . . . 0.0 111.887 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -118.59 20.71 12.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.697 0.799 . . . . 0.0 111.617 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 41.59 42.14 1.91 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.771 2.428 . . . . 0.0 113.67 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.47 163.67 27.64 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.08 130.76 17.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.74 -162.52 34.17 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.029 -168.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -130.86 161.7 31.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.047 . . . . 0.0 112.168 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.43 148.12 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.948 1.299 . . . . 0.0 109.22 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.99 156.75 43.0 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.243 1.817 . . . . 0.0 108.143 -170.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -115.54 121.48 42.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.18 151.26 36.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.487 1.115 . . . . 0.0 109.177 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.14 -28.7 69.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.976 0.51 . . . . 0.0 111.382 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -7.63 48.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.153 0.981 . . . . 0.0 113.259 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.81 -19.57 32.92 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.03 1.3 . . . . 0.0 113.265 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.33 163.66 22.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.918 1.359 . . . . 0.0 110.435 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.89 149.77 5.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 158.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -135.23 144.91 47.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -141.33 144.78 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.85 130.1 13.69 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.07 154.51 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.102 0.864 . . . . 0.0 111.07 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.24 157.16 16.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.927 1.291 . . . . 0.0 109.838 168.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 178.49 40.31 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.715 0.674 . . . . 0.0 112.577 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.49 155.69 40.72 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.311 2.008 . . . . 0.0 110.174 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.27 -47.54 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 111.432 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.06 -39.62 93.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.941 0.337 . . . . 0.0 111.248 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.95 -46.66 77.33 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.02 0.373 . . . . 0.0 110.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 77.4 mt -62.12 -43.19 99.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.687 0.795 . . . . 0.0 110.509 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -71.83 -38.7 70.12 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.757 -0.589 . . . . 0.0 111.918 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.4 m -62.57 -39.56 94.06 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.664 -0.648 . . . . 0.0 110.075 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -60.75 -46.95 88.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.695 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.76 -44.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 119.861 1.21 . . . . 0.0 109.486 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -62.16 -42.04 98.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.972 0.805 . . . . 0.0 111.408 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.39 87.87 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.025 0.93 . . . . 0.0 111.901 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.76 -54.74 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.26 -38.67 80.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.403 1.081 . . . . 0.0 112.062 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.31 -26.23 68.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.135 0.574 . . . . 0.0 111.69 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.34 47.28 91.63 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -53.08 -39.63 72.39 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.901 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -66.23 -174.81 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.806 3.004 . . . . 0.0 114.841 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -63.42 -37.03 85.71 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.319 1.048 . . . . 0.0 111.045 164.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.1 m -70.06 137.98 51.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.377 1.071 . . . . 0.0 108.244 165.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 150.7 35.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.415 0.552 . . . . 0.0 111.049 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.08 151.38 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.152 1.381 . . . . 0.0 107.998 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -128.45 -11.55 5.07 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.099 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -151.56 140.57 21.11 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.652 1.181 . . . . 0.0 108.957 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.1 tt -140.98 149.08 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.793 1.237 . . . . 0.0 108.746 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 m -139.13 144.88 38.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.04 143.0 34.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.6 m -130.04 150.84 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 153.44 50.88 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.529 0.731 . . . . 0.0 110.415 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.6 m -151.53 173.77 14.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.498 1.519 . . . . 0.0 109.208 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 1.33 24.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.901 1.28 . . . . 0.0 110.988 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -72.69 75.73 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.74 2.016 . . . . 0.0 111.839 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.67 153.76 9.99 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.58 -0.7 . . . . 0.0 110.41 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.99 -26.29 7.36 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.781 1.232 . . . . 0.0 110.671 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.11 24.22 59.92 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -163.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 139.78 49.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.685 1.243 . . . . 0.0 108.332 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -134.41 14.58 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.082 . . . . 0.0 111.705 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.2 171.94 15.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.444 1.497 . . . . 0.0 109.111 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -98.33 153.59 18.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -140.38 154.15 46.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 110.075 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.74 111.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.38 138.78 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -80.49 36.88 0.38 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.474 1.109 . . . . 0.0 111.089 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.445 1.498 . . . . 0.0 110.287 178.051 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.46 178.53 7.53 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.979 -1.076 . . . . 0.0 110.062 -167.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -152.91 158.48 42.19 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.988 1.715 . . . . 0.0 108.549 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -123.37 165.99 16.09 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.991 0.916 . . . . 0.0 110.465 168.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -131.03 135.82 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 151.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.27 145.43 33.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.92 138.8 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 170.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.53 146.27 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.136 0.975 . . . . 0.0 109.938 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.87 157.17 46.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 108.805 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.05 25.11 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -81.4 92.61 6.46 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 160.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.77 10.42 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.487 1.515 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -140.09 149.43 43.08 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.917 -1.114 . . . . 0.0 110.663 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.82 -170.38 34.19 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.752 2.12 . . . . 0.0 108.04 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.26 -25.41 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.08 1.41 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.067 0.849 . . . . 0.0 113.6 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -69.4 -43.11 74.13 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.399 1.599 . . . . 0.0 110.144 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -69.28 -23.67 63.86 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.764 -1.21 . . . . 0.0 112.105 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.54 -35.43 80.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.414 1.007 . . . . 0.0 110.608 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -50.22 66.22 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.732 1.151 . . . . 0.0 110.728 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.8 -33.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.218 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -74.11 -25.31 59.71 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.854 1.207 . . . . 0.0 112.278 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -62.83 -47.56 82.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.902 0.773 . . . . 0.0 109.139 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -66.67 -29.66 69.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.613 0.365 . . . . 0.0 110.835 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.866 1.266 . . . . 0.0 109.975 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.27 -39.75 91.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.947 0.499 . . . . 0.0 111.197 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.29 -18.77 51.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.634 1.173 . . . . 0.0 112.545 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -114.59 15.17 17.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.012 1.278 . . . . 0.0 111.389 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.87 33.17 2.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.29 1.836 . . . . 0.0 112.724 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.97 161.96 29.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.18 134.82 42.56 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.2 -172.93 42.98 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 118.182 0.446 . . . . 0.0 112.107 -164.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -135.09 162.39 32.61 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.521 0.729 . . . . 0.0 112.124 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.83 149.76 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.562 1.145 . . . . 0.0 108.84 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.42 156.02 42.49 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.51 1.924 . . . . 0.0 107.585 -170.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.32 122.57 45.3 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -76.88 159.73 29.79 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.135 0.974 . . . . 0.0 110.337 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -61.19 -30.17 70.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.246 0.618 . . . . 0.0 111.458 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -10.19 57.96 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.98 -23.84 24.6 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.527 1.536 . . . . 0.0 112.204 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -87.81 166.09 14.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.229 1.514 . . . . 0.0 110.469 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.9 150.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -133.51 143.41 48.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.89 1.276 . . . . 0.0 107.667 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.05 142.71 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.64 123.55 10.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -154.26 162.98 40.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.413 0.552 . . . . 0.0 110.818 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.61 151.75 32.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 109.871 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.54 177.92 40.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.23 1.395 . . . . 0.0 110.351 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 154.45 67.79 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.353 2.035 . . . . 0.0 110.086 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.0 -42.42 76.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.558 0.743 . . . . 0.0 111.577 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.02 -41.19 99.49 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.148 -0.345 . . . . 0.0 111.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.48 84.19 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.988 0.515 . . . . 0.0 109.987 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 4' ' ' TYR . 86.4 mt -62.92 -43.34 99.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.565 0.746 . . . . 0.0 110.699 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -70.48 -40.9 73.34 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.636 -0.665 . . . . 0.0 111.697 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.5 m -59.8 -39.9 86.54 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.059 -0.401 . . . . 0.0 110.019 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -61.87 -47.43 85.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.952 173.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -53.99 -46.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.078 1.308 . . . . 0.0 109.593 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -61.78 -39.99 93.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.001 0.364 . . . . 0.0 111.039 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.75 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.282 0.633 . . . . 0.0 111.899 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.73 -49.44 80.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -57.86 -41.64 82.86 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.036 0.534 . . . . 0.0 110.826 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -72.12 -20.78 61.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.125 0.97 . . . . 0.0 112.451 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 40.81 92.67 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.365 0.984 . . . . 0.0 111.832 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 m -46.47 -54.33 19.15 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -160.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.36 -52.28 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 121.797 1.678 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -167.82 158.43 10.82 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.253 2.221 . . . . 0.0 107.412 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 p 129.48 176.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 131.713 4.005 . . . . 0.0 108.717 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.77 157.74 43.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 145.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.21 137.65 56.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -126.39 -5.69 6.53 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.233 1.413 . . . . 0.0 110.788 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.17 134.12 13.97 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.363 1.865 . . . . 0.0 106.405 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.42 138.42 21.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.0 m -140.58 147.82 40.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.92 143.63 28.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.1 m -130.19 152.44 49.62 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -129.2 145.07 51.4 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.4 m -143.61 167.65 21.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.902 1.281 . . . . 0.0 109.582 -160.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.73 1.89 10.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 110.971 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.6 m -65.91 -26.17 67.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.145 0.978 . . . . 0.0 112.709 -173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.5 mt 60.82 175.76 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.381 1.872 . . . . 0.0 111.414 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.8 -16.52 0.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.023 0.929 . . . . 0.0 113.046 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.8 90.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.221 -1.322 . . . . 0.0 116.198 155.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -81.83 178.41 8.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.039 1.919 . . . . 0.0 109.929 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -130.16 17.24 5.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.554 1.541 . . . . 0.0 110.718 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -149.38 167.54 25.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.551 1.541 . . . . 0.0 109.292 -172.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -86.04 151.63 23.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 163.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -142.95 162.34 35.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.838 0.855 . . . . 0.0 110.53 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.59 114.82 18.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.75 141.31 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.7 -46.91 87.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.438 0.295 . . . . 0.0 110.845 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.937 1.695 . . . . 0.0 110.744 179.14 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.205 -0.426 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.13 177.42 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.882 1.219 . . . . 0.0 111.248 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -146.79 155.22 42.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.675 2.39 . . . . 0.0 108.081 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.465 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -119.44 165.18 14.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.99 0.916 . . . . 0.0 110.426 169.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -131.06 133.78 46.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 154.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.45 141.63 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.68 128.73 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.16 137.59 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.67 1.188 . . . . 0.0 109.83 -164.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -131.44 150.83 52.0 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.655 1.182 . . . . 0.0 108.393 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -152.65 24.74 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.55 78.88 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 164.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.71 4.17 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.651 0.78 . . . . 0.0 111.892 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -153.21 153.88 33.6 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.76 80.83 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.507 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.68 9.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.607 1.163 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.0 15.38 80.71 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.909 -0.94 . . . . 0.0 113.099 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -50.39 -48.12 56.06 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.099 1.45 . . . . 0.0 111.121 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -75.67 -15.36 60.32 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.315 -0.954 . . . . 0.0 113.294 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -72.33 -45.42 60.01 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.897 1.226 . . . . 0.0 108.97 163.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -48.68 64.12 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.964 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 m -62.12 -37.1 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 119.802 1.183 . . . . 0.0 110.791 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -73.53 -23.18 59.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.5 1.5 . . . . 0.0 112.273 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.4 mtm -62.94 -47.07 84.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.262 0.937 . . . . 0.0 109.34 165.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -66.65 -32.6 74.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.494 . . . . 0.0 110.804 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.51 72.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.585 1.154 . . . . 0.0 109.583 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.34 -42.07 99.09 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 111.235 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.01 -21.49 45.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.635 1.174 . . . . 0.0 112.255 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 16.22 12.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.995 -1.066 . . . . 0.0 111.947 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? 45.69 38.57 4.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.869 2.067 . . . . 0.0 112.31 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.5 mt -75.66 164.23 26.51 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.73 130.98 22.07 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.71 -162.07 33.63 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.39 163.63 30.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.626 0.713 . . . . 0.0 111.994 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.42 142.53 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.058 0.943 . . . . 0.0 109.732 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -149.21 151.86 35.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 125.3 1.44 . . . . 0.0 108.248 -162.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 120.07 29.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 166.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -74.21 153.24 39.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.96 -25.52 67.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.884 0.874 . . . . 0.0 112.341 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.54 -27.64 67.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.382 1.073 . . . . 0.0 112.104 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.21 -31.78 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.318 1.437 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -68.32 163.67 22.49 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.732 0.766 . . . . 0.0 110.54 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.35 156.53 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -134.05 141.53 47.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.658 1.583 . . . . 0.0 107.881 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -134.03 141.01 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.4 tt -149.91 119.41 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.2 160.23 42.78 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.488 0.715 . . . . 0.0 111.205 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 12.9 pt-20 -106.83 154.93 20.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.179 1.392 . . . . 0.0 110.313 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 175.61 37.63 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.057 1.313 . . . . 0.0 111.001 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.89 153.43 68.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.146 1.897 . . . . 0.0 110.261 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -55.33 -43.32 74.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.653 0.781 . . . . 0.0 111.533 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -62.69 -40.43 97.1 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.245 -0.284 . . . . 0.0 111.459 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.64 74.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 4' ' ' TYR . 91.9 mt -59.14 -44.87 92.08 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.45 0.7 . . . . 0.0 110.023 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -68.87 -40.51 79.25 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.88 -0.512 . . . . 0.0 111.955 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -60.67 -42.68 97.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.567 0.621 . . . . 0.0 110.063 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -59.53 -48.97 79.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.432 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.72 -42.92 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.953 1.251 . . . . 0.0 110.0 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.17 -41.89 99.3 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.871 0.76 . . . . 0.0 110.743 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.82 96.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.657 0.783 . . . . 0.0 111.366 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.1 -52.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -56.75 -41.63 77.89 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.81 0.844 . . . . 0.0 111.046 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -72.75 -20.96 61.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.018 -0.515 . . . . 0.0 112.365 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.73 40.42 48.72 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.436 1.017 . . . . 0.0 111.906 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -45.63 -53.94 17.58 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -157.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -49.65 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 CA-C-N 121.481 1.565 . . . . 0.0 112.216 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 67' ' ' SER . 17.5 p90 -167.48 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.012 0.925 . . . . 0.0 112.718 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 66' ' ' PHE 0.269 1.4 m -62.63 -57.32 11.49 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -120.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 161.63 40.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 130.277 3.431 . . . . 0.0 108.511 -5.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.54 157.18 7.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.318 0.647 . . . . 0.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.2 p -127.21 -11.88 5.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.22 1.408 . . . . 0.0 110.378 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.22 144.83 25.87 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.926 1.291 . . . . 0.0 108.471 172.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.28 144.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.0 108.217 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 m -139.46 145.29 38.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.337 1.455 . . . . 0.0 107.219 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.07 142.69 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.375 1.07 . . . . 0.0 108.281 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -132.45 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.396 1.878 . . . . 0.0 106.048 168.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -137.99 149.04 45.75 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 m -148.76 162.83 38.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.375 1.47 . . . . 0.0 109.114 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.11 -13.24 57.55 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.602 -0.686 . . . . 0.0 111.362 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 88.83 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 111.899 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.84 147.58 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.531 0.732 . . . . 0.0 110.26 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -81.95 -28.2 32.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.892 0.877 . . . . 0.0 112.026 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.98 68.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.038 0.828 . . . . 0.0 111.219 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.67 150.17 34.58 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.808 1.304 . . . . 0.0 109.378 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -134.76 9.37 3.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.958 0.903 . . . . 0.0 112.547 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -149.26 177.55 9.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.149 1.38 . . . . 0.0 109.158 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -101.79 145.02 29.74 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 163.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 161.81 37.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.628 0.728 . . . . 0.0 111.431 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.1 mt -133.88 126.86 51.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.72 165.88 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 109.656 -163.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -142.82 50.84 1.43 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.174 0.99 . . . . 0.0 108.661 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.477 1.511 . . . . 0.0 111.416 -177.08 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp -129.29 176.03 8.26 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.686 -1.259 . . . . 0.0 111.18 -165.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.55 152.8 38.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.844 1.658 . . . . 0.0 109.183 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -125.68 165.22 18.98 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.387 1.075 . . . . 0.0 111.054 169.061 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -134.28 133.41 40.73 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 158.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.41 142.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.54 133.26 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.65 141.92 29.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.71 151.77 49.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.888 1.275 . . . . 0.0 108.054 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.61 -153.75 25.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -76.72 82.45 3.34 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 158.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -107.59 -1.63 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.538 HE22 ' HB3' ' A' ' 18' ' ' ARG . 9.9 mm-40 -133.82 156.76 47.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.21 -148.7 15.01 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.43 -30.47 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.73 11.3 66.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 118.982 0.81 . . . . 0.0 112.894 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 36.71 -118.44 0.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.541 2.336 . . . . 0.0 110.316 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.7 ptt-85 -114.68 1.45 14.2 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.134 0.974 . . . . 0.0 111.443 170.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -69.08 -23.56 64.04 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 117.608 -1.186 . . . . 0.0 111.125 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.04 -52.14 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.283 1.402 . . . . 0.0 111.736 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.51 -31.83 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.716 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -66.51 -31.14 71.69 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.872 1.214 . . . . 0.0 112.288 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.7 mtm -65.76 -49.94 66.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.456 1.026 . . . . 0.0 108.637 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -67.8 -33.12 74.19 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.205 0.457 . . . . 0.0 110.875 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -53.21 57.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.482 1.113 . . . . 0.0 110.336 173.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.13 -40.05 93.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.561 0.745 . . . . 0.0 111.288 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -53.52 -28.14 29.61 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.165 1.386 . . . . 0.0 111.817 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -118.58 22.8 11.86 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.567 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 tttt 50.21 36.18 11.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.506 1.922 . . . . 0.0 113.089 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.69 163.6 27.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.23 126.18 21.02 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.1 -161.86 29.72 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.926 0.785 . . . . 0.0 113.148 -168.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -135.06 166.09 23.87 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.79 144.0 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.754 1.221 . . . . 0.0 108.818 162.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.0 161.74 40.19 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.818 0.847 . . . . 0.0 110.34 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.76 148.06 38.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 158.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -126.08 140.29 52.71 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.929 1.291 . . . . 0.0 107.785 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.11 -24.78 63.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.402 1.481 . . . . 0.0 114.318 -163.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.0 -23.03 65.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.188 0.595 . . . . 0.0 112.301 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 37.16 1.39 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.753 1.168 . . . . 0.0 111.123 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -145.81 163.88 33.65 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.358 1.063 . . . . 0.0 109.144 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.26 150.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.26 143.17 51.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.405 1.882 . . . . 0.0 107.259 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -137.6 139.32 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -150.04 126.58 10.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.11 161.96 39.42 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 119.049 0.84 . . . . 0.0 111.374 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.99 154.3 23.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.177 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.39 177.29 39.9 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.312 0.958 . . . . 0.0 111.53 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.28 157.59 53.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.771 2.314 . . . . 0.0 110.757 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -55.37 -53.29 58.09 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.526 0.731 . . . . 0.0 111.511 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -59.98 -37.49 79.81 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.967 -0.458 . . . . 0.0 111.527 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.36 76.25 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 4' ' ' TYR . 90.2 mt -62.28 -47.13 85.69 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.467 0.707 . . . . 0.0 110.534 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -68.53 -42.09 78.96 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.888 -0.508 . . . . 0.0 111.339 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 m -63.37 -37.74 88.46 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.765 -0.584 . . . . 0.0 110.204 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.6 -45.54 93.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.448 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t -55.23 -45.61 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 120.013 1.279 . . . . 0.0 109.535 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.4 -41.01 88.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.043 0.383 . . . . 0.0 111.031 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.79 95.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.14 0.976 . . . . 0.0 111.631 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.55 -50.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.179 0.9 . . . . 0.0 108.668 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -58.77 -41.63 87.07 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.703 0.401 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -71.41 -22.14 61.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.073 0.549 . . . . 0.0 112.393 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.1 39.12 40.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.944 1.259 . . . . 0.0 112.756 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -41.11 -50.05 8.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -159.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.81 -31.49 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.649 1.625 . . . . 0.0 114.704 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -164.26 -31.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.083 1.31 . . . . 0.0 113.264 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.03 170.87 13.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.799 1.64 . . . . 0.0 111.723 -170.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.13 145.03 19.15 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -83.92 153.23 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.6 p -118.25 -14.17 9.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.065 1.346 . . . . 0.0 109.376 165.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.64 137.89 21.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.328 1.451 . . . . 0.0 107.68 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tt -144.61 136.49 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 m -133.77 142.69 48.03 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.84 141.48 40.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -172.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.27 146.2 51.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 171.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.55 154.72 46.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.809 0.731 . . . . 0.0 110.102 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -147.89 176.72 9.92 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.878 1.671 . . . . 0.0 108.245 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -119.46 -7.16 10.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.719 0.808 . . . . 0.0 110.191 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m -70.22 100.54 1.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.623 1.169 . . . . 0.0 108.851 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.3 155.26 9.2 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.97 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.6 -27.74 51.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.668 0.787 . . . . 0.0 110.967 170.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.38 30.62 58.27 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -161.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.11 155.09 35.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.116 0.958 . . . . 0.0 110.202 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.39 14.57 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.345 1.058 . . . . 0.0 111.291 -173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -149.34 172.49 14.83 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.846 1.658 . . . . 0.0 108.644 -170.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -133.42 119.97 20.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 160.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -136.93 156.78 48.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -153.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.45 124.84 64.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.5 t -82.87 140.72 15.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -134.88 7.39 3.47 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.255 1.422 . . . . 0.0 111.369 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.094 1.358 . . . . 0.0 110.663 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.87 177.85 8.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.613 1.097 . . . . 0.0 110.513 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.84 153.49 32.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.411 1.884 . . . . 0.0 108.968 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.426 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.2 p90 -114.18 163.42 15.25 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.81 0.844 . . . . 0.0 109.785 166.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -131.41 138.23 49.0 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 151.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.02 145.64 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -169.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.44 139.28 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 167.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.47 151.1 29.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.47 152.82 49.95 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.63 1.572 . . . . 0.0 107.147 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.76 -155.46 26.55 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -78.51 60.28 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 162.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -85.73 18.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.287 -0.883 . . . . 0.0 111.713 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -156.25 155.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 167.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.02 -84.21 0.1 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.46 -37.85 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 117.022 0.411 . . . . 0.0 110.803 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.73 50.27 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 67' ' ' SER . 12.5 t80 -57.31 -38.69 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 117.433 0.617 . . . . 0.0 110.944 -170.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -67.43 -37.75 83.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.205 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -76.32 -32.51 58.76 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.454 1.479 . . . . 0.0 111.493 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.97 -45.93 75.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.073 1.306 . . . . 0.0 109.967 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.74 -47.96 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.099 0.959 . . . . 0.0 109.285 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -70.05 -25.7 63.68 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.306 1.412 . . . . 0.0 113.45 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.1 mtm -65.5 -48.05 73.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.2 1.364 . . . . 0.0 109.097 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -66.67 -35.06 79.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.307 0.643 . . . . 0.0 110.048 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.31 47.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.555 1.142 . . . . 0.0 109.791 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.08 -39.6 92.98 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.284 0.634 . . . . 0.0 111.406 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -16.09 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 0.0 112.576 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.53 17.57 16.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.304 1.442 . . . . 0.0 110.915 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 49.39 30.36 3.26 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.12 1.768 . . . . 0.0 112.911 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 mt -77.31 160.09 29.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.24 134.86 18.63 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.959 0.504 . . . . 0.0 110.584 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.57 -161.06 31.09 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.086 1.326 . . . . 0.0 110.545 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -106.09 162.29 13.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.226 1.513 . . . . 0.0 113.298 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.14 146.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.697 1.199 . . . . 0.0 108.001 163.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -154.13 155.37 35.24 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 108.958 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -99.72 123.74 44.28 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 161.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -80.3 147.3 31.2 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.04 -27.8 65.83 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.491 0.716 . . . . 0.0 112.25 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.61 -27.44 68.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.338 1.055 . . . . 0.0 112.81 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.06 -21.74 5.48 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.9 1.238 . . . . 0.0 112.322 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.38 157.0 11.77 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.056 0.928 . . . . 0.0 110.753 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -96.6 146.68 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 149.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.54 144.57 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.907 1.683 . . . . 0.0 106.812 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.54 142.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -148.32 123.02 9.88 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.84 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.293 0.951 . . . . 0.0 111.255 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.87 155.43 16.78 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.228 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 177.18 41.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.412 1.482 . . . . 0.0 111.077 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.88 159.78 49.56 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.725 2.283 . . . . 0.0 110.321 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 -48.14 78.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.232 0.613 . . . . 0.0 111.602 -168.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.79 -37.45 86.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.666 0.386 . . . . 0.0 111.852 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -46.3 87.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 4' ' ' TYR . 81.4 mt -59.53 -45.11 92.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.108 0.563 . . . . 0.0 109.556 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.49 -44.83 85.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.769 0.713 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.7 m -60.98 -42.31 98.12 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.849 0.46 . . . . 0.0 109.99 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.54 -48.08 83.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.062 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.0 t -56.96 -41.27 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.913 1.233 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.75 -41.93 99.44 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.692 0.678 . . . . 0.0 110.851 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.0 86.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.676 0.79 . . . . 0.0 111.756 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.01 -55.48 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.25 -38.47 83.56 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.709 0.804 . . . . 0.0 111.263 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.55 -24.75 67.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.47 0.708 . . . . 0.0 112.154 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.2 97.83 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 m -49.72 -45.87 79.52 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.83 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.728 1.653 . . . . 0.0 112.299 -166.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.2 t80 179.51 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.31 2.244 . . . . 0.0 106.094 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 14.9 m -58.85 141.23 53.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 170.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 157.1 40.03 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.971 0.909 . . . . 0.0 110.325 -171.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.96 157.08 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -119.77 -13.91 9.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.004 1.321 . . . . 0.0 109.708 158.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 141.22 25.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.87 1.268 . . . . 0.0 108.547 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.63 135.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.4 m -132.36 140.77 48.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.249 1.419 . . . . 0.0 107.206 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.7 t -140.19 145.53 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -168.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.0 m -127.79 140.72 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 161.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.92 134.34 23.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m -139.1 155.71 47.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.054 0.941 . . . . 0.0 109.983 -162.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -4.85 57.22 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.55 0.74 . . . . 0.0 110.877 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 m -58.57 165.6 2.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.617 1.167 . . . . 0.0 110.361 161.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.3 162.92 40.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.239 1.816 . . . . 0.0 108.173 167.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -79.42 -29.67 42.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.317 0.647 . . . . 0.0 111.823 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.92 54.06 6.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -162.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -51.11 153.63 1.85 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.595 1.158 . . . . 0.0 113.319 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -135.95 -3.88 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.866 1.266 . . . . 0.0 111.715 166.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -156.96 172.06 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.52 1.528 . . . . 0.0 109.158 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.92 140.65 38.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 162.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -148.68 153.92 38.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.813 0.816 . . . . 0.0 112.834 -150.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.46 115.63 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.41 132.6 32.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 164.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -100.72 31.38 3.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.903 0.881 . . . . 0.0 111.278 -170.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.986 0.914 . . . . 0.0 110.835 175.159 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.3 177.03 11.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.499 -0.751 . . . . 0.0 112.773 -161.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -148.48 154.36 39.73 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.609 2.364 . . . . 0.0 108.216 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.07 165.86 17.43 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.551 0.74 . . . . 0.0 110.437 161.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -133.61 141.59 47.72 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 157.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mt -137.45 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.42 140.26 48.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 143.66 21.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.488 0.715 . . . . 0.0 109.702 -166.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -144.11 153.47 42.19 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.972 1.309 . . . . 0.0 108.347 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.74 -157.65 27.43 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 107.524 -2.231 . . . . 0.0 107.524 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -78.22 75.86 4.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 158.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.06 25.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -131.21 -73.07 0.54 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 164.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 -132.06 39.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.68 -33.26 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.023 0.529 . . . . 0.0 110.801 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.79 46.2 0.03 OUTLIER Glycine 0 C--N 1.342 0.875 0 CA-C-N 119.436 1.016 . . . . 0.0 113.957 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -53.8 -40.64 66.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.982 1.391 . . . . 0.0 111.929 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -58.28 -46.69 85.6 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.739 0.416 . . . . 0.0 110.791 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -64.47 -45.31 87.91 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -55.69 -50.03 71.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.623 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.24 -36.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.592 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -74.97 -19.4 60.12 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.642 -1.286 . . . . 0.0 113.069 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -65.22 -48.93 71.65 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.965 1.257 . . . . 0.0 108.708 164.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -65.7 -22.85 66.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 111.383 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.16 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.028 0.931 . . . . 0.0 109.261 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.64 -37.76 71.2 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.502 1.121 . . . . 0.0 111.468 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -49.53 -38.41 30.63 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.882 1.673 . . . . 0.0 112.406 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -112.71 16.78 19.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.24 1.416 . . . . 0.0 111.468 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.77 5.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.636 1.574 . . . . 0.0 112.079 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.5 155.71 40.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.4 133.97 30.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.89 -171.33 42.85 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.937 -166.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -117.06 161.46 19.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.977 0.889 . . . . 0.0 111.541 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.72 142.71 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 158.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -144.37 157.7 44.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.486 1.515 . . . . 0.0 108.357 -164.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -118.06 121.23 40.05 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -75.58 154.28 36.84 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.12 -28.14 67.62 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 0.0 110.759 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.8 -16.1 37.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.787 2.035 . . . . 0.0 113.38 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -37.63 3.72 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.116 1.341 . . . . 0.0 111.525 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.61 150.85 11.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.149 0.979 . . . . 0.0 110.321 171.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.36 157.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 162.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.99 147.48 40.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -138.4 139.69 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -150.29 124.04 9.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.82 162.2 40.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 119.248 0.931 . . . . 0.0 110.896 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.94 156.87 24.23 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.611 1.564 . . . . 0.0 109.714 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.36 40.51 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.828 0.728 . . . . 0.0 111.596 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.22 151.82 49.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.024 1.816 . . . . 0.0 110.477 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.53 -48.57 78.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.387 1.075 . . . . 0.0 111.29 -170.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -64.53 -40.31 95.38 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.262 -0.273 . . . . 0.0 111.339 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 -48.56 75.76 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.78 -43.78 98.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.173 0.589 . . . . 0.0 110.458 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.86 -35.45 76.92 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.482 -0.761 . . . . 0.0 111.299 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 m -62.85 -41.18 99.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.644 -0.66 . . . . 0.0 110.703 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -58.8 -46.91 86.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.243 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.28 -41.92 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.866 1.212 . . . . 0.0 109.521 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.37 -41.18 98.42 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.19 88.86 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.688 0.795 . . . . 0.0 111.748 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.12 -53.24 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.6 -37.93 76.88 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.355 1.062 . . . . 0.0 111.808 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.27 -24.12 67.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.18 0.592 . . . . 0.0 112.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.58 40.13 98.31 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 m -52.82 -44.73 96.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.7 -164.44 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.472 2.115 . . . . 0.0 112.302 -166.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -1.47 0.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.504 2.722 . . . . 0.0 115.616 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.9 m -141.85 148.09 38.24 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.889 2.076 . . . . 0.0 106.304 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.4 154.49 35.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.983 0.811 . . . . 0.0 111.434 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.62 155.62 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.259 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -121.4 -11.75 8.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.187 1.395 . . . . 0.0 109.595 162.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.13 143.04 25.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.283 1.433 . . . . 0.0 108.383 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -148.71 140.42 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -138.33 134.89 34.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.11 144.87 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.702 0.801 . . . . 0.0 109.824 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.1 m -134.43 149.94 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.422 1.889 . . . . 0.0 106.093 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.15 154.45 51.2 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.9 m -155.93 146.5 21.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -71.4 -29.21 64.66 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.538 -0.727 . . . . 0.0 110.95 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.77 121.45 12.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.731 1.212 . . . . 0.0 111.653 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.09 164.17 13.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.47 0.708 . . . . 0.0 109.342 163.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.14 -13.78 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.6 -11.66 7.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.551 158.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.54 145.96 31.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.243 2.021 . . . . 0.0 111.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -132.37 7.65 4.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.891 1.276 . . . . 0.0 111.118 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.11 164.1 35.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.808 1.643 . . . . 0.0 108.564 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -84.15 144.29 29.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 164.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -143.2 157.78 44.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.674 0.79 . . . . 0.0 110.545 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.7 mt -135.5 135.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 142.29 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -152.51 10.22 0.49 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.914 0.886 . . . . 0.0 111.805 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.249 1.075 0 C-N-CA 125.462 1.505 . . . . 0.0 110.933 -178.29 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.43 176.84 6.23 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.092 -1.005 . . . . 0.0 111.115 -163.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -140.92 152.92 45.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.52 1.928 . . . . 0.0 108.498 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.58 162.13 16.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 162.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -137.98 125.77 22.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 165.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.27 139.93 45.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 134.84 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -138.59 154.02 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 110.518 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.45 146.17 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.731 1.613 . . . . 0.0 107.51 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.77 -156.22 26.74 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -78.72 98.3 6.19 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 161.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.99 12.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.85 1.26 . . . . 0.0 110.244 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -145.85 157.06 43.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.012 1.325 . . . . 0.0 109.206 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.65 -116.76 4.25 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 127.898 2.666 . . . . 0.0 110.022 -0.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.12 141.39 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.218 1.007 . . . . 0.0 108.914 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.94 -56.72 4.57 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -67.18 -17.38 64.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.517 1.127 . . . . 0.0 113.863 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -113.86 1.15 14.68 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.875 1.216 . . . . 0.0 114.214 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.74 -33.41 64.31 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.728 1.149 . . . . 0.0 109.711 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -56.74 -39.23 73.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.087 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 m -61.52 -37.14 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.456 1.026 . . . . 0.0 110.447 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -74.63 -28.24 60.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.361 0.982 . . . . 0.0 110.817 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 54.6 mtm -62.17 -49.85 74.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.515 0.598 . . . . 0.0 110.591 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -65.96 -34.22 77.6 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.636 0.775 . . . . 0.0 110.356 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.94 70.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.386 1.475 . . . . 0.0 109.923 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.38 -41.05 96.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.901 0.481 . . . . 0.0 111.178 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -14.97 42.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.138 1.375 . . . . 0.0 112.654 174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -116.57 20.76 13.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.419 1.488 . . . . 0.0 110.874 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.3 pttt 43.59 31.36 0.43 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.143 2.177 . . . . 0.0 114.172 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.91 162.09 29.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.91 0.884 . . . . 0.0 109.017 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.08 138.76 37.38 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.58 -170.94 41.36 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.545 0.611 . . . . 0.0 112.29 -164.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -129.44 160.56 32.76 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.043 0.937 . . . . 0.0 111.525 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.29 140.85 46.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 163.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -145.65 144.22 30.3 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.74 0.816 . . . . 0.0 109.0 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.13 146.45 39.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.97 132.62 55.9 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.94 -25.08 64.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.129 0.972 . . . . 0.0 112.697 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.72 -26.67 67.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.335 1.054 . . . . 0.0 112.284 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.38 -19.57 4.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.823 1.678 . . . . 0.0 112.307 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 172.44 10.8 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.318 1.047 . . . . 0.0 110.532 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.75 147.26 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -115.36 143.84 44.67 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.6 1.96 . . . . 0.0 106.83 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.98 134.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -148.37 124.43 10.73 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.85 162.04 41.79 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.24 0.473 . . . . 0.0 110.568 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.89 151.55 29.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.69 1.596 . . . . 0.0 109.551 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.04 40.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.55 1.071 . . . . 0.0 110.949 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.3 158.32 56.6 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.383 2.055 . . . . 0.0 110.384 171.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.12 -46.48 79.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.435 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -64.2 -37.77 88.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.554 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.86 72.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.305 0.642 . . . . 0.0 109.786 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.83 -46.99 88.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.587 0.755 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.74 -38.2 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.736 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -60.55 -42.62 96.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.734 0.697 . . . . 0.0 110.136 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -59.47 -47.27 86.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.637 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.31 -44.97 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 119.885 1.221 . . . . 0.0 110.071 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.82 -39.9 95.73 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.541 0.609 . . . . 0.0 110.902 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.95 98.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.352 0.661 . . . . 0.0 111.334 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -66.02 -50.35 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -58.29 -38.57 77.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.146 0.578 . . . . 0.0 111.104 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.19 -23.74 63.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.0 112.629 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.8 44.62 94.16 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 118.943 0.792 . . . . 0.0 111.561 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -55.97 -50.93 84.48 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -166.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.39 -49.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.786 1.674 . . . . 0.0 113.491 -163.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.55 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 110.27 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -61.92 151.86 33.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.581 0.752 . . . . 0.0 109.633 169.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.25 146.31 23.64 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 154.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.4 p -122.73 -11.88 8.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.668 1.587 . . . . 0.0 109.485 166.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.63 145.44 25.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.384 1.473 . . . . 0.0 107.848 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.5 tt -149.04 141.87 18.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.713 1.205 . . . . 0.0 107.804 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -135.98 140.77 44.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.409 1.484 . . . . 0.0 107.072 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.7 138.52 47.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.4 m -130.11 155.94 45.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -130.39 152.35 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -147.92 178.48 8.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.334 1.453 . . . . 0.0 107.962 -167.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -130.81 15.5 5.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.474 1.11 . . . . 0.0 109.366 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -69.62 -28.56 66.03 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.386 1.475 . . . . 0.0 112.827 -170.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp 57.75 173.71 0.05 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.988 1.715 . . . . 0.0 111.492 -166.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.95 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.126 0.971 . . . . 0.0 112.948 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 -10.56 60.76 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.461 -1.188 . . . . 0.0 115.689 154.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 173.34 12.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.773 1.787 . . . . 0.0 110.085 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -127.91 19.72 6.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.087 1.355 . . . . 0.0 110.145 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 168.09 24.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.128 1.771 . . . . 0.0 108.732 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -88.03 158.3 18.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.79 0.436 . . . . 0.0 110.102 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -141.62 158.82 43.34 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.231 1.013 . . . . 0.0 110.16 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.14 125.14 43.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.53 154.99 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -161.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.79 -31.49 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.369 -0.832 . . . . 0.0 112.157 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.313 1.445 . . . . 0.0 111.117 177.558 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.17 178.44 8.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.187 2.195 . . . . 0.0 109.364 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -134.73 147.42 50.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.94 2.096 . . . . 0.0 107.937 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.548 0.739 . . . . 0.0 110.045 165.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -134.45 130.95 37.54 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.84 142.7 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 134.7 59.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 170.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.98 147.98 18.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 124.423 1.089 . . . . 0.0 110.257 -170.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -138.07 155.58 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.68 -158.32 27.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -168.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -78.05 90.11 4.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 158.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.73 10.43 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.792 1.237 . . . . 0.0 110.332 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -145.74 142.91 29.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.776 0.716 . . . . 0.0 111.468 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.77 170.73 12.75 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.575 2.036 . . . . 0.0 109.007 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.4 127.39 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 -46.12 2.44 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.171 0.891 . . . . 0.0 111.651 -172.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -65.71 -23.26 66.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 116.682 -1.628 . . . . 0.0 114.069 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -91.73 -23.35 19.8 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 121.296 1.862 . . . . 0.0 112.445 161.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -67.95 -25.43 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.052 0.941 . . . . 0.0 111.621 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -48.67 -43.9 37.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.88 -38.1 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.067 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -73.83 -23.46 59.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.869 1.213 . . . . 0.0 111.465 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.68 -53.57 54.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.295 0.952 . . . . 0.0 110.074 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.66 -37.2 80.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.782 0.433 . . . . 0.0 110.341 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.57 55.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.562 1.145 . . . . 0.0 109.952 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.52 -47.24 86.28 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.585 0.754 . . . . 0.0 110.386 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -58.21 -30.66 66.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.19 1.396 . . . . 0.0 111.731 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.97 10.69 39.47 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.959 1.304 . . . . 0.0 111.379 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? 50.47 32.39 6.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.955 1.702 . . . . 0.0 112.101 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.64 165.95 23.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.117 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.4 20.99 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.13 173.94 36.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.549 0.613 . . . . 0.0 112.677 -169.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -101.09 160.99 13.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.36 1.08 . . . . 0.0 111.858 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.57 144.07 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.887 1.275 . . . . 0.0 107.74 158.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -149.23 159.56 44.15 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 107.703 -171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -112.34 120.74 42.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.987 0.812 . . . . 0.0 109.281 170.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -76.09 146.56 39.26 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.81 -28.53 67.53 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.681 0.792 . . . . 0.0 112.357 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.12 -27.61 69.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.479 0.712 . . . . 0.0 112.479 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.18 -37.13 1.88 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.526 1.06 . . . . 0.0 112.315 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 149.64 49.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.006 0.903 . . . . 0.0 111.314 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.61 150.07 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 167.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -124.13 144.84 49.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.012 1.725 . . . . 0.0 106.502 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -135.95 140.76 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.32 118.8 7.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.15 164.1 34.95 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.402 0.681 . . . . 0.0 111.01 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.47 156.72 29.69 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.526 1.531 . . . . 0.0 109.296 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.81 44.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.53 0.586 . . . . 0.0 111.954 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.76 151.44 63.36 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.206 1.938 . . . . 0.0 110.448 171.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.82 -50.06 64.42 Favored 'General case' 0 C--N 1.334 -0.071 0 C-N-CA 124.22 1.008 . . . . 0.0 111.529 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.37 -36.63 82.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.692 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.88 75.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.61 -46.63 81.81 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.127 0.571 . . . . 0.0 110.522 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -66.96 -42.88 84.44 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 121.759 -0.588 . . . . 0.0 111.138 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 m -68.07 -33.43 74.54 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.678 -0.639 . . . . 0.0 110.927 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -58.95 -50.5 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.557 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.64 -43.83 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.556 1.071 . . . . 0.0 109.424 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.14 -40.32 93.37 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.319 0.509 . . . . 0.0 111.215 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.41 97.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.355 0.662 . . . . 0.0 111.217 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -64.39 -51.54 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.35 -41.38 84.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.666 0.786 . . . . 0.0 111.169 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.22 -24.56 64.03 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 112.0 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.15 48.15 82.05 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m -54.79 -47.0 99.32 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 117.364 -1.303 . . . . 0.0 114.145 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.13 -163.55 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.768 2.312 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -59.42 -31.49 69.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 113.132 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -82.61 145.06 29.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.157 0.889 . . . . 0.0 109.662 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.58 148.56 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.102 0.561 . . . . 0.0 110.033 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.16 156.79 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.206 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -125.91 -8.59 6.63 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.041 1.736 . . . . 0.0 109.915 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.64 141.09 23.32 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.595 1.958 . . . . 0.0 107.49 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.6 tt -152.87 142.44 14.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.427 1.091 . . . . 0.0 108.917 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -142.58 144.5 32.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.092 1.757 . . . . 0.0 107.482 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.79 140.65 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 108.314 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -136.49 157.49 46.66 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.402 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -143.76 159.39 42.59 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.112 -0.992 . . . . 0.0 110.311 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.0 m -144.02 151.97 40.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.117 1.367 . . . . 0.0 108.767 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -87.63 35.27 0.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.308 1.043 . . . . 0.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -139.71 106.64 5.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.327 1.051 . . . . 0.0 108.824 -159.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.01 160.83 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 110.086 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.78 -14.48 0.73 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.943 0.897 . . . . 0.0 113.318 -170.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.06 -2.63 14.49 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.236 155.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -61.11 146.27 48.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 121.001 2.401 . . . . 0.0 110.257 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -129.55 9.47 5.52 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.194 1.398 . . . . 0.0 111.028 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.31 166.5 28.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.565 1.946 . . . . 0.0 107.97 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -80.06 148.23 31.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -141.25 156.74 45.85 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 109.771 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 mt -135.93 113.67 14.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -76.05 148.1 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.03 -33.62 76.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.033 0.533 . . . . 0.0 111.794 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.782 1.233 . . . . 0.0 108.377 171.878 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tp -142.88 178.63 7.53 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.992 -1.067 . . . . 0.0 110.129 -166.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -152.31 155.05 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.234 1.814 . . . . 0.0 108.097 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.99 163.02 16.86 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.447 0.699 . . . . 0.0 109.813 166.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -134.93 135.45 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 163.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.39 143.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 138.67 52.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 162.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.94 154.99 26.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 124.124 0.97 . . . . 0.0 110.454 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -146.12 154.65 42.04 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.593 1.557 . . . . 0.0 107.885 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 -155.33 26.09 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.806 -2.118 . . . . 0.0 107.806 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -76.16 83.76 2.99 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.04 5.55 4.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 111.129 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.96 168.28 21.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.46 70.22 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.84 0.733 . . . . 0.0 113.568 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.56 10.58 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.912 1.285 . . . . 0.0 111.583 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.28 16.11 67.6 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.306 -0.871 . . . . 0.0 113.53 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -52.99 -41.13 64.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.17 1.485 . . . . 0.0 111.681 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.264 21.7 ptt-85 -67.23 -23.34 65.71 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.3 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -76.51 -44.07 36.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.116 1.326 . . . . 0.0 110.084 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.84 -48.65 63.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.461 0.704 . . . . 0.0 111.156 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.25 -35.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.287 0.949 . . . . 0.0 110.994 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.86 -24.24 58.55 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.623 1.101 . . . . 0.0 111.892 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.8 mtm -63.5 -48.86 75.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.292 0.951 . . . . 0.0 109.868 166.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.76 -23.49 63.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.913 0.885 . . . . 0.0 111.595 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.79 41.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.81 -39.0 90.21 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.223 0.609 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -14.69 61.16 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 112.257 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.16 20.07 14.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.802 1.641 . . . . 0.0 111.082 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 43.29 31.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.113 2.165 . . . . 0.0 114.252 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.83 161.61 30.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.842 0.857 . . . . 0.0 108.74 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.15 28.93 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 108.271 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.02 -154.69 25.77 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.393 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.06 164.32 26.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.404 1.102 . . . . 0.0 112.815 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.03 141.09 47.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 165.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -132.78 140.59 48.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.89 148.19 52.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 158.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -125.9 145.4 50.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.87 0.868 . . . . 0.0 109.23 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 39' ' ' ASP . 21.7 t70 -57.81 125.88 24.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 164.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 26.5 t0 -121.57 31.79 6.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.627 3.171 . . . . 0.0 109.834 5.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.98 -16.31 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 O-C-N 121.267 -0.895 . . . . 0.0 113.866 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -59.05 161.47 5.1 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.279 1.039 . . . . 0.0 109.795 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.22 147.53 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.34 143.02 46.39 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.211 1.405 . . . . 0.0 107.213 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.49 134.47 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.66 132.18 28.67 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.38 157.71 32.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.328 0.967 . . . . 0.0 110.843 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.68 151.32 25.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.688 1.195 . . . . 0.0 109.446 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.18 178.43 40.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.745 1.164 . . . . 0.0 110.793 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 154.9 69.53 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.179 1.92 . . . . 0.0 110.319 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.44 -42.97 79.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.807 0.843 . . . . 0.0 111.695 -172.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.37 -41.1 96.89 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.069 -0.394 . . . . 0.0 111.513 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.41 79.95 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.874 0.47 . . . . 0.0 109.88 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.48 -49.66 76.93 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.921 0.888 . . . . 0.0 110.132 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.81 -35.89 79.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.979 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -61.35 -42.7 99.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.01 0.823 . . . . 0.0 110.175 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -60.94 -46.46 90.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.788 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.72 -41.96 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.632 1.105 . . . . 0.0 109.664 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.75 -41.08 99.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.596 0.634 . . . . 0.0 110.819 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -37.77 80.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.248 0.619 . . . . 0.0 111.703 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.94 -57.4 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -60.87 -35.51 76.8 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.941 0.896 . . . . 0.0 111.738 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -63.53 -26.05 68.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.373 0.669 . . . . 0.0 112.297 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.13 47.82 88.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -173.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.6 -47.9 96.65 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.989 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.01 -172.2 1.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.56 2.173 . . . . 0.0 111.511 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -60.24 -31.36 70.12 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.246 -0.909 . . . . 0.0 111.578 167.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -68.65 142.69 55.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.586 1.154 . . . . 0.0 109.182 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.27 152.17 25.75 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.471 -0.768 . . . . 0.0 110.345 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.88 153.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -121.65 -9.52 8.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.175 1.39 . . . . 0.0 109.697 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -146.98 135.08 21.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.175 1.79 . . . . 0.0 107.123 171.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.21 133.62 7.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -136.55 127.37 27.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.1 145.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.067 1.347 . . . . 0.0 109.493 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 m -136.48 156.92 47.92 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.323 1.849 . . . . 0.0 106.053 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -126.14 150.12 48.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 m -145.63 164.45 31.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.102 0.961 . . . . 0.0 109.582 -163.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -119.36 4.54 11.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.252 1.021 . . . . 0.0 110.467 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -64.52 -30.74 71.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.454 1.102 . . . . 0.0 112.11 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.4 mt 58.68 179.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 111.307 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -153.61 -4.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.995 0.918 . . . . 0.0 113.385 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.26 6.48 53.91 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.746 1.165 . . . . 0.0 114.009 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.78 146.33 52.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.396 1.098 . . . . 0.0 109.469 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -130.27 17.85 5.45 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.633 1.573 . . . . 0.0 109.892 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -149.51 173.4 13.64 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.818 2.047 . . . . 0.0 108.131 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -98.35 150.1 21.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 162.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -139.4 156.14 47.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 110.045 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.1 mt -137.94 134.77 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 t -136.71 137.25 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.164 0.986 . . . . 0.0 108.484 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -151.02 12.06 0.66 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.23 1.012 . . . . 0.0 111.687 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.498 1.519 . . . . 0.0 110.911 -179.504 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mt -142.88 175.68 9.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 109.726 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -151.88 157.42 41.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.291 1.837 . . . . 0.0 108.379 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.71 162.51 24.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 165.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -135.67 138.59 42.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 156.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.88 143.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -169.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.86 137.79 55.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.79 146.63 20.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.897 0.879 . . . . 0.0 110.356 -168.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.38 152.3 44.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.808 1.643 . . . . 0.0 108.084 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.11 -153.38 25.04 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.39 73.86 3.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 158.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.45 6.19 9.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.359 1.064 . . . . 0.0 110.898 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -150.11 164.08 36.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.08 1.309 . . . . 0.0 108.411 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 -8.32 76.74 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.084 0.85 . . . . 0.0 113.353 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.99 11.42 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.507 1.123 . . . . 0.0 111.9 -171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.94 8.04 58.27 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.989 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -54.58 -39.78 68.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.398 1.599 . . . . 0.0 111.843 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -60.45 -37.62 81.54 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.203 0.456 . . . . 0.0 110.516 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -72.81 -47.68 44.41 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.481 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.27 -43.71 67.65 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.867 0.758 . . . . 0.0 111.419 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -53.16 -48.88 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.652 0.781 . . . . 0.0 109.246 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -78.34 -20.68 50.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 120.817 -1.177 . . . . 0.0 113.443 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -42.96 85.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.382 0.992 . . . . 0.0 109.243 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.29 -35.36 71.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.953 0.797 . . . . 0.0 110.159 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.24 86.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.993 0.517 . . . . 0.0 110.462 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.48 -41.55 98.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.789 0.836 . . . . 0.0 110.938 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.45 -29.98 68.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.495 0.718 . . . . 0.0 111.516 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -98.49 6.62 47.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.286 1.034 . . . . 0.0 112.581 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 42.82 40.88 2.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.697 1.999 . . . . 0.0 113.235 -172.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.03 164.39 26.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.325 1.05 . . . . 0.0 109.158 166.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 142.48 32.45 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.093 0.957 . . . . 0.0 108.508 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.03 -154.93 26.01 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.194 -168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.57 162.5 31.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.447 1.123 . . . . 0.0 112.627 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.52 144.43 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.905 1.282 . . . . 0.0 107.971 163.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -149.89 165.91 31.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.005 1.322 . . . . 0.0 109.356 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.9 121.77 45.96 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 167.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -73.73 153.97 39.81 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.138 0.975 . . . . 0.0 108.844 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.52 -31.31 70.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 111.379 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -70.74 -11.53 61.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.87 -27.84 8.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.152 1.358 . . . . 0.0 113.125 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.55 149.77 49.97 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.443 1.622 . . . . 0.0 109.495 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.18 149.69 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 158.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 143.43 50.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -133.65 143.03 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -141.46 135.87 30.71 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.33 34.93 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.629 1.104 . . . . 0.0 111.337 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.03 151.81 30.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.038 1.335 . . . . 0.0 109.418 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.52 42.48 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.162 0.886 . . . . 0.0 111.474 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.61 159.96 51.05 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.54 2.16 . . . . 0.0 110.793 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.65 -53.74 50.85 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.78 0.832 . . . . 0.0 111.064 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.06 -35.73 81.21 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 122.281 -0.262 . . . . 0.0 111.278 -173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -49.34 71.51 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.78 0.432 . . . . 0.0 110.604 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.61 -49.08 78.03 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.12 0.568 . . . . 0.0 110.237 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.22 -41.03 90.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.608 0.363 . . . . 0.0 111.148 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -62.89 -40.35 97.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.659 0.663 . . . . 0.0 110.566 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.42 -47.52 85.75 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.599 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.54 -41.91 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.684 1.129 . . . . 0.0 109.705 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.86 -40.68 98.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.712 0.687 . . . . 0.0 110.807 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.72 92.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.797 0.839 . . . . 0.0 111.536 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -66.46 -55.68 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.43 -35.32 75.53 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.963 0.905 . . . . 0.0 111.976 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -63.06 -25.2 68.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.415 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.08 44.16 98.52 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -53.58 -44.17 97.25 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.14 -170.54 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.42 2.08 . . . . 0.0 111.245 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -60.29 -42.98 96.62 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.97 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.18 150.85 33.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.235 1.414 . . . . 0.0 110.637 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.25 33.59 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.704 -0.623 . . . . 0.0 109.878 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.06 154.66 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.3 p -120.4 -12.43 8.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.359 1.464 . . . . 0.0 109.56 162.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -147.35 141.12 25.7 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.224 1.41 . . . . 0.0 107.992 168.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.67 136.48 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -134.99 140.78 45.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.42 141.2 40.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -129.76 148.06 51.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -134.4 145.28 48.77 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 m -151.89 168.3 25.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.229 -150.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -125.54 1.37 7.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.428 1.091 . . . . 0.0 111.79 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -64.35 -32.06 73.52 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.795 0.838 . . . . 0.0 111.661 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.31 -177.26 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.115 1.766 . . . . 0.0 110.782 -171.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.45 -13.41 0.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.86 17.24 79.27 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.091 0.853 . . . . 0.0 113.037 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -63.66 152.53 38.76 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.283 1.041 . . . . 0.0 110.444 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.27 4.69 6.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 110.903 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 157.51 43.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.902 1.281 . . . . 0.0 109.237 172.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -71.2 143.22 50.54 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 155.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -139.33 150.98 46.02 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.586 0.754 . . . . 0.0 109.65 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.9 mt -128.57 109.88 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.0 142.09 16.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -82.98 36.95 0.52 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.604 1.162 . . . . 0.0 111.445 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.072 1.349 . . . . 0.0 110.425 176.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.174 0.035 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.93 -177.1 6.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.376 1.47 . . . . 0.0 110.045 -161.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -146.04 153.7 41.03 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.328 1.851 . . . . 0.0 109.251 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.21 166.74 11.16 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.069 0.947 . . . . 0.0 110.52 164.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -131.92 138.4 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 152.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.0 mt -136.27 146.88 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.89 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 164.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.62 151.8 24.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.53 1.132 . . . . 0.0 109.058 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.71 150.25 39.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.13 -153.87 25.59 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -79.76 63.25 4.26 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.8 m -89.11 8.77 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.806 1.242 . . . . 0.0 111.711 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.86 161.28 42.16 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.02 -156.78 27.85 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 m -60.51 -25.07 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.986 1.393 . . . . 0.0 113.452 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.16 -4.48 78.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.525 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 t80 17.65 59.64 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 1 C-N-CA 131.713 4.005 . . . . 0.0 115.293 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 7.3 ptt180 47.26 2.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.493 2.317 . . . . 0.0 116.766 -174.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.98 -38.17 78.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 120.003 1.274 . . . . 0.0 108.528 160.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -55.91 -41.05 73.96 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.342 0.519 . . . . 0.0 111.527 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.19 -45.83 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -78.88 -16.28 57.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.627 -0.702 . . . . 0.0 112.894 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.17 -47.77 75.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.636 1.107 . . . . 0.0 108.87 164.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -70.49 -23.12 62.61 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.929 -0.482 . . . . 0.0 111.362 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.66 52.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.288 -0.882 . . . . 0.0 109.662 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.16 -39.66 90.95 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.773 0.829 . . . . 0.0 111.544 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -14.35 60.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.721 -0.612 . . . . 0.0 112.013 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -116.79 11.23 14.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.701 1.601 . . . . 0.0 111.55 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 41.08 40.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.963 2.105 . . . . 0.0 113.034 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.63 163.25 28.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.68 131.72 24.64 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.062 0.945 . . . . 0.0 108.715 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.31 -162.95 34.71 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.223 0.465 . . . . 0.0 112.201 -162.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -135.42 167.7 20.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.777 0.789 . . . . 0.0 112.734 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.0 142.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.045 1.338 . . . . 0.0 109.102 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -145.77 157.36 43.94 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.947 1.699 . . . . 0.0 108.095 -163.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -119.32 123.19 43.61 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -78.6 156.66 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.977 1.311 . . . . 0.0 109.727 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.49 -30.65 70.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.239 0.615 . . . . 0.0 111.677 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -4.85 39.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.864 0.866 . . . . 0.0 113.022 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.98 -23.71 28.5 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.102 1.335 . . . . 0.0 113.247 169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -61.69 145.28 52.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.961 1.38 . . . . 0.0 109.804 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.52 143.54 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 160.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -131.21 145.75 52.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.41 142.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -170.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 tt -150.0 125.61 10.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 153.45 27.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.016 0.826 . . . . 0.0 111.454 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -93.53 154.5 17.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.46 1.104 . . . . 0.0 109.696 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.01 42.28 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 110.762 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.28 154.75 61.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.921 1.747 . . . . 0.0 109.918 165.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.72 -43.4 80.58 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.57 0.748 . . . . 0.0 111.437 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.33 -41.04 98.23 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.151 -0.343 . . . . 0.0 111.472 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.81 82.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.737 0.415 . . . . 0.0 110.064 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 72.0 mt -62.12 -44.09 97.41 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.743 0.817 . . . . 0.0 110.371 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -70.48 -41.12 73.15 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.79 -0.569 . . . . 0.0 111.775 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 m -60.22 -40.05 88.79 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.756 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -61.85 -46.45 89.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.858 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.46 -46.56 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.005 1.275 . . . . 0.0 109.426 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.39 -39.62 91.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.168 0.44 . . . . 0.0 111.191 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.191 0.597 . . . . 0.0 112.133 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.05 -49.8 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.91 -44.04 91.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.185 0.594 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -71.52 -19.95 62.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.674 0.79 . . . . 0.0 112.011 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.71 43.34 94.52 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -172.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 m -51.15 -53.33 49.86 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.09 -39.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.654 1.57 . . . . 0.0 112.496 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -165.83 168.77 15.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.086 1.754 . . . . 0.0 108.188 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m 62.55 175.96 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.963 1.705 . . . . 0.0 113.044 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 160.49 40.28 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.92 0.888 . . . . 0.0 109.406 166.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.51 156.95 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.2 p -119.62 -13.56 9.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.939 1.296 . . . . 0.0 109.648 163.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.8 144.99 26.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.081 1.353 . . . . 0.0 108.749 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.82 142.17 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.289 1.436 . . . . 0.0 107.378 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -140.23 147.8 40.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.21 145.9 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.67 155.7 46.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.147 2.179 . . . . 0.0 105.48 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -138.6 158.63 43.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.0 m -155.51 152.88 29.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.145 1.378 . . . . 0.0 107.901 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -73.33 -30.95 63.7 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.718 -0.614 . . . . 0.0 111.352 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 m -60.07 128.57 37.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.102 0.961 . . . . 0.0 110.903 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.18 169.86 12.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.207 1.003 . . . . 0.0 109.242 163.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -104.76 -18.71 14.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.029 0.932 . . . . 0.0 111.074 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 47.85 7.45 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -171.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -126.83 149.86 49.49 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.608 1.163 . . . . 0.0 108.915 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.86 9.2 3.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.945 0.898 . . . . 0.0 112.092 -172.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 174.28 12.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.514 1.526 . . . . 0.0 109.013 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -116.47 148.97 40.24 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.369 1.067 . . . . 0.0 109.458 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.93 159.96 41.65 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.468 0.652 . . . . 0.0 111.963 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.02 114.51 35.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t -68.51 147.84 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -62.74 -31.3 72.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.222 0.609 . . . . 0.0 112.037 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.25 1.124 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 167.566 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.5 tp -142.21 177.26 8.36 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.905 -1.122 . . . . 0.0 110.422 -166.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.404 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 63.7 tt0 -154.57 162.01 41.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.94 1.696 . . . . 0.0 109.47 -171.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p90 -131.36 166.36 21.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.226 1.01 . . . . 0.0 110.273 166.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -130.23 138.58 50.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.42 146.86 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 135.71 58.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.61 153.64 16.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.275 1.03 . . . . 0.0 110.699 -172.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.01 153.0 45.35 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.313 1.445 . . . . 0.0 107.943 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.35 -152.28 24.19 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -75.56 77.98 2.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 162.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.66 -1.77 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 111.306 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -140.37 35.41 1.87 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.63 1.572 . . . . 0.0 109.488 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.51 29.67 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 t 55.91 -71.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 129.027 2.931 . . . . 0.0 113.221 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.77 -11.64 46.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.584 1.564 . . . . 0.0 112.151 173.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 51.17 -162.87 0.06 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.052 1.741 . . . . 0.0 112.077 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -63.87 -14.89 56.95 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.834 -1.166 . . . . 0.0 112.518 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -60.62 -32.83 71.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.405 1.002 . . . . 0.0 110.803 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -48.74 71.94 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.921 1.237 . . . . 0.0 111.61 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.86 -30.92 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.16 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -75.14 -24.66 57.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.948 1.249 . . . . 0.0 112.08 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.2 mtm -63.46 -48.9 75.81 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 165.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.81 -30.11 70.69 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 122.195 -0.316 . . . . 0.0 111.058 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.84 -47.49 68.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.292 . . . . 0.0 110.328 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.63 -38.62 88.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.319 0.647 . . . . 0.0 111.124 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.14 -17.59 41.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.769 1.228 . . . . 0.0 112.523 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -116.65 12.9 15.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.225 1.41 . . . . 0.0 111.41 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.44 34.44 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.16 2.184 . . . . 0.0 113.294 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.41 161.59 27.27 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.816 -0.553 . . . . 0.0 109.629 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 128.62 43.74 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.48 -171.21 43.9 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 118.641 0.655 . . . . 0.0 112.272 -164.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.4 p90 -136.61 161.27 36.36 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.066 0.947 . . . . 0.0 112.036 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.15 144.93 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.171 0.988 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -144.71 162.82 35.75 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.143 2.177 . . . . 0.0 107.656 -170.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.43 122.88 40.76 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -75.77 155.46 35.48 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.479 1.112 . . . . 0.0 109.16 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.45 -31.78 70.75 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.918 0.487 . . . . 0.0 111.357 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -71.34 -10.68 60.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.82 10.83 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.228 -1.318 . . . . 0.0 113.476 170.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.35 148.25 52.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.729 1.764 . . . . 0.0 109.391 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.29 146.48 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 161.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -127.77 137.94 52.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.55 142.55 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.57 126.38 12.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -153.95 159.04 41.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.487 0.585 . . . . 0.0 110.926 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.49 155.83 22.63 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.316 1.846 . . . . 0.0 109.443 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.51 178.04 41.64 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.618 1.104 . . . . 0.0 110.364 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.32 154.3 74.44 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.842 1.695 . . . . 0.0 109.781 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.37 -47.7 78.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.183 0.593 . . . . 0.0 110.715 -172.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -60.17 -40.31 89.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.484 0.584 . . . . 0.0 111.788 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.59 83.09 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.855 0.462 . . . . 0.0 110.091 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.66 -45.96 84.48 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 122.809 0.443 . . . . 0.0 110.826 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -64.98 -43.47 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.864 -0.522 . . . . 0.0 110.68 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.4 m -60.93 -40.84 94.77 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.935 0.334 . . . . 0.0 110.54 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.24 -49.09 79.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.575 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.67 -43.25 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.735 1.152 . . . . 0.0 109.67 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.92 -40.91 97.11 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.628 0.649 . . . . 0.0 110.834 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.47 0.708 . . . . 0.0 111.465 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -61.79 -54.04 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.37 -39.44 79.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.809 0.844 . . . . 0.0 111.375 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.4 -27.23 68.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.488 0.715 . . . . 0.0 111.979 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.47 51.26 58.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -173.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -55.53 -49.2 93.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.976 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.49 -173.45 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.261 1.974 . . . . 0.0 111.627 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -40.84 82.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.431 1.092 . . . . 0.0 111.449 173.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.3 m -74.29 138.92 43.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -157.81 164.45 36.99 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 109.533 -162.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.42 149.6 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -127.68 -7.58 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.809 1.643 . . . . 0.0 109.803 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.61 141.22 29.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.224 1.81 . . . . 0.0 106.963 166.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -149.27 140.68 17.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 107.972 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 m -139.29 148.94 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.687 1.595 . . . . 0.0 107.328 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.18 146.18 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.05 149.01 51.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.04 133.17 39.1 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -171.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -145.47 167.93 21.79 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.701 0.4 . . . . 0.0 111.683 -155.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.97 0.11 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.898 1.279 . . . . 0.0 111.253 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.0 m -66.26 -24.88 66.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.121 0.969 . . . . 0.0 113.088 -170.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.48 174.0 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 0.0 111.684 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.18 -16.44 0.58 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 113.179 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 1.41 82.2 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.253 -1.304 . . . . 0.0 116.304 155.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -82.92 -175.48 5.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.102 1.951 . . . . 0.0 109.542 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -129.55 2.85 5.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 112.421 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.57 170.76 17.89 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.052 1.341 . . . . 0.0 109.697 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -72.48 153.27 41.45 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.956 0.503 . . . . 0.0 109.965 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.39 159.22 42.67 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.703 1.201 . . . . 0.0 109.453 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 mt -135.09 110.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.67 140.64 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -136.42 4.19 2.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.468 1.107 . . . . 0.0 112.096 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 125.347 1.459 . . . . 0.0 110.883 179.368 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.507 0.194 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.13 176.03 9.06 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.946 0.898 . . . . 0.0 111.666 -149.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -147.71 157.81 43.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.446 1.498 . . . . 0.0 109.384 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.14 168.09 11.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 110.629 163.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -134.58 135.42 42.22 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 156.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.34 144.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.78 136.42 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.14 155.48 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.576 1.151 . . . . 0.0 110.293 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -145.98 157.38 43.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 0.0 108.935 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -148.36 19.87 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 106.821 -2.512 . . . . 0.0 106.821 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -77.02 54.48 1.04 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 160.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.73 -13.92 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 111.21 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.64 155.4 47.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 168.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.29 -153.26 24.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -57.88 -24.43 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 117.766 0.783 . . . . 0.0 112.685 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -0.56 86.02 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.68 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 t80 44.58 -147.27 0.09 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.326 1.45 . . . . 0.0 110.064 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -86.68 -0.82 57.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.128 -0.982 . . . . 0.0 111.117 158.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.9 -34.47 73.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.171 0.896 . . . . 0.0 111.295 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -37.61 65.23 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.678 0.672 . . . . 0.0 111.288 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.84 -45.22 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -78.97 -18.95 52.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.488 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -63.21 -48.95 76.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.335 0.971 . . . . 0.0 109.309 165.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.58 -29.95 67.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.784 0.434 . . . . 0.0 110.421 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.61 74.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.767 0.827 . . . . 0.0 110.405 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.92 -41.02 90.81 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.341 0.656 . . . . 0.0 110.724 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -59.41 -18.09 36.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.487 1.115 . . . . 0.0 112.854 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -117.33 15.76 14.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.977 1.262 . . . . 0.0 112.372 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.2 mmpt? 47.01 34.0 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.574 1.55 . . . . 0.0 112.768 -176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.3 mt -74.41 163.51 27.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.172 0.589 . . . . 0.0 109.703 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.73 130.11 22.42 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.167 0.987 . . . . 0.0 108.581 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.35 -158.34 28.66 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 123.592 0.615 . . . . 0.0 111.596 -171.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -136.73 163.28 30.97 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.787 0.794 . . . . 0.0 112.047 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.874 1.27 . . . . 0.0 108.66 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -149.22 163.25 38.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.883 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -119.58 131.15 55.44 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -120.77 149.72 42.11 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.925 0.89 . . . . 0.0 110.37 -167.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.08 -19.46 62.96 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.443 1.497 . . . . 0.0 113.524 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.78 -15.29 28.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.757 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.05 45.83 3.77 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.52 153.32 42.47 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.392 1.477 . . . . 0.0 107.238 -168.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.19 148.36 5.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 157.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.96 142.48 48.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -138.62 141.48 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.98 126.37 10.8 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.1 157.02 36.86 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.442 0.697 . . . . 0.0 110.877 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.98 156.9 17.35 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.634 1.573 . . . . 0.0 109.874 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.25 -179.42 41.89 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.039 0.828 . . . . 0.0 111.865 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.4 161.74 37.13 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.554 2.17 . . . . 0.0 110.652 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.35 -47.23 79.23 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.73 0.812 . . . . 0.0 111.137 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.76 -43.06 98.49 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.005 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.96 79.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.1 mt -63.22 -47.08 84.03 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.326 0.65 . . . . 0.0 110.247 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -68.52 -43.51 76.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.031 0.532 . . . . 0.0 111.893 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -62.89 -39.09 93.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.471 0.578 . . . . 0.0 110.139 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.3 -49.24 78.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.423 173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.56 -45.65 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.57 1.077 . . . . 0.0 109.515 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -62.42 -37.81 87.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.096 0.407 . . . . 0.0 111.155 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.85 86.94 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.501 0.72 . . . . 0.0 111.792 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.2 -51.03 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.34 -41.95 76.92 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.442 1.097 . . . . 0.0 111.29 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -68.22 -25.53 65.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.517 0.727 . . . . 0.0 111.933 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.94 48.64 81.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.61 -47.32 98.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.409 -1.281 . . . . 0.0 114.289 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.84 -166.53 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.201 . . . . 0.0 111.479 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -40.74 67.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.828 1.251 . . . . 0.0 111.939 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -79.6 143.72 34.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 162.46 40.51 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.687 0.795 . . . . 0.0 110.548 -172.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.88 158.3 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.371 0.668 . . . . 0.0 110.689 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 p -125.81 -4.8 6.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.715 1.606 . . . . 0.0 110.023 163.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -150.66 138.73 20.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.777 2.031 . . . . 0.0 107.446 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.64 140.98 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.336 1.054 . . . . 0.0 108.613 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -140.86 142.9 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.101 1.76 . . . . 0.0 107.053 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -138.19 143.6 32.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -129.99 151.06 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -137.05 145.36 43.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.0 m -143.2 175.0 10.21 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.037 1.335 . . . . 0.0 109.375 -165.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -128.37 33.53 4.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.537 1.135 . . . . 0.0 109.447 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -134.24 105.09 6.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 108.404 -165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.09 168.63 8.09 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.949 0.9 . . . . 0.0 111.235 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.78 -23.47 9.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.832 1.653 . . . . 0.0 110.496 -175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.69 19.04 76.52 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -166.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.31 139.78 32.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -134.82 25.09 3.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.808 1.243 . . . . 0.0 109.584 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -148.23 167.4 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 127.003 2.121 . . . . 0.0 107.184 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -120.85 132.94 55.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 163.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 m -134.7 160.87 36.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.126 0.57 . . . . 0.0 111.211 -166.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.9 mt -132.24 114.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.61 142.28 15.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -139.73 5.14 2.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.819 1.248 . . . . 0.0 112.086 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.36 1.464 . . . . 0.0 110.919 179.349 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 119.111 -0.471 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tp -147.46 -177.01 5.47 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.207 1.367 . . . . 0.0 111.344 -159.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.61 152.57 39.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.613 1.965 . . . . 0.0 109.086 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.46 163.7 12.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.319 0.648 . . . . 0.0 109.724 162.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -136.05 131.09 34.45 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 159.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.19 139.65 45.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.29 134.4 66.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -140.35 153.19 21.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.146 0.979 . . . . 0.0 109.557 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.28 151.36 37.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.935 1.294 . . . . 0.0 107.522 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.67 -152.04 24.06 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.67 58.56 1.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 m -85.0 -12.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.019 0.928 . . . . 0.0 110.783 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.411 HE22 ' CG ' ' A' ' 18' ' ' ARG . 7.5 mm-40 -125.33 146.36 49.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 164.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.8 -163.28 30.0 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -161.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 -23.09 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.535 1.168 . . . . 0.0 113.641 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.34 0.93 89.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.62 -1.655 . . . . 0.0 114.347 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 21.09 51.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 130.398 3.479 . . . . 0.0 115.06 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' CG ' HE22 ' A' ' 13' ' ' GLN 0.301 12.9 ptt85 45.06 -1.6 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -66.38 -21.96 66.24 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 122.013 2.188 . . . . 0.0 110.468 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.099 1.318 . . . . 0.0 111.349 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.21 -33.66 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.394 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -73.39 -25.98 60.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.051 1.296 . . . . 0.0 112.284 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.4 mtm -65.36 -47.3 76.91 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 166.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -66.09 -27.99 68.48 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.285 -0.26 . . . . 0.0 111.329 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 -48.47 64.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.734 1.614 . . . . 0.0 109.975 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.06 -38.68 87.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.984 0.514 . . . . 0.0 111.209 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -60.0 -16.96 34.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.354 1.062 . . . . 0.0 112.594 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -116.88 11.24 14.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.127 1.371 . . . . 0.0 111.565 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 41.52 39.52 1.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.697 1.999 . . . . 0.0 113.015 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.63 164.85 25.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.732 0.813 . . . . 0.0 108.981 167.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.32 26.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.18 -167.68 38.91 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 118.402 0.546 . . . . 0.0 112.14 -163.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -136.64 159.56 41.44 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.75 0.82 . . . . 0.0 111.991 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.99 141.94 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.735 0.814 . . . . 0.0 110.412 174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -141.85 153.31 44.37 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.833 1.653 . . . . 0.0 108.613 -166.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -106.62 125.22 50.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 170.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -85.33 145.29 27.58 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.961 0.904 . . . . 0.0 108.676 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.55 -29.45 69.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.351 0.66 . . . . 0.0 111.882 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -8.8 56.03 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 45.95 2.23 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 119.109 0.868 . . . . 0.0 112.084 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -136.43 172.99 12.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 107.802 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -116.16 144.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 164.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 140.34 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.79 140.72 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.7 127.69 14.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.44 149.28 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 122.997 0.519 . . . . 0.0 110.24 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.28 153.77 20.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.708 0.803 . . . . 0.0 109.147 166.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.47 173.71 36.56 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.309 0.957 . . . . 0.0 111.604 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.59 153.41 60.06 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.149 1.899 . . . . 0.0 110.073 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.83 -42.3 75.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.679 0.792 . . . . 0.0 111.507 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.4 -41.1 98.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.068 -0.395 . . . . 0.0 111.632 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -45.1 77.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.786 0.434 . . . . 0.0 109.856 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.99 -45.38 95.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.863 0.865 . . . . 0.0 110.129 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -69.71 -39.73 76.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.857 -0.527 . . . . 0.0 112.019 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.1 m -61.05 -41.7 97.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.642 0.656 . . . . 0.0 110.183 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.36 -47.27 86.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.575 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -55.01 -45.84 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.754 1.161 . . . . 0.0 109.602 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.82 -39.1 90.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.585 0.63 . . . . 0.0 111.052 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.55 87.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.425 0.69 . . . . 0.0 111.411 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.61 -48.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.96 -39.76 86.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.41 0.684 . . . . 0.0 111.452 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.49 -24.74 66.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.004 0.522 . . . . 0.0 111.832 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.28 44.0 96.84 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -54.48 -47.68 97.07 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.935 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.78 -169.09 0.67 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.546 2.164 . . . . 0.0 111.722 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -2.87 0.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.911 2.084 . . . . 0.0 115.241 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.4 m -129.53 143.65 50.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.395 1.478 . . . . 0.0 107.737 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.0 164.75 37.66 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.404 0.682 . . . . 0.0 111.21 -162.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.8 m -106.37 158.79 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 123.543 0.737 . . . . 0.0 110.444 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 p -123.01 -11.72 8.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.915 1.686 . . . . 0.0 109.827 162.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.7 146.82 27.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.108 1.363 . . . . 0.0 108.992 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.7 tt -148.19 143.6 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.991 1.316 . . . . 0.0 108.309 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -136.73 144.08 43.65 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.126 1.77 . . . . 0.0 107.213 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.67 140.21 36.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -132.68 157.34 45.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.989 2.115 . . . . 0.0 105.778 168.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.36 142.8 48.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -136.94 153.29 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.785 1.634 . . . . 0.0 107.07 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 mmt-85 -87.76 -24.49 23.78 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.011 -1.056 . . . . 0.0 111.166 -175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 m -62.93 114.67 3.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.81 1.244 . . . . 0.0 111.027 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.61 177.66 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.32 1.048 . . . . 0.0 110.641 164.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -126.92 0.21 6.61 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.893 1.277 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.57 27.94 66.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.878 0.751 . . . . 0.0 111.675 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -94.53 150.35 20.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.894 0.847 . . . . 0.0 109.8 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -137.84 14.98 2.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.64 1.176 . . . . 0.0 111.57 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -148.51 166.72 27.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.16 1.384 . . . . 0.0 108.963 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -88.16 155.88 19.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 163.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.2 m -142.55 156.7 45.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.614 1.166 . . . . 0.0 110.66 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 mt -128.17 112.96 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.3 138.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -174.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -138.18 -19.93 1.11 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.594 0.758 . . . . 0.0 112.55 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.53 1.532 . . . . 0.0 107.565 -178.733 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.3 tp -140.65 -178.6 5.6 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.789 -1.194 . . . . 0.0 109.527 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 33.3 tt0 -155.12 158.14 38.55 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.868 1.667 . . . . 0.0 108.449 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -120.05 164.94 15.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.661 0.785 . . . . 0.0 110.536 166.27 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.27 131.3 29.95 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 157.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.97 147.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -167.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.41 137.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 m -141.53 156.28 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 124.03 0.932 . . . . 0.0 111.301 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.36 155.51 45.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.751 1.62 . . . . 0.0 107.788 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.24 -155.36 26.29 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -77.61 100.21 6.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 152.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.39 6.24 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 124.611 1.194 . . . . 0.0 110.752 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -141.49 153.38 44.89 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.587 1.085 . . . . 0.0 111.12 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.88 169.14 11.72 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.175 2.321 . . . . 0.0 108.623 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.07 126.2 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.07 -46.34 2.11 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.942 0.782 . . . . 0.0 111.773 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.01 -7.16 10.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.74 -11.85 10.9 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.124 1.784 . . . . 0.0 114.166 155.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -59.89 -32.34 70.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.289 0.95 . . . . 0.0 110.578 169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -51.72 -37.53 51.33 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.538 0.608 . . . . 0.0 112.07 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.68 -48.06 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -71.29 -25.47 62.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.42 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.71 -39.47 64.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.858 1.208 . . . . 0.0 110.589 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -69.28 -29.82 67.78 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.344 -0.847 . . . . 0.0 111.096 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.54 65.07 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.093 -1.005 . . . . 0.0 109.672 172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.11 -40.42 93.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.053 0.941 . . . . 0.0 111.42 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -15.26 62.72 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.67 -0.644 . . . . 0.0 112.295 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -113.33 15.11 19.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 111.665 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.27 32.97 3.41 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.067 1.747 . . . . 0.0 112.326 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.0 162.22 29.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.09 121.39 19.18 Favored 'General case' 0 CA--C 1.527 0.075 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 -162.17 32.27 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -142.7 163.7 32.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.14 145.98 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.086 1.354 . . . . 0.0 109.507 165.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -149.49 146.14 27.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.641 1.577 . . . . 0.0 108.372 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.98 153.93 40.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.703 0.801 . . . . 0.0 109.487 168.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -134.64 154.6 51.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.297 1.408 . . . . 0.0 110.843 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.01 -30.63 69.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -155.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.05 -27.45 68.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.139 0.576 . . . . 0.0 112.402 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.65 -17.84 10.12 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.366 1.46 . . . . 0.0 110.946 -172.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -59.17 168.32 1.44 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 122.962 1.363 . . . . 0.0 110.422 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.52 150.12 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -131.18 140.12 49.86 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -171.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -136.89 140.81 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -171.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -149.88 126.91 11.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.19 149.52 28.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.527 0.603 . . . . 0.0 110.093 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.92 153.77 19.95 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 174.69 39.72 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.661 0.648 . . . . 0.0 111.807 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.21 152.39 66.98 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.966 1.777 . . . . 0.0 110.152 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.05 -43.87 74.19 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.813 0.845 . . . . 0.0 111.481 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.43 -40.93 98.49 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 122.227 -0.295 . . . . 0.0 111.544 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.33 80.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.988 0.515 . . . . 0.0 110.116 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 4' ' ' TYR . 67.4 mt -62.04 -45.22 94.54 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.583 0.753 . . . . 0.0 110.211 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.57 -40.12 76.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.885 -0.51 . . . . 0.0 111.75 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 m -61.37 -42.0 98.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.746 0.703 . . . . 0.0 110.215 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.21 -49.81 75.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.591 -0.719 . . . . 0.0 110.243 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.3 t -56.65 -43.59 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 119.496 1.043 . . . . 0.0 109.988 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.69 -41.46 97.6 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.109 0.868 . . . . 0.0 110.72 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.33 97.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 111.438 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.28 -53.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -58.53 -40.93 84.32 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.078 0.951 . . . . 0.0 111.207 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -69.9 -23.65 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.49 . . . . 0.0 111.897 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.33 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -58.41 -42.15 93.08 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-O 117.745 -1.121 . . . . 0.0 112.871 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.13 -172.29 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.742 2.961 . . . . 0.0 114.128 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -59.48 -39.61 84.28 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.48 1.112 . . . . 0.0 111.785 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -72.96 151.71 41.7 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.586 0.755 . . . . 0.0 110.363 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 145.53 23.33 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.76 156.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -124.87 -8.95 7.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.601 . . . . 0.0 109.734 166.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.46 139.7 20.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.419 1.887 . . . . 0.0 107.411 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -152.95 142.75 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.65 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -141.29 145.36 35.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.806 1.643 . . . . 0.0 107.779 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.51 138.85 44.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -169.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -131.73 152.79 50.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.598 1.959 . . . . 0.0 106.063 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -131.31 151.21 51.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 m -146.95 165.29 30.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.539 1.136 . . . . 0.0 109.465 -165.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -118.78 1.34 11.56 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.148 0.979 . . . . 0.0 110.751 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 m -62.2 -37.45 85.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.42 1.088 . . . . 0.0 112.211 -171.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 mp 58.5 170.59 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.26 1.824 . . . . 0.0 111.951 -170.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.19 -20.19 4.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.852 1.261 . . . . 0.0 111.392 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.83 24.69 74.26 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.17 139.52 42.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.126 0.963 . . . . 0.0 108.433 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -131.88 21.0 4.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.498 1.119 . . . . 0.0 110.743 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -149.03 178.28 8.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.022 1.729 . . . . 0.0 108.099 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.46 132.16 35.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.0 m -143.9 163.26 33.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.63 1.205 . . . . 0.0 114.032 -152.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.4 mt -128.39 118.66 48.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.44 155.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -60.49 -44.12 96.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.653 -0.655 . . . . 0.0 110.688 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.511 1.524 . . . . 0.0 109.147 174.632 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -141.76 179.85 6.61 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.889 -1.132 . . . . 0.0 109.677 -167.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -155.37 156.29 35.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 109.159 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.5 163.21 18.3 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.688 0.795 . . . . 0.0 110.524 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -132.33 137.06 47.28 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 154.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.78 142.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -173.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.21 135.28 59.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 171.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.52 151.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.783 0.833 . . . . 0.0 110.6 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.83 153.31 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 107.681 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.88 -154.36 25.77 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -75.1 88.64 2.44 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -124.52 6.51 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.398 1.079 . . . . 0.0 111.237 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -146.61 165.75 28.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.78 1.173 . . . . 0.0 108.496 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -10.1 73.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.998 0.809 . . . . 0.0 113.255 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.41 15.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.061 1.345 . . . . 0.0 111.289 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.14 70.63 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.969 -0.906 . . . . 0.0 113.575 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -52.87 -43.72 66.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.236 1.518 . . . . 0.0 111.898 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -66.23 -30.91 71.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.685 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.65 -43.32 69.4 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.574 -0.704 . . . . 0.0 110.07 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -53.86 -48.33 70.13 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.029 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.17 -33.99 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 119.39 0.996 . . . . 0.0 110.929 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.61 -32.16 73.59 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.385 1.448 . . . . 0.0 112.164 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -64.0 -46.55 84.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.181 0.901 . . . . 0.0 109.385 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -68.58 -33.3 73.83 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.101 -0.375 . . . . 0.0 110.887 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.48 77.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.299 1.04 . . . . 0.0 109.584 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.68 -35.0 78.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.862 0.465 . . . . 0.0 112.096 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.2 -40.93 59.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.27 1.028 . . . . 0.0 111.715 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -114.87 24.01 12.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.86 1.264 . . . . 0.0 111.279 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp 46.17 39.96 6.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.32 157.43 22.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.12 126.16 44.87 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.33 -171.88 44.67 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 118.643 0.656 . . . . 0.0 112.885 -167.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -142.9 165.85 26.25 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.313 0.645 . . . . 0.0 112.463 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.38 146.56 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.053 1.341 . . . . 0.0 110.075 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.46 159.17 44.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.914 1.286 . . . . 0.0 110.222 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.34 153.94 28.07 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 166.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -112.32 145.25 40.36 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 166.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.64 -28.39 65.63 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.36 -28.05 68.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.922 0.889 . . . . 0.0 112.65 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.08 -17.57 7.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.297 1.427 . . . . 0.0 111.614 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -58.46 164.8 2.39 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.949 0.881 . . . . 0.0 110.691 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 t -119.31 149.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 161.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -129.27 139.53 51.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 141.8 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.79 129.39 14.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.94 145.14 23.89 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.754 0.706 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.69 151.82 23.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 164.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.45 175.68 40.0 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 112.457 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.61 154.95 64.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.142 1.895 . . . . 0.0 110.526 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.46 -45.78 76.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.905 0.882 . . . . 0.0 111.512 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.41 -40.84 98.29 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.294 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.2 80.07 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.48 -46.39 88.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.477 0.711 . . . . 0.0 110.492 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -69.17 -39.58 78.67 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.888 -0.508 . . . . 0.0 111.755 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 m -62.1 -40.49 96.06 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.663 0.665 . . . . 0.0 110.259 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -59.46 -47.54 85.09 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.303 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.88 -42.62 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 119.72 1.145 . . . . 0.0 109.898 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.46 -41.31 98.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.083 0.856 . . . . 0.0 110.984 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.16 89.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.908 0.483 . . . . 0.0 111.619 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.27 -56.02 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.99 -37.18 78.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.955 0.902 . . . . 0.0 111.573 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.01 -24.63 66.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.557 0.743 . . . . 0.0 112.415 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.49 42.62 97.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.785 0.72 . . . . 0.0 111.387 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -51.26 -47.37 88.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.95 -56.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.711 1.647 . . . . 0.0 112.198 -166.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -174.92 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.952 2.101 . . . . 0.0 107.104 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.81 145.34 29.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.553 1.541 . . . . 0.0 109.782 168.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.52 151.52 24.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.561 0.745 . . . . 0.0 109.206 -172.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.85 156.18 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.8 p -121.17 -12.43 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.585 1.554 . . . . 0.0 109.774 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.36 136.02 20.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.266 1.826 . . . . 0.0 106.967 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 tt -148.5 137.73 15.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -139.63 146.14 39.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.311 1.444 . . . . 0.0 107.397 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.49 144.4 32.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.96 147.61 50.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 167.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -138.76 134.53 33.6 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 m -143.62 168.07 20.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.01 0.924 . . . . 0.0 110.634 -155.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.55 0.45 10.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.349 1.059 . . . . 0.0 111.726 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -66.14 -37.2 85.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.29 0.95 . . . . 0.0 112.61 -171.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.52 177.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 0.0 111.236 -165.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -124.06 -26.52 4.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.122 0.969 . . . . 0.0 110.978 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.17 41.24 6.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.351 0.977 . . . . 0.0 110.906 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 165.78 24.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 112.536 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -140.39 33.11 1.88 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.366 1.867 . . . . 0.0 109.279 -172.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -131.14 160.98 33.16 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.467 1.507 . . . . 0.0 108.434 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.35 122.33 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -141.81 163.62 32.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.184 0.992 . . . . 0.0 113.42 -152.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.08 119.89 41.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.96 170.99 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.505 -160.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -131.21 16.31 5.05 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.729 1.612 . . . . 0.0 110.567 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.624 1.57 . . . . 0.0 111.105 -177.883 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.8 ttp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 119.084 -0.484 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mp -143.42 -177.12 5.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.011 1.278 . . . . 0.0 111.605 -167.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -142.53 155.95 45.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.816 2.846 . . . . 0.0 108.552 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.4 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -114.68 164.68 13.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.794 0.838 . . . . 0.0 109.731 161.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -133.26 137.0 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 153.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -136.19 141.42 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -170.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.55 33.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 163.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.84 155.34 30.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.531 1.132 . . . . 0.0 109.99 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -145.56 155.81 43.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 107.19 172.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.21 -152.48 24.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 107.786 -2.125 . . . . 0.0 107.786 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -78.15 101.66 7.14 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 104.421 -2.436 . . . . 0.0 104.421 154.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.61 18.56 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.403 1.081 . . . . 0.0 110.352 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -148.48 166.81 27.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.966 1.706 . . . . 0.0 107.109 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 154.63 26.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t 60.39 -56.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.799 2.04 . . . . 0.0 110.981 -161.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.98 39.37 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-O 118.621 -1.1 . . . . 0.0 112.162 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -53.63 -43.34 68.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.489 1.645 . . . . 0.0 112.652 -169.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -69.11 -27.69 65.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.615 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.28 -44.25 65.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.485 1.039 . . . . 0.0 109.914 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.9 -50.81 63.18 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.765 0.826 . . . . 0.0 110.998 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.13 -35.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.034 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.53 -21.62 60.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.377 1.444 . . . . 0.0 113.054 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.4 mtm -64.06 -46.32 84.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.755 1.161 . . . . 0.0 109.03 165.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -68.32 -23.98 64.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.465 0.706 . . . . 0.0 111.582 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.66 -53.04 38.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.356 -0.84 . . . . 0.0 108.921 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.61 -40.26 91.21 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.205 0.602 . . . . 0.0 111.594 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.27 62.58 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.78 -0.575 . . . . 0.0 112.295 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.1 15.03 17.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.455 1.502 . . . . 0.0 111.393 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 47.94 32.07 2.65 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.183 1.793 . . . . 0.0 112.849 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -73.43 162.26 29.5 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.79 134.87 25.56 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.42 -165.39 38.6 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 118.566 0.621 . . . . 0.0 112.143 -160.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CZ3' ' HE2' ' A' ' 35' ' ' LYS . 3.0 p-90 -135.81 169.22 17.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.652 0.781 . . . . 0.0 112.514 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.42 149.85 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.16 1.384 . . . . 0.0 109.73 170.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE2' ' CZ3' ' A' ' 33' ' ' TRP . 44.3 mtmt -142.23 150.47 40.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.181 1.792 . . . . 0.0 108.56 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -81.27 130.88 35.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 148.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -77.93 137.18 38.2 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 166.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.88 -24.82 62.72 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.196 0.598 . . . . 0.0 111.985 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -28.33 65.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.915 1.686 . . . . 0.0 112.869 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.18 3.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.228 1.394 . . . . 0.0 112.262 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.87 172.15 2.42 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.003 0.921 . . . . 0.0 111.197 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.58 140.58 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -127.07 143.54 51.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.073 0.949 . . . . 0.0 108.805 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.76 143.13 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 tt -149.58 127.74 12.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.55 157.24 35.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.135 0.88 . . . . 0.0 111.284 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.81 150.35 21.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.217 1.407 . . . . 0.0 109.71 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.55 174.08 38.27 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.635 1.588 . . . . 0.0 111.211 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.48 155.34 55.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.659 2.24 . . . . 0.0 110.306 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.55 -42.11 74.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -172.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.71 -41.53 99.19 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.075 -0.391 . . . . 0.0 111.576 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -45.56 79.84 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.945 0.498 . . . . 0.0 110.065 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 4' ' ' TYR . 93.7 mt -59.83 -45.37 92.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.894 0.878 . . . . 0.0 110.142 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -70.95 -40.87 71.77 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.582 -0.699 . . . . 0.0 112.057 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.6 m -60.18 -40.32 89.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.557 0.617 . . . . 0.0 110.021 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.16 -49.19 78.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.705 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.85 -44.31 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.683 1.129 . . . . 0.0 109.9 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.56 -41.4 98.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 111.215 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.46 96.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.527 0.731 . . . . 0.0 111.316 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 t -64.04 -53.38 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -57.02 -42.16 79.86 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.4 0.68 . . . . 0.0 111.014 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.52 -22.59 62.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.444 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.61 46.03 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 118.931 0.787 . . . . 0.0 111.386 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -50.69 -51.66 63.67 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -161.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.66 -40.42 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.402 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -165.09 172.94 12.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.792 2.037 . . . . 0.0 107.881 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m 62.71 170.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.159 1.383 . . . . 0.0 112.595 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.29 141.73 10.98 Favored 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.85 154.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -119.37 -12.66 9.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.245 1.418 . . . . 0.0 109.38 165.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.26 142.96 25.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.411 1.485 . . . . 0.0 108.155 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.3 tt -146.98 141.08 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -138.09 143.3 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.7 142.88 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -171.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.0 m -130.18 151.43 50.71 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 167.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -136.26 146.1 46.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -137.98 158.1 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.638 1.575 . . . . 0.0 108.384 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.92 -20.05 21.81 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.687 -0.633 . . . . 0.0 111.031 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 m -64.11 126.59 28.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.58 0.752 . . . . 0.0 110.242 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 1' ' ' MET . 10.5 mp -68.21 173.45 4.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.386 1.075 . . . . 0.0 109.9 159.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -125.15 6.24 7.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.999 1.72 . . . . 0.0 111.025 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.18 22.96 61.37 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.455 1.026 . . . . 0.0 112.386 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -88.17 140.66 29.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.215 1.007 . . . . 0.0 108.713 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -132.69 11.57 4.39 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.55 165.47 32.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.241 1.817 . . . . 0.0 108.025 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -93.34 152.57 19.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.7 m -141.1 150.99 43.59 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.849 0.833 . . . . 0.0 111.185 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.0 110.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 t -75.37 132.61 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.51 36.21 1.28 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.955 0.902 . . . . 0.0 110.431 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 126.025 1.73 . . . . 0.0 111.046 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.06 178.78 4.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.21 1.004 . . . . 0.0 110.994 -165.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -153.78 157.5 39.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.217 2.207 . . . . 0.0 108.469 -168.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.1 p90 -134.9 166.14 23.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.161 0.584 . . . . 0.0 110.673 166.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -133.88 141.1 47.24 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 152.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.1 146.61 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -168.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 134.43 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.2 154.86 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.469 1.108 . . . . 0.0 111.072 -167.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -143.18 157.56 44.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.969 1.708 . . . . 0.0 108.876 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 -154.6 26.0 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 106.649 -2.581 . . . . 0.0 106.649 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -74.93 54.89 0.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.827 -0.807 . . . . 0.0 108.839 163.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.08 -10.72 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 121.256 -0.902 . . . . 0.0 113.206 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.562 HE22 ' HB3' ' A' ' 18' ' ' ARG . 22.0 mm-40 -132.05 113.6 13.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -144.66 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.35 -9.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.37 14.22 30.51 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.445 1.021 . . . . 0.0 112.392 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.6 t80 35.62 -127.65 0.12 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.502 2.321 . . . . 0.0 110.185 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HB3' HE22 ' A' ' 13' ' ' GLN . 15.6 ptp180 -95.89 -12.41 25.21 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.875 0.87 . . . . 0.0 112.167 166.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.75 -15.55 63.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 117.432 -1.271 . . . . 0.0 112.457 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.916 1.689 . . . . 0.0 111.886 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.35 -35.32 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.17 0.895 . . . . 0.0 110.245 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.89 -28.36 66.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.566 1.075 . . . . 0.0 110.813 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -42.89 69.78 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.483 -0.76 . . . . 0.0 109.864 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.66 -35.97 81.44 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.621 -0.675 . . . . 0.0 110.197 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.16 89.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.598 1.159 . . . . 0.0 110.178 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.78 -39.4 84.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.115 0.566 . . . . 0.0 111.575 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -57.22 -42.12 80.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.655 0.661 . . . . 0.0 110.58 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -85.62 3.35 41.21 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 111.772 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 46.99 35.77 3.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.44 171.71 8.32 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 163.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.52 139.25 21.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -165.52 38.73 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.023 -163.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.15 160.47 27.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.955 1.302 . . . . 0.0 112.295 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.16 142.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.342 1.057 . . . . 0.0 109.444 164.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -147.88 171.89 15.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 109.563 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -123.76 114.92 20.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -75.57 152.69 37.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.08 -28.56 67.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 112.009 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.0 -27.03 68.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.001 0.921 . . . . 0.0 112.522 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.12 -27.39 4.55 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.086 1.327 . . . . 0.0 112.457 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.37 151.58 31.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.007 0.903 . . . . 0.0 110.258 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.96 149.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 155.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -128.04 144.93 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.068 1.347 . . . . 0.0 107.384 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 146.44 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -141.28 138.52 33.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -161.78 169.3 21.65 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.712 1.596 . . . . 0.0 110.869 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.91 154.87 37.76 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.999 1.32 . . . . 0.0 110.456 167.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.55 179.91 41.11 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.99 1.281 . . . . 0.0 111.49 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.44 156.63 54.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.681 2.254 . . . . 0.0 110.889 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -55.29 -46.88 76.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 111.688 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.6 -38.44 91.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.855 0.298 . . . . 0.0 111.469 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -47.34 75.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.576 0.35 . . . . 0.0 110.147 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 4' ' ' TYR . 76.5 mt -61.07 -48.53 81.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.385 0.674 . . . . 0.0 109.906 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -65.27 -45.84 82.85 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.197 0.599 . . . . 0.0 111.59 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -40.44 97.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.235 0.47 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.76 -48.68 80.38 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.684 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.02 -40.63 74.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.705 1.139 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.98 -42.13 99.75 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.172 0.897 . . . . 0.0 110.811 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.61 98.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.016 0.526 . . . . 0.0 111.667 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.17 -57.67 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.27 -42.71 91.85 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -171.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.07 -24.86 66.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.627 0.371 . . . . 0.0 111.652 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.97 50.05 66.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -52.09 77.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.831 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.45 -176.22 3.15 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.555 2.17 . . . . 0.0 110.584 170.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -106.23 154.34 20.86 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 153.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 171.3 1.55 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.412 2.685 . . . . 0.0 111.293 -7.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -135.57 161.66 34.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.173 -0.955 . . . . 0.0 110.748 -156.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.72 146.37 34.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -133.26 -5.42 3.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.228 1.011 . . . . 0.0 110.864 171.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.81 141.92 22.23 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.707 1.203 . . . . 0.0 108.858 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.9 146.98 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.506 1.123 . . . . 0.0 108.843 -173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 m -136.0 143.01 44.57 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.76 146.14 26.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -170.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 m -126.93 141.4 51.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 161.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.88 139.92 48.92 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -149.58 175.88 11.14 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.96 1.304 . . . . 0.0 109.43 -159.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.29 17.55 2.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.304 1.042 . . . . 0.0 111.113 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -66.97 -27.64 67.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.114 0.966 . . . . 0.0 111.695 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.95 175.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.154 2.182 . . . . 0.0 111.84 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.52 -13.08 0.39 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.46 1.104 . . . . 0.0 112.487 -170.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.92 15.03 79.96 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.031 0.824 . . . . 0.0 112.387 176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -66.49 126.06 27.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.554 1.177 . . . . 0.0 108.596 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -129.23 23.89 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.543 1.537 . . . . 0.0 108.244 164.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -148.18 161.33 41.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.386 2.274 . . . . 0.0 106.758 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -106.07 145.15 31.79 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -138.38 150.6 46.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.521 1.153 . . . . 0.0 111.675 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.72 133.37 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.65 157.01 38.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.89 -57.65 6.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 C--O 1.247 0.959 0 C-N-CA 127.03 2.132 . . . . 0.0 107.974 179.076 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ttp . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.28 176.91 6.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.65 1.114 . . . . 0.0 111.183 -167.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.24 143.94 25.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.474 2.31 . . . . 0.0 107.345 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -103.41 159.64 15.4 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 168.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -119.22 141.38 48.95 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 151.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -140.64 140.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.95 139.18 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.86 153.03 24.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.722 0.809 . . . . 0.0 110.773 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -140.37 147.93 40.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.555 1.542 . . . . 0.0 108.06 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -154.55 25.98 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -76.42 80.71 3.15 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 162.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -107.5 0.76 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.082 0.953 . . . . 0.0 111.391 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -139.05 140.82 38.19 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 121.075 -1.016 . . . . 0.0 109.239 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.1 179.5 33.03 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.81 105.07 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.123 0.969 . . . . 0.0 110.098 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 5.73 73.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.322 0.963 . . . . 0.0 113.861 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -70.03 -31.5 69.17 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.979 1.89 . . . . 0.0 111.899 -172.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -82.84 -17.7 43.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.229 0.922 . . . . 0.0 112.938 168.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -68.65 -36.33 78.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.415 1.007 . . . . 0.0 109.763 171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -52.02 -48.02 64.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.239 0.615 . . . . 0.0 111.907 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.65 -35.21 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.684 0.674 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -75.07 -23.5 58.03 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.803 -1.185 . . . . 0.0 112.037 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.1 mtm -64.33 -50.25 68.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.218 0.917 . . . . 0.0 109.411 167.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.59 -39.27 90.6 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.262 0.625 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.74 54.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.211 1.005 . . . . 0.0 109.843 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.14 -45.71 93.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.152 0.581 . . . . 0.0 110.883 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -59.21 -24.7 63.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.523 1.529 . . . . 0.0 111.888 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -108.38 13.24 25.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.236 1.414 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 50.41 31.15 5.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.974 1.71 . . . . 0.0 112.843 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.8 160.09 28.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.121 0.969 . . . . 0.0 108.503 169.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.03 124.43 12.35 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.488 0.715 . . . . 0.0 109.922 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.51 -175.01 35.67 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.851 0.739 . . . . 0.0 112.091 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -99.78 161.14 13.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -164.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.71 143.61 38.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 156.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.41 152.59 38.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.429 0.692 . . . . 0.0 110.137 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -72.54 123.25 22.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -81.55 132.39 35.31 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.34 -29.44 65.95 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -167.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -17.18 62.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.06 0.944 . . . . 0.0 113.246 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.31 -15.53 6.09 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.472 1.511 . . . . 0.0 112.891 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.12 175.96 3.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.951 1.376 . . . . 0.0 109.721 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.12 145.01 24.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -116.81 143.13 46.04 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.8 133.45 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -150.41 117.18 5.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.54 149.98 28.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.542 0.61 . . . . 0.0 112.355 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.29 157.29 18.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.692 1.197 . . . . 0.0 110.345 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.83 38.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.895 1.236 . . . . 0.0 111.582 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.31 153.99 65.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.259 1.972 . . . . 0.0 110.368 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.3 -48.32 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 111.494 -170.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.14 -38.34 90.69 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.087 0.403 . . . . 0.0 111.786 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.67 89.48 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.045 0.538 . . . . 0.0 109.832 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 4' ' ' TYR . 79.3 mt -61.69 -47.55 84.81 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.438 0.695 . . . . 0.0 110.004 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -67.34 -40.51 85.9 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.802 -0.561 . . . . 0.0 111.553 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -67.15 -35.67 80.21 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.79 -0.568 . . . . 0.0 110.69 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.47 -47.04 87.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.971 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.41 -42.71 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.913 1.233 . . . . 0.0 109.55 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -41.0 96.06 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.257 0.935 . . . . 0.0 111.313 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.74 -40.73 89.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.737 0.815 . . . . 0.0 111.46 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -55.33 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -59.24 -37.89 78.66 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.195 0.598 . . . . 0.0 111.734 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.98 -23.55 65.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.179 0.592 . . . . 0.0 112.261 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.35 43.03 89.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 118.672 0.669 . . . . 0.0 111.508 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -50.28 -49.11 78.41 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -168.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.54 -59.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.735 1.655 . . . . 0.0 112.204 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -171.3 -47.44 0.02 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.213 1.805 . . . . 0.0 108.173 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.61 146.79 24.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.04 0.936 . . . . 0.0 109.546 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -156.2 162.52 40.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.994 0.918 . . . . 0.0 108.97 -167.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -115.02 148.91 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 p -121.42 -9.07 9.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.684 1.594 . . . . 0.0 109.455 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -150.44 143.08 24.55 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.696 1.598 . . . . 0.0 107.57 166.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.5 140.9 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -136.46 143.39 43.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.527 1.531 . . . . 0.0 106.87 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -140.1 147.98 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -127.28 154.32 45.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -133.04 143.6 49.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -158.37 170.8 21.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.037 . . . . 0.0 109.752 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.06 5.47 44.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.829 0.852 . . . . 0.0 110.981 171.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 m -71.53 73.31 0.75 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.755 2.022 . . . . 0.0 111.59 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.16 140.92 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.444 -0.785 . . . . 0.0 109.763 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -78.58 -23.72 45.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.524 0.73 . . . . 0.0 111.394 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.68 48.14 13.53 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -167.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.78 154.87 43.67 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.477 1.111 . . . . 0.0 109.662 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -136.42 8.32 3.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.856 0.862 . . . . 0.0 112.438 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -149.13 166.47 28.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.519 1.528 . . . . 0.0 108.417 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -76.87 163.11 27.06 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.4 m -140.07 152.57 46.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.805 1.242 . . . . 0.0 109.331 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mt -135.11 116.44 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.65 144.64 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.37 5.09 3.74 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.679 1.192 . . . . 0.0 111.54 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.251 1.162 0 C-N-CA 125.073 1.349 . . . . 0.0 110.72 178.356 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttp . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.01 176.99 7.19 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.878 -1.139 . . . . 0.0 111.891 -159.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -145.4 156.32 43.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.23 1.812 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.2 165.67 15.08 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.53 0.732 . . . . 0.0 110.508 161.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -128.09 143.28 51.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 149.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 57' ' ' VAL . 98.0 mt -137.62 138.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.36 133.38 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.18 153.33 18.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 111.24 -169.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.42 145.93 35.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.034 1.734 . . . . 0.0 107.447 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.24 -154.12 25.76 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -172.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -78.05 88.31 4.19 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 157.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.96 3.28 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.761 1.224 . . . . 0.0 111.092 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -145.92 142.01 28.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.333 1.053 . . . . 0.0 109.391 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.69 159.51 8.09 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.025 2.25 . . . . 0.0 108.232 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.13 -29.22 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.104 0.562 . . . . 0.0 112.397 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.86 -41.79 3.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.09 -29.6 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 117.581 -1.2 . . . . 0.0 113.458 -169.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -103.7 -4.12 24.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.201 1.364 . . . . 0.0 114.093 167.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -62.99 -35.87 81.64 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.108 1.322 . . . . 0.0 109.025 161.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.55 -50.26 24.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.002 0.819 . . . . 0.0 112.564 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.64 -40.07 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 119.215 0.916 . . . . 0.0 109.898 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -74.25 -23.65 59.18 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.631 -1.293 . . . . 0.0 112.152 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.24 82.46 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 169.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -62.79 -37.38 86.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.083 0.856 . . . . 0.0 109.91 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.53 57.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.13 0.572 . . . . 0.0 109.856 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.82 -46.16 91.62 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.253 0.621 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -58.11 -28.1 64.33 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.892 1.277 . . . . 0.0 111.937 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -107.4 12.43 28.0 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.914 1.286 . . . . 0.0 111.159 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 49.61 31.91 4.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 112.742 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.5 mt -73.88 164.09 27.09 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 168.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.66 135.67 31.9 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.79 -165.79 38.99 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -140.15 161.77 36.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.648 0.779 . . . . 0.0 111.987 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.81 143.08 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.48 1.112 . . . . 0.0 108.625 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -143.95 163.09 34.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.962 1.705 . . . . 0.0 108.435 -164.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -115.21 120.63 40.36 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -75.92 147.23 39.11 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.27 -28.34 66.64 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.377 0.671 . . . . 0.0 112.084 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.01 0.924 . . . . 0.0 112.461 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.36 -29.4 3.17 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.173 1.368 . . . . 0.0 112.225 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.75 152.2 31.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.911 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.34 148.1 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 160.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -128.38 144.6 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.69 141.35 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -146.15 125.76 13.33 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.69 161.07 42.93 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.019 0.528 . . . . 0.0 110.409 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.31 154.47 22.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.409 1.483 . . . . 0.0 108.051 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 179.32 40.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.39 0.519 . . . . 0.0 111.826 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.24 157.44 59.43 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.325 2.016 . . . . 0.0 110.793 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.08 -49.25 74.33 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.148 0.979 . . . . 0.0 111.527 -170.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -66.84 -38.06 85.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 119.406 -0.331 . . . . 0.0 111.395 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.88 74.02 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.238 0.615 . . . . 0.0 109.714 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.98 -44.61 96.38 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.352 0.661 . . . . 0.0 110.803 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.31 -34.7 55.35 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.766 -0.584 . . . . 0.0 111.583 -173.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -68.85 -35.39 76.87 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.305 -0.872 . . . . 0.0 110.743 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.99 -48.72 79.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.316 0.646 . . . . 0.0 109.549 168.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 6' ' ' ILE . 42.1 t -55.81 -42.97 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.19 0.904 . . . . 0.0 109.67 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.48 -41.91 97.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.401 1.0 . . . . 0.0 111.419 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -40.98 82.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.006 0.923 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.39 -52.49 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.86 0.755 . . . . 0.0 109.5 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.77 -39.17 90.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.132 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -64.33 -21.07 66.49 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.298 1.039 . . . . 0.0 111.904 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.62 172.83 21.55 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -152.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 p -139.65 -179.98 1.15 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 121.839 -0.8 . . . . 0.0 110.031 -164.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.16 -24.62 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.461 2.774 . . . . 0.0 115.742 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.95 2.6 0.44 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 m -126.62 159.1 34.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.56 1.527 . . . . 0.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 145.83 20.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.333 0.969 . . . . 0.0 111.175 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.01 156.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -122.59 -12.46 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.62 1.568 . . . . 0.0 109.506 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -150.07 145.92 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.362 1.465 . . . . 0.0 108.185 165.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.38 144.25 16.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.773 1.229 . . . . 0.0 108.503 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m -139.29 145.64 39.37 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.726 1.611 . . . . 0.0 107.355 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.12 144.27 29.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.8 m -130.91 151.09 51.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.48 145.99 50.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.5 m -147.55 -176.59 5.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.987 1.315 . . . . 0.0 109.263 -167.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -127.73 10.33 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 110.977 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -67.66 -29.46 68.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.788 1.235 . . . . 0.0 114.02 -161.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.9 mt 62.04 171.82 0.13 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.351 1.86 . . . . 0.0 111.924 -170.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -139.03 -30.96 0.72 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.597 1.159 . . . . 0.0 111.412 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.79 30.47 77.29 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -72.86 164.0 27.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.04 1.336 . . . . 0.0 108.922 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.82 11.59 4.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.623 0.769 . . . . 0.0 111.763 -173.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -145.84 167.47 23.14 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.221 1.008 . . . . 0.0 109.253 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -89.04 141.94 28.06 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 139.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -133.14 163.35 29.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.502 0.721 . . . . 0.0 110.758 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 mt -138.06 127.39 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.82 162.58 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.537 1.135 . . . . 0.0 107.95 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -143.9 -28.3 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.619 0.768 . . . . 0.0 112.199 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.388 1.475 . . . . 0.0 111.048 176.448 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.416 0.151 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mp -134.19 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.596 1.159 . . . . 0.0 111.051 -160.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.32 154.08 42.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.46 1.904 . . . . 0.0 107.401 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -118.7 164.62 15.09 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.453 0.701 . . . . 0.0 110.51 165.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -125.67 140.83 52.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 147.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.52 142.98 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 137.49 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.87 149.79 23.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.202 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -138.96 155.71 47.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.572 1.549 . . . . 0.0 107.807 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.71 -156.35 25.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -79.75 65.98 5.08 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 163.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 27.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.133 0.973 . . . . 0.0 111.076 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.366 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.66 -45.48 75.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.941 0.791 . . . . 0.0 109.931 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.32 -50.29 65.28 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.2 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.4 -38.92 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.463 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -71.67 -22.58 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 113.078 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.1 mtm -64.32 -46.75 82.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.637 1.108 . . . . 0.0 108.826 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.79 -31.33 72.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.54 -54.79 41.16 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.988 0.915 . . . . 0.0 109.675 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.15 -40.49 96.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.957 0.503 . . . . 0.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -55.21 -28.7 54.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.122 . . . . 0.0 111.887 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -118.59 20.71 12.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.697 0.799 . . . . 0.0 111.617 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 41.59 42.14 1.91 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.771 2.428 . . . . 0.0 113.67 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.47 163.67 27.64 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.08 130.76 17.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.74 -162.52 34.17 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.029 -168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -130.86 161.7 31.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.047 . . . . 0.0 112.168 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.43 148.12 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.948 1.299 . . . . 0.0 109.22 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.99 156.75 43.0 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.243 1.817 . . . . 0.0 108.143 -170.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -115.54 121.48 42.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.18 151.26 36.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.487 1.115 . . . . 0.0 109.177 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.14 -28.7 69.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.976 0.51 . . . . 0.0 111.382 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -7.63 48.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.153 0.981 . . . . 0.0 113.259 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.81 -19.57 32.92 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.03 1.3 . . . . 0.0 113.265 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.33 163.66 22.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.918 1.359 . . . . 0.0 110.435 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.89 149.77 5.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 158.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -135.23 144.91 47.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -141.33 144.78 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.85 130.1 13.69 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.07 154.51 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.102 0.864 . . . . 0.0 111.07 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.24 157.16 16.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.927 1.291 . . . . 0.0 109.838 168.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 178.49 40.31 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.715 0.674 . . . . 0.0 112.577 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.49 155.69 40.72 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.311 2.008 . . . . 0.0 110.174 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.27 -47.54 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 111.432 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.06 -39.62 93.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.941 0.337 . . . . 0.0 111.248 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.95 -46.66 77.33 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.02 0.373 . . . . 0.0 110.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 77.4 mt -62.12 -43.19 99.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.687 0.795 . . . . 0.0 110.509 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -71.83 -38.7 70.12 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.757 -0.589 . . . . 0.0 111.918 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.4 m -62.57 -39.56 94.06 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.664 -0.648 . . . . 0.0 110.075 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -60.75 -46.95 88.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.695 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.76 -44.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 119.861 1.21 . . . . 0.0 109.486 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -62.16 -42.04 98.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.972 0.805 . . . . 0.0 111.408 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.39 87.87 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.025 0.93 . . . . 0.0 111.901 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.76 -54.74 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.26 -38.67 80.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.403 1.081 . . . . 0.0 112.062 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.31 -26.23 68.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.135 0.574 . . . . 0.0 111.69 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.34 47.28 91.63 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -53.08 -39.63 72.39 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.901 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -66.23 -174.81 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.806 3.004 . . . . 0.0 114.841 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -63.42 -37.03 85.71 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.319 1.048 . . . . 0.0 111.045 164.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.1 m -70.06 137.98 51.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.377 1.071 . . . . 0.0 108.244 165.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 150.7 35.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.415 0.552 . . . . 0.0 111.049 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.08 151.38 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.152 1.381 . . . . 0.0 107.998 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -128.45 -11.55 5.07 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.099 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -151.56 140.57 21.11 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.652 1.181 . . . . 0.0 108.957 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.1 tt -140.98 149.08 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.793 1.237 . . . . 0.0 108.746 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 m -139.13 144.88 38.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.04 143.0 34.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.6 m -130.04 150.84 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 153.44 50.88 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.529 0.731 . . . . 0.0 110.415 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.6 m -151.53 173.77 14.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.498 1.519 . . . . 0.0 109.208 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 1.33 24.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.901 1.28 . . . . 0.0 110.988 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -72.69 75.73 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.74 2.016 . . . . 0.0 111.839 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.67 153.76 9.99 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.58 -0.7 . . . . 0.0 110.41 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.99 -26.29 7.36 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.781 1.232 . . . . 0.0 110.671 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.11 24.22 59.92 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -163.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 139.78 49.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.685 1.243 . . . . 0.0 108.332 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -134.41 14.58 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.082 . . . . 0.0 111.705 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.2 171.94 15.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.444 1.497 . . . . 0.0 109.111 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -98.33 153.59 18.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -140.38 154.15 46.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 110.075 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.74 111.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.237 0.421 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 173.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.46 178.53 7.53 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.979 -1.076 . . . . 0.0 110.062 -167.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -152.91 158.48 42.19 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.988 1.715 . . . . 0.0 108.549 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -123.37 165.99 16.09 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.991 0.916 . . . . 0.0 110.465 168.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -131.03 135.82 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 151.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.27 145.43 33.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.92 138.8 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 170.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.53 146.27 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.136 0.975 . . . . 0.0 109.938 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.87 157.17 46.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 108.805 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.05 25.11 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -81.4 92.61 6.46 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 160.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.77 10.42 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.487 1.515 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 . . . . . 0 N--CA 1.465 0.287 0 O-C-N 120.917 -1.114 . . . . 0.0 110.663 -178.66 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.54 -35.43 80.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.414 1.007 . . . . 0.0 110.608 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -50.22 66.22 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.732 1.151 . . . . 0.0 110.728 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.8 -33.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.218 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -74.11 -25.31 59.71 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.854 1.207 . . . . 0.0 112.278 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -62.83 -47.56 82.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.902 0.773 . . . . 0.0 109.139 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -66.67 -29.66 69.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.613 0.365 . . . . 0.0 110.835 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.866 1.266 . . . . 0.0 109.975 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.27 -39.75 91.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.947 0.499 . . . . 0.0 111.197 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.29 -18.77 51.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.634 1.173 . . . . 0.0 112.545 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -114.59 15.17 17.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.012 1.278 . . . . 0.0 111.389 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.87 33.17 2.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.29 1.836 . . . . 0.0 112.724 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.97 161.96 29.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.18 134.82 42.56 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.2 -172.93 42.98 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 118.182 0.446 . . . . 0.0 112.107 -164.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -135.09 162.39 32.61 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.521 0.729 . . . . 0.0 112.124 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.83 149.76 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.562 1.145 . . . . 0.0 108.84 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.42 156.02 42.49 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.51 1.924 . . . . 0.0 107.585 -170.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.32 122.57 45.3 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -76.88 159.73 29.79 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.135 0.974 . . . . 0.0 110.337 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -61.19 -30.17 70.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.246 0.618 . . . . 0.0 111.458 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -10.19 57.96 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.98 -23.84 24.6 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.527 1.536 . . . . 0.0 112.204 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -87.81 166.09 14.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.229 1.514 . . . . 0.0 110.469 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.9 150.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -133.51 143.41 48.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.89 1.276 . . . . 0.0 107.667 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.05 142.71 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.64 123.55 10.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -154.26 162.98 40.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.413 0.552 . . . . 0.0 110.818 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.61 151.75 32.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 109.871 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.54 177.92 40.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.23 1.395 . . . . 0.0 110.351 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 154.45 67.79 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.353 2.035 . . . . 0.0 110.086 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.0 -42.42 76.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.558 0.743 . . . . 0.0 111.577 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.02 -41.19 99.49 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.148 -0.345 . . . . 0.0 111.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.48 84.19 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.988 0.515 . . . . 0.0 109.987 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 4' ' ' TYR . 86.4 mt -62.92 -43.34 99.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.565 0.746 . . . . 0.0 110.699 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -70.48 -40.9 73.34 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.636 -0.665 . . . . 0.0 111.697 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.5 m -59.8 -39.9 86.54 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.059 -0.401 . . . . 0.0 110.019 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -61.87 -47.43 85.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.952 173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -53.99 -46.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.078 1.308 . . . . 0.0 109.593 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -61.78 -39.99 93.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.001 0.364 . . . . 0.0 111.039 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.75 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.282 0.633 . . . . 0.0 111.899 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.73 -49.44 80.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -57.86 -41.64 82.86 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.036 0.534 . . . . 0.0 110.826 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -72.12 -20.78 61.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.125 0.97 . . . . 0.0 112.451 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 40.81 92.67 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.365 0.984 . . . . 0.0 111.832 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 m -46.47 -54.33 19.15 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -160.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.36 -52.28 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 121.797 1.678 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -167.82 158.43 10.82 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.253 2.221 . . . . 0.0 107.412 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 p 129.48 176.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 131.713 4.005 . . . . 0.0 108.717 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.77 157.74 43.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 145.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.21 137.65 56.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -126.39 -5.69 6.53 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.233 1.413 . . . . 0.0 110.788 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.17 134.12 13.97 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.363 1.865 . . . . 0.0 106.405 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.42 138.42 21.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.0 m -140.58 147.82 40.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.92 143.63 28.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.1 m -130.19 152.44 49.62 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -129.2 145.07 51.4 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.4 m -143.61 167.65 21.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.902 1.281 . . . . 0.0 109.582 -160.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.73 1.89 10.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 110.971 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.6 m -65.91 -26.17 67.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.145 0.978 . . . . 0.0 112.709 -173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.5 mt 60.82 175.76 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.381 1.872 . . . . 0.0 111.414 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.8 -16.52 0.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.023 0.929 . . . . 0.0 113.046 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.8 90.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.221 -1.322 . . . . 0.0 116.198 155.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -81.83 178.41 8.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.039 1.919 . . . . 0.0 109.929 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -130.16 17.24 5.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.554 1.541 . . . . 0.0 110.718 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -149.38 167.54 25.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.551 1.541 . . . . 0.0 109.292 -172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -86.04 151.63 23.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 163.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -142.95 162.34 35.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.838 0.855 . . . . 0.0 110.53 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.59 114.82 18.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.095 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.205 -0.426 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.13 177.42 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.882 1.219 . . . . 0.0 111.248 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -146.79 155.22 42.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.675 2.39 . . . . 0.0 108.081 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.465 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -119.44 165.18 14.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.99 0.916 . . . . 0.0 110.426 169.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -131.06 133.78 46.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 154.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.45 141.63 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.68 128.73 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.16 137.59 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.67 1.188 . . . . 0.0 109.83 -164.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -131.44 150.83 52.0 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.655 1.182 . . . . 0.0 108.393 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -152.65 24.74 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.55 78.88 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 164.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.71 4.17 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.651 0.78 . . . . 0.0 111.892 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.235 0.322 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.281 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -72.33 -45.42 60.01 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.897 1.226 . . . . 0.0 108.97 163.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -48.68 64.12 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.964 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 m -62.12 -37.1 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 119.802 1.183 . . . . 0.0 110.791 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -73.53 -23.18 59.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.5 1.5 . . . . 0.0 112.273 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.4 mtm -62.94 -47.07 84.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.262 0.937 . . . . 0.0 109.34 165.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -66.65 -32.6 74.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.494 . . . . 0.0 110.804 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.51 72.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.585 1.154 . . . . 0.0 109.583 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.34 -42.07 99.09 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 111.235 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.01 -21.49 45.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.635 1.174 . . . . 0.0 112.255 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 16.22 12.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.995 -1.066 . . . . 0.0 111.947 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? 45.69 38.57 4.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.869 2.067 . . . . 0.0 112.31 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.5 mt -75.66 164.23 26.51 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.73 130.98 22.07 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.71 -162.07 33.63 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.39 163.63 30.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.626 0.713 . . . . 0.0 111.994 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.42 142.53 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.058 0.943 . . . . 0.0 109.732 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -149.21 151.86 35.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 125.3 1.44 . . . . 0.0 108.248 -162.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 120.07 29.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 166.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -74.21 153.24 39.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.96 -25.52 67.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.884 0.874 . . . . 0.0 112.341 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.54 -27.64 67.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.382 1.073 . . . . 0.0 112.104 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.21 -31.78 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.318 1.437 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -68.32 163.67 22.49 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.732 0.766 . . . . 0.0 110.54 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.35 156.53 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -134.05 141.53 47.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.658 1.583 . . . . 0.0 107.881 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -134.03 141.01 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.4 tt -149.91 119.41 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.2 160.23 42.78 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.488 0.715 . . . . 0.0 111.205 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 12.9 pt-20 -106.83 154.93 20.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.179 1.392 . . . . 0.0 110.313 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 175.61 37.63 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.057 1.313 . . . . 0.0 111.001 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.89 153.43 68.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.146 1.897 . . . . 0.0 110.261 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -55.33 -43.32 74.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.653 0.781 . . . . 0.0 111.533 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -62.69 -40.43 97.1 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.245 -0.284 . . . . 0.0 111.459 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.64 74.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 4' ' ' TYR . 91.9 mt -59.14 -44.87 92.08 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.45 0.7 . . . . 0.0 110.023 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -68.87 -40.51 79.25 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.88 -0.512 . . . . 0.0 111.955 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -60.67 -42.68 97.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.567 0.621 . . . . 0.0 110.063 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -59.53 -48.97 79.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.432 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.72 -42.92 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.953 1.251 . . . . 0.0 110.0 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.17 -41.89 99.3 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.871 0.76 . . . . 0.0 110.743 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.82 96.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.657 0.783 . . . . 0.0 111.366 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.1 -52.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -56.75 -41.63 77.89 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.81 0.844 . . . . 0.0 111.046 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -72.75 -20.96 61.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.018 -0.515 . . . . 0.0 112.365 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.73 40.42 48.72 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.436 1.017 . . . . 0.0 111.906 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -45.63 -53.94 17.58 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -157.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -49.65 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 CA-C-N 121.481 1.565 . . . . 0.0 112.216 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 67' ' ' SER . 17.5 p90 -167.48 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.012 0.925 . . . . 0.0 112.718 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 66' ' ' PHE 0.269 1.4 m -62.63 -57.32 11.49 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -120.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 161.63 40.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 130.277 3.431 . . . . 0.0 108.511 -5.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.54 157.18 7.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.318 0.647 . . . . 0.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.2 p -127.21 -11.88 5.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.22 1.408 . . . . 0.0 110.378 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.22 144.83 25.87 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.926 1.291 . . . . 0.0 108.471 172.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.28 144.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.0 108.217 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 m -139.46 145.29 38.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.337 1.455 . . . . 0.0 107.219 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.07 142.69 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.375 1.07 . . . . 0.0 108.281 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -132.45 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.396 1.878 . . . . 0.0 106.048 168.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -137.99 149.04 45.75 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 m -148.76 162.83 38.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.375 1.47 . . . . 0.0 109.114 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.11 -13.24 57.55 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.602 -0.686 . . . . 0.0 111.362 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 88.83 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 111.899 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.84 147.58 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.531 0.732 . . . . 0.0 110.26 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -81.95 -28.2 32.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.892 0.877 . . . . 0.0 112.026 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.98 68.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.038 0.828 . . . . 0.0 111.219 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.67 150.17 34.58 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.808 1.304 . . . . 0.0 109.378 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -134.76 9.37 3.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.958 0.903 . . . . 0.0 112.547 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -149.26 177.55 9.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.149 1.38 . . . . 0.0 109.158 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -101.79 145.02 29.74 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 163.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 161.81 37.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.628 0.728 . . . . 0.0 111.431 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.1 mt -133.88 126.86 51.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 109.656 -163.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp -129.29 176.03 8.26 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.686 -1.259 . . . . 0.0 111.18 -165.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.55 152.8 38.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.844 1.658 . . . . 0.0 109.183 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -125.68 165.22 18.98 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.387 1.075 . . . . 0.0 111.054 169.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -134.28 133.41 40.73 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 158.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.41 142.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.54 133.26 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.65 141.92 29.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.71 151.77 49.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.888 1.275 . . . . 0.0 108.054 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.61 -153.75 25.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -76.72 82.45 3.34 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 158.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -107.59 -1.63 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.538 HE22 ' HB3' ' A' ' 18' ' ' ARG . 9.9 mm-40 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.7 ptt-85 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -69.08 -23.56 64.04 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 117.608 -1.186 . . . . 0.0 111.125 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.04 -52.14 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.283 1.402 . . . . 0.0 111.736 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.51 -31.83 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.716 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -66.51 -31.14 71.69 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.872 1.214 . . . . 0.0 112.288 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.7 mtm -65.76 -49.94 66.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.456 1.026 . . . . 0.0 108.637 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -67.8 -33.12 74.19 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.205 0.457 . . . . 0.0 110.875 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -53.21 57.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.482 1.113 . . . . 0.0 110.336 173.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.13 -40.05 93.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.561 0.745 . . . . 0.0 111.288 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -53.52 -28.14 29.61 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.165 1.386 . . . . 0.0 111.817 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -118.58 22.8 11.86 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.567 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 tttt 50.21 36.18 11.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.506 1.922 . . . . 0.0 113.089 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.69 163.6 27.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.23 126.18 21.02 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.1 -161.86 29.72 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.926 0.785 . . . . 0.0 113.148 -168.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -135.06 166.09 23.87 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.79 144.0 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.754 1.221 . . . . 0.0 108.818 162.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.0 161.74 40.19 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.818 0.847 . . . . 0.0 110.34 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.76 148.06 38.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 158.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -126.08 140.29 52.71 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.929 1.291 . . . . 0.0 107.785 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.11 -24.78 63.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.402 1.481 . . . . 0.0 114.318 -163.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.0 -23.03 65.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.188 0.595 . . . . 0.0 112.301 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 37.16 1.39 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.753 1.168 . . . . 0.0 111.123 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -145.81 163.88 33.65 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.358 1.063 . . . . 0.0 109.144 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.26 150.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.26 143.17 51.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.405 1.882 . . . . 0.0 107.259 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -137.6 139.32 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -150.04 126.58 10.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.11 161.96 39.42 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 119.049 0.84 . . . . 0.0 111.374 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.99 154.3 23.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.177 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.39 177.29 39.9 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.312 0.958 . . . . 0.0 111.53 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.28 157.59 53.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.771 2.314 . . . . 0.0 110.757 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -55.37 -53.29 58.09 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.526 0.731 . . . . 0.0 111.511 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -59.98 -37.49 79.81 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.967 -0.458 . . . . 0.0 111.527 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.36 76.25 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 4' ' ' TYR . 90.2 mt -62.28 -47.13 85.69 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.467 0.707 . . . . 0.0 110.534 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -68.53 -42.09 78.96 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.888 -0.508 . . . . 0.0 111.339 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 m -63.37 -37.74 88.46 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.765 -0.584 . . . . 0.0 110.204 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.6 -45.54 93.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.448 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t -55.23 -45.61 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 120.013 1.279 . . . . 0.0 109.535 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.4 -41.01 88.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.043 0.383 . . . . 0.0 111.031 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.79 95.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.14 0.976 . . . . 0.0 111.631 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.55 -50.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.179 0.9 . . . . 0.0 108.668 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -58.77 -41.63 87.07 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.703 0.401 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -71.41 -22.14 61.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.073 0.549 . . . . 0.0 112.393 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.1 39.12 40.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.944 1.259 . . . . 0.0 112.756 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -41.11 -50.05 8.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -159.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.81 -31.49 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.649 1.625 . . . . 0.0 114.704 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -164.26 -31.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.083 1.31 . . . . 0.0 113.264 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.03 170.87 13.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.799 1.64 . . . . 0.0 111.723 -170.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.13 145.03 19.15 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -83.92 153.23 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.6 p -118.25 -14.17 9.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.065 1.346 . . . . 0.0 109.376 165.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.64 137.89 21.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.328 1.451 . . . . 0.0 107.68 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tt -144.61 136.49 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 m -133.77 142.69 48.03 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.84 141.48 40.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -172.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.27 146.2 51.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 171.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.55 154.72 46.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.809 0.731 . . . . 0.0 110.102 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -147.89 176.72 9.92 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.878 1.671 . . . . 0.0 108.245 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -119.46 -7.16 10.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.719 0.808 . . . . 0.0 110.191 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m -70.22 100.54 1.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.623 1.169 . . . . 0.0 108.851 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.3 155.26 9.2 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.97 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.6 -27.74 51.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.668 0.787 . . . . 0.0 110.967 170.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.38 30.62 58.27 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -161.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.11 155.09 35.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.116 0.958 . . . . 0.0 110.202 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.39 14.57 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.345 1.058 . . . . 0.0 111.291 -173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -149.34 172.49 14.83 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.846 1.658 . . . . 0.0 108.644 -170.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -133.42 119.97 20.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 160.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -136.93 156.78 48.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -153.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.45 124.84 64.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.5 t . . . . . 0 C--O 1.237 0.42 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.234 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.87 177.85 8.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.613 1.097 . . . . 0.0 110.513 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.84 153.49 32.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.411 1.884 . . . . 0.0 108.968 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.426 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.2 p90 -114.18 163.42 15.25 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.81 0.844 . . . . 0.0 109.785 166.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -131.41 138.23 49.0 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 151.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.02 145.64 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -169.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.44 139.28 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 167.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.47 151.1 29.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.47 152.82 49.95 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.63 1.572 . . . . 0.0 107.147 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.76 -155.46 26.55 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -78.51 60.28 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 162.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -85.73 18.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.287 -0.883 . . . . 0.0 111.713 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 167.032 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -76.32 -32.51 58.76 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.454 1.479 . . . . 0.0 111.493 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.97 -45.93 75.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.073 1.306 . . . . 0.0 109.967 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.74 -47.96 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.099 0.959 . . . . 0.0 109.285 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -70.05 -25.7 63.68 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.306 1.412 . . . . 0.0 113.45 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.1 mtm -65.5 -48.05 73.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.2 1.364 . . . . 0.0 109.097 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -66.67 -35.06 79.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.307 0.643 . . . . 0.0 110.048 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.31 47.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.555 1.142 . . . . 0.0 109.791 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.08 -39.6 92.98 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.284 0.634 . . . . 0.0 111.406 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -16.09 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 0.0 112.576 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.53 17.57 16.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.304 1.442 . . . . 0.0 110.915 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 49.39 30.36 3.26 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.12 1.768 . . . . 0.0 112.911 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 mt -77.31 160.09 29.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.24 134.86 18.63 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.959 0.504 . . . . 0.0 110.584 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.57 -161.06 31.09 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.086 1.326 . . . . 0.0 110.545 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -106.09 162.29 13.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.226 1.513 . . . . 0.0 113.298 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.14 146.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.697 1.199 . . . . 0.0 108.001 163.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -154.13 155.37 35.24 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 108.958 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -99.72 123.74 44.28 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 161.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -80.3 147.3 31.2 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.04 -27.8 65.83 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.491 0.716 . . . . 0.0 112.25 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.61 -27.44 68.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.338 1.055 . . . . 0.0 112.81 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.06 -21.74 5.48 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.9 1.238 . . . . 0.0 112.322 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.38 157.0 11.77 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.056 0.928 . . . . 0.0 110.753 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -96.6 146.68 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 149.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.54 144.57 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.907 1.683 . . . . 0.0 106.812 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.54 142.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -148.32 123.02 9.88 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.84 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.293 0.951 . . . . 0.0 111.255 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.87 155.43 16.78 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.228 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 177.18 41.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.412 1.482 . . . . 0.0 111.077 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.88 159.78 49.56 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.725 2.283 . . . . 0.0 110.321 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 -48.14 78.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.232 0.613 . . . . 0.0 111.602 -168.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.79 -37.45 86.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.666 0.386 . . . . 0.0 111.852 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -46.3 87.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 4' ' ' TYR . 81.4 mt -59.53 -45.11 92.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.108 0.563 . . . . 0.0 109.556 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.49 -44.83 85.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.769 0.713 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.7 m -60.98 -42.31 98.12 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.849 0.46 . . . . 0.0 109.99 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.54 -48.08 83.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.062 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.0 t -56.96 -41.27 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.913 1.233 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.75 -41.93 99.44 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.692 0.678 . . . . 0.0 110.851 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.0 86.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.676 0.79 . . . . 0.0 111.756 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.01 -55.48 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.25 -38.47 83.56 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.709 0.804 . . . . 0.0 111.263 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.55 -24.75 67.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.47 0.708 . . . . 0.0 112.154 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.2 97.83 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 m -49.72 -45.87 79.52 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.83 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.728 1.653 . . . . 0.0 112.299 -166.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.2 t80 179.51 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.31 2.244 . . . . 0.0 106.094 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -58.85 141.23 53.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 157.1 40.03 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.971 0.909 . . . . 0.0 110.325 -171.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.96 157.08 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -119.77 -13.91 9.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.004 1.321 . . . . 0.0 109.708 158.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 141.22 25.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.87 1.268 . . . . 0.0 108.547 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.63 135.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.4 m -132.36 140.77 48.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.249 1.419 . . . . 0.0 107.206 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.7 t -140.19 145.53 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -168.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.0 m -127.79 140.72 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 161.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.92 134.34 23.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m -139.1 155.71 47.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.054 0.941 . . . . 0.0 109.983 -162.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -4.85 57.22 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.55 0.74 . . . . 0.0 110.877 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 m -58.57 165.6 2.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.617 1.167 . . . . 0.0 110.361 161.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.3 162.92 40.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.239 1.816 . . . . 0.0 108.173 167.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -79.42 -29.67 42.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.317 0.647 . . . . 0.0 111.823 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.92 54.06 6.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -162.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -51.11 153.63 1.85 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.595 1.158 . . . . 0.0 113.319 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -135.95 -3.88 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.866 1.266 . . . . 0.0 111.715 166.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -156.96 172.06 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.52 1.528 . . . . 0.0 109.158 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.92 140.65 38.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 162.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -148.68 153.92 38.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.813 0.816 . . . . 0.0 112.834 -150.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.46 115.63 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.237 0.398 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 164.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.3 177.03 11.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.499 -0.751 . . . . 0.0 112.773 -161.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -148.48 154.36 39.73 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.609 2.364 . . . . 0.0 108.216 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.07 165.86 17.43 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.551 0.74 . . . . 0.0 110.437 161.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -133.61 141.59 47.72 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 157.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mt -137.45 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.42 140.26 48.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 143.66 21.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.488 0.715 . . . . 0.0 109.702 -166.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -144.11 153.47 42.19 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.972 1.309 . . . . 0.0 108.347 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.74 -157.65 27.43 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 107.524 -2.231 . . . . 0.0 107.524 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -78.22 75.86 4.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 158.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.06 25.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 164.762 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -64.47 -45.31 87.91 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -55.69 -50.03 71.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.623 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.24 -36.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.592 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -74.97 -19.4 60.12 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.642 -1.286 . . . . 0.0 113.069 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -65.22 -48.93 71.65 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.965 1.257 . . . . 0.0 108.708 164.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -65.7 -22.85 66.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 111.383 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.16 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.028 0.931 . . . . 0.0 109.261 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.64 -37.76 71.2 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.502 1.121 . . . . 0.0 111.468 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -49.53 -38.41 30.63 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.882 1.673 . . . . 0.0 112.406 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -112.71 16.78 19.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.24 1.416 . . . . 0.0 111.468 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.77 5.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.636 1.574 . . . . 0.0 112.079 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.5 155.71 40.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.4 133.97 30.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.89 -171.33 42.85 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.937 -166.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -117.06 161.46 19.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.977 0.889 . . . . 0.0 111.541 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.72 142.71 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 158.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -144.37 157.7 44.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.486 1.515 . . . . 0.0 108.357 -164.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -118.06 121.23 40.05 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -75.58 154.28 36.84 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.12 -28.14 67.62 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 0.0 110.759 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.8 -16.1 37.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.787 2.035 . . . . 0.0 113.38 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -37.63 3.72 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.116 1.341 . . . . 0.0 111.525 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.61 150.85 11.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.149 0.979 . . . . 0.0 110.321 171.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.36 157.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 162.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.99 147.48 40.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -138.4 139.69 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -150.29 124.04 9.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.82 162.2 40.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 119.248 0.931 . . . . 0.0 110.896 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.94 156.87 24.23 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.611 1.564 . . . . 0.0 109.714 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.36 40.51 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.828 0.728 . . . . 0.0 111.596 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.22 151.82 49.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.024 1.816 . . . . 0.0 110.477 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.53 -48.57 78.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.387 1.075 . . . . 0.0 111.29 -170.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -64.53 -40.31 95.38 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.262 -0.273 . . . . 0.0 111.339 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 -48.56 75.76 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.78 -43.78 98.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.173 0.589 . . . . 0.0 110.458 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.86 -35.45 76.92 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.482 -0.761 . . . . 0.0 111.299 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 m -62.85 -41.18 99.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.644 -0.66 . . . . 0.0 110.703 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -58.8 -46.91 86.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.243 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.28 -41.92 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.866 1.212 . . . . 0.0 109.521 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.37 -41.18 98.42 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.19 88.86 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.688 0.795 . . . . 0.0 111.748 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.12 -53.24 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.6 -37.93 76.88 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.355 1.062 . . . . 0.0 111.808 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.27 -24.12 67.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.18 0.592 . . . . 0.0 112.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.58 40.13 98.31 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 m -52.82 -44.73 96.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.7 -164.44 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.472 2.115 . . . . 0.0 112.302 -166.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -1.47 0.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.504 2.722 . . . . 0.0 115.616 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.9 m -141.85 148.09 38.24 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.889 2.076 . . . . 0.0 106.304 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.4 154.49 35.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.983 0.811 . . . . 0.0 111.434 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.62 155.62 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.259 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -121.4 -11.75 8.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.187 1.395 . . . . 0.0 109.595 162.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.13 143.04 25.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.283 1.433 . . . . 0.0 108.383 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -148.71 140.42 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -138.33 134.89 34.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.11 144.87 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.702 0.801 . . . . 0.0 109.824 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.1 m -134.43 149.94 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.422 1.889 . . . . 0.0 106.093 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.15 154.45 51.2 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.9 m -155.93 146.5 21.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -71.4 -29.21 64.66 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.538 -0.727 . . . . 0.0 110.95 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.77 121.45 12.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.731 1.212 . . . . 0.0 111.653 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.09 164.17 13.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.47 0.708 . . . . 0.0 109.342 163.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.14 -13.78 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.6 -11.66 7.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.551 158.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.54 145.96 31.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.243 2.021 . . . . 0.0 111.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -132.37 7.65 4.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.891 1.276 . . . . 0.0 111.118 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.11 164.1 35.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.808 1.643 . . . . 0.0 108.564 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -84.15 144.29 29.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 164.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -143.2 157.78 44.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.674 0.79 . . . . 0.0 110.545 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.7 mt -135.5 135.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.418 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.43 176.84 6.23 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.092 -1.005 . . . . 0.0 111.115 -163.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -140.92 152.92 45.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.52 1.928 . . . . 0.0 108.498 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.58 162.13 16.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 162.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -137.98 125.77 22.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 165.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.27 139.93 45.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 134.84 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -138.59 154.02 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 110.518 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.45 146.17 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.731 1.613 . . . . 0.0 107.51 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.77 -156.22 26.74 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -78.72 98.3 6.19 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 161.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.99 12.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.85 1.26 . . . . 0.0 110.244 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 125.012 1.325 . . . . 0.0 109.206 -177.374 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.74 -33.41 64.31 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.728 1.149 . . . . 0.0 109.711 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -56.74 -39.23 73.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.087 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 m -61.52 -37.14 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.456 1.026 . . . . 0.0 110.447 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -74.63 -28.24 60.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.361 0.982 . . . . 0.0 110.817 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 54.6 mtm -62.17 -49.85 74.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.515 0.598 . . . . 0.0 110.591 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -65.96 -34.22 77.6 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.636 0.775 . . . . 0.0 110.356 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.94 70.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.386 1.475 . . . . 0.0 109.923 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.38 -41.05 96.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.901 0.481 . . . . 0.0 111.178 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -14.97 42.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.138 1.375 . . . . 0.0 112.654 174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -116.57 20.76 13.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.419 1.488 . . . . 0.0 110.874 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.3 pttt 43.59 31.36 0.43 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.143 2.177 . . . . 0.0 114.172 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.91 162.09 29.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.91 0.884 . . . . 0.0 109.017 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.08 138.76 37.38 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.58 -170.94 41.36 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.545 0.611 . . . . 0.0 112.29 -164.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -129.44 160.56 32.76 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.043 0.937 . . . . 0.0 111.525 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.29 140.85 46.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 163.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -145.65 144.22 30.3 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.74 0.816 . . . . 0.0 109.0 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.13 146.45 39.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.97 132.62 55.9 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.94 -25.08 64.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.129 0.972 . . . . 0.0 112.697 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.72 -26.67 67.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.335 1.054 . . . . 0.0 112.284 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.38 -19.57 4.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.823 1.678 . . . . 0.0 112.307 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 172.44 10.8 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.318 1.047 . . . . 0.0 110.532 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.75 147.26 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -115.36 143.84 44.67 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.6 1.96 . . . . 0.0 106.83 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.98 134.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -148.37 124.43 10.73 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.85 162.04 41.79 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.24 0.473 . . . . 0.0 110.568 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.89 151.55 29.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.69 1.596 . . . . 0.0 109.551 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.04 40.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.55 1.071 . . . . 0.0 110.949 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.3 158.32 56.6 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.383 2.055 . . . . 0.0 110.384 171.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.12 -46.48 79.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.435 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -64.2 -37.77 88.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.554 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.86 72.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.305 0.642 . . . . 0.0 109.786 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.83 -46.99 88.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.587 0.755 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.74 -38.2 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.736 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -60.55 -42.62 96.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.734 0.697 . . . . 0.0 110.136 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -59.47 -47.27 86.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.637 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.31 -44.97 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 119.885 1.221 . . . . 0.0 110.071 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.82 -39.9 95.73 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.541 0.609 . . . . 0.0 110.902 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.95 98.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.352 0.661 . . . . 0.0 111.334 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -66.02 -50.35 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -58.29 -38.57 77.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.146 0.578 . . . . 0.0 111.104 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.19 -23.74 63.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.0 112.629 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.8 44.62 94.16 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 118.943 0.792 . . . . 0.0 111.561 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -55.97 -50.93 84.48 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -166.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.39 -49.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.786 1.674 . . . . 0.0 113.491 -163.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.55 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 110.27 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -61.92 151.86 33.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.581 0.752 . . . . 0.0 109.633 169.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.25 146.31 23.64 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 154.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.4 p -122.73 -11.88 8.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.668 1.587 . . . . 0.0 109.485 166.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.63 145.44 25.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.384 1.473 . . . . 0.0 107.848 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.5 tt -149.04 141.87 18.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.713 1.205 . . . . 0.0 107.804 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -135.98 140.77 44.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.409 1.484 . . . . 0.0 107.072 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.7 138.52 47.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.4 m -130.11 155.94 45.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -130.39 152.35 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -147.92 178.48 8.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.334 1.453 . . . . 0.0 107.962 -167.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -130.81 15.5 5.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.474 1.11 . . . . 0.0 109.366 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -69.62 -28.56 66.03 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.386 1.475 . . . . 0.0 112.827 -170.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp 57.75 173.71 0.05 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.988 1.715 . . . . 0.0 111.492 -166.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.95 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.126 0.971 . . . . 0.0 112.948 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 -10.56 60.76 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.461 -1.188 . . . . 0.0 115.689 154.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 173.34 12.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.773 1.787 . . . . 0.0 110.085 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -127.91 19.72 6.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.087 1.355 . . . . 0.0 110.145 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 168.09 24.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.128 1.771 . . . . 0.0 108.732 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -88.03 158.3 18.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.79 0.436 . . . . 0.0 110.102 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -141.62 158.82 43.34 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.231 1.013 . . . . 0.0 110.16 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.14 125.14 43.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -161.082 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.17 178.44 8.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.187 2.195 . . . . 0.0 109.364 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -134.73 147.42 50.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.94 2.096 . . . . 0.0 107.937 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.548 0.739 . . . . 0.0 110.045 165.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -134.45 130.95 37.54 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.84 142.7 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 134.7 59.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 170.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.98 147.98 18.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 124.423 1.089 . . . . 0.0 110.257 -170.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -138.07 155.58 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.68 -158.32 27.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -168.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -78.05 90.11 4.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 158.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.73 10.43 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.792 1.237 . . . . 0.0 110.332 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 . . . . . 0 C--N 1.342 0.258 0 CA-C-N 118.776 0.716 . . . . 0.0 111.468 -166.864 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -67.95 -25.43 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.052 0.941 . . . . 0.0 111.621 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -48.67 -43.9 37.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.88 -38.1 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.067 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -73.83 -23.46 59.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.869 1.213 . . . . 0.0 111.465 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.68 -53.57 54.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.295 0.952 . . . . 0.0 110.074 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.66 -37.2 80.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.782 0.433 . . . . 0.0 110.341 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.57 55.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.562 1.145 . . . . 0.0 109.952 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.52 -47.24 86.28 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.585 0.754 . . . . 0.0 110.386 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -58.21 -30.66 66.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.19 1.396 . . . . 0.0 111.731 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.97 10.69 39.47 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.959 1.304 . . . . 0.0 111.379 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? 50.47 32.39 6.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.955 1.702 . . . . 0.0 112.101 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.64 165.95 23.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.117 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.4 20.99 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.13 173.94 36.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.549 0.613 . . . . 0.0 112.677 -169.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -101.09 160.99 13.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.36 1.08 . . . . 0.0 111.858 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.57 144.07 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.887 1.275 . . . . 0.0 107.74 158.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -149.23 159.56 44.15 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 107.703 -171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -112.34 120.74 42.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.987 0.812 . . . . 0.0 109.281 170.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -76.09 146.56 39.26 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.81 -28.53 67.53 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.681 0.792 . . . . 0.0 112.357 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.12 -27.61 69.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.479 0.712 . . . . 0.0 112.479 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.18 -37.13 1.88 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.526 1.06 . . . . 0.0 112.315 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 149.64 49.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.006 0.903 . . . . 0.0 111.314 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.61 150.07 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 167.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -124.13 144.84 49.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.012 1.725 . . . . 0.0 106.502 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -135.95 140.76 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.32 118.8 7.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.15 164.1 34.95 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.402 0.681 . . . . 0.0 111.01 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.47 156.72 29.69 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.526 1.531 . . . . 0.0 109.296 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.81 44.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.53 0.586 . . . . 0.0 111.954 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.76 151.44 63.36 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.206 1.938 . . . . 0.0 110.448 171.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.82 -50.06 64.42 Favored 'General case' 0 C--N 1.334 -0.071 0 C-N-CA 124.22 1.008 . . . . 0.0 111.529 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.37 -36.63 82.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.692 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.88 75.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.61 -46.63 81.81 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.127 0.571 . . . . 0.0 110.522 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -66.96 -42.88 84.44 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 121.759 -0.588 . . . . 0.0 111.138 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 m -68.07 -33.43 74.54 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.678 -0.639 . . . . 0.0 110.927 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -58.95 -50.5 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.557 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.64 -43.83 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.556 1.071 . . . . 0.0 109.424 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.14 -40.32 93.37 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.319 0.509 . . . . 0.0 111.215 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.41 97.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.355 0.662 . . . . 0.0 111.217 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -64.39 -51.54 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.35 -41.38 84.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.666 0.786 . . . . 0.0 111.169 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.22 -24.56 64.03 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 112.0 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.15 48.15 82.05 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m -54.79 -47.0 99.32 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 117.364 -1.303 . . . . 0.0 114.145 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.13 -163.55 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.768 2.312 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -59.42 -31.49 69.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 113.132 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -82.61 145.06 29.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.157 0.889 . . . . 0.0 109.662 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.58 148.56 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.102 0.561 . . . . 0.0 110.033 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.16 156.79 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.206 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -125.91 -8.59 6.63 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.041 1.736 . . . . 0.0 109.915 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.64 141.09 23.32 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.595 1.958 . . . . 0.0 107.49 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.6 tt -152.87 142.44 14.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.427 1.091 . . . . 0.0 108.917 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -142.58 144.5 32.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.092 1.757 . . . . 0.0 107.482 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.79 140.65 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 108.314 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -136.49 157.49 46.66 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.402 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -143.76 159.39 42.59 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.112 -0.992 . . . . 0.0 110.311 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.0 m -144.02 151.97 40.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.117 1.367 . . . . 0.0 108.767 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -87.63 35.27 0.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.308 1.043 . . . . 0.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -139.71 106.64 5.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.327 1.051 . . . . 0.0 108.824 -159.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.01 160.83 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 110.086 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.78 -14.48 0.73 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.943 0.897 . . . . 0.0 113.318 -170.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.06 -2.63 14.49 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.236 155.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -61.11 146.27 48.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 121.001 2.401 . . . . 0.0 110.257 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -129.55 9.47 5.52 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.194 1.398 . . . . 0.0 111.028 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.31 166.5 28.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.565 1.946 . . . . 0.0 107.97 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -80.06 148.23 31.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -141.25 156.74 45.85 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 109.771 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 mt -135.93 113.67 14.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tp -142.88 178.63 7.53 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.992 -1.067 . . . . 0.0 110.129 -166.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -152.31 155.05 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.234 1.814 . . . . 0.0 108.097 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.99 163.02 16.86 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.447 0.699 . . . . 0.0 109.813 166.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -134.93 135.45 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 163.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.39 143.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 138.67 52.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 162.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.94 154.99 26.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 124.124 0.97 . . . . 0.0 110.454 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -146.12 154.65 42.04 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.593 1.557 . . . . 0.0 107.885 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 -155.33 26.09 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.806 -2.118 . . . . 0.0 107.806 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -76.16 83.76 2.99 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.04 5.55 4.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 111.129 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.198 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.264 21.7 ptt-85 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -76.51 -44.07 36.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.116 1.326 . . . . 0.0 110.084 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.84 -48.65 63.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.461 0.704 . . . . 0.0 111.156 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.25 -35.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.287 0.949 . . . . 0.0 110.994 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.86 -24.24 58.55 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.623 1.101 . . . . 0.0 111.892 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.8 mtm -63.5 -48.86 75.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.292 0.951 . . . . 0.0 109.868 166.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.76 -23.49 63.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.913 0.885 . . . . 0.0 111.595 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.79 41.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.81 -39.0 90.21 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.223 0.609 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -14.69 61.16 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 112.257 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.16 20.07 14.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.802 1.641 . . . . 0.0 111.082 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 43.29 31.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.113 2.165 . . . . 0.0 114.252 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.83 161.61 30.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.842 0.857 . . . . 0.0 108.74 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.15 28.93 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 108.271 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.02 -154.69 25.77 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.393 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.06 164.32 26.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.404 1.102 . . . . 0.0 112.815 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.03 141.09 47.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 165.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -132.78 140.59 48.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.89 148.19 52.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 158.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -125.9 145.4 50.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.87 0.868 . . . . 0.0 109.23 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 39' ' ' ASP . 21.7 t70 -57.81 125.88 24.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 164.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 26.5 t0 -121.57 31.79 6.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.627 3.171 . . . . 0.0 109.834 5.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.98 -16.31 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 O-C-N 121.267 -0.895 . . . . 0.0 113.866 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -59.05 161.47 5.1 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.279 1.039 . . . . 0.0 109.795 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.22 147.53 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.34 143.02 46.39 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.211 1.405 . . . . 0.0 107.213 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.49 134.47 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.66 132.18 28.67 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.38 157.71 32.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.328 0.967 . . . . 0.0 110.843 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.68 151.32 25.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.688 1.195 . . . . 0.0 109.446 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.18 178.43 40.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.745 1.164 . . . . 0.0 110.793 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 154.9 69.53 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.179 1.92 . . . . 0.0 110.319 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.44 -42.97 79.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.807 0.843 . . . . 0.0 111.695 -172.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.37 -41.1 96.89 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.069 -0.394 . . . . 0.0 111.513 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.41 79.95 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.874 0.47 . . . . 0.0 109.88 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.48 -49.66 76.93 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.921 0.888 . . . . 0.0 110.132 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.81 -35.89 79.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.979 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -61.35 -42.7 99.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.01 0.823 . . . . 0.0 110.175 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -60.94 -46.46 90.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.788 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.72 -41.96 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.632 1.105 . . . . 0.0 109.664 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.75 -41.08 99.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.596 0.634 . . . . 0.0 110.819 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -37.77 80.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.248 0.619 . . . . 0.0 111.703 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.94 -57.4 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -60.87 -35.51 76.8 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.941 0.896 . . . . 0.0 111.738 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -63.53 -26.05 68.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.373 0.669 . . . . 0.0 112.297 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.13 47.82 88.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -173.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.6 -47.9 96.65 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.989 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.01 -172.2 1.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.56 2.173 . . . . 0.0 111.511 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -60.24 -31.36 70.12 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.246 -0.909 . . . . 0.0 111.578 167.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -68.65 142.69 55.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.586 1.154 . . . . 0.0 109.182 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.27 152.17 25.75 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.471 -0.768 . . . . 0.0 110.345 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.88 153.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -121.65 -9.52 8.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.175 1.39 . . . . 0.0 109.697 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -146.98 135.08 21.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.175 1.79 . . . . 0.0 107.123 171.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.21 133.62 7.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -136.55 127.37 27.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.1 145.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.067 1.347 . . . . 0.0 109.493 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 m -136.48 156.92 47.92 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.323 1.849 . . . . 0.0 106.053 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -126.14 150.12 48.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 m -145.63 164.45 31.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.102 0.961 . . . . 0.0 109.582 -163.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -119.36 4.54 11.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.252 1.021 . . . . 0.0 110.467 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -64.52 -30.74 71.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.454 1.102 . . . . 0.0 112.11 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.4 mt 58.68 179.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 111.307 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -153.61 -4.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.995 0.918 . . . . 0.0 113.385 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.26 6.48 53.91 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.746 1.165 . . . . 0.0 114.009 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.78 146.33 52.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.396 1.098 . . . . 0.0 109.469 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -130.27 17.85 5.45 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.633 1.573 . . . . 0.0 109.892 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -149.51 173.4 13.64 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.818 2.047 . . . . 0.0 108.131 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -98.35 150.1 21.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 162.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -139.4 156.14 47.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 110.045 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.1 mt -137.94 134.77 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.164 0.986 . . . . 0.0 108.484 -172.392 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mt -142.88 175.68 9.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 109.726 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -151.88 157.42 41.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.291 1.837 . . . . 0.0 108.379 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.71 162.51 24.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 165.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -135.67 138.59 42.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 156.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.88 143.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -169.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.86 137.79 55.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.79 146.63 20.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.897 0.879 . . . . 0.0 110.356 -168.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.38 152.3 44.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.808 1.643 . . . . 0.0 108.084 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.11 -153.38 25.04 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.39 73.86 3.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 158.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.45 6.19 9.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.359 1.064 . . . . 0.0 110.898 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 120.08 1.309 . . . . 0.0 108.411 174.07 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 119.572 -0.251 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -72.81 -47.68 44.41 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.481 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.27 -43.71 67.65 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.867 0.758 . . . . 0.0 111.419 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -53.16 -48.88 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.652 0.781 . . . . 0.0 109.246 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -78.34 -20.68 50.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 120.817 -1.177 . . . . 0.0 113.443 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -42.96 85.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.382 0.992 . . . . 0.0 109.243 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.29 -35.36 71.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.953 0.797 . . . . 0.0 110.159 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.24 86.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.993 0.517 . . . . 0.0 110.462 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.48 -41.55 98.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.789 0.836 . . . . 0.0 110.938 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.45 -29.98 68.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.495 0.718 . . . . 0.0 111.516 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -98.49 6.62 47.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.286 1.034 . . . . 0.0 112.581 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 42.82 40.88 2.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.697 1.999 . . . . 0.0 113.235 -172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.03 164.39 26.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.325 1.05 . . . . 0.0 109.158 166.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 142.48 32.45 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.093 0.957 . . . . 0.0 108.508 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.03 -154.93 26.01 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.194 -168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.57 162.5 31.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.447 1.123 . . . . 0.0 112.627 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.52 144.43 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.905 1.282 . . . . 0.0 107.971 163.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -149.89 165.91 31.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.005 1.322 . . . . 0.0 109.356 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.9 121.77 45.96 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 167.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -73.73 153.97 39.81 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.138 0.975 . . . . 0.0 108.844 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.52 -31.31 70.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 111.379 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -70.74 -11.53 61.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.87 -27.84 8.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.152 1.358 . . . . 0.0 113.125 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.55 149.77 49.97 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.443 1.622 . . . . 0.0 109.495 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.18 149.69 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 158.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 143.43 50.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -133.65 143.03 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -141.46 135.87 30.71 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.33 34.93 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.629 1.104 . . . . 0.0 111.337 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.03 151.81 30.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.038 1.335 . . . . 0.0 109.418 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.52 42.48 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.162 0.886 . . . . 0.0 111.474 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.61 159.96 51.05 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.54 2.16 . . . . 0.0 110.793 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.65 -53.74 50.85 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.78 0.832 . . . . 0.0 111.064 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.06 -35.73 81.21 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 122.281 -0.262 . . . . 0.0 111.278 -173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -49.34 71.51 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.78 0.432 . . . . 0.0 110.604 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.61 -49.08 78.03 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.12 0.568 . . . . 0.0 110.237 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.22 -41.03 90.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.608 0.363 . . . . 0.0 111.148 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -62.89 -40.35 97.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.659 0.663 . . . . 0.0 110.566 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.42 -47.52 85.75 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.599 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.54 -41.91 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.684 1.129 . . . . 0.0 109.705 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.86 -40.68 98.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.712 0.687 . . . . 0.0 110.807 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.72 92.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.797 0.839 . . . . 0.0 111.536 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -66.46 -55.68 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.43 -35.32 75.53 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.963 0.905 . . . . 0.0 111.976 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -63.06 -25.2 68.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.415 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.08 44.16 98.52 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -53.58 -44.17 97.25 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.14 -170.54 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.42 2.08 . . . . 0.0 111.245 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -60.29 -42.98 96.62 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.97 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.18 150.85 33.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.235 1.414 . . . . 0.0 110.637 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.25 33.59 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.704 -0.623 . . . . 0.0 109.878 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.06 154.66 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.3 p -120.4 -12.43 8.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.359 1.464 . . . . 0.0 109.56 162.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -147.35 141.12 25.7 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.224 1.41 . . . . 0.0 107.992 168.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.67 136.48 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -134.99 140.78 45.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.42 141.2 40.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -129.76 148.06 51.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -134.4 145.28 48.77 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 m -151.89 168.3 25.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.229 -150.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -125.54 1.37 7.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.428 1.091 . . . . 0.0 111.79 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -64.35 -32.06 73.52 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.795 0.838 . . . . 0.0 111.661 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.31 -177.26 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.115 1.766 . . . . 0.0 110.782 -171.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.45 -13.41 0.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.86 17.24 79.27 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.091 0.853 . . . . 0.0 113.037 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -63.66 152.53 38.76 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.283 1.041 . . . . 0.0 110.444 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.27 4.69 6.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 110.903 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 157.51 43.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.902 1.281 . . . . 0.0 109.237 172.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -71.2 143.22 50.54 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 155.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -139.33 150.98 46.02 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.586 0.754 . . . . 0.0 109.65 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.9 mt -128.57 109.88 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.236 0.367 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.046 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.174 0.035 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.93 -177.1 6.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.376 1.47 . . . . 0.0 110.045 -161.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -146.04 153.7 41.03 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.328 1.851 . . . . 0.0 109.251 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.21 166.74 11.16 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.069 0.947 . . . . 0.0 110.52 164.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -131.92 138.4 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 152.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.0 mt -136.27 146.88 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.89 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 164.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.62 151.8 24.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.53 1.132 . . . . 0.0 109.058 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.71 150.25 39.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.13 -153.87 25.59 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -79.76 63.25 4.26 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.8 m -89.11 8.77 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.806 1.242 . . . . 0.0 111.711 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 7.3 ptt180 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.98 -38.17 78.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 120.003 1.274 . . . . 0.0 108.528 160.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -55.91 -41.05 73.96 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.342 0.519 . . . . 0.0 111.527 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.19 -45.83 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -78.88 -16.28 57.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.627 -0.702 . . . . 0.0 112.894 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.17 -47.77 75.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.636 1.107 . . . . 0.0 108.87 164.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -70.49 -23.12 62.61 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.929 -0.482 . . . . 0.0 111.362 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.66 52.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.288 -0.882 . . . . 0.0 109.662 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.16 -39.66 90.95 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.773 0.829 . . . . 0.0 111.544 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -14.35 60.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.721 -0.612 . . . . 0.0 112.013 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -116.79 11.23 14.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.701 1.601 . . . . 0.0 111.55 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 41.08 40.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.963 2.105 . . . . 0.0 113.034 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.63 163.25 28.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.68 131.72 24.64 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.062 0.945 . . . . 0.0 108.715 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.31 -162.95 34.71 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.223 0.465 . . . . 0.0 112.201 -162.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -135.42 167.7 20.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.777 0.789 . . . . 0.0 112.734 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.0 142.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.045 1.338 . . . . 0.0 109.102 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -145.77 157.36 43.94 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.947 1.699 . . . . 0.0 108.095 -163.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -119.32 123.19 43.61 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -78.6 156.66 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.977 1.311 . . . . 0.0 109.727 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.49 -30.65 70.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.239 0.615 . . . . 0.0 111.677 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -4.85 39.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.864 0.866 . . . . 0.0 113.022 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.98 -23.71 28.5 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.102 1.335 . . . . 0.0 113.247 169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -61.69 145.28 52.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.961 1.38 . . . . 0.0 109.804 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.52 143.54 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 160.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -131.21 145.75 52.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.41 142.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -170.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 tt -150.0 125.61 10.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 153.45 27.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.016 0.826 . . . . 0.0 111.454 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -93.53 154.5 17.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.46 1.104 . . . . 0.0 109.696 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.01 42.28 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 110.762 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.28 154.75 61.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.921 1.747 . . . . 0.0 109.918 165.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.72 -43.4 80.58 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.57 0.748 . . . . 0.0 111.437 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.33 -41.04 98.23 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.151 -0.343 . . . . 0.0 111.472 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.81 82.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.737 0.415 . . . . 0.0 110.064 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 72.0 mt -62.12 -44.09 97.41 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.743 0.817 . . . . 0.0 110.371 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -70.48 -41.12 73.15 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.79 -0.569 . . . . 0.0 111.775 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 m -60.22 -40.05 88.79 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.756 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -61.85 -46.45 89.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.858 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.46 -46.56 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.005 1.275 . . . . 0.0 109.426 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.39 -39.62 91.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.168 0.44 . . . . 0.0 111.191 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.191 0.597 . . . . 0.0 112.133 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.05 -49.8 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.91 -44.04 91.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.185 0.594 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -71.52 -19.95 62.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.674 0.79 . . . . 0.0 112.011 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.71 43.34 94.52 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -172.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 m -51.15 -53.33 49.86 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.09 -39.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.654 1.57 . . . . 0.0 112.496 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -165.83 168.77 15.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.086 1.754 . . . . 0.0 108.188 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m 62.55 175.96 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.963 1.705 . . . . 0.0 113.044 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 160.49 40.28 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.92 0.888 . . . . 0.0 109.406 166.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.51 156.95 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.2 p -119.62 -13.56 9.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.939 1.296 . . . . 0.0 109.648 163.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.8 144.99 26.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.081 1.353 . . . . 0.0 108.749 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.82 142.17 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.289 1.436 . . . . 0.0 107.378 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -140.23 147.8 40.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.21 145.9 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.67 155.7 46.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.147 2.179 . . . . 0.0 105.48 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -138.6 158.63 43.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.0 m -155.51 152.88 29.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.145 1.378 . . . . 0.0 107.901 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -73.33 -30.95 63.7 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.718 -0.614 . . . . 0.0 111.352 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 m -60.07 128.57 37.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.102 0.961 . . . . 0.0 110.903 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.18 169.86 12.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.207 1.003 . . . . 0.0 109.242 163.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -104.76 -18.71 14.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.029 0.932 . . . . 0.0 111.074 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 47.85 7.45 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -171.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -126.83 149.86 49.49 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.608 1.163 . . . . 0.0 108.915 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.86 9.2 3.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.945 0.898 . . . . 0.0 112.092 -172.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 174.28 12.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.514 1.526 . . . . 0.0 109.013 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -116.47 148.97 40.24 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.369 1.067 . . . . 0.0 109.458 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.93 159.96 41.65 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.468 0.652 . . . . 0.0 111.963 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.02 114.51 35.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.153 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.5 tp -142.21 177.26 8.36 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.905 -1.122 . . . . 0.0 110.422 -166.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.404 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 63.7 tt0 -154.57 162.01 41.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.94 1.696 . . . . 0.0 109.47 -171.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p90 -131.36 166.36 21.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.226 1.01 . . . . 0.0 110.273 166.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -130.23 138.58 50.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.42 146.86 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 135.71 58.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.61 153.64 16.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.275 1.03 . . . . 0.0 110.699 -172.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.01 153.0 45.35 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.313 1.445 . . . . 0.0 107.943 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.35 -152.28 24.19 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -75.56 77.98 2.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 162.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.66 -1.77 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 111.306 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 125.63 1.572 . . . . 0.0 109.488 -177.892 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -60.62 -32.83 71.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.405 1.002 . . . . 0.0 110.803 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -48.74 71.94 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.921 1.237 . . . . 0.0 111.61 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.86 -30.92 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.16 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -75.14 -24.66 57.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.948 1.249 . . . . 0.0 112.08 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.2 mtm -63.46 -48.9 75.81 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 165.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.81 -30.11 70.69 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 122.195 -0.316 . . . . 0.0 111.058 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.84 -47.49 68.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.292 . . . . 0.0 110.328 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.63 -38.62 88.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.319 0.647 . . . . 0.0 111.124 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.14 -17.59 41.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.769 1.228 . . . . 0.0 112.523 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -116.65 12.9 15.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.225 1.41 . . . . 0.0 111.41 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.44 34.44 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.16 2.184 . . . . 0.0 113.294 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.41 161.59 27.27 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.816 -0.553 . . . . 0.0 109.629 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 128.62 43.74 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.48 -171.21 43.9 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 118.641 0.655 . . . . 0.0 112.272 -164.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.4 p90 -136.61 161.27 36.36 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.066 0.947 . . . . 0.0 112.036 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.15 144.93 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.171 0.988 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -144.71 162.82 35.75 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.143 2.177 . . . . 0.0 107.656 -170.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.43 122.88 40.76 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -75.77 155.46 35.48 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.479 1.112 . . . . 0.0 109.16 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.45 -31.78 70.75 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.918 0.487 . . . . 0.0 111.357 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -71.34 -10.68 60.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.82 10.83 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.228 -1.318 . . . . 0.0 113.476 170.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.35 148.25 52.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.729 1.764 . . . . 0.0 109.391 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.29 146.48 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 161.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -127.77 137.94 52.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.55 142.55 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.57 126.38 12.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -153.95 159.04 41.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.487 0.585 . . . . 0.0 110.926 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.49 155.83 22.63 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.316 1.846 . . . . 0.0 109.443 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.51 178.04 41.64 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.618 1.104 . . . . 0.0 110.364 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.32 154.3 74.44 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.842 1.695 . . . . 0.0 109.781 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.37 -47.7 78.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.183 0.593 . . . . 0.0 110.715 -172.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -60.17 -40.31 89.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.484 0.584 . . . . 0.0 111.788 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.59 83.09 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.855 0.462 . . . . 0.0 110.091 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.66 -45.96 84.48 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 122.809 0.443 . . . . 0.0 110.826 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -64.98 -43.47 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.864 -0.522 . . . . 0.0 110.68 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.4 m -60.93 -40.84 94.77 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.935 0.334 . . . . 0.0 110.54 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.24 -49.09 79.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.575 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.67 -43.25 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.735 1.152 . . . . 0.0 109.67 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.92 -40.91 97.11 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.628 0.649 . . . . 0.0 110.834 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.47 0.708 . . . . 0.0 111.465 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -61.79 -54.04 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.37 -39.44 79.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.809 0.844 . . . . 0.0 111.375 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.4 -27.23 68.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.488 0.715 . . . . 0.0 111.979 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.47 51.26 58.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -173.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -55.53 -49.2 93.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.976 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.49 -173.45 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.261 1.974 . . . . 0.0 111.627 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -40.84 82.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.431 1.092 . . . . 0.0 111.449 173.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.3 m -74.29 138.92 43.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -157.81 164.45 36.99 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 109.533 -162.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.42 149.6 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -127.68 -7.58 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.809 1.643 . . . . 0.0 109.803 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.61 141.22 29.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.224 1.81 . . . . 0.0 106.963 166.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -149.27 140.68 17.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 107.972 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 m -139.29 148.94 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.687 1.595 . . . . 0.0 107.328 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.18 146.18 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.05 149.01 51.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.04 133.17 39.1 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -171.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -145.47 167.93 21.79 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.701 0.4 . . . . 0.0 111.683 -155.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.97 0.11 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.898 1.279 . . . . 0.0 111.253 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.0 m -66.26 -24.88 66.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.121 0.969 . . . . 0.0 113.088 -170.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.48 174.0 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 0.0 111.684 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.18 -16.44 0.58 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 113.179 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 1.41 82.2 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.253 -1.304 . . . . 0.0 116.304 155.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -82.92 -175.48 5.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.102 1.951 . . . . 0.0 109.542 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -129.55 2.85 5.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 112.421 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.57 170.76 17.89 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.052 1.341 . . . . 0.0 109.697 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -72.48 153.27 41.45 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.956 0.503 . . . . 0.0 109.965 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.39 159.22 42.67 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.703 1.201 . . . . 0.0 109.453 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 mt -135.09 110.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -171.102 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.507 0.194 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.13 176.03 9.06 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.946 0.898 . . . . 0.0 111.666 -149.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -147.71 157.81 43.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.446 1.498 . . . . 0.0 109.384 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.14 168.09 11.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 110.629 163.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -134.58 135.42 42.22 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 156.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.34 144.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.78 136.42 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.14 155.48 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.576 1.151 . . . . 0.0 110.293 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -145.98 157.38 43.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 0.0 108.935 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -148.36 19.87 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 106.821 -2.512 . . . . 0.0 106.821 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -77.02 54.48 1.04 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 160.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.73 -13.92 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 111.21 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 168.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.9 -34.47 73.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.171 0.896 . . . . 0.0 111.295 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -37.61 65.23 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.678 0.672 . . . . 0.0 111.288 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.84 -45.22 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -78.97 -18.95 52.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.488 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -63.21 -48.95 76.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.335 0.971 . . . . 0.0 109.309 165.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.58 -29.95 67.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.784 0.434 . . . . 0.0 110.421 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.61 74.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.767 0.827 . . . . 0.0 110.405 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.92 -41.02 90.81 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.341 0.656 . . . . 0.0 110.724 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -59.41 -18.09 36.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.487 1.115 . . . . 0.0 112.854 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -117.33 15.76 14.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.977 1.262 . . . . 0.0 112.372 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.2 mmpt? 47.01 34.0 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.574 1.55 . . . . 0.0 112.768 -176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.3 mt -74.41 163.51 27.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.172 0.589 . . . . 0.0 109.703 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.73 130.11 22.42 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.167 0.987 . . . . 0.0 108.581 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.35 -158.34 28.66 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 123.592 0.615 . . . . 0.0 111.596 -171.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -136.73 163.28 30.97 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.787 0.794 . . . . 0.0 112.047 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.874 1.27 . . . . 0.0 108.66 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -149.22 163.25 38.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.883 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -119.58 131.15 55.44 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -120.77 149.72 42.11 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.925 0.89 . . . . 0.0 110.37 -167.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.08 -19.46 62.96 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.443 1.497 . . . . 0.0 113.524 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.78 -15.29 28.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.757 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.05 45.83 3.77 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.52 153.32 42.47 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.392 1.477 . . . . 0.0 107.238 -168.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.19 148.36 5.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 157.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.96 142.48 48.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -138.62 141.48 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.98 126.37 10.8 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.1 157.02 36.86 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.442 0.697 . . . . 0.0 110.877 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.98 156.9 17.35 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.634 1.573 . . . . 0.0 109.874 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.25 -179.42 41.89 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.039 0.828 . . . . 0.0 111.865 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.4 161.74 37.13 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.554 2.17 . . . . 0.0 110.652 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.35 -47.23 79.23 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.73 0.812 . . . . 0.0 111.137 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.76 -43.06 98.49 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.005 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.96 79.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.1 mt -63.22 -47.08 84.03 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.326 0.65 . . . . 0.0 110.247 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -68.52 -43.51 76.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.031 0.532 . . . . 0.0 111.893 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -62.89 -39.09 93.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.471 0.578 . . . . 0.0 110.139 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.3 -49.24 78.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.423 173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.56 -45.65 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.57 1.077 . . . . 0.0 109.515 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -62.42 -37.81 87.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.096 0.407 . . . . 0.0 111.155 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.85 86.94 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.501 0.72 . . . . 0.0 111.792 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.2 -51.03 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.34 -41.95 76.92 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.442 1.097 . . . . 0.0 111.29 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -68.22 -25.53 65.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.517 0.727 . . . . 0.0 111.933 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.94 48.64 81.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.61 -47.32 98.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.409 -1.281 . . . . 0.0 114.289 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.84 -166.53 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.201 . . . . 0.0 111.479 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -40.74 67.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.828 1.251 . . . . 0.0 111.939 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -79.6 143.72 34.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 162.46 40.51 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.687 0.795 . . . . 0.0 110.548 -172.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.88 158.3 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.371 0.668 . . . . 0.0 110.689 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 p -125.81 -4.8 6.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.715 1.606 . . . . 0.0 110.023 163.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -150.66 138.73 20.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.777 2.031 . . . . 0.0 107.446 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.64 140.98 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.336 1.054 . . . . 0.0 108.613 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -140.86 142.9 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.101 1.76 . . . . 0.0 107.053 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -138.19 143.6 32.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -129.99 151.06 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -137.05 145.36 43.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.0 m -143.2 175.0 10.21 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.037 1.335 . . . . 0.0 109.375 -165.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -128.37 33.53 4.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.537 1.135 . . . . 0.0 109.447 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -134.24 105.09 6.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 108.404 -165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.09 168.63 8.09 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.949 0.9 . . . . 0.0 111.235 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.78 -23.47 9.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.832 1.653 . . . . 0.0 110.496 -175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.69 19.04 76.52 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -166.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.31 139.78 32.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -134.82 25.09 3.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.808 1.243 . . . . 0.0 109.584 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -148.23 167.4 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 127.003 2.121 . . . . 0.0 107.184 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -120.85 132.94 55.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 163.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 m -134.7 160.87 36.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.126 0.57 . . . . 0.0 111.211 -166.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.9 mt -132.24 114.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.237 0.438 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.263 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 119.111 -0.471 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tp -147.46 -177.01 5.47 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.207 1.367 . . . . 0.0 111.344 -159.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.61 152.57 39.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.613 1.965 . . . . 0.0 109.086 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.46 163.7 12.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.319 0.648 . . . . 0.0 109.724 162.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -136.05 131.09 34.45 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 159.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.19 139.65 45.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.29 134.4 66.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -140.35 153.19 21.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.146 0.979 . . . . 0.0 109.557 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.28 151.36 37.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.935 1.294 . . . . 0.0 107.522 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.67 -152.04 24.06 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.67 58.56 1.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 m -85.0 -12.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.019 0.928 . . . . 0.0 110.783 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.411 HE22 ' CG ' ' A' ' 18' ' ' ARG . 7.5 mm-40 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 164.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' CG ' HE22 ' A' ' 13' ' ' GLN 0.301 12.9 ptt85 . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -66.38 -21.96 66.24 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 122.013 2.188 . . . . 0.0 110.468 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.099 1.318 . . . . 0.0 111.349 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.21 -33.66 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.394 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -73.39 -25.98 60.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.051 1.296 . . . . 0.0 112.284 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.4 mtm -65.36 -47.3 76.91 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 166.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -66.09 -27.99 68.48 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.285 -0.26 . . . . 0.0 111.329 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 -48.47 64.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.734 1.614 . . . . 0.0 109.975 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.06 -38.68 87.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.984 0.514 . . . . 0.0 111.209 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -60.0 -16.96 34.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.354 1.062 . . . . 0.0 112.594 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -116.88 11.24 14.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.127 1.371 . . . . 0.0 111.565 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 41.52 39.52 1.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.697 1.999 . . . . 0.0 113.015 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.63 164.85 25.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.732 0.813 . . . . 0.0 108.981 167.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.32 26.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.18 -167.68 38.91 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 118.402 0.546 . . . . 0.0 112.14 -163.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -136.64 159.56 41.44 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.75 0.82 . . . . 0.0 111.991 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.99 141.94 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.735 0.814 . . . . 0.0 110.412 174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -141.85 153.31 44.37 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.833 1.653 . . . . 0.0 108.613 -166.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -106.62 125.22 50.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 170.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -85.33 145.29 27.58 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.961 0.904 . . . . 0.0 108.676 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.55 -29.45 69.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.351 0.66 . . . . 0.0 111.882 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -8.8 56.03 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 45.95 2.23 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 119.109 0.868 . . . . 0.0 112.084 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -136.43 172.99 12.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 107.802 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -116.16 144.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 164.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 140.34 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.79 140.72 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.7 127.69 14.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.44 149.28 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 122.997 0.519 . . . . 0.0 110.24 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.28 153.77 20.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.708 0.803 . . . . 0.0 109.147 166.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.47 173.71 36.56 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.309 0.957 . . . . 0.0 111.604 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.59 153.41 60.06 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.149 1.899 . . . . 0.0 110.073 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.83 -42.3 75.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.679 0.792 . . . . 0.0 111.507 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.4 -41.1 98.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.068 -0.395 . . . . 0.0 111.632 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -45.1 77.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.786 0.434 . . . . 0.0 109.856 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.99 -45.38 95.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.863 0.865 . . . . 0.0 110.129 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -69.71 -39.73 76.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.857 -0.527 . . . . 0.0 112.019 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.1 m -61.05 -41.7 97.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.642 0.656 . . . . 0.0 110.183 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.36 -47.27 86.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.575 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -55.01 -45.84 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.754 1.161 . . . . 0.0 109.602 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.82 -39.1 90.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.585 0.63 . . . . 0.0 111.052 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.55 87.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.425 0.69 . . . . 0.0 111.411 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.61 -48.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.96 -39.76 86.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.41 0.684 . . . . 0.0 111.452 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.49 -24.74 66.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.004 0.522 . . . . 0.0 111.832 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.28 44.0 96.84 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -54.48 -47.68 97.07 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.935 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.78 -169.09 0.67 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.546 2.164 . . . . 0.0 111.722 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -2.87 0.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.911 2.084 . . . . 0.0 115.241 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.4 m -129.53 143.65 50.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.395 1.478 . . . . 0.0 107.737 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.0 164.75 37.66 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.404 0.682 . . . . 0.0 111.21 -162.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.8 m -106.37 158.79 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 123.543 0.737 . . . . 0.0 110.444 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 p -123.01 -11.72 8.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.915 1.686 . . . . 0.0 109.827 162.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.7 146.82 27.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.108 1.363 . . . . 0.0 108.992 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.7 tt -148.19 143.6 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.991 1.316 . . . . 0.0 108.309 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -136.73 144.08 43.65 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.126 1.77 . . . . 0.0 107.213 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.67 140.21 36.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -132.68 157.34 45.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.989 2.115 . . . . 0.0 105.778 168.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.36 142.8 48.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -136.94 153.29 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.785 1.634 . . . . 0.0 107.07 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 mmt-85 -87.76 -24.49 23.78 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.011 -1.056 . . . . 0.0 111.166 -175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 m -62.93 114.67 3.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.81 1.244 . . . . 0.0 111.027 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.61 177.66 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.32 1.048 . . . . 0.0 110.641 164.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -126.92 0.21 6.61 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.893 1.277 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.57 27.94 66.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.878 0.751 . . . . 0.0 111.675 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -94.53 150.35 20.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.894 0.847 . . . . 0.0 109.8 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -137.84 14.98 2.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.64 1.176 . . . . 0.0 111.57 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -148.51 166.72 27.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.16 1.384 . . . . 0.0 108.963 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -88.16 155.88 19.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 163.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.2 m -142.55 156.7 45.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.614 1.166 . . . . 0.0 110.66 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 mt -128.17 112.96 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -174.577 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.3 tp -140.65 -178.6 5.6 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.789 -1.194 . . . . 0.0 109.527 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 33.3 tt0 -155.12 158.14 38.55 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.868 1.667 . . . . 0.0 108.449 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -120.05 164.94 15.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.661 0.785 . . . . 0.0 110.536 166.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.27 131.3 29.95 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 157.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.97 147.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -167.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.41 137.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 m -141.53 156.28 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 124.03 0.932 . . . . 0.0 111.301 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.36 155.51 45.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.751 1.62 . . . . 0.0 107.788 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.24 -155.36 26.29 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -77.61 100.21 6.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 152.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.39 6.24 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 124.611 1.194 . . . . 0.0 110.752 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 . . . . . 0 C--N 1.344 0.352 0 CA-C-N 119.587 1.085 . . . . 0.0 111.12 179.073 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -59.89 -32.34 70.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.289 0.95 . . . . 0.0 110.578 169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -51.72 -37.53 51.33 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.538 0.608 . . . . 0.0 112.07 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.68 -48.06 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -71.29 -25.47 62.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.42 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.71 -39.47 64.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.858 1.208 . . . . 0.0 110.589 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -69.28 -29.82 67.78 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.344 -0.847 . . . . 0.0 111.096 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.54 65.07 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.093 -1.005 . . . . 0.0 109.672 172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.11 -40.42 93.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.053 0.941 . . . . 0.0 111.42 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -15.26 62.72 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.67 -0.644 . . . . 0.0 112.295 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -113.33 15.11 19.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 111.665 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.27 32.97 3.41 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.067 1.747 . . . . 0.0 112.326 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.0 162.22 29.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.09 121.39 19.18 Favored 'General case' 0 CA--C 1.527 0.075 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 -162.17 32.27 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -142.7 163.7 32.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.14 145.98 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.086 1.354 . . . . 0.0 109.507 165.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -149.49 146.14 27.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.641 1.577 . . . . 0.0 108.372 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.98 153.93 40.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.703 0.801 . . . . 0.0 109.487 168.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -134.64 154.6 51.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.297 1.408 . . . . 0.0 110.843 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.01 -30.63 69.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -155.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.05 -27.45 68.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.139 0.576 . . . . 0.0 112.402 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.65 -17.84 10.12 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.366 1.46 . . . . 0.0 110.946 -172.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -59.17 168.32 1.44 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 122.962 1.363 . . . . 0.0 110.422 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.52 150.12 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -131.18 140.12 49.86 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -171.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -136.89 140.81 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -171.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -149.88 126.91 11.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.19 149.52 28.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.527 0.603 . . . . 0.0 110.093 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.92 153.77 19.95 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 174.69 39.72 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.661 0.648 . . . . 0.0 111.807 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.21 152.39 66.98 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.966 1.777 . . . . 0.0 110.152 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.05 -43.87 74.19 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.813 0.845 . . . . 0.0 111.481 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.43 -40.93 98.49 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 122.227 -0.295 . . . . 0.0 111.544 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.33 80.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.988 0.515 . . . . 0.0 110.116 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 4' ' ' TYR . 67.4 mt -62.04 -45.22 94.54 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.583 0.753 . . . . 0.0 110.211 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.57 -40.12 76.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.885 -0.51 . . . . 0.0 111.75 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 m -61.37 -42.0 98.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.746 0.703 . . . . 0.0 110.215 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.21 -49.81 75.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.591 -0.719 . . . . 0.0 110.243 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.3 t -56.65 -43.59 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 119.496 1.043 . . . . 0.0 109.988 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.69 -41.46 97.6 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.109 0.868 . . . . 0.0 110.72 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.33 97.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 111.438 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.28 -53.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -58.53 -40.93 84.32 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.078 0.951 . . . . 0.0 111.207 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -69.9 -23.65 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.49 . . . . 0.0 111.897 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.33 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -58.41 -42.15 93.08 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-O 117.745 -1.121 . . . . 0.0 112.871 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.13 -172.29 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.742 2.961 . . . . 0.0 114.128 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -59.48 -39.61 84.28 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.48 1.112 . . . . 0.0 111.785 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -72.96 151.71 41.7 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.586 0.755 . . . . 0.0 110.363 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 145.53 23.33 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.76 156.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -124.87 -8.95 7.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.601 . . . . 0.0 109.734 166.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.46 139.7 20.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.419 1.887 . . . . 0.0 107.411 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -152.95 142.75 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.65 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -141.29 145.36 35.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.806 1.643 . . . . 0.0 107.779 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.51 138.85 44.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -169.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -131.73 152.79 50.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.598 1.959 . . . . 0.0 106.063 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -131.31 151.21 51.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 m -146.95 165.29 30.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.539 1.136 . . . . 0.0 109.465 -165.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -118.78 1.34 11.56 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.148 0.979 . . . . 0.0 110.751 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 m -62.2 -37.45 85.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.42 1.088 . . . . 0.0 112.211 -171.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 mp 58.5 170.59 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.26 1.824 . . . . 0.0 111.951 -170.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.19 -20.19 4.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.852 1.261 . . . . 0.0 111.392 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.83 24.69 74.26 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.17 139.52 42.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.126 0.963 . . . . 0.0 108.433 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -131.88 21.0 4.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.498 1.119 . . . . 0.0 110.743 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -149.03 178.28 8.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.022 1.729 . . . . 0.0 108.099 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.46 132.16 35.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.0 m -143.9 163.26 33.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.63 1.205 . . . . 0.0 114.032 -152.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.4 mt -128.39 118.66 48.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.251 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -141.76 179.85 6.61 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.889 -1.132 . . . . 0.0 109.677 -167.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -155.37 156.29 35.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 109.159 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.5 163.21 18.3 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.688 0.795 . . . . 0.0 110.524 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -132.33 137.06 47.28 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 154.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.78 142.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -173.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.21 135.28 59.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 171.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.52 151.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.783 0.833 . . . . 0.0 110.6 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.83 153.31 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 107.681 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.88 -154.36 25.77 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -75.1 88.64 2.44 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -124.52 6.51 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.398 1.079 . . . . 0.0 111.237 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 CA--C 1.534 0.36 0 CA-C-N 119.78 1.173 . . . . 0.0 108.496 168.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.65 -43.32 69.4 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.574 -0.704 . . . . 0.0 110.07 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -53.86 -48.33 70.13 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.029 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.17 -33.99 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 119.39 0.996 . . . . 0.0 110.929 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.61 -32.16 73.59 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.385 1.448 . . . . 0.0 112.164 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -64.0 -46.55 84.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.181 0.901 . . . . 0.0 109.385 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -68.58 -33.3 73.83 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.101 -0.375 . . . . 0.0 110.887 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.48 77.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.299 1.04 . . . . 0.0 109.584 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.68 -35.0 78.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.862 0.465 . . . . 0.0 112.096 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.2 -40.93 59.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.27 1.028 . . . . 0.0 111.715 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -114.87 24.01 12.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.86 1.264 . . . . 0.0 111.279 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp 46.17 39.96 6.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.32 157.43 22.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.12 126.16 44.87 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.33 -171.88 44.67 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 118.643 0.656 . . . . 0.0 112.885 -167.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -142.9 165.85 26.25 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.313 0.645 . . . . 0.0 112.463 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.38 146.56 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.053 1.341 . . . . 0.0 110.075 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.46 159.17 44.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.914 1.286 . . . . 0.0 110.222 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.34 153.94 28.07 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 166.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -112.32 145.25 40.36 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 166.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.64 -28.39 65.63 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.36 -28.05 68.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.922 0.889 . . . . 0.0 112.65 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.08 -17.57 7.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.297 1.427 . . . . 0.0 111.614 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -58.46 164.8 2.39 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.949 0.881 . . . . 0.0 110.691 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 t -119.31 149.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 161.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -129.27 139.53 51.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 141.8 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.79 129.39 14.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.94 145.14 23.89 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.754 0.706 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.69 151.82 23.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 164.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.45 175.68 40.0 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 112.457 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.61 154.95 64.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.142 1.895 . . . . 0.0 110.526 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.46 -45.78 76.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.905 0.882 . . . . 0.0 111.512 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.41 -40.84 98.29 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.294 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.2 80.07 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.48 -46.39 88.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.477 0.711 . . . . 0.0 110.492 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -69.17 -39.58 78.67 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.888 -0.508 . . . . 0.0 111.755 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 m -62.1 -40.49 96.06 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.663 0.665 . . . . 0.0 110.259 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -59.46 -47.54 85.09 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.303 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.88 -42.62 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 119.72 1.145 . . . . 0.0 109.898 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.46 -41.31 98.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.083 0.856 . . . . 0.0 110.984 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.16 89.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.908 0.483 . . . . 0.0 111.619 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.27 -56.02 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.99 -37.18 78.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.955 0.902 . . . . 0.0 111.573 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.01 -24.63 66.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.557 0.743 . . . . 0.0 112.415 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.49 42.62 97.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.785 0.72 . . . . 0.0 111.387 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -51.26 -47.37 88.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.95 -56.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.711 1.647 . . . . 0.0 112.198 -166.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -174.92 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.952 2.101 . . . . 0.0 107.104 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.81 145.34 29.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.553 1.541 . . . . 0.0 109.782 168.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.52 151.52 24.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.561 0.745 . . . . 0.0 109.206 -172.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.85 156.18 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.8 p -121.17 -12.43 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.585 1.554 . . . . 0.0 109.774 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.36 136.02 20.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.266 1.826 . . . . 0.0 106.967 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 tt -148.5 137.73 15.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -139.63 146.14 39.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.311 1.444 . . . . 0.0 107.397 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.49 144.4 32.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.96 147.61 50.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 167.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -138.76 134.53 33.6 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 m -143.62 168.07 20.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.01 0.924 . . . . 0.0 110.634 -155.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.55 0.45 10.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.349 1.059 . . . . 0.0 111.726 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -66.14 -37.2 85.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.29 0.95 . . . . 0.0 112.61 -171.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.52 177.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 0.0 111.236 -165.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -124.06 -26.52 4.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.122 0.969 . . . . 0.0 110.978 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.17 41.24 6.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.351 0.977 . . . . 0.0 110.906 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 165.78 24.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 112.536 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -140.39 33.11 1.88 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.366 1.867 . . . . 0.0 109.279 -172.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -131.14 160.98 33.16 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.467 1.507 . . . . 0.0 108.434 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.35 122.33 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -141.81 163.62 32.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.184 0.992 . . . . 0.0 113.42 -152.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.08 119.89 41.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.505 -160.669 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.8 ttp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 119.084 -0.484 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mp -143.42 -177.12 5.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.011 1.278 . . . . 0.0 111.605 -167.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -142.53 155.95 45.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.816 2.846 . . . . 0.0 108.552 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.4 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -114.68 164.68 13.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.794 0.838 . . . . 0.0 109.731 161.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -133.26 137.0 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 153.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -136.19 141.42 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -170.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.55 33.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 163.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.84 155.34 30.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.531 1.132 . . . . 0.0 109.99 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -145.56 155.81 43.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 107.19 172.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.21 -152.48 24.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 107.786 -2.125 . . . . 0.0 107.786 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -78.15 101.66 7.14 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 104.421 -2.436 . . . . 0.0 104.421 154.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.61 18.56 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.403 1.081 . . . . 0.0 110.352 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 125.966 1.706 . . . . 0.0 107.109 169.42 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.28 -44.25 65.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.485 1.039 . . . . 0.0 109.914 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.9 -50.81 63.18 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.765 0.826 . . . . 0.0 110.998 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.13 -35.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.034 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.53 -21.62 60.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.377 1.444 . . . . 0.0 113.054 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.4 mtm -64.06 -46.32 84.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.755 1.161 . . . . 0.0 109.03 165.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -68.32 -23.98 64.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.465 0.706 . . . . 0.0 111.582 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.66 -53.04 38.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.356 -0.84 . . . . 0.0 108.921 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.61 -40.26 91.21 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.205 0.602 . . . . 0.0 111.594 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.27 62.58 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.78 -0.575 . . . . 0.0 112.295 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.1 15.03 17.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.455 1.502 . . . . 0.0 111.393 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 47.94 32.07 2.65 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.183 1.793 . . . . 0.0 112.849 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -73.43 162.26 29.5 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.79 134.87 25.56 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.42 -165.39 38.6 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 118.566 0.621 . . . . 0.0 112.143 -160.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CZ3' ' HE2' ' A' ' 35' ' ' LYS . 3.0 p-90 -135.81 169.22 17.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.652 0.781 . . . . 0.0 112.514 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.42 149.85 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.16 1.384 . . . . 0.0 109.73 170.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE2' ' CZ3' ' A' ' 33' ' ' TRP . 44.3 mtmt -142.23 150.47 40.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.181 1.792 . . . . 0.0 108.56 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -81.27 130.88 35.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 148.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -77.93 137.18 38.2 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 166.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.88 -24.82 62.72 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.196 0.598 . . . . 0.0 111.985 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -28.33 65.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.915 1.686 . . . . 0.0 112.869 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.18 3.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.228 1.394 . . . . 0.0 112.262 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.87 172.15 2.42 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.003 0.921 . . . . 0.0 111.197 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.58 140.58 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -127.07 143.54 51.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.073 0.949 . . . . 0.0 108.805 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.76 143.13 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 tt -149.58 127.74 12.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.55 157.24 35.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.135 0.88 . . . . 0.0 111.284 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.81 150.35 21.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.217 1.407 . . . . 0.0 109.71 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.55 174.08 38.27 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.635 1.588 . . . . 0.0 111.211 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.48 155.34 55.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.659 2.24 . . . . 0.0 110.306 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.55 -42.11 74.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -172.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.71 -41.53 99.19 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.075 -0.391 . . . . 0.0 111.576 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -45.56 79.84 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.945 0.498 . . . . 0.0 110.065 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 4' ' ' TYR . 93.7 mt -59.83 -45.37 92.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.894 0.878 . . . . 0.0 110.142 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -70.95 -40.87 71.77 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.582 -0.699 . . . . 0.0 112.057 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.6 m -60.18 -40.32 89.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.557 0.617 . . . . 0.0 110.021 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.16 -49.19 78.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.705 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.85 -44.31 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.683 1.129 . . . . 0.0 109.9 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.56 -41.4 98.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 111.215 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.46 96.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.527 0.731 . . . . 0.0 111.316 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 t -64.04 -53.38 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -57.02 -42.16 79.86 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.4 0.68 . . . . 0.0 111.014 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.52 -22.59 62.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.444 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.61 46.03 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 118.931 0.787 . . . . 0.0 111.386 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -50.69 -51.66 63.67 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -161.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.66 -40.42 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.402 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -165.09 172.94 12.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.792 2.037 . . . . 0.0 107.881 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m 62.71 170.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.159 1.383 . . . . 0.0 112.595 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.29 141.73 10.98 Favored 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.85 154.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -119.37 -12.66 9.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.245 1.418 . . . . 0.0 109.38 165.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.26 142.96 25.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.411 1.485 . . . . 0.0 108.155 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.3 tt -146.98 141.08 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -138.09 143.3 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.7 142.88 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -171.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.0 m -130.18 151.43 50.71 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 167.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -136.26 146.1 46.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -137.98 158.1 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.638 1.575 . . . . 0.0 108.384 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.92 -20.05 21.81 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.687 -0.633 . . . . 0.0 111.031 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 m -64.11 126.59 28.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.58 0.752 . . . . 0.0 110.242 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 1' ' ' MET . 10.5 mp -68.21 173.45 4.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.386 1.075 . . . . 0.0 109.9 159.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -125.15 6.24 7.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.999 1.72 . . . . 0.0 111.025 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.18 22.96 61.37 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.455 1.026 . . . . 0.0 112.386 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -88.17 140.66 29.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.215 1.007 . . . . 0.0 108.713 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -132.69 11.57 4.39 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.55 165.47 32.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.241 1.817 . . . . 0.0 108.025 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -93.34 152.57 19.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.7 m -141.1 150.99 43.59 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.849 0.833 . . . . 0.0 111.185 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.0 110.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 165.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.06 178.78 4.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.21 1.004 . . . . 0.0 110.994 -165.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -153.78 157.5 39.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.217 2.207 . . . . 0.0 108.469 -168.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.1 p90 -134.9 166.14 23.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.161 0.584 . . . . 0.0 110.673 166.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -133.88 141.1 47.24 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 152.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.1 146.61 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -168.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 134.43 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.2 154.86 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.469 1.108 . . . . 0.0 111.072 -167.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -143.18 157.56 44.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.969 1.708 . . . . 0.0 108.876 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 -154.6 26.0 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 106.649 -2.581 . . . . 0.0 106.649 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -74.93 54.89 0.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.827 -0.807 . . . . 0.0 108.839 163.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.08 -10.72 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 121.256 -0.902 . . . . 0.0 113.206 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.562 HE22 ' HB3' ' A' ' 18' ' ' ARG . 22.0 mm-40 . . . . . 0 C--O 1.232 0.17 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HB3' HE22 ' A' ' 13' ' ' GLN . 15.6 ptp180 . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.75 -15.55 63.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 117.432 -1.271 . . . . 0.0 112.457 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.916 1.689 . . . . 0.0 111.886 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.35 -35.32 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.17 0.895 . . . . 0.0 110.245 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.89 -28.36 66.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.566 1.075 . . . . 0.0 110.813 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -42.89 69.78 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.483 -0.76 . . . . 0.0 109.864 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.66 -35.97 81.44 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.621 -0.675 . . . . 0.0 110.197 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.16 89.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.598 1.159 . . . . 0.0 110.178 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.78 -39.4 84.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.115 0.566 . . . . 0.0 111.575 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -57.22 -42.12 80.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.655 0.661 . . . . 0.0 110.58 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -85.62 3.35 41.21 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 111.772 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 46.99 35.77 3.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.44 171.71 8.32 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 163.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.52 139.25 21.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -165.52 38.73 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.023 -163.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.15 160.47 27.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.955 1.302 . . . . 0.0 112.295 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.16 142.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.342 1.057 . . . . 0.0 109.444 164.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -147.88 171.89 15.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 109.563 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -123.76 114.92 20.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -75.57 152.69 37.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.08 -28.56 67.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 112.009 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.0 -27.03 68.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.001 0.921 . . . . 0.0 112.522 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.12 -27.39 4.55 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.086 1.327 . . . . 0.0 112.457 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.37 151.58 31.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.007 0.903 . . . . 0.0 110.258 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.96 149.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 155.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -128.04 144.93 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.068 1.347 . . . . 0.0 107.384 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 146.44 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -141.28 138.52 33.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -161.78 169.3 21.65 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.712 1.596 . . . . 0.0 110.869 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.91 154.87 37.76 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.999 1.32 . . . . 0.0 110.456 167.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.55 179.91 41.11 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.99 1.281 . . . . 0.0 111.49 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.44 156.63 54.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.681 2.254 . . . . 0.0 110.889 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -55.29 -46.88 76.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 111.688 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.6 -38.44 91.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.855 0.298 . . . . 0.0 111.469 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -47.34 75.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.576 0.35 . . . . 0.0 110.147 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 4' ' ' TYR . 76.5 mt -61.07 -48.53 81.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.385 0.674 . . . . 0.0 109.906 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -65.27 -45.84 82.85 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.197 0.599 . . . . 0.0 111.59 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -40.44 97.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.235 0.47 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.76 -48.68 80.38 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.684 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.02 -40.63 74.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.705 1.139 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.98 -42.13 99.75 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.172 0.897 . . . . 0.0 110.811 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.61 98.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.016 0.526 . . . . 0.0 111.667 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.17 -57.67 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.27 -42.71 91.85 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -171.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.07 -24.86 66.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.627 0.371 . . . . 0.0 111.652 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.97 50.05 66.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -52.09 77.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.831 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.45 -176.22 3.15 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.555 2.17 . . . . 0.0 110.584 170.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -106.23 154.34 20.86 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 153.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 171.3 1.55 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.412 2.685 . . . . 0.0 111.293 -7.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -135.57 161.66 34.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.173 -0.955 . . . . 0.0 110.748 -156.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.72 146.37 34.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -133.26 -5.42 3.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.228 1.011 . . . . 0.0 110.864 171.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.81 141.92 22.23 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.707 1.203 . . . . 0.0 108.858 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.9 146.98 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.506 1.123 . . . . 0.0 108.843 -173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 m -136.0 143.01 44.57 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.76 146.14 26.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -170.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 m -126.93 141.4 51.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 161.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.88 139.92 48.92 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -149.58 175.88 11.14 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.96 1.304 . . . . 0.0 109.43 -159.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.29 17.55 2.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.304 1.042 . . . . 0.0 111.113 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -66.97 -27.64 67.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.114 0.966 . . . . 0.0 111.695 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.95 175.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.154 2.182 . . . . 0.0 111.84 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.52 -13.08 0.39 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.46 1.104 . . . . 0.0 112.487 -170.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.92 15.03 79.96 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.031 0.824 . . . . 0.0 112.387 176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -66.49 126.06 27.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.554 1.177 . . . . 0.0 108.596 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -129.23 23.89 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.543 1.537 . . . . 0.0 108.244 164.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -148.18 161.33 41.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.386 2.274 . . . . 0.0 106.758 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -106.07 145.15 31.79 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -138.38 150.6 46.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.521 1.153 . . . . 0.0 111.675 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.72 133.37 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.237 0.414 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -174.646 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ttp . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.28 176.91 6.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.65 1.114 . . . . 0.0 111.183 -167.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.24 143.94 25.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.474 2.31 . . . . 0.0 107.345 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -103.41 159.64 15.4 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 168.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -119.22 141.38 48.95 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 151.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -140.64 140.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.95 139.18 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.86 153.03 24.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.722 0.809 . . . . 0.0 110.773 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -140.37 147.93 40.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.555 1.542 . . . . 0.0 108.06 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -154.55 25.98 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -76.42 80.71 3.15 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 162.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -107.5 0.76 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.082 0.953 . . . . 0.0 111.391 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.341 0.237 0 O-C-N 121.075 -1.016 . . . . 0.0 109.239 178.048 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -68.65 -36.33 78.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.415 1.007 . . . . 0.0 109.763 171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -52.02 -48.02 64.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.239 0.615 . . . . 0.0 111.907 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.65 -35.21 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.684 0.674 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -75.07 -23.5 58.03 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.803 -1.185 . . . . 0.0 112.037 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.1 mtm -64.33 -50.25 68.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.218 0.917 . . . . 0.0 109.411 167.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.59 -39.27 90.6 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.262 0.625 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.74 54.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.211 1.005 . . . . 0.0 109.843 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.14 -45.71 93.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.152 0.581 . . . . 0.0 110.883 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -59.21 -24.7 63.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.523 1.529 . . . . 0.0 111.888 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -108.38 13.24 25.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.236 1.414 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 50.41 31.15 5.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.974 1.71 . . . . 0.0 112.843 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.8 160.09 28.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.121 0.969 . . . . 0.0 108.503 169.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.03 124.43 12.35 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.488 0.715 . . . . 0.0 109.922 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.51 -175.01 35.67 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.851 0.739 . . . . 0.0 112.091 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -99.78 161.14 13.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -164.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.71 143.61 38.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 156.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.41 152.59 38.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.429 0.692 . . . . 0.0 110.137 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -72.54 123.25 22.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -81.55 132.39 35.31 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.34 -29.44 65.95 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -167.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -17.18 62.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.06 0.944 . . . . 0.0 113.246 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.31 -15.53 6.09 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.472 1.511 . . . . 0.0 112.891 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.12 175.96 3.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.951 1.376 . . . . 0.0 109.721 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.12 145.01 24.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -116.81 143.13 46.04 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.8 133.45 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -150.41 117.18 5.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.54 149.98 28.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.542 0.61 . . . . 0.0 112.355 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.29 157.29 18.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.692 1.197 . . . . 0.0 110.345 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.83 38.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.895 1.236 . . . . 0.0 111.582 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.31 153.99 65.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.259 1.972 . . . . 0.0 110.368 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.3 -48.32 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 111.494 -170.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.14 -38.34 90.69 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.087 0.403 . . . . 0.0 111.786 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.67 89.48 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.045 0.538 . . . . 0.0 109.832 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 4' ' ' TYR . 79.3 mt -61.69 -47.55 84.81 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.438 0.695 . . . . 0.0 110.004 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -67.34 -40.51 85.9 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.802 -0.561 . . . . 0.0 111.553 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -67.15 -35.67 80.21 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.79 -0.568 . . . . 0.0 110.69 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.47 -47.04 87.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.971 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.41 -42.71 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.913 1.233 . . . . 0.0 109.55 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -41.0 96.06 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.257 0.935 . . . . 0.0 111.313 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.74 -40.73 89.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.737 0.815 . . . . 0.0 111.46 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -55.33 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -59.24 -37.89 78.66 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.195 0.598 . . . . 0.0 111.734 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.98 -23.55 65.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.179 0.592 . . . . 0.0 112.261 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.35 43.03 89.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 118.672 0.669 . . . . 0.0 111.508 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -50.28 -49.11 78.41 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -168.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.54 -59.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.735 1.655 . . . . 0.0 112.204 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -171.3 -47.44 0.02 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.213 1.805 . . . . 0.0 108.173 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.61 146.79 24.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.04 0.936 . . . . 0.0 109.546 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -156.2 162.52 40.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.994 0.918 . . . . 0.0 108.97 -167.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -115.02 148.91 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 p -121.42 -9.07 9.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.684 1.594 . . . . 0.0 109.455 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -150.44 143.08 24.55 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.696 1.598 . . . . 0.0 107.57 166.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.5 140.9 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -136.46 143.39 43.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.527 1.531 . . . . 0.0 106.87 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -140.1 147.98 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -127.28 154.32 45.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -133.04 143.6 49.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -158.37 170.8 21.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.037 . . . . 0.0 109.752 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.06 5.47 44.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.829 0.852 . . . . 0.0 110.981 171.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 m -71.53 73.31 0.75 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.755 2.022 . . . . 0.0 111.59 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.16 140.92 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.444 -0.785 . . . . 0.0 109.763 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -78.58 -23.72 45.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.524 0.73 . . . . 0.0 111.394 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.68 48.14 13.53 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -167.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.78 154.87 43.67 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.477 1.111 . . . . 0.0 109.662 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -136.42 8.32 3.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.856 0.862 . . . . 0.0 112.438 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -149.13 166.47 28.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.519 1.528 . . . . 0.0 108.417 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -76.87 163.11 27.06 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.4 m -140.07 152.57 46.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.805 1.242 . . . . 0.0 109.331 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mt -135.11 116.44 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttp . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.01 176.99 7.19 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.878 -1.139 . . . . 0.0 111.891 -159.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -145.4 156.32 43.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.23 1.812 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.2 165.67 15.08 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.53 0.732 . . . . 0.0 110.508 161.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -128.09 143.28 51.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 149.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 57' ' ' VAL . 98.0 mt -137.62 138.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.36 133.38 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.18 153.33 18.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 111.24 -169.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.42 145.93 35.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.034 1.734 . . . . 0.0 107.447 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.24 -154.12 25.76 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -172.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -78.05 88.31 4.19 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 157.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.96 3.28 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.761 1.224 . . . . 0.0 111.092 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.333 1.053 . . . . 0.0 109.391 -168.784 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -62.99 -35.87 81.64 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.108 1.322 . . . . 0.0 109.025 161.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.55 -50.26 24.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.002 0.819 . . . . 0.0 112.564 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.64 -40.07 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 119.215 0.916 . . . . 0.0 109.898 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -74.25 -23.65 59.18 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.631 -1.293 . . . . 0.0 112.152 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.24 82.46 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 169.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -62.79 -37.38 86.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.083 0.856 . . . . 0.0 109.91 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.53 57.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.13 0.572 . . . . 0.0 109.856 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.82 -46.16 91.62 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.253 0.621 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -58.11 -28.1 64.33 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.892 1.277 . . . . 0.0 111.937 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -107.4 12.43 28.0 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.914 1.286 . . . . 0.0 111.159 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 49.61 31.91 4.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 112.742 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.5 mt -73.88 164.09 27.09 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 168.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.66 135.67 31.9 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.79 -165.79 38.99 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -140.15 161.77 36.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.648 0.779 . . . . 0.0 111.987 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.81 143.08 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.48 1.112 . . . . 0.0 108.625 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -143.95 163.09 34.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.962 1.705 . . . . 0.0 108.435 -164.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -115.21 120.63 40.36 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -75.92 147.23 39.11 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.27 -28.34 66.64 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.377 0.671 . . . . 0.0 112.084 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.01 0.924 . . . . 0.0 112.461 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.36 -29.4 3.17 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.173 1.368 . . . . 0.0 112.225 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.75 152.2 31.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.911 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.34 148.1 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 160.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -128.38 144.6 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.69 141.35 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -146.15 125.76 13.33 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.69 161.07 42.93 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.019 0.528 . . . . 0.0 110.409 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.31 154.47 22.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.409 1.483 . . . . 0.0 108.051 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 179.32 40.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.39 0.519 . . . . 0.0 111.826 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.24 157.44 59.43 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.325 2.016 . . . . 0.0 110.793 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.08 -49.25 74.33 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.148 0.979 . . . . 0.0 111.527 -170.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -66.84 -38.06 85.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 119.406 -0.331 . . . . 0.0 111.395 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.88 74.02 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.238 0.615 . . . . 0.0 109.714 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.98 -44.61 96.38 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.352 0.661 . . . . 0.0 110.803 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.31 -34.7 55.35 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.766 -0.584 . . . . 0.0 111.583 -173.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -68.85 -35.39 76.87 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.305 -0.872 . . . . 0.0 110.743 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.99 -48.72 79.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.316 0.646 . . . . 0.0 109.549 168.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 6' ' ' ILE . 42.1 t -55.81 -42.97 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.19 0.904 . . . . 0.0 109.67 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.48 -41.91 97.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.401 1.0 . . . . 0.0 111.419 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -40.98 82.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.006 0.923 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.39 -52.49 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.86 0.755 . . . . 0.0 109.5 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.77 -39.17 90.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.132 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -64.33 -21.07 66.49 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.298 1.039 . . . . 0.0 111.904 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.62 172.83 21.55 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -152.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 p -139.65 -179.98 1.15 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 121.839 -0.8 . . . . 0.0 110.031 -164.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.16 -24.62 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.461 2.774 . . . . 0.0 115.742 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.95 2.6 0.44 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 m -126.62 159.1 34.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.56 1.527 . . . . 0.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 145.83 20.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.333 0.969 . . . . 0.0 111.175 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.01 156.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -122.59 -12.46 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.62 1.568 . . . . 0.0 109.506 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -150.07 145.92 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.362 1.465 . . . . 0.0 108.185 165.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.38 144.25 16.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.773 1.229 . . . . 0.0 108.503 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m -139.29 145.64 39.37 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.726 1.611 . . . . 0.0 107.355 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.12 144.27 29.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.8 m -130.91 151.09 51.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.48 145.99 50.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.5 m -147.55 -176.59 5.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.987 1.315 . . . . 0.0 109.263 -167.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -127.73 10.33 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 110.977 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -67.66 -29.46 68.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.788 1.235 . . . . 0.0 114.02 -161.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.9 mt 62.04 171.82 0.13 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.351 1.86 . . . . 0.0 111.924 -170.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -139.03 -30.96 0.72 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.597 1.159 . . . . 0.0 111.412 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.79 30.47 77.29 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -72.86 164.0 27.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.04 1.336 . . . . 0.0 108.922 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.82 11.59 4.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.623 0.769 . . . . 0.0 111.763 -173.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -145.84 167.47 23.14 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.221 1.008 . . . . 0.0 109.253 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -89.04 141.94 28.06 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 139.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -133.14 163.35 29.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.502 0.721 . . . . 0.0 110.758 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 mt -138.06 127.39 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.535 0.397 0 C-N-CA 124.537 1.135 . . . . 0.0 107.95 -175.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.6 mtp . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.416 0.151 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mp -134.19 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.596 1.159 . . . . 0.0 111.051 -160.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.32 154.08 42.67 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.46 1.904 . . . . 0.0 107.401 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -118.7 164.62 15.09 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.453 0.701 . . . . 0.0 110.51 165.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 47.9 ttm-85 -125.67 140.83 52.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 147.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -132.52 142.98 41.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.02 137.49 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.87 149.79 23.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.854 0.862 . . . . 0.0 110.202 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -138.96 155.71 47.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.572 1.549 . . . . 0.0 107.807 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.71 -156.35 25.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -170.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -79.75 65.98 5.08 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 163.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.2 27.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.133 0.973 . . . . 0.0 111.076 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -159.44 -174.73 4.81 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.38 -45.27 0.35 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -150.89 -30.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.251 1.02 . . . . 0.0 110.434 168.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.49 47.44 0.13 Allowed Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.108 0.867 . . . . 0.0 113.281 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -60.72 -37.43 81.71 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.207 1.504 . . . . 0.0 109.96 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -61.28 -35.48 77.45 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.916 -0.49 . . . . 0.0 111.087 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.66 -45.48 75.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.941 0.791 . . . . 0.0 109.931 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.32 -50.29 65.28 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.2 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.4 -38.92 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.463 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -71.67 -22.58 61.64 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 113.078 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.1 mtm -64.32 -46.75 82.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.637 1.108 . . . . 0.0 108.826 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.79 -31.33 72.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.037 0.535 . . . . 0.0 110.714 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.54 -54.79 41.16 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.988 0.915 . . . . 0.0 109.675 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.15 -40.49 96.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.957 0.503 . . . . 0.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -55.21 -28.7 54.97 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.504 1.122 . . . . 0.0 111.887 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -118.59 20.71 12.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.697 0.799 . . . . 0.0 111.617 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 41.59 42.14 1.91 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.771 2.428 . . . . 0.0 113.67 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.47 163.67 27.64 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 159.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.08 130.76 17.94 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.74 -162.52 34.17 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.589 -0.562 . . . . 0.0 112.029 -168.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -130.86 161.7 31.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.295 1.047 . . . . 0.0 112.168 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.43 148.12 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.948 1.299 . . . . 0.0 109.22 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.99 156.75 43.0 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.243 1.817 . . . . 0.0 108.143 -170.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -115.54 121.48 42.78 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.18 151.26 36.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.487 1.115 . . . . 0.0 109.177 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.14 -28.7 69.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.976 0.51 . . . . 0.0 111.382 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -7.63 48.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.153 0.981 . . . . 0.0 113.259 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.81 -19.57 32.92 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.03 1.3 . . . . 0.0 113.265 170.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.33 163.66 22.54 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.918 1.359 . . . . 0.0 110.435 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 t -98.89 149.77 5.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 158.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -135.23 144.91 47.16 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -141.33 144.78 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.85 130.1 13.69 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.07 154.51 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.102 0.864 . . . . 0.0 111.07 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.24 157.16 16.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.927 1.291 . . . . 0.0 109.838 168.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.69 178.49 40.31 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.715 0.674 . . . . 0.0 112.577 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.49 155.69 40.72 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.311 2.008 . . . . 0.0 110.174 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -56.27 -47.54 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.573 0.749 . . . . 0.0 111.432 -171.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.06 -39.62 93.01 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.941 0.337 . . . . 0.0 111.248 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.95 -46.66 77.33 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.02 0.373 . . . . 0.0 110.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 77.4 mt -62.12 -43.19 99.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.687 0.795 . . . . 0.0 110.509 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -71.83 -38.7 70.12 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.757 -0.589 . . . . 0.0 111.918 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.4 m -62.57 -39.56 94.06 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.664 -0.648 . . . . 0.0 110.075 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -60.75 -46.95 88.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.695 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.76 -44.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 119.861 1.21 . . . . 0.0 109.486 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -62.16 -42.04 98.89 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.972 0.805 . . . . 0.0 111.408 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.39 87.87 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.025 0.93 . . . . 0.0 111.901 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.76 -54.74 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.26 -38.67 80.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.403 1.081 . . . . 0.0 112.062 -170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -62.31 -26.23 68.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.135 0.574 . . . . 0.0 111.69 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.34 47.28 91.63 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -53.08 -39.63 72.39 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-O 117.594 -1.193 . . . . 0.0 113.901 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -66.23 -174.81 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.806 3.004 . . . . 0.0 114.841 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -63.42 -37.03 85.71 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.319 1.048 . . . . 0.0 111.045 164.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.1 m -70.06 137.98 51.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.377 1.071 . . . . 0.0 108.244 165.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.63 150.7 35.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 118.415 0.552 . . . . 0.0 111.049 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.2 t -84.08 151.38 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.152 1.381 . . . . 0.0 107.998 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -128.45 -11.55 5.07 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.099 168.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -151.56 140.57 21.11 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.652 1.181 . . . . 0.0 108.957 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.1 tt -140.98 149.08 21.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.793 1.237 . . . . 0.0 108.746 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 m -139.13 144.88 38.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.1 t -138.04 143.0 34.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.6 m -130.04 150.84 51.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.7 153.44 50.88 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.529 0.731 . . . . 0.0 110.415 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.6 m -151.53 173.77 14.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.498 1.519 . . . . 0.0 109.208 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 1.33 24.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.901 1.28 . . . . 0.0 110.988 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -72.69 75.73 1.11 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.74 2.016 . . . . 0.0 111.839 -174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.67 153.76 9.99 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.58 -0.7 . . . . 0.0 110.41 168.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -115.99 -26.29 7.36 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.781 1.232 . . . . 0.0 110.671 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.11 24.22 59.92 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 -163.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 139.78 49.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.685 1.243 . . . . 0.0 108.332 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -134.41 14.58 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.082 . . . . 0.0 111.705 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -149.2 171.94 15.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.444 1.497 . . . . 0.0 109.111 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -98.33 153.59 18.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -140.38 154.15 46.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 110.075 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.5 mt -135.74 111.39 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.38 138.78 21.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -80.49 36.88 0.38 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.474 1.109 . . . . 0.0 111.089 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.445 1.498 . . . . 0.0 110.287 178.051 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.46 178.53 7.53 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.979 -1.076 . . . . 0.0 110.062 -167.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -152.91 158.48 42.19 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.988 1.715 . . . . 0.0 108.549 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.451 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -123.37 165.99 16.09 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.991 0.916 . . . . 0.0 110.465 168.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -131.03 135.82 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 151.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.27 145.43 33.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.92 138.8 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 170.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.53 146.27 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.136 0.975 . . . . 0.0 109.938 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.87 157.17 46.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 108.805 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.85 -153.05 25.11 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.413 -2.275 . . . . 0.0 107.413 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -81.4 92.61 6.46 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 160.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.77 10.42 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.487 1.515 . . . . 0.0 110.853 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -140.09 149.43 43.08 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.917 -1.114 . . . . 0.0 110.663 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.82 -170.38 34.19 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.752 2.12 . . . . 0.0 108.04 -174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -58.26 -25.41 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.08 1.41 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.067 0.849 . . . . 0.0 113.6 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -69.4 -43.11 74.13 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.399 1.599 . . . . 0.0 110.144 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -69.28 -23.67 63.86 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.764 -1.21 . . . . 0.0 112.105 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.54 -35.43 80.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.414 1.007 . . . . 0.0 110.608 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -50.22 66.22 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.732 1.151 . . . . 0.0 110.728 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.8 m -62.8 -33.34 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.218 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -74.11 -25.31 59.71 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.854 1.207 . . . . 0.0 112.278 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -62.83 -47.56 82.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.902 0.773 . . . . 0.0 109.139 166.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -66.67 -29.66 69.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.613 0.365 . . . . 0.0 110.835 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.866 1.266 . . . . 0.0 109.975 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.27 -39.75 91.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.947 0.499 . . . . 0.0 111.197 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.29 -18.77 51.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.634 1.173 . . . . 0.0 112.545 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -114.59 15.17 17.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.012 1.278 . . . . 0.0 111.389 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp 46.87 33.17 2.07 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.29 1.836 . . . . 0.0 112.724 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.2 mt -73.97 161.96 29.55 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -134.18 134.82 42.56 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.2 -172.93 42.98 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 118.182 0.446 . . . . 0.0 112.107 -164.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 21.2 p90 -135.09 162.39 32.61 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.521 0.729 . . . . 0.0 112.124 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.83 149.76 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.562 1.145 . . . . 0.0 108.84 171.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -147.42 156.02 42.49 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.51 1.924 . . . . 0.0 107.585 -170.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.32 122.57 45.3 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -76.88 159.73 29.79 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.135 0.974 . . . . 0.0 110.337 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -61.19 -30.17 70.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.246 0.618 . . . . 0.0 111.458 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.12 -10.19 57.96 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.98 -23.84 24.6 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.527 1.536 . . . . 0.0 112.204 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -87.81 166.09 14.84 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.229 1.514 . . . . 0.0 110.469 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.9 150.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -133.51 143.41 48.74 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.89 1.276 . . . . 0.0 107.667 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.05 142.71 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.64 123.55 10.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -154.26 162.98 40.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.413 0.552 . . . . 0.0 110.818 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.61 151.75 32.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 109.871 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.54 177.92 40.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.23 1.395 . . . . 0.0 110.351 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.74 154.45 67.79 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.353 2.035 . . . . 0.0 110.086 171.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.0 -42.42 76.36 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.558 0.743 . . . . 0.0 111.577 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -63.02 -41.19 99.49 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.148 -0.345 . . . . 0.0 111.573 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 -45.48 84.19 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 122.988 0.515 . . . . 0.0 109.987 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 4' ' ' TYR . 86.4 mt -62.92 -43.34 99.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.565 0.746 . . . . 0.0 110.699 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -70.48 -40.9 73.34 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.636 -0.665 . . . . 0.0 111.697 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.5 m -59.8 -39.9 86.54 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.059 -0.401 . . . . 0.0 110.019 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -61.87 -47.43 85.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.952 173.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -53.99 -46.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 120.078 1.308 . . . . 0.0 109.593 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -61.78 -39.99 93.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.001 0.364 . . . . 0.0 111.039 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.64 -41.75 98.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.282 0.633 . . . . 0.0 111.899 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.73 -49.44 80.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -57.86 -41.64 82.86 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.036 0.534 . . . . 0.0 110.826 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -72.12 -20.78 61.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.125 0.97 . . . . 0.0 112.451 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 40.81 92.67 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.365 0.984 . . . . 0.0 111.832 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 m -46.47 -54.33 19.15 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -160.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.36 -52.28 0.15 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 121.797 1.678 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -167.82 158.43 10.82 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.253 2.221 . . . . 0.0 107.412 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 p 129.48 176.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 131.713 4.005 . . . . 0.0 108.717 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.77 157.74 43.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 145.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.21 137.65 56.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -126.39 -5.69 6.53 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.233 1.413 . . . . 0.0 110.788 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -153.17 134.12 13.97 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.363 1.865 . . . . 0.0 106.405 174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 tt -145.42 138.42 21.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.0 m -140.58 147.82 40.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.92 143.63 28.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.1 m -130.19 152.44 49.62 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -129.2 145.07 51.4 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.4 m -143.61 167.65 21.74 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.902 1.281 . . . . 0.0 109.582 -160.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.73 1.89 10.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 110.971 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.6 m -65.91 -26.17 67.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.145 0.978 . . . . 0.0 112.709 -173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.5 mt 60.82 175.76 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.381 1.872 . . . . 0.0 111.414 -171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.8 -16.52 0.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.023 0.929 . . . . 0.0 113.046 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.96 3.8 90.31 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.221 -1.322 . . . . 0.0 116.198 155.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -81.83 178.41 8.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.039 1.919 . . . . 0.0 109.929 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -130.16 17.24 5.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.554 1.541 . . . . 0.0 110.718 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -149.38 167.54 25.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.551 1.541 . . . . 0.0 109.292 -172.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -86.04 151.63 23.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 163.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -142.95 162.34 35.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.838 0.855 . . . . 0.0 110.53 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 mt -134.59 114.82 18.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -172.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.9 t -66.75 141.31 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -61.7 -46.91 87.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.438 0.295 . . . . 0.0 110.845 -176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.937 1.695 . . . . 0.0 110.744 179.14 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 119.205 -0.426 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mp -133.13 177.42 7.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.882 1.219 . . . . 0.0 111.248 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -146.79 155.22 42.2 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.675 2.39 . . . . 0.0 108.081 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.465 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -119.44 165.18 14.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.99 0.916 . . . . 0.0 110.426 169.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -131.06 133.78 46.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 154.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.45 141.63 43.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.68 128.73 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -139.16 137.59 41.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 124.67 1.188 . . . . 0.0 109.83 -164.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -131.44 150.83 52.0 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.655 1.182 . . . . 0.0 108.393 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -152.65 24.74 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -79.55 78.88 6.07 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 164.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.5 m -108.71 4.17 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.651 0.78 . . . . 0.0 111.892 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -153.21 153.88 33.6 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.76 80.83 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.086 -0.841 . . . . 0.0 113.507 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.68 9.66 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.607 1.163 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.0 15.38 80.71 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.909 -0.94 . . . . 0.0 113.099 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -50.39 -48.12 56.06 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.099 1.45 . . . . 0.0 111.121 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -75.67 -15.36 60.32 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 119.315 -0.954 . . . . 0.0 113.294 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -72.33 -45.42 60.01 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.897 1.226 . . . . 0.0 108.97 163.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -48.68 64.12 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.964 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 m -62.12 -37.1 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 119.802 1.183 . . . . 0.0 110.791 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -73.53 -23.18 59.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 120.5 1.5 . . . . 0.0 112.273 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.4 mtm -62.94 -47.07 84.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.262 0.937 . . . . 0.0 109.34 165.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -66.65 -32.6 74.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.494 . . . . 0.0 110.804 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.51 72.93 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.585 1.154 . . . . 0.0 109.583 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.34 -42.07 99.09 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.886 0.474 . . . . 0.0 111.235 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.01 -21.49 45.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.635 1.174 . . . . 0.0 112.255 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.8 16.22 12.67 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.995 -1.066 . . . . 0.0 111.947 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? 45.69 38.57 4.25 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.869 2.067 . . . . 0.0 112.31 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.5 mt -75.66 164.23 26.51 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.73 130.98 22.07 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.71 -162.07 33.63 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -170.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -136.39 163.63 30.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 117.626 0.713 . . . . 0.0 111.994 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.42 142.53 41.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.058 0.943 . . . . 0.0 109.732 174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -149.21 151.86 35.01 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 125.3 1.44 . . . . 0.0 108.248 -162.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.04 120.07 29.03 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 166.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -74.21 153.24 39.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.96 -25.52 67.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.884 0.874 . . . . 0.0 112.341 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.54 -27.64 67.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.382 1.073 . . . . 0.0 112.104 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.21 -31.78 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.318 1.437 . . . . 0.0 110.966 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -68.32 163.67 22.49 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.732 0.766 . . . . 0.0 110.54 172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -95.35 156.53 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -134.05 141.53 47.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.658 1.583 . . . . 0.0 107.881 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -134.03 141.01 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.4 tt -149.91 119.41 6.93 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.2 160.23 42.78 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.488 0.715 . . . . 0.0 111.205 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 12.9 pt-20 -106.83 154.93 20.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.179 1.392 . . . . 0.0 110.313 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 175.61 37.63 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.057 1.313 . . . . 0.0 111.001 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.89 153.43 68.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.146 1.897 . . . . 0.0 110.261 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -55.33 -43.32 74.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.653 0.781 . . . . 0.0 111.533 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -62.69 -40.43 97.1 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.245 -0.284 . . . . 0.0 111.459 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -45.64 74.65 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 4' ' ' TYR . 91.9 mt -59.14 -44.87 92.08 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.45 0.7 . . . . 0.0 110.023 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -68.87 -40.51 79.25 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.88 -0.512 . . . . 0.0 111.955 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -60.67 -42.68 97.53 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.567 0.621 . . . . 0.0 110.063 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -59.53 -48.97 79.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.432 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.72 -42.92 71.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.953 1.251 . . . . 0.0 110.0 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.17 -41.89 99.3 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.871 0.76 . . . . 0.0 110.743 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.44 -43.82 96.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.657 0.783 . . . . 0.0 111.366 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.1 -52.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -56.75 -41.63 77.89 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.81 0.844 . . . . 0.0 111.046 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -72.75 -20.96 61.09 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.018 -0.515 . . . . 0.0 112.365 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.73 40.42 48.72 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.436 1.017 . . . . 0.0 111.906 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -45.63 -53.94 17.58 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -157.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -49.65 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 CA-C-N 121.481 1.565 . . . . 0.0 112.216 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 67' ' ' SER . 17.5 p90 -167.48 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.012 0.925 . . . . 0.0 112.718 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.457 ' HA ' ' CD1' ' A' ' 66' ' ' PHE 0.269 1.4 m -62.63 -57.32 11.49 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -120.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 161.63 40.61 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 130.277 3.431 . . . . 0.0 108.511 -5.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.54 157.18 7.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.318 0.647 . . . . 0.0 109.408 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.2 p -127.21 -11.88 5.77 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.22 1.408 . . . . 0.0 110.378 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.22 144.83 25.87 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.926 1.291 . . . . 0.0 108.471 172.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.28 144.02 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.0 108.217 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 m -139.46 145.29 38.62 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.337 1.455 . . . . 0.0 107.219 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.07 142.69 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.375 1.07 . . . . 0.0 108.281 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.9 m -132.45 150.41 52.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.396 1.878 . . . . 0.0 106.048 168.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -137.99 149.04 45.75 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 m -148.76 162.83 38.99 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.375 1.47 . . . . 0.0 109.114 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.11 -13.24 57.55 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.602 -0.686 . . . . 0.0 111.362 167.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 88.83 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 111.899 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.84 147.58 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.531 0.732 . . . . 0.0 110.26 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -81.95 -28.2 32.85 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.892 0.877 . . . . 0.0 112.026 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.34 21.98 68.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.038 0.828 . . . . 0.0 111.219 -163.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.67 150.17 34.58 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.808 1.304 . . . . 0.0 109.378 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -134.76 9.37 3.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.958 0.903 . . . . 0.0 112.547 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -149.26 177.55 9.55 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.149 1.38 . . . . 0.0 109.158 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -101.79 145.02 29.74 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 163.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 m -141.73 161.81 37.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.628 0.728 . . . . 0.0 111.431 -176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.1 mt -133.88 126.86 51.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.72 165.88 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.375 0.67 . . . . 0.0 109.656 -163.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -142.82 50.84 1.43 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.174 0.99 . . . . 0.0 108.661 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.477 1.511 . . . . 0.0 111.416 -177.08 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp -129.29 176.03 8.26 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.686 -1.259 . . . . 0.0 111.18 -165.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -147.55 152.8 38.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.844 1.658 . . . . 0.0 109.183 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -125.68 165.22 18.98 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.387 1.075 . . . . 0.0 111.054 169.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -134.28 133.41 40.73 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 158.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -135.41 142.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.54 133.26 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.65 141.92 29.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.71 151.77 49.62 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.888 1.275 . . . . 0.0 108.054 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.61 -153.75 25.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -76.72 82.45 3.34 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 158.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -107.59 -1.63 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.443 1.097 . . . . 0.0 111.201 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.538 HE22 ' HB3' ' A' ' 18' ' ' ARG . 9.9 mm-40 -133.82 156.76 47.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.21 -148.7 15.01 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.43 -30.47 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.73 11.3 66.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 118.982 0.81 . . . . 0.0 112.894 177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 36.71 -118.44 0.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.541 2.336 . . . . 0.0 110.316 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.7 ptt-85 -114.68 1.45 14.2 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.134 0.974 . . . . 0.0 111.443 170.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -69.08 -23.56 64.04 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 117.608 -1.186 . . . . 0.0 111.125 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.04 -52.14 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.283 1.402 . . . . 0.0 111.736 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -68.51 -31.83 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.716 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -66.51 -31.14 71.69 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.872 1.214 . . . . 0.0 112.288 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 72.7 mtm -65.76 -49.94 66.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.456 1.026 . . . . 0.0 108.637 174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -67.8 -33.12 74.19 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.205 0.457 . . . . 0.0 110.875 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.0 -53.21 57.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.482 1.113 . . . . 0.0 110.336 173.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.13 -40.05 93.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.561 0.745 . . . . 0.0 111.288 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -53.52 -28.14 29.61 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.165 1.386 . . . . 0.0 111.817 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -118.58 22.8 11.86 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.567 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.4 tttt 50.21 36.18 11.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.506 1.922 . . . . 0.0 113.089 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.7 mt -73.69 163.6 27.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.23 126.18 21.02 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.1 -161.86 29.72 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 118.926 0.785 . . . . 0.0 113.148 -168.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.2 p90 -135.06 166.09 23.87 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.375 1.07 . . . . 0.0 111.606 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.79 144.0 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.754 1.221 . . . . 0.0 108.818 162.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -147.0 161.74 40.19 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.818 0.847 . . . . 0.0 110.34 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.76 148.06 38.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 158.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.7 ttt85 -126.08 140.29 52.71 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.929 1.291 . . . . 0.0 107.785 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.11 -24.78 63.26 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.402 1.481 . . . . 0.0 114.318 -163.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -61.0 -23.03 65.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.188 0.595 . . . . 0.0 112.301 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.14 37.16 1.39 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.753 1.168 . . . . 0.0 111.123 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -145.81 163.88 33.65 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.358 1.063 . . . . 0.0 109.144 -173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.26 150.26 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.26 143.17 51.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.405 1.882 . . . . 0.0 107.259 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.8 mt -137.6 139.32 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 tt -150.04 126.58 10.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.11 161.96 39.42 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 119.049 0.84 . . . . 0.0 111.374 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.99 154.3 23.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.177 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.39 177.29 39.9 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.312 0.958 . . . . 0.0 111.53 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.28 157.59 53.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.771 2.314 . . . . 0.0 110.757 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -55.37 -53.29 58.09 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.526 0.731 . . . . 0.0 111.511 -170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -59.98 -37.49 79.81 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.967 -0.458 . . . . 0.0 111.527 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.36 76.25 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 4' ' ' TYR . 90.2 mt -62.28 -47.13 85.69 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.467 0.707 . . . . 0.0 110.534 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -68.53 -42.09 78.96 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.888 -0.508 . . . . 0.0 111.339 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 m -63.37 -37.74 88.46 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.765 -0.584 . . . . 0.0 110.204 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -61.6 -45.54 93.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.448 173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.3 t -55.23 -45.61 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 120.013 1.279 . . . . 0.0 109.535 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.4 -41.01 88.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.043 0.383 . . . . 0.0 111.031 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.66 -43.79 95.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.14 0.976 . . . . 0.0 111.631 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.55 -50.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.179 0.9 . . . . 0.0 108.668 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -58.77 -41.63 87.07 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 122.703 0.401 . . . . 0.0 110.935 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -71.41 -22.14 61.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.073 0.549 . . . . 0.0 112.393 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.1 39.12 40.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.944 1.259 . . . . 0.0 112.756 -175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -41.11 -50.05 8.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -159.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.81 -31.49 3.99 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.649 1.625 . . . . 0.0 114.704 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -164.26 -31.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.083 1.31 . . . . 0.0 113.264 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.03 170.87 13.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.799 1.64 . . . . 0.0 111.723 -170.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.13 145.03 19.15 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.4 m -83.92 153.23 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.6 p -118.25 -14.17 9.84 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.065 1.346 . . . . 0.0 109.376 165.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -148.64 137.89 21.77 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.328 1.451 . . . . 0.0 107.68 168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 tt -144.61 136.49 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 m -133.77 142.69 48.03 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -136.84 141.48 40.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -172.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.27 146.2 51.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 171.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -140.55 154.72 46.64 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.809 0.731 . . . . 0.0 110.102 172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m -147.89 176.72 9.92 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.878 1.671 . . . . 0.0 108.245 -171.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -119.46 -7.16 10.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.719 0.808 . . . . 0.0 110.191 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m -70.22 100.54 1.7 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.623 1.169 . . . . 0.0 108.851 165.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.3 155.26 9.2 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.188 0.995 . . . . 0.0 109.97 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.6 -27.74 51.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.668 0.787 . . . . 0.0 110.967 170.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.38 30.62 58.27 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -161.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.11 155.09 35.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.116 0.958 . . . . 0.0 110.202 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.39 14.57 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.345 1.058 . . . . 0.0 111.291 -173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 52.4 mtm-85 -149.34 172.49 14.83 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.846 1.658 . . . . 0.0 108.644 -170.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -133.42 119.97 20.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 160.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -136.93 156.78 48.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -153.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.45 124.84 64.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 52.5 t -82.87 140.72 15.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -134.88 7.39 3.47 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.255 1.422 . . . . 0.0 111.369 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 C--O 1.25 1.082 0 C-N-CA 125.094 1.358 . . . . 0.0 110.663 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.87 177.85 8.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.613 1.097 . . . . 0.0 110.513 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.84 153.49 32.21 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.411 1.884 . . . . 0.0 108.968 177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.426 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.2 p90 -114.18 163.42 15.25 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.81 0.844 . . . . 0.0 109.785 166.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -131.41 138.23 49.0 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 151.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.02 145.64 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -169.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.44 139.28 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 167.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.9 m -135.47 151.1 29.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.292 1.037 . . . . 0.0 109.8 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.47 152.82 49.95 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.63 1.572 . . . . 0.0 107.147 171.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.76 -155.46 26.55 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -78.51 60.28 2.61 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 162.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -85.73 18.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.287 -0.883 . . . . 0.0 111.713 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -156.25 155.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 167.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.02 -84.21 0.1 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.1 m -70.46 -37.85 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 117.022 0.411 . . . . 0.0 110.803 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.73 50.27 0.02 OUTLIER Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 67' ' ' SER . 12.5 t80 -57.31 -38.69 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 117.433 0.617 . . . . 0.0 110.944 -170.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -67.43 -37.75 83.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.205 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -76.32 -32.51 58.76 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.454 1.479 . . . . 0.0 111.493 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.97 -45.93 75.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.073 1.306 . . . . 0.0 109.967 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.74 -47.96 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.099 0.959 . . . . 0.0 109.285 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -70.05 -25.7 63.68 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.306 1.412 . . . . 0.0 113.45 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.1 mtm -65.5 -48.05 73.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.2 1.364 . . . . 0.0 109.097 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -66.67 -35.06 79.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.307 0.643 . . . . 0.0 110.048 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.6 -54.31 47.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.555 1.142 . . . . 0.0 109.791 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.08 -39.6 92.98 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.284 0.634 . . . . 0.0 111.406 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -16.09 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 0.0 112.576 174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.53 17.57 16.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.304 1.442 . . . . 0.0 110.915 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 49.39 30.36 3.26 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.12 1.768 . . . . 0.0 112.911 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.0 mt -77.31 160.09 29.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.24 134.86 18.63 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.959 0.504 . . . . 0.0 110.584 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.57 -161.06 31.09 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.086 1.326 . . . . 0.0 110.545 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -106.09 162.29 13.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.226 1.513 . . . . 0.0 113.298 -169.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.14 146.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.697 1.199 . . . . 0.0 108.001 163.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -154.13 155.37 35.24 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.414 1.086 . . . . 0.0 108.958 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -99.72 123.74 44.28 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 161.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -80.3 147.3 31.2 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.04 -27.8 65.83 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.491 0.716 . . . . 0.0 112.25 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.61 -27.44 68.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.338 1.055 . . . . 0.0 112.81 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.06 -21.74 5.48 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.9 1.238 . . . . 0.0 112.322 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -59.38 157.0 11.77 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.056 0.928 . . . . 0.0 110.753 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -96.6 146.68 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 149.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.54 144.57 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.907 1.683 . . . . 0.0 106.812 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.54 142.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -148.32 123.02 9.88 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.84 31.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.293 0.951 . . . . 0.0 111.255 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.87 155.43 16.78 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.228 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 177.18 41.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.412 1.482 . . . . 0.0 111.077 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.88 159.78 49.56 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.725 2.283 . . . . 0.0 110.321 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.76 -48.14 78.51 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.232 0.613 . . . . 0.0 111.602 -168.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.79 -37.45 86.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.666 0.386 . . . . 0.0 111.852 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -46.3 87.96 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 4' ' ' TYR . 81.4 mt -59.53 -45.11 92.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.108 0.563 . . . . 0.0 109.556 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -65.49 -44.83 85.84 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.769 0.713 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.7 m -60.98 -42.31 98.12 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.849 0.46 . . . . 0.0 109.99 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.54 -48.08 83.32 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.062 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.0 t -56.96 -41.27 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.913 1.233 . . . . 0.0 109.792 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -62.75 -41.93 99.44 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.692 0.678 . . . . 0.0 110.851 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.0 86.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.676 0.79 . . . . 0.0 111.756 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -67.01 -55.48 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.25 -38.47 83.56 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.709 0.804 . . . . 0.0 111.263 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.55 -24.75 67.94 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.47 0.708 . . . . 0.0 112.154 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.2 97.83 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.8 m -49.72 -45.87 79.52 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.83 -51.78 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.728 1.653 . . . . 0.0 112.299 -166.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.2 t80 179.51 -56.09 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 127.31 2.244 . . . . 0.0 106.094 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 14.9 m -58.85 141.23 53.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 170.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.01 157.1 40.03 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.971 0.909 . . . . 0.0 110.325 -171.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.96 157.08 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -119.77 -13.91 9.06 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.004 1.321 . . . . 0.0 109.708 158.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 141.22 25.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.87 1.268 . . . . 0.0 108.547 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -137.63 135.77 46.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.4 m -132.36 140.77 48.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.249 1.419 . . . . 0.0 107.206 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.7 t -140.19 145.53 26.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -168.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.0 m -127.79 140.72 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 161.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.92 134.34 23.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 m -139.1 155.71 47.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.054 0.941 . . . . 0.0 109.983 -162.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -4.85 57.22 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.55 0.74 . . . . 0.0 110.877 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 m -58.57 165.6 2.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.617 1.167 . . . . 0.0 110.361 161.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.3 162.92 40.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.239 1.816 . . . . 0.0 108.173 167.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -79.42 -29.67 42.02 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.317 0.647 . . . . 0.0 111.823 -171.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.92 54.06 6.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -162.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -51.11 153.63 1.85 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.595 1.158 . . . . 0.0 113.319 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -135.95 -3.88 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.866 1.266 . . . . 0.0 111.715 166.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -156.96 172.06 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.52 1.528 . . . . 0.0 109.158 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -138.92 140.65 38.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 162.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -148.68 153.92 38.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.813 0.816 . . . . 0.0 112.834 -150.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.46 115.63 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.41 132.6 32.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 164.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -100.72 31.38 3.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.903 0.881 . . . . 0.0 111.278 -170.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.986 0.914 . . . . 0.0 110.835 175.159 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 119.437 -0.316 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.3 177.03 11.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.499 -0.751 . . . . 0.0 112.773 -161.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -148.48 154.36 39.73 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.609 2.364 . . . . 0.0 108.216 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.07 165.86 17.43 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.551 0.74 . . . . 0.0 110.437 161.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -133.61 141.59 47.72 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 157.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mt -137.45 143.03 35.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.42 140.26 48.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 143.66 21.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.488 0.715 . . . . 0.0 109.702 -166.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -144.11 153.47 42.19 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.972 1.309 . . . . 0.0 108.347 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.74 -157.65 27.43 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 107.524 -2.231 . . . . 0.0 107.524 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.1 tpp85 -78.22 75.86 4.74 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 158.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.06 25.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -131.21 -73.07 0.54 Allowed 'General case' 0 C--O 1.232 0.155 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 164.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 -132.06 39.66 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.68 -33.26 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.023 0.529 . . . . 0.0 110.801 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.79 46.2 0.03 OUTLIER Glycine 0 C--N 1.342 0.875 0 CA-C-N 119.436 1.016 . . . . 0.0 113.957 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -53.8 -40.64 66.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.982 1.391 . . . . 0.0 111.929 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.8 mtm105 -58.28 -46.69 85.6 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.739 0.416 . . . . 0.0 110.791 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -64.47 -45.31 87.91 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -55.69 -50.03 71.38 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.623 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.9 m -63.24 -36.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.592 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -74.97 -19.4 60.12 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.642 -1.286 . . . . 0.0 113.069 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -65.22 -48.93 71.65 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.965 1.257 . . . . 0.0 108.708 164.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -65.7 -22.85 66.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.921 0.888 . . . . 0.0 111.383 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.16 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.028 0.931 . . . . 0.0 109.261 170.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -56.64 -37.76 71.2 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.502 1.121 . . . . 0.0 111.468 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -49.53 -38.41 30.63 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.882 1.673 . . . . 0.0 112.406 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -112.71 16.78 19.52 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.24 1.416 . . . . 0.0 111.468 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.97 31.77 5.05 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.636 1.574 . . . . 0.0 112.079 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.5 155.71 40.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 172.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.4 133.97 30.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.89 -171.33 42.85 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.937 -166.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -117.06 161.46 19.37 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.977 0.889 . . . . 0.0 111.541 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.72 142.71 42.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 158.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -144.37 157.7 44.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.486 1.515 . . . . 0.0 108.357 -164.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -118.06 121.23 40.05 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -75.58 154.28 36.84 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.12 -28.14 67.62 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.162 0.506 . . . . 0.0 110.759 166.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.8 -16.1 37.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.787 2.035 . . . . 0.0 113.38 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -37.63 3.72 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.116 1.341 . . . . 0.0 111.525 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.61 150.85 11.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.149 0.979 . . . . 0.0 110.321 171.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 t -82.36 157.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 162.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.99 147.48 40.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -138.4 139.69 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 tt -150.29 124.04 9.2 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.82 162.2 40.29 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 119.248 0.931 . . . . 0.0 110.896 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.94 156.87 24.23 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.611 1.564 . . . . 0.0 109.714 172.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 164.66 -176.36 40.51 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.828 0.728 . . . . 0.0 111.596 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -73.22 151.82 49.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.024 1.816 . . . . 0.0 110.477 172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.53 -48.57 78.92 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.387 1.075 . . . . 0.0 111.29 -170.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -64.53 -40.31 95.38 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.262 -0.273 . . . . 0.0 111.339 -177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 -48.56 75.76 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.4 mt -61.78 -43.78 98.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.173 0.589 . . . . 0.0 110.458 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.86 -35.45 76.92 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.482 -0.761 . . . . 0.0 111.299 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 m -62.85 -41.18 99.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.644 -0.66 . . . . 0.0 110.703 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -58.8 -46.91 86.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.559 -0.734 . . . . 0.0 110.243 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.5 t -57.28 -41.92 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.866 1.212 . . . . 0.0 109.521 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.37 -41.18 98.42 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.19 88.86 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.688 0.795 . . . . 0.0 111.748 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.12 -53.24 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.6 -37.93 76.88 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.355 1.062 . . . . 0.0 111.808 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.27 -24.12 67.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.18 0.592 . . . . 0.0 112.333 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.58 40.13 98.31 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 m -52.82 -44.73 96.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.7 -164.44 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.472 2.115 . . . . 0.0 112.302 -166.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.94 -1.47 0.11 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.504 2.722 . . . . 0.0 115.616 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.9 m -141.85 148.09 38.24 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.889 2.076 . . . . 0.0 106.304 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.4 154.49 35.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.983 0.811 . . . . 0.0 111.434 -172.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.5 m -83.62 155.62 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.259 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -121.4 -11.75 8.7 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.187 1.395 . . . . 0.0 109.595 162.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.13 143.04 25.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.283 1.433 . . . . 0.0 108.383 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -148.71 140.42 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -138.33 134.89 34.83 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -135.11 144.87 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 123.702 0.801 . . . . 0.0 109.824 -169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.1 m -134.43 149.94 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.422 1.889 . . . . 0.0 106.093 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.15 154.45 51.2 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.9 m -155.93 146.5 21.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -71.4 -29.21 64.66 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.538 -0.727 . . . . 0.0 110.95 -177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.5 m -61.77 121.45 12.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.731 1.212 . . . . 0.0 111.653 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.09 164.17 13.49 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.47 0.708 . . . . 0.0 109.342 163.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.14 -13.78 0.91 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.6 -11.66 7.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.551 158.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -57.54 145.96 31.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.243 2.021 . . . . 0.0 111.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -132.37 7.65 4.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.891 1.276 . . . . 0.0 111.118 176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.11 164.1 35.65 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.808 1.643 . . . . 0.0 108.564 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -84.15 144.29 29.1 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 164.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -143.2 157.78 44.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.674 0.79 . . . . 0.0 110.545 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.7 mt -135.5 135.46 51.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 142.29 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -152.51 10.22 0.49 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.914 0.886 . . . . 0.0 111.805 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.249 1.075 0 C-N-CA 125.462 1.505 . . . . 0.0 110.933 -178.29 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ttp . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.43 176.84 6.23 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.092 -1.005 . . . . 0.0 111.115 -163.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -140.92 152.92 45.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.52 1.928 . . . . 0.0 108.498 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.58 162.13 16.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 162.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -137.98 125.77 22.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 165.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.27 139.93 45.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -168.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.1 134.84 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 172.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -138.59 154.02 26.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.807 0.843 . . . . 0.0 110.518 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -140.45 146.17 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.731 1.613 . . . . 0.0 107.51 174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.77 -156.22 26.74 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -78.72 98.3 6.19 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 161.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.99 12.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.85 1.26 . . . . 0.0 110.244 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -145.85 157.06 43.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.012 1.325 . . . . 0.0 109.206 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.65 -116.76 4.25 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 127.898 2.666 . . . . 0.0 110.022 -0.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.12 141.39 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.218 1.007 . . . . 0.0 108.914 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.94 -56.72 4.57 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -67.18 -17.38 64.81 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.517 1.127 . . . . 0.0 113.863 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -113.86 1.15 14.68 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.875 1.216 . . . . 0.0 114.214 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.74 -33.41 64.31 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.728 1.149 . . . . 0.0 109.711 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -56.74 -39.23 73.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.087 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 m -61.52 -37.14 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.456 1.026 . . . . 0.0 110.447 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -74.63 -28.24 60.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.361 0.982 . . . . 0.0 110.817 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 54.6 mtm -62.17 -49.85 74.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.515 0.598 . . . . 0.0 110.591 167.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -65.96 -34.22 77.6 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.636 0.775 . . . . 0.0 110.356 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.94 -50.94 70.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.386 1.475 . . . . 0.0 109.923 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.38 -41.05 96.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.901 0.481 . . . . 0.0 111.178 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.16 -14.97 42.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.138 1.375 . . . . 0.0 112.654 174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -116.57 20.76 13.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.419 1.488 . . . . 0.0 110.874 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.3 pttt 43.59 31.36 0.43 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.143 2.177 . . . . 0.0 114.172 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.91 162.09 29.44 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.91 0.884 . . . . 0.0 109.017 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.08 138.76 37.38 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.58 -170.94 41.36 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.545 0.611 . . . . 0.0 112.29 -164.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -129.44 160.56 32.76 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.043 0.937 . . . . 0.0 111.525 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.29 140.85 46.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 163.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -145.65 144.22 30.3 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.74 0.816 . . . . 0.0 109.0 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -76.13 146.45 39.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.97 132.62 55.9 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.94 -25.08 64.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.129 0.972 . . . . 0.0 112.697 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.72 -26.67 67.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.335 1.054 . . . . 0.0 112.284 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.38 -19.57 4.28 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.823 1.678 . . . . 0.0 112.307 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 172.44 10.8 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.318 1.047 . . . . 0.0 110.532 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.75 147.26 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -115.36 143.84 44.67 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.6 1.96 . . . . 0.0 106.83 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.98 134.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 tt -148.37 124.43 10.73 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.85 162.04 41.79 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.24 0.473 . . . . 0.0 110.568 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.89 151.55 29.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.69 1.596 . . . . 0.0 109.551 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.04 40.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.55 1.071 . . . . 0.0 110.949 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.3 158.32 56.6 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.383 2.055 . . . . 0.0 110.384 171.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.12 -46.48 79.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.638 0.775 . . . . 0.0 111.435 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -64.2 -37.77 88.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.554 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -47.86 72.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.305 0.642 . . . . 0.0 109.786 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.83 -46.99 88.39 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.587 0.755 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.74 -38.2 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.736 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -60.55 -42.62 96.94 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.734 0.697 . . . . 0.0 110.136 175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -59.47 -47.27 86.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.637 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.31 -44.97 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 119.885 1.221 . . . . 0.0 110.071 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.82 -39.9 95.73 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.541 0.609 . . . . 0.0 110.902 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.95 98.22 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.352 0.661 . . . . 0.0 111.334 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.5 t -66.02 -50.35 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -58.29 -38.57 77.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.146 0.578 . . . . 0.0 111.104 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -69.19 -23.74 63.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.296 0.638 . . . . 0.0 112.629 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.8 44.62 94.16 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 118.943 0.792 . . . . 0.0 111.561 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -55.97 -50.93 84.48 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -166.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.39 -49.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.786 1.674 . . . . 0.0 113.491 -163.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.55 -46.04 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 110.27 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -61.92 151.86 33.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.581 0.752 . . . . 0.0 109.633 169.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.25 146.31 23.64 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 172.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.15 154.88 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.4 p -122.73 -11.88 8.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.668 1.587 . . . . 0.0 109.485 166.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.63 145.44 25.87 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.384 1.473 . . . . 0.0 107.848 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.5 tt -149.04 141.87 18.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.713 1.205 . . . . 0.0 107.804 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -135.98 140.77 44.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.409 1.484 . . . . 0.0 107.072 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.7 138.52 47.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.4 m -130.11 155.94 45.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 166.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -130.39 152.35 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 m -147.92 178.48 8.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.334 1.453 . . . . 0.0 107.962 -167.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -130.81 15.5 5.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.474 1.11 . . . . 0.0 109.366 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -69.62 -28.56 66.03 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.386 1.475 . . . . 0.0 112.827 -170.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp 57.75 173.71 0.05 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.988 1.715 . . . . 0.0 111.492 -166.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.95 0.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.126 0.971 . . . . 0.0 112.948 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 -10.56 60.76 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.461 -1.188 . . . . 0.0 115.689 154.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 173.34 12.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.773 1.787 . . . . 0.0 110.085 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -127.91 19.72 6.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.087 1.355 . . . . 0.0 110.145 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 168.09 24.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.128 1.771 . . . . 0.0 108.732 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -88.03 158.3 18.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.79 0.436 . . . . 0.0 110.102 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -141.62 158.82 43.34 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.231 1.013 . . . . 0.0 110.16 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.14 125.14 43.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.53 154.99 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -161.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.79 -31.49 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.369 -0.832 . . . . 0.0 112.157 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.313 1.445 . . . . 0.0 111.117 177.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.851 0.358 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -149.17 178.44 8.73 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.187 2.195 . . . . 0.0 109.364 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -134.73 147.42 50.05 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.94 2.096 . . . . 0.0 107.937 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.548 0.739 . . . . 0.0 110.045 165.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -134.45 130.95 37.54 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 161.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.84 142.7 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 134.7 59.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 170.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.98 147.98 18.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 C-N-CA 124.423 1.089 . . . . 0.0 110.257 -170.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -138.07 155.58 48.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.68 -158.32 27.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -168.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -78.05 90.11 4.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 158.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.73 10.43 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.792 1.237 . . . . 0.0 110.332 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -145.74 142.91 29.38 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.776 0.716 . . . . 0.0 111.468 -166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.77 170.73 12.75 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.575 2.036 . . . . 0.0 109.007 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.4 127.39 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.3 -46.12 2.44 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.171 0.891 . . . . 0.0 111.651 -172.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -65.71 -23.26 66.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 116.682 -1.628 . . . . 0.0 114.069 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -91.73 -23.35 19.8 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 121.296 1.862 . . . . 0.0 112.445 161.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -67.95 -25.43 65.45 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.052 0.941 . . . . 0.0 111.621 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -48.67 -43.9 37.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.88 -38.1 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.067 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -73.83 -23.46 59.65 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.869 1.213 . . . . 0.0 111.465 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 48.9 mtm -61.68 -53.57 54.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.295 0.952 . . . . 0.0 110.074 164.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.66 -37.2 80.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.782 0.433 . . . . 0.0 110.341 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.67 -53.57 55.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.562 1.145 . . . . 0.0 109.952 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.52 -47.24 86.28 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 123.585 0.754 . . . . 0.0 110.386 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -58.21 -30.66 66.65 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.19 1.396 . . . . 0.0 111.731 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.97 10.69 39.47 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.959 1.304 . . . . 0.0 111.379 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? 50.47 32.39 6.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.955 1.702 . . . . 0.0 112.101 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -77.64 165.95 23.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.292 1.037 . . . . 0.0 109.117 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.4 20.99 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.13 173.94 36.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.549 0.613 . . . . 0.0 112.677 -169.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -101.09 160.99 13.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.36 1.08 . . . . 0.0 111.858 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.57 144.07 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.887 1.275 . . . . 0.0 107.74 158.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -149.23 159.56 44.15 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 107.703 -171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -112.34 120.74 42.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.987 0.812 . . . . 0.0 109.281 170.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -76.09 146.56 39.26 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.81 -28.53 67.53 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.681 0.792 . . . . 0.0 112.357 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.12 -27.61 69.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.479 0.712 . . . . 0.0 112.479 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.18 -37.13 1.88 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.526 1.06 . . . . 0.0 112.315 170.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.35 149.64 49.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.006 0.903 . . . . 0.0 111.314 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.61 150.07 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 167.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -124.13 144.84 49.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.012 1.725 . . . . 0.0 106.502 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -135.95 140.76 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.32 118.8 7.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.15 164.1 34.95 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.402 0.681 . . . . 0.0 111.01 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.47 156.72 29.69 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.526 1.531 . . . . 0.0 109.296 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.81 44.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.53 0.586 . . . . 0.0 111.954 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.76 151.44 63.36 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.206 1.938 . . . . 0.0 110.448 171.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -52.82 -50.06 64.42 Favored 'General case' 0 C--N 1.334 -0.071 0 C-N-CA 124.22 1.008 . . . . 0.0 111.529 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.37 -36.63 82.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.692 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.88 75.02 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.61 -46.63 81.81 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.127 0.571 . . . . 0.0 110.522 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -66.96 -42.88 84.44 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 121.759 -0.588 . . . . 0.0 111.138 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 m -68.07 -33.43 74.54 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.678 -0.639 . . . . 0.0 110.927 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -58.95 -50.5 73.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.557 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.64 -43.83 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.556 1.071 . . . . 0.0 109.424 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.14 -40.32 93.37 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.319 0.509 . . . . 0.0 111.215 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.41 97.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.355 0.662 . . . . 0.0 111.217 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -64.39 -51.54 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.35 -41.38 84.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.666 0.786 . . . . 0.0 111.169 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.22 -24.56 64.03 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 112.0 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.15 48.15 82.05 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.5 m -54.79 -47.0 99.32 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-O 117.364 -1.303 . . . . 0.0 114.145 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.13 -163.55 0.23 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.768 2.312 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -59.42 -31.49 69.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.144 1.378 . . . . 0.0 113.132 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -82.61 145.06 29.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.157 0.889 . . . . 0.0 109.662 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.58 148.56 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.102 0.561 . . . . 0.0 110.033 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.5 m -86.16 156.79 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 110.206 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.4 p -125.91 -8.59 6.63 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.041 1.736 . . . . 0.0 109.915 164.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -149.64 141.09 23.32 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.595 1.958 . . . . 0.0 107.49 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.6 tt -152.87 142.44 14.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 124.427 1.091 . . . . 0.0 108.917 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -142.58 144.5 32.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.092 1.757 . . . . 0.0 107.482 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.79 140.65 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 108.314 -172.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -136.49 157.49 46.66 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.402 170.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -143.76 159.39 42.59 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.112 -0.992 . . . . 0.0 110.311 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.0 m -144.02 151.97 40.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.117 1.367 . . . . 0.0 108.767 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -87.63 35.27 0.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.308 1.043 . . . . 0.0 109.975 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -139.71 106.64 5.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.327 1.051 . . . . 0.0 108.824 -159.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.01 160.83 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.583 1.153 . . . . 0.0 110.086 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.78 -14.48 0.73 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.943 0.897 . . . . 0.0 113.318 -170.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.06 -2.63 14.49 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 117.57 -1.683 . . . . 0.0 116.236 155.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -61.11 146.27 48.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 121.001 2.401 . . . . 0.0 110.257 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -129.55 9.47 5.52 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.194 1.398 . . . . 0.0 111.028 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.31 166.5 28.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.565 1.946 . . . . 0.0 107.97 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -80.06 148.23 31.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 162.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -141.25 156.74 45.85 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 109.771 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 mt -135.93 113.67 14.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -171.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -76.05 148.1 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -64.03 -33.62 76.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.033 0.533 . . . . 0.0 111.794 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.782 1.233 . . . . 0.0 108.377 171.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ttp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tp -142.88 178.63 7.53 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.992 -1.067 . . . . 0.0 110.129 -166.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -152.31 155.05 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.234 1.814 . . . . 0.0 108.097 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.99 163.02 16.86 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.447 0.699 . . . . 0.0 109.813 166.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.1 mtt85 -134.93 135.45 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 163.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 mt -140.39 143.16 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 138.67 52.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 162.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -138.94 154.99 26.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 124.124 0.97 . . . . 0.0 110.454 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -146.12 154.65 42.04 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.593 1.557 . . . . 0.0 107.885 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 -155.33 26.09 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.806 -2.118 . . . . 0.0 107.806 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -76.16 83.76 2.99 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 158.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.04 5.55 4.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 111.129 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -146.96 168.28 21.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 171.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.46 70.22 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.84 0.733 . . . . 0.0 113.568 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.56 10.58 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.912 1.285 . . . . 0.0 111.583 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.28 16.11 67.6 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.306 -0.871 . . . . 0.0 113.53 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -52.99 -41.13 64.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.17 1.485 . . . . 0.0 111.681 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.264 21.7 ptt-85 -67.23 -23.34 65.71 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.3 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -76.51 -44.07 36.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.116 1.326 . . . . 0.0 110.084 168.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -51.84 -48.65 63.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.461 0.704 . . . . 0.0 111.156 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.25 -35.5 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 119.287 0.949 . . . . 0.0 110.994 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -74.86 -24.24 58.55 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.623 1.101 . . . . 0.0 111.892 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.8 mtm -63.5 -48.86 75.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.292 0.951 . . . . 0.0 109.868 166.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -69.76 -23.49 63.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.913 0.885 . . . . 0.0 111.595 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.79 41.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.81 -39.0 90.21 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.223 0.609 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -14.69 61.16 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 112.257 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.16 20.07 14.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.802 1.641 . . . . 0.0 111.082 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 43.29 31.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.113 2.165 . . . . 0.0 114.252 -176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.83 161.61 30.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.842 0.857 . . . . 0.0 108.74 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.15 28.93 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.362 1.065 . . . . 0.0 108.271 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.02 -154.69 25.77 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.393 -172.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.06 164.32 26.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.404 1.102 . . . . 0.0 112.815 -175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.03 141.09 47.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 165.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -132.78 140.59 48.09 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.89 148.19 52.26 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 158.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -125.9 145.4 50.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.87 0.868 . . . . 0.0 109.23 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 39' ' ' ASP . 21.7 t70 -57.81 125.88 24.94 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 164.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' ASP . 26.5 t0 -121.57 31.79 6.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.627 3.171 . . . . 0.0 109.834 5.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.98 -16.31 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 O-C-N 121.267 -0.895 . . . . 0.0 113.866 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -59.05 161.47 5.1 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.279 1.039 . . . . 0.0 109.795 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.22 147.53 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 164.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -117.34 143.02 46.39 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.211 1.405 . . . . 0.0 107.213 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.49 134.47 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.66 132.18 28.67 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.38 157.71 32.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.328 0.967 . . . . 0.0 110.843 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -107.68 151.32 25.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.688 1.195 . . . . 0.0 109.446 170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.18 178.43 40.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.745 1.164 . . . . 0.0 110.793 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.12 154.9 69.53 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.179 1.92 . . . . 0.0 110.319 172.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.44 -42.97 79.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.807 0.843 . . . . 0.0 111.695 -172.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -64.37 -41.1 96.89 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.069 -0.394 . . . . 0.0 111.513 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.41 79.95 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.874 0.47 . . . . 0.0 109.88 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.48 -49.66 76.93 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.921 0.888 . . . . 0.0 110.132 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.81 -35.89 79.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.979 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -61.35 -42.7 99.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.01 0.823 . . . . 0.0 110.175 174.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -60.94 -46.46 90.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.788 172.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.72 -41.96 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.632 1.105 . . . . 0.0 109.664 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -62.75 -41.08 99.03 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.596 0.634 . . . . 0.0 110.819 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.97 -37.77 80.59 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.248 0.619 . . . . 0.0 111.703 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.94 -57.4 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -60.87 -35.51 76.8 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.941 0.896 . . . . 0.0 111.738 -168.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -63.53 -26.05 68.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.373 0.669 . . . . 0.0 112.297 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.13 47.82 88.92 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -173.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.6 -47.9 96.65 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.989 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.01 -172.2 1.36 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.56 2.173 . . . . 0.0 111.511 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -60.24 -31.36 70.12 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.246 -0.909 . . . . 0.0 111.578 167.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -68.65 142.69 55.02 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.586 1.154 . . . . 0.0 109.182 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.27 152.17 25.75 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.471 -0.768 . . . . 0.0 110.345 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.88 153.25 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -121.65 -9.52 8.9 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.175 1.39 . . . . 0.0 109.697 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -146.98 135.08 21.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.175 1.79 . . . . 0.0 107.123 171.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.21 133.62 7.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -136.55 127.37 27.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.1 145.59 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.067 1.347 . . . . 0.0 109.493 -169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 m -136.48 156.92 47.92 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.323 1.849 . . . . 0.0 106.053 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -126.14 150.12 48.48 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 m -145.63 164.45 31.69 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.102 0.961 . . . . 0.0 109.582 -163.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -119.36 4.54 11.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.252 1.021 . . . . 0.0 110.467 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 m -64.52 -30.74 71.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.454 1.102 . . . . 0.0 112.11 -174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.4 mt 58.68 179.7 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 111.307 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -153.61 -4.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.995 0.918 . . . . 0.0 113.385 -173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.26 6.48 53.91 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.746 1.165 . . . . 0.0 114.009 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.78 146.33 52.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.396 1.098 . . . . 0.0 109.469 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -130.27 17.85 5.45 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.633 1.573 . . . . 0.0 109.892 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -149.51 173.4 13.64 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.818 2.047 . . . . 0.0 108.131 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -98.35 150.1 21.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 162.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.4 m -139.4 156.14 47.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.062 0.945 . . . . 0.0 110.045 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.1 mt -137.94 134.77 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.5 t -136.71 137.25 47.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.164 0.986 . . . . 0.0 108.484 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -151.02 12.06 0.66 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.23 1.012 . . . . 0.0 111.687 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.498 1.519 . . . . 0.0 110.911 -179.504 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mt -142.88 175.68 9.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 109.726 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -151.88 157.42 41.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.291 1.837 . . . . 0.0 108.379 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.71 162.51 24.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 165.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -135.67 138.59 42.97 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 156.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.88 143.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -169.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.86 137.79 55.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.79 146.63 20.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.897 0.879 . . . . 0.0 110.356 -168.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.38 152.3 44.22 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.808 1.643 . . . . 0.0 108.084 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.11 -153.38 25.04 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -76.39 73.86 3.16 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 106.212 -1.774 . . . . 0.0 106.212 158.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.45 6.19 9.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 124.359 1.064 . . . . 0.0 110.898 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -150.11 164.08 36.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.08 1.309 . . . . 0.0 108.411 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.71 -8.32 76.74 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.084 0.85 . . . . 0.0 113.353 172.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.99 11.42 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.507 1.123 . . . . 0.0 111.9 -171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.94 8.04 58.27 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.989 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -54.58 -39.78 68.15 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.398 1.599 . . . . 0.0 111.843 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -60.45 -37.62 81.54 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.203 0.456 . . . . 0.0 110.516 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -72.81 -47.68 44.41 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.481 173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.27 -43.71 67.65 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.867 0.758 . . . . 0.0 111.419 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -53.16 -48.88 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 123.652 0.781 . . . . 0.0 109.246 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -78.34 -20.68 50.87 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 120.817 -1.177 . . . . 0.0 113.443 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -42.96 85.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.382 0.992 . . . . 0.0 109.243 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -71.29 -35.36 71.3 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.953 0.797 . . . . 0.0 110.159 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.24 86.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.993 0.517 . . . . 0.0 110.462 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.48 -41.55 98.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.789 0.836 . . . . 0.0 110.938 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -59.45 -29.98 68.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.495 0.718 . . . . 0.0 111.516 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -98.49 6.62 47.03 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.286 1.034 . . . . 0.0 112.581 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 42.82 40.88 2.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.697 1.999 . . . . 0.0 113.235 -172.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.03 164.39 26.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.325 1.05 . . . . 0.0 109.158 166.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.37 142.48 32.45 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.093 0.957 . . . . 0.0 108.508 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.03 -154.93 26.01 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.194 -168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -132.57 162.5 31.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.447 1.123 . . . . 0.0 112.627 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.52 144.43 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.905 1.282 . . . . 0.0 107.971 163.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -149.89 165.91 31.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.005 1.322 . . . . 0.0 109.356 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.9 121.77 45.96 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 167.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -73.73 153.97 39.81 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.138 0.975 . . . . 0.0 108.844 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.52 -31.31 70.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 111.379 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 p30 -70.74 -11.53 61.01 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.87 -27.84 8.44 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.152 1.358 . . . . 0.0 113.125 169.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.55 149.77 49.97 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.443 1.622 . . . . 0.0 109.495 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -77.18 149.69 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 158.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 143.43 50.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -133.65 143.03 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -141.46 135.87 30.71 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.33 34.93 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.629 1.104 . . . . 0.0 111.337 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -113.03 151.81 30.22 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.038 1.335 . . . . 0.0 109.418 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.33 179.52 42.48 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.162 0.886 . . . . 0.0 111.474 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.61 159.96 51.05 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.54 2.16 . . . . 0.0 110.793 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.65 -53.74 50.85 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.78 0.832 . . . . 0.0 111.064 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.06 -35.73 81.21 Favored 'General case' 0 N--CA 1.462 0.139 0 O-C-N 122.281 -0.262 . . . . 0.0 111.278 -173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -49.34 71.51 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.78 0.432 . . . . 0.0 110.604 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.61 -49.08 78.03 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.12 0.568 . . . . 0.0 110.237 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -66.22 -41.03 90.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.608 0.363 . . . . 0.0 111.148 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -62.89 -40.35 97.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.659 0.663 . . . . 0.0 110.566 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -60.42 -47.52 85.75 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.599 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.54 -41.91 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.684 1.129 . . . . 0.0 109.705 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.86 -40.68 98.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.712 0.687 . . . . 0.0 110.807 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.72 92.48 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.797 0.839 . . . . 0.0 111.536 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -66.46 -55.68 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -60.43 -35.32 75.53 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.963 0.905 . . . . 0.0 111.976 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -63.06 -25.2 68.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.513 0.725 . . . . 0.0 112.415 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.08 44.16 98.52 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -53.58 -44.17 97.25 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.14 -170.54 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.42 2.08 . . . . 0.0 111.245 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -60.29 -42.98 96.62 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.299 -0.876 . . . . 0.0 109.97 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.18 150.85 33.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.235 1.414 . . . . 0.0 110.637 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.25 33.59 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.704 -0.623 . . . . 0.0 109.878 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -89.06 154.66 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.3 p -120.4 -12.43 8.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.359 1.464 . . . . 0.0 109.56 162.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -147.35 141.12 25.7 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.224 1.41 . . . . 0.0 107.992 168.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.67 136.48 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -134.99 140.78 45.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.42 141.2 40.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -129.76 148.06 51.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -134.4 145.28 48.77 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.0 m -151.89 168.3 25.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.229 -150.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -125.54 1.37 7.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.428 1.091 . . . . 0.0 111.79 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -64.35 -32.06 73.52 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.795 0.838 . . . . 0.0 111.661 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.31 -177.26 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.115 1.766 . . . . 0.0 110.782 -171.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -149.45 -13.41 0.29 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.86 17.24 79.27 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.091 0.853 . . . . 0.0 113.037 173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -63.66 152.53 38.76 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.283 1.041 . . . . 0.0 110.444 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -127.27 4.69 6.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.897 1.279 . . . . 0.0 110.903 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 157.51 43.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.902 1.281 . . . . 0.0 109.237 172.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -71.2 143.22 50.54 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 155.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -139.33 150.98 46.02 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.586 0.754 . . . . 0.0 109.65 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.9 mt -128.57 109.88 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.0 142.09 16.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -82.98 36.95 0.52 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.604 1.162 . . . . 0.0 111.445 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.072 1.349 . . . . 0.0 110.425 176.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.174 0.035 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.93 -177.1 6.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.376 1.47 . . . . 0.0 110.045 -161.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -146.04 153.7 41.03 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.328 1.851 . . . . 0.0 109.251 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.411 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -113.21 166.74 11.16 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.069 0.947 . . . . 0.0 110.52 164.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -131.92 138.4 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 152.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.0 mt -136.27 146.88 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.89 144.77 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 164.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.62 151.8 24.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.53 1.132 . . . . 0.0 109.058 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -142.71 150.25 39.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.13 -153.87 25.59 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -79.76 63.25 4.26 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.8 m -89.11 8.77 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.806 1.242 . . . . 0.0 111.711 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.86 161.28 42.16 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.02 -156.78 27.85 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 107.341 -2.304 . . . . 0.0 107.341 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 m -60.51 -25.07 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.986 1.393 . . . . 0.0 113.452 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.16 -4.48 78.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.525 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.9 t80 17.65 59.64 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 1 C-N-CA 131.713 4.005 . . . . 0.0 115.293 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 7.3 ptt180 47.26 2.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.493 2.317 . . . . 0.0 116.766 -174.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.98 -38.17 78.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 120.003 1.274 . . . . 0.0 108.528 160.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -55.91 -41.05 73.96 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.342 0.519 . . . . 0.0 111.527 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.19 -45.83 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -78.88 -16.28 57.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.627 -0.702 . . . . 0.0 112.894 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.17 -47.77 75.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.636 1.107 . . . . 0.0 108.87 164.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -70.49 -23.12 62.61 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.929 -0.482 . . . . 0.0 111.362 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.66 52.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.288 -0.882 . . . . 0.0 109.662 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.16 -39.66 90.95 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.773 0.829 . . . . 0.0 111.544 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -14.35 60.48 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.721 -0.612 . . . . 0.0 112.013 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -116.79 11.23 14.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.701 1.601 . . . . 0.0 111.55 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 41.08 40.35 1.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.963 2.105 . . . . 0.0 113.034 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.63 163.25 28.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 168.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.68 131.72 24.64 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 124.062 0.945 . . . . 0.0 108.715 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.31 -162.95 34.71 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 118.223 0.465 . . . . 0.0 112.201 -162.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -135.42 167.7 20.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.777 0.789 . . . . 0.0 112.734 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.0 142.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.045 1.338 . . . . 0.0 109.102 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -145.77 157.36 43.94 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.947 1.699 . . . . 0.0 108.095 -163.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -119.32 123.19 43.61 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -78.6 156.66 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.977 1.311 . . . . 0.0 109.727 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.49 -30.65 70.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.239 0.615 . . . . 0.0 111.677 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -4.85 39.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.864 0.866 . . . . 0.0 113.022 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.98 -23.71 28.5 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.102 1.335 . . . . 0.0 113.247 169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -61.69 145.28 52.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 118.961 1.38 . . . . 0.0 109.804 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.0 t -86.52 143.54 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 160.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -131.21 145.75 52.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -139.41 142.96 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -170.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 tt -150.0 125.61 10.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.33 153.45 27.39 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.016 0.826 . . . . 0.0 111.454 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -93.53 154.5 17.85 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.46 1.104 . . . . 0.0 109.696 167.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.19 175.01 42.28 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 110.762 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.28 154.75 61.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.921 1.747 . . . . 0.0 109.918 165.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.72 -43.4 80.58 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.57 0.748 . . . . 0.0 111.437 -172.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.33 -41.04 98.23 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.151 -0.343 . . . . 0.0 111.472 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.81 82.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.737 0.415 . . . . 0.0 110.064 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 4' ' ' TYR . 72.0 mt -62.12 -44.09 97.41 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.743 0.817 . . . . 0.0 110.371 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -70.48 -41.12 73.15 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.79 -0.569 . . . . 0.0 111.775 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 m -60.22 -40.05 88.79 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.756 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -61.85 -46.45 89.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.858 173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.46 -46.56 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 120.005 1.275 . . . . 0.0 109.426 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.39 -39.62 91.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.168 0.44 . . . . 0.0 111.191 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.71 97.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.191 0.597 . . . . 0.0 112.133 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.05 -49.8 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.91 -44.04 91.19 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.185 0.594 . . . . 0.0 111.003 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -71.52 -19.95 62.11 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.674 0.79 . . . . 0.0 112.011 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.71 43.34 94.52 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -172.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 m -51.15 -53.33 49.86 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.09 -39.23 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.654 1.57 . . . . 0.0 112.496 178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -165.83 168.77 15.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.086 1.754 . . . . 0.0 108.188 -168.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m 62.55 175.96 0.14 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.963 1.705 . . . . 0.0 113.044 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.81 160.49 40.28 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.92 0.888 . . . . 0.0 109.406 166.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.51 156.95 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.2 p -119.62 -13.56 9.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.939 1.296 . . . . 0.0 109.648 163.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.8 144.99 26.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.081 1.353 . . . . 0.0 108.749 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.82 142.17 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.289 1.436 . . . . 0.0 107.378 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -140.23 147.8 40.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -138.21 145.9 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.67 155.7 46.15 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.147 2.179 . . . . 0.0 105.48 170.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -138.6 158.63 43.88 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.0 m -155.51 152.88 29.43 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.145 1.378 . . . . 0.0 107.901 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -73.33 -30.95 63.7 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.718 -0.614 . . . . 0.0 111.352 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.9 m -60.07 128.57 37.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.102 0.961 . . . . 0.0 110.903 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.18 169.86 12.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.207 1.003 . . . . 0.0 109.242 163.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -104.76 -18.71 14.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.029 0.932 . . . . 0.0 111.074 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.88 47.85 7.45 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -171.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -126.83 149.86 49.49 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.608 1.163 . . . . 0.0 108.915 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -136.86 9.2 3.05 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.945 0.898 . . . . 0.0 112.092 -172.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 174.28 12.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.514 1.526 . . . . 0.0 109.013 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -116.47 148.97 40.24 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.369 1.067 . . . . 0.0 109.458 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.8 m -143.93 159.96 41.65 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.468 0.652 . . . . 0.0 111.963 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 mt -128.02 114.51 35.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.6 t -68.51 147.84 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -62.74 -31.3 72.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.222 0.609 . . . . 0.0 112.037 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.25 1.124 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 167.566 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.5 tp -142.21 177.26 8.36 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.905 -1.122 . . . . 0.0 110.422 -166.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.404 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 63.7 tt0 -154.57 162.01 41.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.94 1.696 . . . . 0.0 109.47 -171.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 p90 -131.36 166.36 21.42 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.226 1.01 . . . . 0.0 110.273 166.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -130.23 138.58 50.62 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.42 146.86 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.9 135.71 58.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 170.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.61 153.64 16.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.275 1.03 . . . . 0.0 110.699 -172.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.01 153.0 45.35 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.313 1.445 . . . . 0.0 107.943 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.35 -152.28 24.19 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 106.963 -2.455 . . . . 0.0 106.963 -171.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -75.56 77.98 2.58 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 162.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.2 m -112.66 -1.77 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 111.306 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -140.37 35.41 1.87 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.63 1.572 . . . . 0.0 109.488 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.51 29.67 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 t 55.91 -71.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 129.027 2.931 . . . . 0.0 113.221 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.77 -11.64 46.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.584 1.564 . . . . 0.0 112.151 173.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 51.17 -162.87 0.06 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.052 1.741 . . . . 0.0 112.077 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -63.87 -14.89 56.95 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 120.834 -1.166 . . . . 0.0 112.518 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -60.62 -32.83 71.96 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.405 1.002 . . . . 0.0 110.803 171.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -48.74 71.94 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.921 1.237 . . . . 0.0 111.61 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.86 -30.92 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.16 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -75.14 -24.66 57.99 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.948 1.249 . . . . 0.0 112.08 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 69.2 mtm -63.46 -48.9 75.81 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 165.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.81 -30.11 70.69 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 122.195 -0.316 . . . . 0.0 111.058 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.84 -47.49 68.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.292 . . . . 0.0 110.328 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.63 -38.62 88.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.319 0.647 . . . . 0.0 111.124 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -60.14 -17.59 41.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.769 1.228 . . . . 0.0 112.523 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -116.65 12.9 15.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.225 1.41 . . . . 0.0 111.41 172.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.44 34.44 0.76 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.16 2.184 . . . . 0.0 113.294 -174.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.41 161.59 27.27 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.816 -0.553 . . . . 0.0 109.629 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.18 128.62 43.74 Favored 'General case' 0 C--N 1.334 -0.07 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.48 -171.21 43.9 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 118.641 0.655 . . . . 0.0 112.272 -164.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.4 p90 -136.61 161.27 36.36 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.066 0.947 . . . . 0.0 112.036 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.15 144.93 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.171 0.988 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -144.71 162.82 35.75 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.143 2.177 . . . . 0.0 107.656 -170.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -121.43 122.88 40.76 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -75.77 155.46 35.48 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.479 1.112 . . . . 0.0 109.16 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.45 -31.78 70.75 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.918 0.487 . . . . 0.0 111.357 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -71.34 -10.68 60.15 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.15 -26.82 10.83 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 118.228 -1.318 . . . . 0.0 113.476 170.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.35 148.25 52.02 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.729 1.764 . . . . 0.0 109.391 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.29 146.48 7.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 161.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -127.77 137.94 52.59 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -132.55 142.55 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tt -147.57 126.38 12.67 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -153.95 159.04 41.53 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.487 0.585 . . . . 0.0 110.926 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.49 155.83 22.63 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.316 1.846 . . . . 0.0 109.443 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.51 178.04 41.64 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.618 1.104 . . . . 0.0 110.364 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.32 154.3 74.44 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.842 1.695 . . . . 0.0 109.781 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -56.37 -47.7 78.36 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.183 0.593 . . . . 0.0 110.715 -172.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -60.17 -40.31 89.48 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.484 0.584 . . . . 0.0 111.788 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.59 83.09 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.855 0.462 . . . . 0.0 110.091 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.0 mt -64.66 -45.96 84.48 Favored 'General case' 0 C--O 1.228 -0.078 0 C-N-CA 122.809 0.443 . . . . 0.0 110.826 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -64.98 -43.47 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.864 -0.522 . . . . 0.0 110.68 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.4 m -60.93 -40.84 94.77 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.935 0.334 . . . . 0.0 110.54 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -59.24 -49.09 79.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.575 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.0 t -57.67 -43.25 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.735 1.152 . . . . 0.0 109.67 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.92 -40.91 97.11 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.628 0.649 . . . . 0.0 110.834 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.3 99.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.47 0.708 . . . . 0.0 111.465 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -61.79 -54.04 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 174.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.37 -39.44 79.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.809 0.844 . . . . 0.0 111.375 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.4 -27.23 68.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.488 0.715 . . . . 0.0 111.979 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.47 51.26 58.82 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -173.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -55.53 -49.2 93.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.976 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.49 -173.45 1.8 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.261 1.974 . . . . 0.0 111.627 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -40.84 82.55 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.431 1.092 . . . . 0.0 111.449 173.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.3 m -74.29 138.92 43.88 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -157.81 164.45 36.99 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 109.533 -162.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.42 149.6 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.4 p -127.68 -7.58 5.64 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.809 1.643 . . . . 0.0 109.803 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.61 141.22 29.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.224 1.81 . . . . 0.0 106.963 166.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.5 tt -149.27 140.68 17.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.754 1.222 . . . . 0.0 107.972 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.3 m -139.29 148.94 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.687 1.595 . . . . 0.0 107.328 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.18 146.18 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.05 149.01 51.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.04 133.17 39.1 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -171.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -145.47 167.93 21.79 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.701 0.4 . . . . 0.0 111.683 -155.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.97 0.11 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.898 1.279 . . . . 0.0 111.253 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.0 m -66.26 -24.88 66.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.121 0.969 . . . . 0.0 113.088 -170.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.8 mt 61.48 174.0 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.686 1.994 . . . . 0.0 111.684 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.18 -16.44 0.58 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 113.179 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.01 1.41 82.2 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.253 -1.304 . . . . 0.0 116.304 155.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -82.92 -175.48 5.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.102 1.951 . . . . 0.0 109.542 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -129.55 2.85 5.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.43 1.092 . . . . 0.0 112.421 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -149.57 170.76 17.89 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.052 1.341 . . . . 0.0 109.697 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -72.48 153.27 41.45 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.956 0.503 . . . . 0.0 109.965 171.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.39 159.22 42.67 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.703 1.201 . . . . 0.0 109.453 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 mt -135.09 110.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.67 140.64 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -136.42 4.19 2.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.468 1.107 . . . . 0.0 112.096 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.028 0 C-N-CA 125.347 1.459 . . . . 0.0 110.883 179.368 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtp . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.507 0.194 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.13 176.03 9.06 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.946 0.898 . . . . 0.0 111.666 -149.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -147.71 157.81 43.72 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.446 1.498 . . . . 0.0 109.384 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.14 168.09 11.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.77 0.828 . . . . 0.0 110.629 163.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -134.58 135.42 42.22 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 156.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.34 144.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.78 136.42 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.14 155.48 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.576 1.151 . . . . 0.0 110.293 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -145.98 157.38 43.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.186 0.994 . . . . 0.0 108.935 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.55 -148.36 19.87 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 106.821 -2.512 . . . . 0.0 106.821 -171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -77.02 54.48 1.04 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 160.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.73 -13.92 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 111.21 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.64 155.4 47.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 168.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.29 -153.26 24.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 -166.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -57.88 -24.43 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 117.766 0.783 . . . . 0.0 112.685 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -0.56 86.02 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.68 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.0 t80 44.58 -147.27 0.09 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.326 1.45 . . . . 0.0 110.064 -170.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -86.68 -0.82 57.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.128 -0.982 . . . . 0.0 111.117 158.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -59.9 -34.47 73.23 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.171 0.896 . . . . 0.0 111.295 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -37.61 65.23 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.678 0.672 . . . . 0.0 111.288 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.84 -45.22 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -78.97 -18.95 52.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.557 -0.735 . . . . 0.0 112.488 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 mtm -63.21 -48.95 76.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.335 0.971 . . . . 0.0 109.309 165.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.58 -29.95 67.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.784 0.434 . . . . 0.0 110.421 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.61 74.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.767 0.827 . . . . 0.0 110.405 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.92 -41.02 90.81 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.341 0.656 . . . . 0.0 110.724 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -59.41 -18.09 36.07 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.487 1.115 . . . . 0.0 112.854 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -117.33 15.76 14.8 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.977 1.262 . . . . 0.0 112.372 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 11.2 mmpt? 47.01 34.0 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.574 1.55 . . . . 0.0 112.768 -176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.3 mt -74.41 163.51 27.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.172 0.589 . . . . 0.0 109.703 172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.73 130.11 22.42 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.167 0.987 . . . . 0.0 108.581 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.35 -158.34 28.66 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 123.592 0.615 . . . . 0.0 111.596 -171.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -136.73 163.28 30.97 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.787 0.794 . . . . 0.0 112.047 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.874 1.27 . . . . 0.0 108.66 173.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -149.22 163.25 38.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.959 1.703 . . . . 0.0 107.883 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -119.58 131.15 55.44 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.2 ptm85 -120.77 149.72 42.11 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.925 0.89 . . . . 0.0 110.37 -167.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.08 -19.46 62.96 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.443 1.497 . . . . 0.0 113.524 -169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -60.78 -15.29 28.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.7 1.2 . . . . 0.0 112.757 172.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.05 45.83 3.77 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -143.52 153.32 42.47 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.392 1.477 . . . . 0.0 107.238 -168.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.19 148.36 5.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 157.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -132.96 142.48 48.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -138.62 141.48 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.98 126.37 10.8 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.1 157.02 36.86 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.442 0.697 . . . . 0.0 110.877 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -102.98 156.9 17.35 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.634 1.573 . . . . 0.0 109.874 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.25 -179.42 41.89 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.039 0.828 . . . . 0.0 111.865 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.4 161.74 37.13 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.554 2.17 . . . . 0.0 110.652 170.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.35 -47.23 79.23 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.73 0.812 . . . . 0.0 111.137 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.76 -43.06 98.49 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.005 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 -47.96 79.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.1 mt -63.22 -47.08 84.03 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.326 0.65 . . . . 0.0 110.247 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -68.52 -43.51 76.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.031 0.532 . . . . 0.0 111.893 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -62.89 -39.09 93.44 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.471 0.578 . . . . 0.0 110.139 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -60.3 -49.24 78.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.423 173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.56 -45.65 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 119.57 1.077 . . . . 0.0 109.515 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -62.42 -37.81 87.25 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.096 0.407 . . . . 0.0 111.155 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.85 86.94 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.501 0.72 . . . . 0.0 111.792 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.2 -51.03 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.34 -41.95 76.92 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.442 1.097 . . . . 0.0 111.29 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -68.22 -25.53 65.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.517 0.727 . . . . 0.0 111.933 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.94 48.64 81.12 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -54.61 -47.32 98.24 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.409 -1.281 . . . . 0.0 114.289 -177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.84 -166.53 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.601 2.201 . . . . 0.0 111.479 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.1 -40.74 67.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.828 1.251 . . . . 0.0 111.939 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -79.6 143.72 34.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 0.0 109.506 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 162.46 40.51 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.687 0.795 . . . . 0.0 110.548 -172.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.88 158.3 7.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 123.371 0.668 . . . . 0.0 110.689 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.9 p -125.81 -4.8 6.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.715 1.606 . . . . 0.0 110.023 163.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -150.66 138.73 20.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.777 2.031 . . . . 0.0 107.446 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.64 140.98 14.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.336 1.054 . . . . 0.0 108.613 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.6 m -140.86 142.9 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.101 1.76 . . . . 0.0 107.053 172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.9 t -138.19 143.6 32.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.5 m -129.99 151.06 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -137.05 145.36 43.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.0 m -143.2 175.0 10.21 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.037 1.335 . . . . 0.0 109.375 -165.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmt-85 -128.37 33.53 4.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.537 1.135 . . . . 0.0 109.447 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -134.24 105.09 6.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.972 1.309 . . . . 0.0 108.404 -165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.09 168.63 8.09 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.949 0.9 . . . . 0.0 111.235 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -114.78 -23.47 9.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.832 1.653 . . . . 0.0 110.496 -175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.69 19.04 76.52 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -166.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.31 139.78 32.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -134.82 25.09 3.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.808 1.243 . . . . 0.0 109.584 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -148.23 167.4 25.21 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 127.003 2.121 . . . . 0.0 107.184 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -120.85 132.94 55.28 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 163.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 m -134.7 160.87 36.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.126 0.57 . . . . 0.0 111.211 -166.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.9 mt -132.24 114.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.9 t -70.61 142.28 15.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -139.73 5.14 2.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.819 1.248 . . . . 0.0 112.086 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.249 1.051 0 C-N-CA 125.36 1.464 . . . . 0.0 110.919 179.349 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 119.111 -0.471 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tp -147.46 -177.01 5.47 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.207 1.367 . . . . 0.0 111.344 -159.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.61 152.57 39.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.613 1.965 . . . . 0.0 109.086 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.46 163.7 12.83 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.319 0.648 . . . . 0.0 109.724 162.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -136.05 131.09 34.45 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 159.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.19 139.65 45.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.29 134.4 66.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -140.35 153.19 21.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.146 0.979 . . . . 0.0 109.557 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.28 151.36 37.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.935 1.294 . . . . 0.0 107.522 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.67 -152.04 24.06 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 107.203 -2.359 . . . . 0.0 107.203 -170.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.67 58.56 1.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 m -85.0 -12.7 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.019 0.928 . . . . 0.0 110.783 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.411 HE22 ' CG ' ' A' ' 18' ' ' ARG . 7.5 mm-40 -125.33 146.36 49.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 164.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.8 -163.28 30.0 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -161.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.97 -23.09 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 118.535 1.168 . . . . 0.0 113.641 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.34 0.93 89.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.62 -1.655 . . . . 0.0 114.347 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 21.09 51.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 130.398 3.479 . . . . 0.0 115.06 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' CG ' HE22 ' A' ' 13' ' ' GLN 0.301 12.9 ptt85 45.06 -1.6 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 -169.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -66.38 -21.96 66.24 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 122.013 2.188 . . . . 0.0 110.468 165.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -54.9 -49.54 71.0 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 120.099 1.318 . . . . 0.0 111.349 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.21 -33.66 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.394 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -73.39 -25.98 60.79 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.051 1.296 . . . . 0.0 112.284 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.4 mtm -65.36 -47.3 76.91 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 166.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -66.09 -27.99 68.48 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.285 -0.26 . . . . 0.0 111.329 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 -48.47 64.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.734 1.614 . . . . 0.0 109.975 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.06 -38.68 87.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.984 0.514 . . . . 0.0 111.209 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? -60.0 -16.96 34.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.354 1.062 . . . . 0.0 112.594 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -116.88 11.24 14.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.127 1.371 . . . . 0.0 111.565 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 41.52 39.52 1.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.697 1.999 . . . . 0.0 113.015 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.63 164.85 25.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.732 0.813 . . . . 0.0 108.981 167.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.32 26.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.18 -167.68 38.91 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 118.402 0.546 . . . . 0.0 112.14 -163.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -136.64 159.56 41.44 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.75 0.82 . . . . 0.0 111.991 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.99 141.94 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.735 0.814 . . . . 0.0 110.412 174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -141.85 153.31 44.37 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.833 1.653 . . . . 0.0 108.613 -166.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -106.62 125.22 50.73 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 170.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -85.33 145.29 27.58 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.961 0.904 . . . . 0.0 108.676 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.55 -29.45 69.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.351 0.66 . . . . 0.0 111.882 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 -8.8 56.03 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.52 45.95 2.23 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 119.109 0.868 . . . . 0.0 112.084 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -136.43 172.99 12.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.712 1.605 . . . . 0.0 107.802 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -116.16 144.05 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 164.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -126.68 140.34 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.79 140.72 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -146.7 127.69 14.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.44 149.28 29.8 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 122.997 0.519 . . . . 0.0 110.24 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.28 153.77 20.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.708 0.803 . . . . 0.0 109.147 166.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.47 173.71 36.56 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.309 0.957 . . . . 0.0 111.604 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.59 153.41 60.06 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.149 1.899 . . . . 0.0 110.073 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.83 -42.3 75.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.679 0.792 . . . . 0.0 111.507 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.4 -41.1 98.41 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.068 -0.395 . . . . 0.0 111.632 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.38 -45.1 77.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 122.786 0.434 . . . . 0.0 109.856 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.99 -45.38 95.05 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.863 0.865 . . . . 0.0 110.129 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -69.71 -39.73 76.69 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.857 -0.527 . . . . 0.0 112.019 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.1 m -61.05 -41.7 97.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.642 0.656 . . . . 0.0 110.183 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.36 -47.27 86.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.575 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -55.01 -45.84 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.754 1.161 . . . . 0.0 109.602 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.82 -39.1 90.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.585 0.63 . . . . 0.0 111.052 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.55 87.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.425 0.69 . . . . 0.0 111.411 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.61 -48.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -59.96 -39.76 86.7 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.41 0.684 . . . . 0.0 111.452 -175.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -66.49 -24.74 66.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.004 0.522 . . . . 0.0 111.832 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.28 44.0 96.84 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -54.48 -47.68 97.07 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.935 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.78 -169.09 0.67 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.546 2.164 . . . . 0.0 111.722 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -2.87 0.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.911 2.084 . . . . 0.0 115.241 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.4 m -129.53 143.65 50.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.395 1.478 . . . . 0.0 107.737 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.0 164.75 37.66 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.404 0.682 . . . . 0.0 111.21 -162.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.8 m -106.37 158.79 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 123.543 0.737 . . . . 0.0 110.444 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.6 p -123.01 -11.72 8.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.915 1.686 . . . . 0.0 109.827 162.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -149.7 146.82 27.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.108 1.363 . . . . 0.0 108.992 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.7 tt -148.19 143.6 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.991 1.316 . . . . 0.0 108.309 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -136.73 144.08 43.65 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.126 1.77 . . . . 0.0 107.213 171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.67 140.21 36.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 m -132.68 157.34 45.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.989 2.115 . . . . 0.0 105.778 168.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.36 142.8 48.58 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -136.94 153.29 50.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.785 1.634 . . . . 0.0 107.07 -169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 mmt-85 -87.76 -24.49 23.78 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.011 -1.056 . . . . 0.0 111.166 -175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 m -62.93 114.67 3.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.81 1.244 . . . . 0.0 111.027 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.61 177.66 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.32 1.048 . . . . 0.0 110.641 164.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -126.92 0.21 6.61 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.893 1.277 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.57 27.94 66.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.878 0.751 . . . . 0.0 111.675 -173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -94.53 150.35 20.33 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.894 0.847 . . . . 0.0 109.8 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -137.84 14.98 2.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.64 1.176 . . . . 0.0 111.57 -176.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -148.51 166.72 27.36 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.16 1.384 . . . . 0.0 108.963 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -88.16 155.88 19.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 163.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.2 m -142.55 156.7 45.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.614 1.166 . . . . 0.0 110.66 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 mt -128.17 112.96 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.3 138.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -174.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -138.18 -19.93 1.11 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.594 0.758 . . . . 0.0 112.55 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.53 1.532 . . . . 0.0 107.565 -178.733 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttp . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 3' ' ' GLN . 3.3 tp -140.65 -178.6 5.6 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.789 -1.194 . . . . 0.0 109.527 -168.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.413 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 33.3 tt0 -155.12 158.14 38.55 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.868 1.667 . . . . 0.0 108.449 -177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -120.05 164.94 15.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.661 0.785 . . . . 0.0 110.536 166.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.27 131.3 29.95 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 157.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.97 147.48 27.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -167.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.41 137.07 56.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.9 m -141.53 156.28 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 124.03 0.932 . . . . 0.0 111.301 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.36 155.51 45.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.751 1.62 . . . . 0.0 107.788 167.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.24 -155.36 26.29 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -77.61 100.21 6.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 152.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.39 6.24 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 124.611 1.194 . . . . 0.0 110.752 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -141.49 153.38 44.89 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.587 1.085 . . . . 0.0 111.12 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.88 169.14 11.72 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.175 2.321 . . . . 0.0 108.623 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.07 126.2 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.07 -46.34 2.11 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.942 0.782 . . . . 0.0 111.773 -169.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -65.01 -7.16 10.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.74 -11.85 10.9 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 121.124 1.784 . . . . 0.0 114.166 155.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -59.89 -32.34 70.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.289 0.95 . . . . 0.0 110.578 169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -51.72 -37.53 51.33 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.538 0.608 . . . . 0.0 112.07 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.68 -48.06 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -71.29 -25.47 62.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.42 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -73.71 -39.47 64.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.858 1.208 . . . . 0.0 110.589 177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -69.28 -29.82 67.78 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.344 -0.847 . . . . 0.0 111.096 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -50.54 65.07 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.093 -1.005 . . . . 0.0 109.672 172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -61.11 -40.42 93.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.053 0.941 . . . . 0.0 111.42 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -15.26 62.72 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.67 -0.644 . . . . 0.0 112.295 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -113.33 15.11 19.32 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.21 1.404 . . . . 0.0 111.665 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.27 32.97 3.41 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.067 1.747 . . . . 0.0 112.326 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.0 162.22 29.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.09 121.39 19.18 Favored 'General case' 0 CA--C 1.527 0.075 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.5 -162.17 32.27 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -142.7 163.7 32.11 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.14 145.98 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.086 1.354 . . . . 0.0 109.507 165.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -149.49 146.14 27.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.641 1.577 . . . . 0.0 108.372 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.98 153.93 40.73 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.703 0.801 . . . . 0.0 109.487 168.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptm85 -134.64 154.6 51.44 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.297 1.408 . . . . 0.0 110.843 164.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.01 -30.63 69.28 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -155.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.05 -27.45 68.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.139 0.576 . . . . 0.0 112.402 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.65 -17.84 10.12 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.366 1.46 . . . . 0.0 110.946 -172.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -59.17 168.32 1.44 Allowed 'General case' 0 C--N 1.342 0.241 0 CA-C-O 122.962 1.363 . . . . 0.0 110.422 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.52 150.12 31.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -131.18 140.12 49.86 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -171.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -136.89 140.81 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -171.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -149.88 126.91 11.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.19 149.52 28.84 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 118.527 0.603 . . . . 0.0 110.093 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -90.92 153.77 19.95 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.1 174.69 39.72 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.661 0.648 . . . . 0.0 111.807 173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.21 152.39 66.98 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.966 1.777 . . . . 0.0 110.152 172.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -55.05 -43.87 74.19 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.813 0.845 . . . . 0.0 111.481 -172.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.43 -40.93 98.49 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 122.227 -0.295 . . . . 0.0 111.544 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.28 -46.33 80.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.988 0.515 . . . . 0.0 110.116 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 4' ' ' TYR . 67.4 mt -62.04 -45.22 94.54 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.583 0.753 . . . . 0.0 110.211 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.57 -40.12 76.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.885 -0.51 . . . . 0.0 111.75 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 m -61.37 -42.0 98.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.746 0.703 . . . . 0.0 110.215 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -58.21 -49.81 75.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.591 -0.719 . . . . 0.0 110.243 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 37.3 t -56.65 -43.59 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 119.496 1.043 . . . . 0.0 109.988 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.69 -41.46 97.6 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.109 0.868 . . . . 0.0 110.72 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.33 97.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.14 0.576 . . . . 0.0 111.438 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.28 -53.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -58.53 -40.93 84.32 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.078 0.951 . . . . 0.0 111.207 -174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -69.9 -23.65 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.924 0.49 . . . . 0.0 111.897 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.08 46.33 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -58.41 -42.15 93.08 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-O 117.745 -1.121 . . . . 0.0 112.871 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -65.13 -172.29 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.742 2.961 . . . . 0.0 114.128 173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -59.48 -39.61 84.28 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.48 1.112 . . . . 0.0 111.785 171.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -72.96 151.71 41.7 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.586 0.755 . . . . 0.0 110.363 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 145.53 23.33 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -83.76 156.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -124.87 -8.95 7.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.601 . . . . 0.0 109.734 166.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.46 139.7 20.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.419 1.887 . . . . 0.0 107.411 173.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 tt -152.95 142.75 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.65 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -141.29 145.36 35.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.806 1.643 . . . . 0.0 107.779 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.51 138.85 44.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -169.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -131.73 152.79 50.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.598 1.959 . . . . 0.0 106.063 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -131.31 151.21 51.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 m -146.95 165.29 30.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.539 1.136 . . . . 0.0 109.465 -165.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -118.78 1.34 11.56 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.148 0.979 . . . . 0.0 110.751 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 m -62.2 -37.45 85.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.42 1.088 . . . . 0.0 112.211 -171.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.4 mp 58.5 170.59 0.06 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.26 1.824 . . . . 0.0 111.951 -170.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.19 -20.19 4.55 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.852 1.261 . . . . 0.0 111.392 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.83 24.69 74.26 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -165.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.17 139.52 42.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.126 0.963 . . . . 0.0 108.433 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -131.88 21.0 4.56 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.498 1.119 . . . . 0.0 110.743 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -149.03 178.28 8.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.022 1.729 . . . . 0.0 108.099 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.46 132.16 35.01 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.0 m -143.9 163.26 33.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.63 1.205 . . . . 0.0 114.032 -152.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.4 mt -128.39 118.66 48.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.44 155.32 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -60.49 -44.12 96.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.653 -0.655 . . . . 0.0 110.688 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.511 1.524 . . . . 0.0 109.147 174.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -141.76 179.85 6.61 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.889 -1.132 . . . . 0.0 109.677 -167.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -155.37 156.29 35.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.704 1.202 . . . . 0.0 109.159 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.5 163.21 18.3 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.688 0.795 . . . . 0.0 110.524 165.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -132.33 137.06 47.28 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 154.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -136.78 142.96 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -173.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.21 135.28 59.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 171.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.52 151.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 123.783 0.833 . . . . 0.0 110.6 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -142.83 153.31 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 107.681 169.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.88 -154.36 25.77 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -75.1 88.64 2.44 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 158.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -124.52 6.51 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.398 1.079 . . . . 0.0 111.237 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -146.61 165.75 28.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.78 1.173 . . . . 0.0 108.496 168.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -10.1 73.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.998 0.809 . . . . 0.0 113.255 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.41 15.86 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.061 1.345 . . . . 0.0 111.289 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.14 70.63 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.969 -0.906 . . . . 0.0 113.575 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -52.87 -43.72 66.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.236 1.518 . . . . 0.0 111.898 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -66.23 -30.91 71.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.685 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -70.65 -43.32 69.4 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.574 -0.704 . . . . 0.0 110.07 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -53.86 -48.33 70.13 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.029 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.17 -33.99 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 119.39 0.996 . . . . 0.0 110.929 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.61 -32.16 73.59 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 120.385 1.448 . . . . 0.0 112.164 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 67.0 mtm -64.0 -46.55 84.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.181 0.901 . . . . 0.0 109.385 172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -68.58 -33.3 73.83 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.101 -0.375 . . . . 0.0 110.887 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.48 77.47 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.299 1.04 . . . . 0.0 109.584 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.68 -35.0 78.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.862 0.465 . . . . 0.0 112.096 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -51.2 -40.93 59.8 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.27 1.028 . . . . 0.0 111.715 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -114.87 24.01 12.12 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.86 1.264 . . . . 0.0 111.279 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp 46.17 39.96 6.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.519 1.928 . . . . 0.0 112.963 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -63.32 157.43 22.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 165.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.12 126.16 44.87 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.33 -171.88 44.67 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 118.643 0.656 . . . . 0.0 112.885 -167.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -142.9 165.85 26.25 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.313 0.645 . . . . 0.0 112.463 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.38 146.56 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.053 1.341 . . . . 0.0 110.075 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.46 159.17 44.52 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.914 1.286 . . . . 0.0 110.222 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.34 153.94 28.07 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 166.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -112.32 145.25 40.36 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 166.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.64 -28.39 65.63 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.921 0.888 . . . . 0.0 113.153 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -61.36 -28.05 68.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.922 0.889 . . . . 0.0 112.65 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.08 -17.57 7.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.297 1.427 . . . . 0.0 111.614 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -58.46 164.8 2.39 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 121.949 0.881 . . . . 0.0 110.691 173.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.4 t -119.31 149.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 161.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -129.27 139.53 51.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 141.8 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.79 129.39 14.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.94 145.14 23.89 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.754 0.706 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.69 151.82 23.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 164.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.45 175.68 40.0 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.6 -0.687 . . . . 0.0 112.457 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.61 154.95 64.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.142 1.895 . . . . 0.0 110.526 172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -55.46 -45.78 76.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.905 0.882 . . . . 0.0 111.512 -172.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.41 -40.84 98.29 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.294 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.86 -48.2 80.07 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -62.48 -46.39 88.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.477 0.711 . . . . 0.0 110.492 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -69.17 -39.58 78.67 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.888 -0.508 . . . . 0.0 111.755 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 m -62.1 -40.49 96.06 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.663 0.665 . . . . 0.0 110.259 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -59.46 -47.54 85.09 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.303 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.1 t -56.88 -42.62 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 119.72 1.145 . . . . 0.0 109.898 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.46 -41.31 98.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.083 0.856 . . . . 0.0 110.984 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.16 89.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.908 0.483 . . . . 0.0 111.619 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.27 -56.02 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -59.99 -37.18 78.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.955 0.902 . . . . 0.0 111.573 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.01 -24.63 66.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.557 0.743 . . . . 0.0 112.415 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.49 42.62 97.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.785 0.72 . . . . 0.0 111.387 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -51.26 -47.37 88.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.95 -56.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 121.711 1.647 . . . . 0.0 112.198 -166.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -174.92 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.952 2.101 . . . . 0.0 107.104 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.81 145.34 29.76 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.553 1.541 . . . . 0.0 109.782 168.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.52 151.52 24.46 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.561 0.745 . . . . 0.0 109.206 -172.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.85 156.18 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.8 p -121.17 -12.43 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.585 1.554 . . . . 0.0 109.774 163.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -148.36 136.02 20.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.266 1.826 . . . . 0.0 106.967 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.6 tt -148.5 137.73 15.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -139.63 146.14 39.36 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.311 1.444 . . . . 0.0 107.397 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.9 t -136.49 144.4 32.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -174.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.96 147.61 50.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 167.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -138.76 134.53 33.6 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 m -143.62 168.07 20.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.01 0.924 . . . . 0.0 110.634 -155.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.55 0.45 10.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.349 1.059 . . . . 0.0 111.726 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -66.14 -37.2 85.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.29 0.95 . . . . 0.0 112.61 -171.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.52 177.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.729 2.012 . . . . 0.0 111.236 -165.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -124.06 -26.52 4.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.122 0.969 . . . . 0.0 110.978 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.17 41.24 6.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.351 0.977 . . . . 0.0 110.906 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 165.78 24.8 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 112.536 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -140.39 33.11 1.88 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.366 1.867 . . . . 0.0 109.279 -172.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 ptt85 -131.14 160.98 33.16 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.467 1.507 . . . . 0.0 108.434 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.35 122.33 22.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.8 m -141.81 163.62 32.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.184 0.992 . . . . 0.0 113.42 -152.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mt -132.08 119.89 41.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.96 170.99 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.505 -160.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -131.21 16.31 5.05 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.729 1.612 . . . . 0.0 110.567 174.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.624 1.57 . . . . 0.0 111.105 -177.883 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.8 ttp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 119.084 -0.484 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 mp -143.42 -177.12 5.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.011 1.278 . . . . 0.0 111.605 -167.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -142.53 155.95 45.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.816 2.846 . . . . 0.0 108.552 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.4 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -114.68 164.68 13.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.794 0.838 . . . . 0.0 109.731 161.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -133.26 137.0 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 153.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -136.19 141.42 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -170.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.45 144.55 33.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 163.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.84 155.34 30.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.531 1.132 . . . . 0.0 109.99 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -145.56 155.81 43.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 107.19 172.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.21 -152.48 24.08 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 107.786 -2.125 . . . . 0.0 107.786 -171.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -78.15 101.66 7.14 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 104.421 -2.436 . . . . 0.0 104.421 154.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.61 18.56 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.403 1.081 . . . . 0.0 110.352 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -148.48 166.81 27.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.966 1.706 . . . . 0.0 107.109 169.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.89 154.63 26.18 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t 60.39 -56.74 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.799 2.04 . . . . 0.0 110.981 -161.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.98 39.37 0.02 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-O 118.621 -1.1 . . . . 0.0 112.162 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -53.63 -43.34 68.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.489 1.645 . . . . 0.0 112.652 -169.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -69.11 -27.69 65.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.615 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.28 -44.25 65.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.485 1.039 . . . . 0.0 109.914 168.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -52.9 -50.81 63.18 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.765 0.826 . . . . 0.0 110.998 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -61.13 -35.99 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.034 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.53 -21.62 60.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.377 1.444 . . . . 0.0 113.054 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 64.4 mtm -64.06 -46.32 84.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.755 1.161 . . . . 0.0 109.03 165.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -68.32 -23.98 64.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.465 0.706 . . . . 0.0 111.582 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.66 -53.04 38.14 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.356 -0.84 . . . . 0.0 108.921 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.61 -40.26 91.21 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.205 0.602 . . . . 0.0 111.594 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.27 62.58 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.78 -0.575 . . . . 0.0 112.295 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.1 15.03 17.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.455 1.502 . . . . 0.0 111.393 173.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 47.94 32.07 2.65 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.183 1.793 . . . . 0.0 112.849 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.6 mt -73.43 162.26 29.5 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.79 134.87 25.56 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.42 -165.39 38.6 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 118.566 0.621 . . . . 0.0 112.143 -160.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.455 ' CZ3' ' HE2' ' A' ' 35' ' ' LYS . 3.0 p-90 -135.81 169.22 17.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.652 0.781 . . . . 0.0 112.514 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -133.42 149.85 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.16 1.384 . . . . 0.0 109.73 170.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE2' ' CZ3' ' A' ' 33' ' ' TRP . 44.3 mtmt -142.23 150.47 40.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.181 1.792 . . . . 0.0 108.56 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -81.27 130.88 35.22 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 148.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -77.93 137.18 38.2 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 166.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.88 -24.82 62.72 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.196 0.598 . . . . 0.0 111.985 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -28.33 65.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.915 1.686 . . . . 0.0 112.869 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.43 -31.18 3.87 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.228 1.394 . . . . 0.0 112.262 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.87 172.15 2.42 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.003 0.921 . . . . 0.0 111.197 175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.58 140.58 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -127.07 143.54 51.25 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.073 0.949 . . . . 0.0 108.805 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mt -136.76 143.13 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 tt -149.58 127.74 12.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.55 157.24 35.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.135 0.88 . . . . 0.0 111.284 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.81 150.35 21.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.217 1.407 . . . . 0.0 109.71 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.55 174.08 38.27 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.635 1.588 . . . . 0.0 111.211 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.48 155.34 55.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.659 2.24 . . . . 0.0 110.306 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -55.55 -42.11 74.2 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -172.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.71 -41.53 99.19 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.075 -0.391 . . . . 0.0 111.576 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.33 -45.56 79.84 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.945 0.498 . . . . 0.0 110.065 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 4' ' ' TYR . 93.7 mt -59.83 -45.37 92.59 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.894 0.878 . . . . 0.0 110.142 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -70.95 -40.87 71.77 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.582 -0.699 . . . . 0.0 112.057 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.6 m -60.18 -40.32 89.59 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.557 0.617 . . . . 0.0 110.021 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.16 -49.19 78.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.705 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.85 -44.31 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.683 1.129 . . . . 0.0 109.9 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.56 -41.4 98.89 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.545 0.611 . . . . 0.0 111.215 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.46 96.22 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.527 0.731 . . . . 0.0 111.316 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 t -64.04 -53.38 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -57.02 -42.16 79.86 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.4 0.68 . . . . 0.0 111.014 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.52 -22.59 62.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.444 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.61 46.03 53.88 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 118.931 0.787 . . . . 0.0 111.386 -175.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -50.69 -51.66 63.67 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -161.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.66 -40.42 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.402 -177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -165.09 172.94 12.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.792 2.037 . . . . 0.0 107.881 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m 62.71 170.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.159 1.383 . . . . 0.0 112.595 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.29 141.73 10.98 Favored 'General case' 0 CA--C 1.517 -0.305 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 m -78.85 154.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 p -119.37 -12.66 9.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.245 1.418 . . . . 0.0 109.38 165.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.26 142.96 25.55 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.411 1.485 . . . . 0.0 108.155 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.3 tt -146.98 141.08 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -138.09 143.3 40.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.7 142.88 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -171.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.0 m -130.18 151.43 50.71 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 167.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -136.26 146.1 46.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -137.98 158.1 45.01 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.638 1.575 . . . . 0.0 108.384 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.92 -20.05 21.81 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.687 -0.633 . . . . 0.0 111.031 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 m -64.11 126.59 28.21 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.58 0.752 . . . . 0.0 110.242 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 1' ' ' MET . 10.5 mp -68.21 173.45 4.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.386 1.075 . . . . 0.0 109.9 159.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -125.15 6.24 7.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.999 1.72 . . . . 0.0 111.025 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.18 22.96 61.37 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.455 1.026 . . . . 0.0 112.386 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -88.17 140.66 29.26 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.215 1.007 . . . . 0.0 108.713 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -132.69 11.57 4.39 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.695 1.198 . . . . 0.0 111.274 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.55 165.47 32.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.241 1.817 . . . . 0.0 108.025 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -93.34 152.57 19.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.7 m -141.1 150.99 43.59 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.849 0.833 . . . . 0.0 111.185 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.0 110.2 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.4 t -75.37 132.61 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.51 36.21 1.28 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.955 0.902 . . . . 0.0 110.431 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.996 0 C-N-CA 126.025 1.73 . . . . 0.0 111.046 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.06 178.78 4.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.21 1.004 . . . . 0.0 110.994 -165.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -153.78 157.5 39.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.217 2.207 . . . . 0.0 108.469 -168.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 53' ' ' LEU . 1.1 p90 -134.9 166.14 23.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.161 0.584 . . . . 0.0 110.673 166.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -133.88 141.1 47.24 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 152.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.1 146.61 26.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 -168.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.94 134.43 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.2 154.86 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.469 1.108 . . . . 0.0 111.072 -167.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -143.18 157.56 44.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.969 1.708 . . . . 0.0 108.876 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 -154.6 26.0 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 106.649 -2.581 . . . . 0.0 106.649 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -74.93 54.89 0.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.827 -0.807 . . . . 0.0 108.839 163.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.08 -10.72 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 121.256 -0.902 . . . . 0.0 113.206 -170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.562 HE22 ' HB3' ' A' ' 18' ' ' ARG . 22.0 mm-40 -132.05 113.6 13.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.93 -144.66 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -64.35 -9.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.37 14.22 30.51 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.445 1.021 . . . . 0.0 112.392 172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.6 t80 35.62 -127.65 0.12 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.502 2.321 . . . . 0.0 110.185 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HB3' HE22 ' A' ' 13' ' ' GLN . 15.6 ptp180 -95.89 -12.41 25.21 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.875 0.87 . . . . 0.0 112.167 166.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.75 -15.55 63.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 117.432 -1.271 . . . . 0.0 112.457 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.916 1.689 . . . . 0.0 111.886 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.35 -35.32 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.17 0.895 . . . . 0.0 110.245 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.89 -28.36 66.61 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.566 1.075 . . . . 0.0 110.813 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -42.89 69.78 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.483 -0.76 . . . . 0.0 109.864 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -66.66 -35.97 81.44 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.621 -0.675 . . . . 0.0 110.197 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.52 -46.16 89.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.598 1.159 . . . . 0.0 110.178 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.78 -39.4 84.77 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.115 0.566 . . . . 0.0 111.575 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -57.22 -42.12 80.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.655 0.661 . . . . 0.0 110.58 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -85.62 3.35 41.21 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 111.772 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 46.99 35.77 3.58 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.44 171.71 8.32 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 163.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.52 139.25 21.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -165.52 38.73 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.634 -0.537 . . . . 0.0 113.023 -163.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.15 160.47 27.76 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.955 1.302 . . . . 0.0 112.295 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.16 142.65 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.342 1.057 . . . . 0.0 109.444 164.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -147.88 171.89 15.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.443 1.497 . . . . 0.0 109.563 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -123.76 114.92 20.56 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -75.57 152.69 37.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.08 -28.56 67.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.567 0.747 . . . . 0.0 112.009 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.0 -27.03 68.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.001 0.921 . . . . 0.0 112.522 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.12 -27.39 4.55 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.086 1.327 . . . . 0.0 112.457 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -61.37 151.58 31.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.007 0.903 . . . . 0.0 110.258 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.4 t -83.96 149.66 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 155.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -128.04 144.93 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.068 1.347 . . . . 0.0 107.384 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -136.09 146.44 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tp -141.28 138.52 33.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . . . -161.78 169.3 21.65 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.712 1.596 . . . . 0.0 110.869 171.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.91 154.87 37.76 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.999 1.32 . . . . 0.0 110.456 167.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.55 179.91 41.11 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.99 1.281 . . . . 0.0 111.49 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.44 156.63 54.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.681 2.254 . . . . 0.0 110.889 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -55.29 -46.88 76.21 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.921 0.888 . . . . 0.0 111.688 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.6 -38.44 91.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.855 0.298 . . . . 0.0 111.469 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.71 -47.34 75.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.576 0.35 . . . . 0.0 110.147 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 4' ' ' TYR . 76.5 mt -61.07 -48.53 81.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.385 0.674 . . . . 0.0 109.906 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -65.27 -45.84 82.85 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.197 0.599 . . . . 0.0 111.59 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 m -63.18 -40.44 97.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.235 0.47 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -58.76 -48.68 80.38 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.684 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.02 -40.63 74.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.705 1.139 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.98 -42.13 99.75 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.172 0.897 . . . . 0.0 110.811 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.61 98.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.016 0.526 . . . . 0.0 111.667 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.17 -57.67 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 173.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.27 -42.71 91.85 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -171.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.07 -24.86 66.01 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.627 0.371 . . . . 0.0 111.652 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.97 50.05 66.93 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 m -58.96 -52.09 77.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.831 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.45 -176.22 3.15 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.555 2.17 . . . . 0.0 110.584 170.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -106.23 154.34 20.86 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 153.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 171.3 1.55 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.412 2.685 . . . . 0.0 111.293 -7.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -135.57 161.66 34.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.173 -0.955 . . . . 0.0 110.748 -156.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.72 146.37 34.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -133.26 -5.42 3.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.228 1.011 . . . . 0.0 110.864 171.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.81 141.92 22.23 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.707 1.203 . . . . 0.0 108.858 174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.9 146.98 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.506 1.123 . . . . 0.0 108.843 -173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 m -136.0 143.01 44.57 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.9 t -138.76 146.14 26.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -170.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.3 m -126.93 141.4 51.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 161.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.88 139.92 48.92 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.5 m -149.58 175.88 11.14 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.96 1.304 . . . . 0.0 109.43 -159.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.29 17.55 2.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.304 1.042 . . . . 0.0 111.113 173.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 m -66.97 -27.64 67.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.114 0.966 . . . . 0.0 111.695 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.95 175.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.154 2.182 . . . . 0.0 111.84 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.52 -13.08 0.39 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.46 1.104 . . . . 0.0 112.487 -170.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.92 15.03 79.96 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.031 0.824 . . . . 0.0 112.387 176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -66.49 126.06 27.68 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.554 1.177 . . . . 0.0 108.596 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -129.23 23.89 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.543 1.537 . . . . 0.0 108.244 164.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -148.18 161.33 41.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.386 2.274 . . . . 0.0 106.758 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -106.07 145.15 31.79 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -138.38 150.6 46.7 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.521 1.153 . . . . 0.0 111.675 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.7 mt -135.72 133.37 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.0 t -135.65 157.01 38.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -66.89 -57.65 6.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 C--O 1.247 0.959 0 C-N-CA 127.03 2.132 . . . . 0.0 107.974 179.076 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ttp . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.28 176.91 6.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.65 1.114 . . . . 0.0 111.183 -167.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.24 143.94 25.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.474 2.31 . . . . 0.0 107.345 174.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' CD2' HD22 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -103.41 159.64 15.4 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 168.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -119.22 141.38 48.95 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 151.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -140.64 140.75 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.95 139.18 52.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 167.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -138.86 153.03 24.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.722 0.809 . . . . 0.0 110.773 -174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -140.37 147.93 40.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.555 1.542 . . . . 0.0 108.06 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.83 -154.55 25.98 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -76.42 80.71 3.15 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 162.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.1 m -107.5 0.76 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.082 0.953 . . . . 0.0 111.391 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -139.05 140.82 38.19 Favored 'General case' 0 C--N 1.341 0.237 0 O-C-N 121.075 -1.016 . . . . 0.0 109.239 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.1 179.5 33.03 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.81 105.07 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.123 0.969 . . . . 0.0 110.098 -172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.34 5.73 73.14 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.322 0.963 . . . . 0.0 113.861 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -70.03 -31.5 69.17 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.979 1.89 . . . . 0.0 111.899 -172.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -82.84 -17.7 43.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.229 0.922 . . . . 0.0 112.938 168.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -68.65 -36.33 78.44 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.415 1.007 . . . . 0.0 109.763 171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -52.02 -48.02 64.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.239 0.615 . . . . 0.0 111.907 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.65 -35.21 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.684 0.674 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -75.07 -23.5 58.03 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.803 -1.185 . . . . 0.0 112.037 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 59.1 mtm -64.33 -50.25 68.5 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.218 0.917 . . . . 0.0 109.411 167.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.59 -39.27 90.6 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.262 0.625 . . . . 0.0 109.941 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -53.74 54.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.211 1.005 . . . . 0.0 109.843 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -61.14 -45.71 93.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.152 0.581 . . . . 0.0 110.883 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -59.21 -24.7 63.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.523 1.529 . . . . 0.0 111.888 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -108.38 13.24 25.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.236 1.414 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 50.41 31.15 5.13 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.974 1.71 . . . . 0.0 112.843 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.8 160.09 28.58 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.121 0.969 . . . . 0.0 108.503 169.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.03 124.43 12.35 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.488 0.715 . . . . 0.0 109.922 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.51 -175.01 35.67 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 123.851 0.739 . . . . 0.0 112.091 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -99.78 161.14 13.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -164.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.71 143.61 38.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 156.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -147.41 152.59 38.39 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.429 0.692 . . . . 0.0 110.137 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -72.54 123.25 22.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 166.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -81.55 132.39 35.31 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.34 -29.44 65.95 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -167.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -17.18 62.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.06 0.944 . . . . 0.0 113.246 178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.31 -15.53 6.09 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.472 1.511 . . . . 0.0 112.891 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.12 175.96 3.5 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.951 1.376 . . . . 0.0 109.721 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.5 t -118.12 145.01 24.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 161.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -116.81 143.13 46.04 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.8 133.45 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 tt -150.41 117.18 5.84 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.54 149.98 28.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.542 0.61 . . . . 0.0 112.355 -173.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -88.29 157.29 18.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.692 1.197 . . . . 0.0 110.345 171.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.69 176.83 38.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.895 1.236 . . . . 0.0 111.582 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.31 153.99 65.93 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.259 1.972 . . . . 0.0 110.368 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.3 -48.32 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.468 0.707 . . . . 0.0 111.494 -170.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.14 -38.34 90.69 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.087 0.403 . . . . 0.0 111.786 -176.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.67 89.48 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.045 0.538 . . . . 0.0 109.832 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 4' ' ' TYR . 79.3 mt -61.69 -47.55 84.81 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.438 0.695 . . . . 0.0 110.004 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -67.34 -40.51 85.9 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.802 -0.561 . . . . 0.0 111.553 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.3 m -67.15 -35.67 80.21 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.79 -0.568 . . . . 0.0 110.69 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.47 -47.04 87.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.971 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.41 -42.71 81.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.913 1.233 . . . . 0.0 109.55 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -41.0 96.06 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.257 0.935 . . . . 0.0 111.313 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.74 -40.73 89.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.737 0.815 . . . . 0.0 111.46 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -55.33 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -59.24 -37.89 78.66 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.195 0.598 . . . . 0.0 111.734 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -66.98 -23.55 65.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.179 0.592 . . . . 0.0 112.261 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.35 43.03 89.87 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 118.672 0.669 . . . . 0.0 111.508 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -50.28 -49.11 78.41 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -168.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.54 -59.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.735 1.655 . . . . 0.0 112.204 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -171.3 -47.44 0.02 OUTLIER 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.213 1.805 . . . . 0.0 108.173 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.61 146.79 24.15 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.04 0.936 . . . . 0.0 109.546 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -156.2 162.52 40.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.994 0.918 . . . . 0.0 108.97 -167.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -115.02 148.91 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 p -121.42 -9.07 9.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.684 1.594 . . . . 0.0 109.455 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -150.44 143.08 24.55 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.696 1.598 . . . . 0.0 107.57 166.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.5 140.9 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -136.46 143.39 43.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.527 1.531 . . . . 0.0 106.87 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -140.1 147.98 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -169.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -127.28 154.32 45.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -133.04 143.6 49.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.8 m -158.37 170.8 21.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.294 1.037 . . . . 0.0 109.752 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.06 5.47 44.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.829 0.852 . . . . 0.0 110.981 171.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.1 m -71.53 73.31 0.75 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.755 2.022 . . . . 0.0 111.59 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -56.16 140.92 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.444 -0.785 . . . . 0.0 109.763 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -78.58 -23.72 45.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.524 0.73 . . . . 0.0 111.394 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.68 48.14 13.53 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -167.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.78 154.87 43.67 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.477 1.111 . . . . 0.0 109.662 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -136.42 8.32 3.12 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.856 0.862 . . . . 0.0 112.438 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -149.13 166.47 28.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.519 1.528 . . . . 0.0 108.417 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -76.87 163.11 27.06 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.4 m -140.07 152.57 46.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.805 1.242 . . . . 0.0 109.331 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.1 mt -135.11 116.44 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.4 t -78.65 144.64 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.37 5.09 3.74 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.679 1.192 . . . . 0.0 111.54 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.251 1.162 0 C-N-CA 125.073 1.349 . . . . 0.0 110.72 178.356 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ttp . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.01 176.99 7.19 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.878 -1.139 . . . . 0.0 111.891 -159.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -145.4 156.32 43.69 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.23 1.812 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.2 165.67 15.08 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.53 0.732 . . . . 0.0 110.508 161.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -128.09 143.28 51.06 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 149.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 57' ' ' VAL . 98.0 mt -137.62 138.83 44.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.36 133.38 64.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 173.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.18 153.33 18.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 111.24 -169.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.42 145.93 35.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.034 1.734 . . . . 0.0 107.447 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.24 -154.12 25.76 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -172.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -78.05 88.31 4.19 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 157.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.96 3.28 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.761 1.224 . . . . 0.0 111.092 -174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -145.92 142.01 28.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.333 1.053 . . . . 0.0 109.391 -168.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.69 159.51 8.09 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.025 2.25 . . . . 0.0 108.232 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -60.13 -29.22 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.104 0.562 . . . . 0.0 112.397 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.86 -41.79 3.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -63.09 -29.6 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 117.581 -1.2 . . . . 0.0 113.458 -169.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -103.7 -4.12 24.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.201 1.364 . . . . 0.0 114.093 167.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -62.99 -35.87 81.64 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.108 1.322 . . . . 0.0 109.025 161.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.55 -50.26 24.21 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.002 0.819 . . . . 0.0 112.564 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -62.64 -40.07 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 119.215 0.916 . . . . 0.0 109.898 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -74.25 -23.65 59.18 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 120.631 -1.293 . . . . 0.0 112.152 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -45.24 82.46 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 169.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -62.79 -37.38 86.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.083 0.856 . . . . 0.0 109.91 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.53 57.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.13 0.572 . . . . 0.0 109.856 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.82 -46.16 91.62 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.253 0.621 . . . . 0.0 110.765 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -58.11 -28.1 64.33 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.892 1.277 . . . . 0.0 111.937 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -107.4 12.43 28.0 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.914 1.286 . . . . 0.0 111.159 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 49.61 31.91 4.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 112.742 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.5 mt -73.88 164.09 27.09 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 168.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.66 135.67 31.9 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.79 -165.79 38.99 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -140.15 161.77 36.84 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.648 0.779 . . . . 0.0 111.987 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.81 143.08 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.48 1.112 . . . . 0.0 108.625 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -143.95 163.09 34.45 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.962 1.705 . . . . 0.0 108.435 -164.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -115.21 120.63 40.36 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -75.92 147.23 39.11 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.27 -28.34 66.64 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.377 0.671 . . . . 0.0 112.084 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.01 0.924 . . . . 0.0 112.461 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.36 -29.4 3.17 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.173 1.368 . . . . 0.0 112.225 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.75 152.2 31.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.862 0.865 . . . . 0.0 109.911 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.34 148.1 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 160.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -128.38 144.6 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mt -133.69 141.35 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -146.15 125.76 13.33 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.69 161.07 42.93 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.019 0.528 . . . . 0.0 110.409 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.31 154.47 22.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.409 1.483 . . . . 0.0 108.051 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.62 179.32 40.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 123.39 0.519 . . . . 0.0 111.826 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.24 157.44 59.43 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.325 2.016 . . . . 0.0 110.793 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -56.08 -49.25 74.33 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.148 0.979 . . . . 0.0 111.527 -170.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -66.84 -38.06 85.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 119.406 -0.331 . . . . 0.0 111.395 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.88 74.02 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.238 0.615 . . . . 0.0 109.714 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.0 mt -61.98 -44.61 96.38 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.352 0.661 . . . . 0.0 110.803 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -77.31 -34.7 55.35 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.766 -0.584 . . . . 0.0 111.583 -173.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -68.85 -35.39 76.87 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.305 -0.872 . . . . 0.0 110.743 173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -57.99 -48.72 79.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.316 0.646 . . . . 0.0 109.549 168.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 6' ' ' ILE . 42.1 t -55.81 -42.97 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.19 0.904 . . . . 0.0 109.67 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.48 -41.91 97.98 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.401 1.0 . . . . 0.0 111.419 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -40.98 82.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.006 0.923 . . . . 0.0 111.127 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.39 -52.49 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 118.86 0.755 . . . . 0.0 109.5 175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.77 -39.17 90.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.132 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -64.33 -21.07 66.49 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.298 1.039 . . . . 0.0 111.904 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.62 172.83 21.55 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -152.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 p -139.65 -179.98 1.15 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 121.839 -0.8 . . . . 0.0 110.031 -164.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.16 -24.62 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.461 2.774 . . . . 0.0 115.742 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -150.95 2.6 0.44 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 m -126.62 159.1 34.54 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.56 1.527 . . . . 0.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 145.83 20.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.333 0.969 . . . . 0.0 111.175 172.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.01 156.17 3.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.9 p -122.59 -12.46 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.62 1.568 . . . . 0.0 109.506 164.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -150.07 145.92 26.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.362 1.465 . . . . 0.0 108.185 165.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.38 144.25 16.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.773 1.229 . . . . 0.0 108.503 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m -139.29 145.64 39.37 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.726 1.611 . . . . 0.0 107.355 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.12 144.27 29.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.8 m -130.91 151.09 51.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -133.48 145.99 50.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.5 m -147.55 -176.59 5.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.987 1.315 . . . . 0.0 109.263 -167.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -127.73 10.33 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.067 0.947 . . . . 0.0 110.977 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -67.66 -29.46 68.76 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.788 1.235 . . . . 0.0 114.02 -161.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.9 mt 62.04 171.82 0.13 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.351 1.86 . . . . 0.0 111.924 -170.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -139.03 -30.96 0.72 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.597 1.159 . . . . 0.0 111.412 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.79 30.47 77.29 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.766 0.712 . . . . 0.0 111.425 -171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -72.86 164.0 27.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.04 1.336 . . . . 0.0 108.922 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.82 11.59 4.34 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.623 0.769 . . . . 0.0 111.763 -173.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -145.84 167.47 23.14 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.221 1.008 . . . . 0.0 109.253 -172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -89.04 141.94 28.06 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 139.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -133.14 163.35 29.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.502 0.721 . . . . 0.0 110.758 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 mt -138.06 127.39 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.82 162.58 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.537 1.135 . . . . 0.0 107.95 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -143.9 -28.3 0.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.619 0.768 . . . . 0.0 112.199 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.388 1.475 . . . . 0.0 111.048 176.448 . . . . . . . . 0 0 . 1 stop_ save_